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 Preface 
 
At its birth in 1948 as the United Nations’ first specialized agency, the World Health Organization 
(WHO) enshrined the right to health as its foremost aspiration. Its constitution proclaims: 
The enjoyment of the highest attainable standard of health is one of the 
fundamental rights of every human being without distinction of race, religion, 
political belief, economic or social condition…. The health of all peoples is 
fundamental to the attainment of peace and security and is dependent upon the 
fullest co-operation of individuals and States. 
What is less well understood is that progressively realizing the right to health is a legal obligation 
enshrined in the International Covenant on Economic, Social and Cultural Rights and other 
international treaties, as well as in constitutions and statutes in many countries around the world. 
Both at international and domestic levels, law is a powerful tool for safeguarding and promoting the 
public’s health and safety. All sovereign states have the power, and the duty, to advance the right to 
health. 
What are the most effective legal tools for advancing the right to health? This ground-breaking 
report – sponsored by WHO, the International Development Law Organization (IDLO), and its 
academic partners the University of Sydney and the O’Neill Institute for National and Global Health 
Law at Georgetown University – illustrates how countries have enacted and implemented a wide 
range of laws and regulations with a demonstrable impact on the health and safety of their 
populations. Public health laws should be evidence-based, fairly and effectively implemented, and 
for the good of the population. 
Communicable disease control 
The control of infectious diseases is perhaps the best understood, and most historically powerful, 
illustration of law’s vital role in public health. From the earliest days, governments introduced 
measures to detect, report and respond to infectious diseases –from smallpox, malaria and 
tuberculosis, to the modern-day HIV/AIDS pandemic, and to fast moving novel infections such as 
SARS and new strains of influenza. The recent outbreaks of Ebola virus disease and Zika virus disease 
demonstrate the urgent need for all countries to fully implement the International Health 
Regulations. At the national level, public health laws in this area address matters including screening, 
reporting, contact tracing, isolation and quarantine. 
Noncommunicable diseases 
Beyond infectious diseases, the law plays a vital role in prevention and control of noncommunicable 
diseases (NCDs) such as cancer, cardiovascular disease, diabetes and respiratory disease. The world 
xiii 
 
has witnessed an epidemiological transition from infectious to noncommunicable diseases, which 
are now responsible for the greatest global burden of disease and early death. Most of this suffering 
takes place in low- and middle-income countries – which often face the twin burdens of under- and 
over-nutrition. It may be tempting for some to view NCDs as the product of behavioural risk factors 
for which individuals – rather than governments – are responsible. But innovative governments have 
demonstrated that public health laws can make a substantial difference to health outcomes in this 
area. For example, smoking rates have dropped sharply in countries that have taken steps to fully 
implement the WHO Framework Convention on Tobacco Control. Legal interventions such as 
taxation, marketing restrictions, graphic label warnings, plain packaging and bans on smoking in 
public places have transformed culture and behaviour. 
With due regard to the differences between them, many tools that have proven to be successful in 
tobacco control can be applied to other NCD risk factors such as harmful use of alcoholic beverages, 
unhealthy foods and sugary drinks, and physical inactivity. Law can transform the economic, 
informational and built environments to reduce the morbidity and premature mortality caused by 
NCDs from current historic highs. The economic environment can incentivize healthy behaviours 
(e.g. subsidizing fruits and vegetables) and disincentivize unhealthy behaviours (e.g. taxes on sugary 
drinks). Changing the informational environment can empower consumers to make healthier 
choices, through laws regulating packaging and menu labelling (e.g. laws requiring disclosure of 
calories and unhealthy ingredients such as added sugars and saturated fats). Governments can also 
use law to improve the built environment, making walking, cycling, participation in sports, and other 
physical activities safer and more attractive. 
Most legal interventions in this area simply “nudge” consumers in a healthier direction, making 
health the easier choice. But governments can also directly regulate businesses, and have done so 
with considerable impact on NCD risk factors. Examples include legal bans on trans-fatty acids, 
controls on sale and advertising of tobacco, and liquor licensing laws. In addition, governments can 
influence the actions of businesses through public/private partnerships; for example, food 
reformulation to reduce the salt content of high-sodium foods. Sodium and trans-fats contribute to 
cardiovascular and other diseases, and evidence-based regulation can reduce these risks. 
Mental health 
Although the major NCD risk factors (tobacco, unhealthy foods and physical inactivity) do not apply 
in the same way to mental illness, global mental health is a major goal. Historically, laws have been 
used to structure the response to mental illness, but not always consistently with human rights. 
People with mental illness, like those with physical illness, require a full range of medical and social 
services. Instead, law has sometimes been used to incarcerate mentally ill people in sterile 
institutions and without the protection required under the rule of law. WHO has published a 
resource book on Mental health, human rights and legislation intended to guide governments in 
reforming their mental health laws in accordance with human rights principles. 
Injuries 
Individuals may experience horrific injuries, particularly in low- and middle-income countries. These 
injuries occur on the roads, in homes and at workplaces. We often call these “accidents”, which 
suggests they are not preventable. But laws and regulations can significantly reduce injuries – both 
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unintentional and intentional. Road traffic regulations have pushed injury rates considerably lower in 
many countries. Injuries would be significantly reduced if automobiles, motorcycles and bicycles 
were road worthy and safe; if roads were designed to separate traffic and slow vehicles; and safety 
equipment were standard and required (e.g. seat belts, passive restraints, helmets). It is also 
possible to regulate drivers, for example, by prohibiting driving while under the influence of alcohol 
and other drugs, and texting while driving. 
In the home, women in particular face hazards such as unsafe, open stoves. Many people live and 
work in buildings that are unsafe, because, for example, they are prone to fire or unable to 
withstand natural disasters such as earthquakes or floods. At work, individuals face major risks, such 
as unsafe machines, exposure to asbestos, toxic chemicals or other environmental hazards, or by 
working in mining and other hazardous occupations. 
Intentional injuries – assaults, murder and suicide – are also preventable. Consider gun control laws 
that restrict access to dangerous weapons and require safety devices such as trigger locks. Or think 
about laws that prevent intimate partner assaults, such as laws requiring the police to enforce 
restraining orders against domestic abuse. Laws that make it harder to obtain the means to harm 
oneself, such as barriers on bridges, or reducing carbon monoxide exhaust from petrol, can also 
reduce suicides. 
Universal health coverage 
Perhaps the most important policy to advance the right to health is universal health coverage (UHC) 
– a major WHO priority that is also a key health target in the United Nations Sustainable 
Development Goals (SDGs). Building robust health systems starts with advance planning and 
sustainable financing. It requires clinics, hospitals, and human resources (e.g. doctors, nurses and 
community health workers). Law also plays a role in UHC, regulating and ensuring universal access, 
equity, and quality at an affordable cost. For example, we now know that charging a fee for services, 
even if very small, can lower access, particularly for the poor, vulnerable, marginalized, and those in 
remote locations. 
Fulfilling the SDG target for UHC will be of major importance in advancing the right to health, and 
law can expedite that process. It requires mutual responsibilities from international partners and 
national governments, together with “bottom-up” social mobilization. 
Multisectoral engagement 
Legal regimes, whether national or global, extend well beyond the health sector. A “health-in-all 
policies” or “all-of-government” strategy is needed. Ensuring the public’s health and safety requires 
more than effective health policies. It requires active engagement with finance, justice, housing, 
energy, transportation, and other ministries – with leadership at the highest levels of government. 
This is also true at the global level. Consider, for example, the role of trade and intellectual property 
in ensuring (or denying) access to essential medicines or vaccines. Or consider the role of agriculture 
in reducing the proliferation of antimicrobial resistance. Indeed, health requires an “all-of-society” 
strategy that fully engages civil society and businesses for the public good. 
Stigma and discrimination 
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The law does not merely operate as a tool to advance the right to health. Equitable and fair 
treatment lies at the heart of human rights and the right to health itself. Law’s role is to prohibit 
discrimination in the health sector and beyond. The greatest health burdens usually fall on the most 
vulnerable, marginalized and impoverished individuals. Law’s goal is to protect them against 
discrimination and affirmatively improve their access to needed services. In many societies, women, 
LGBT (lesbian, gay, bisexual, and transgender) communities, certain religious/ethnic minorities, and 
the poor are routinely denied equal access to opportunities and services. The human rights of 
women are infringed in many societies as governments restrict their access to reproductive health 
services, including safe and effective contraception and abortion. The highest role for law is to 
ensure access to justice, particularly for the least powerful and most disadvantaged in society. 
Law as an obstacle to health 
Law is not always an unmitigated social good, but can actually stand in the way of progress in health 
and human rights. During major disease outbreaks, many countries put in place restrictions on travel 
and trade or enforced quarantine against WHO recommendations. Some countries punish people 
simply for their status (e.g. LGBT) or impede public health policies for harm reduction, such as the 
distribution or exchange of safe drug injection equipment. Consequently, to advance the right to 
health it may be necessary to dismantle harmful and stigmatizing laws that stand in the way of 
progress. 
Good governance 
Law is not only concerned with discrete interventions to safeguard and promote the public’s health 
and safety. The rule of law also requires “good governance” that ensures the fair and efficient 
operation of public institutions and social structures. Good governance includes setting priorities, 
monitoring outcomes, transparency, civil society participation, anti-corruption and accountability. It 
requires a legal infrastructure with impartial courts and tribunals and the regulatory capacity to 
effectively implement legal rules. In short, good governance encompasses all the norms, processes 
and institutions of a just society that passes and enforces laws for the common good and with an 
equal hand. 
There is a saying that goes to the heart of this report on Advancing the Right to Health: “Law is but 
the means, health and justice are the ends”. We hope that our examination of what countries can do 
to protect the health and nurture the dignity of all peoples will contribute to a greater 
understanding, and effective use, of the law in advancing the right to health. 
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Introduction 
SUMMARY POINTS 
 
· This report aims to raise awareness about the role that the reform of public health laws can 
play in advancing the right to health and in creating the conditions for people to live healthy lives. 
By encouraging a better understanding of how public health law can be used to improve the 
health of the population, the report aims to encourage and assist governments to reform their 
public health laws in order to advance the right to health. 
· The report highlights important issues that may arise during the process of public health law 
reform. It provides guidance about issues and requirements to be addressed during the process of 
developing public health laws. It also includes case studies and examples of legislation from a 
variety of countries to illustrate effective law reform practices and some features of effective 
public health legislation. 
Purpose and scope of this report 
The right to health is a fundamental human right that is indispensable for human well-being, for 
well-functioning societies and economies, and for the ability to exercise all other human rights. 
Without a basic level of health, it may be difficult or impossible for people to work, to attend school 
and obtain an education, to enjoy recreation, to fully participate in society, and to enjoy other basic 
freedoms. Countries around the world face many challenges that threaten the health of their 
populations. These include endemic and emerging communicable diseases (e.g. HIV, tuberculosis, 
malaria, emerging strains of influenza), and noncommunicable diseases (e.g. cancer, cardiovascular 
disease, respiratory diseases and diabetes). Added to this are intentional and unintentional injuries, 
global environmental degradation, threats to food safety and security, and trade in harmful 
products. 
Although these challenges have an impact on health in all countries, they disproportionately affect 
poorer countries, which not only lack the resources to manage them but may also lack the political 
and economic power to negotiate effective international agreements to achieve better health and 
justice for their populations. Within countries, poorer segments of the population are 
disproportionately affected by health risks, and by mortality and disability from disease.1 
Law is increasingly being recognized and used as a tool for improving the health of populations at 
global, national and subnational levels. At the national level, governments need functioning health 
systems that are supported by strong legal frameworks. Public health legislation sets out the 
responsibilities and functions of governments to coordinate responses to public health risks, to 
create healthier environments, to promote healthier behaviours, to generate the information base 
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that is needed for effective action and policies, to manage a competent health workforce, and many 
other functions. 
This report aims to raise awareness about the role that the reform of public health laws can play in 
advancing the right to health and in creating the conditions for people to live healthy lives. By 
encouraging a better understanding of how public health law can be used to improve the health of 
the population, the report aims to encourage and assist governments to reform their public health 
laws in order to advance the right to health. 
Governments may choose to reform their public health laws for many reasons: for example, to 
modernize old and out-of-date laws, to address neglected issues and to respond to problems that 
have arisen as a result of the application or enforcement of other laws. The process of revising public 
health laws will vary significantly according to the historical and constitutional context and the legal 
tradition of each country. These legal traditions include common law, civil law, tribal laws and 
customs, and Sharia law. Public health law reform may occur in very different ways at national and 
subnational levels. For all these reasons, there is no single approach to the reform process, and this 
report is not intended to be prescriptive. 
In order to achieve its aims, this report highlights important issues that may arise during the process 
of public health law reform. Secondly, it provides guidance about issues and requirements to be 
addressed during the process of developing public health laws on particular topics, such as access to 
essential medicines, tobacco control or the regulation of infectious diseases. Thirdly, it includes case 
studies and examples of legislation from a variety of countries, both large and small, to illustrate 
effective law reform practices and some features of effective public health legislation. 
In this report, public health law refers to the formal set of laws – and to the legal processes for 
implementing and enforcing them – that seek to ensure the conditions for people to live healthy 
lives. At the international level, law includes global, regional and bilateral intergovernmental 
agreements, as well as the rules and regulations made by international bodies (e.g. WHO, the World 
Trade Organization). At the national level, law includes executive orders and decrees issued by the 
executive body or under the authority of the head of State or government; legislation passed by 
Parliaments at national, state and local levels; subsidiary legislation (issued by executive agencies in 
order to implement or give effect to principal legislation); the judgments and rulings of courts and 
tribunals, and customary and tribal laws. In addition to legally binding instruments, executive 
agencies and other government bodies may also issue non-binding guidelines and technical 
standards: these may have normative effects and may play an important subsidiary role in reducing 
health risks and creating healthier environments. 
Who should read this report? 
This report is intended to inform a wide audience, including: 
• senior officials working within ministries of health; 
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• officials of other ministries within government who can significantly influence public health 
through their actions and policies, and through the laws they administer. The relevant 
ministries or departments may include: finance, foreign affairs, justice, agriculture, 
consumer affairs, education, housing, infrastructure, transport, energy, trade, environment, 
communications and social security; 
• members of the legislative, executive and judicial branches of government (including 
parliamentarians, ministers, judicial officers, and their advisers); and 
• other stakeholders, including members of health organizations, philanthropic organizations, 
the media, industry, academia, employer and labour organizations, and civil society 
organizations. 
Individuals have a critical role to play in protecting their health and in minimizing risks to their 
health. Parents also play an important role in protecting their children’s health and in creating a 
healthy home environment. At the same time, the State bears primary responsibility for realizing the 
right to health for the population as a whole. Collectively, through the legislature, courts and 
executive and statutory agencies, the State has the capacity to pass public health laws, to implement 
them and enforce them, and to balance health with other policy and social goals. 
Typically, the health ministry serves as the steward of the health sector, with primary responsibility 
for health services and for protecting and promoting public health. On the other hand, responsibility 
for administering laws and for regulating matters that may directly affect the health of the 
population will be allocated between the health ministry and a range of other ministries, including 
law and justice, finance and revenue, agriculture, media and communications, housing and 
infrastructure, and transport. Officials from these sectors will be important stakeholders in the 
public health law reform process. 
States will need to build appropriate executive and legislative structures to facilitate a cooperative 
approach to health protection spanning different ministries, agencies, and (where applicable) 
different tiers of government. For these reasons, the audience for this report will extend across a 
number of government ministries, and may include officials and elected representatives at regional 
and city levels of government. 
In some countries, the impetus for reform of public health legislation may come from non-State 
actors, rather than from government. Civil society organizations, professional associations and 
community groups – including patient advocacy groups – make important contributions to public 
health by advocating for effective policies and laws within their areas of expertise and influence. 
Meaningful participation by affected communities in the design and implementation of public health 
laws will help to ensure support for the law within the community, thereby improving its 
effectiveness. 
In summary, this report is intended to support the actions of both governments – as they lead the 
process of public health law reform – and non-government stakeholders who are involved in 
advocating for the reform of public health laws and supporting effective public health practices. 
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The structure of this report 
This report aims to encourage a better understanding of how public health law can help 
governments to discharge their international obligations under the right to health. The structure of 
the report reflects the consensus reached at the second of two international consultations of experts 
in public health law, hosted by WHO and the International Development Law Organization, in 
collaboration with the O’Neill Institute for National and Global Health Law at Georgetown University, 
Washington (DC) and Sydney Law School, University of Sydney, Australia. The first consultation, held 
in Rome (27–29 April, 2009), called for the development of this report. The second consultation, 
held in Cairo (26–28 April, 2010), identified the key topics and issues that this report should include, 
and strategies for its dissemination. 
Part 2 of this report discusses the process of public health law reform. The law reform process refers 
to the practical steps involved in advancing the political goal of law reform, and the kinds of issues 
and obstacles that may be encountered along the way. The context in which law reform occurs, and 
the specific scope of the law reform process, will vary significantly between countries. Nevertheless, 
there are a number of common reasons for reviewing and updating public health laws, and many of 
the most important risks to health are shared by most countries. Part 2 identifies some of the actors 
who may initiate or lead the public health law reform process, discusses principles of good 
governance during that process, and ways of building a consensus around the need for public health 
law reform. 
As noted earlier, health is frequently shaped by factors and policies that lie outside the operational 
sphere of the health ministry. On the other hand, the right to health is an obligation of government 
as a whole. For this reason, Chapter 6 considers the law’s role in achieving an intersectoral, whole-
of-government approach to public health law reform. 
Part 3 turns from the process of reforming public health laws to the substance or content of those 
laws. It identifies a number of core areas of public health practice where regulation is essential in 
order to ensure that governments (at different levels) discharge their basic public health functions. 
Traditionally, these core areas of public health practice have included: the provision of clean water 
and sanitation, monitoring and surveillance of public health threats, the management of 
communicable diseases, and emergency powers. Part 3 also considers the role of law in advancing 
universal access to quality health services for all members of the population. 
Building on these core public health functions, Part 3 goes on to consider a range of other public 
health priorities where law has a critical role to play. These priorities include tobacco control, access 
to essential medicines, the migration of health care workers, nutrition, maternal, reproductive and 
child health, and the role of law in advancing universal access to quality health services for all 
members of the population. The report includes many examples that illustrate the ways in which 
different countries have used law to protect the health of their populations in ways that are 
consistent with their human rights obligations. Countries vary widely in terms of their constitutional 
structure, size, history and political culture. For these reasons, the examples given are not intended 
to be prescriptive, but to provide useful comparisons for countries involved in the process of 
legislative review. 
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PART 1 
ADVANCING THE RIGHT TO HEALTH THROUGH 
LAW REFORM   
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Chapter 1: Public health regulation and  
the right to health 
 
SUMMARY POINTS 
 
· The human right to health, understood as the right to the highest attainable standard of 
health, provides an overarching and exacting standard to guide the actions of governments as they 
strengthen their health systems by reforming their public health laws. 
· The principles of availability, accessibility, acceptability and quality are essential elements of 
the right to health. They serve a diagnostic function, drawing attention to what remains to be 
done as governments move towards universal health coverage. By increasing the capacity and 
quality of health care and public health services, by ensuring that the entire population is covered 
by these services, and by ensuring that these services remain affordable to everyone, 
governments can help to respect, protect and fulfil the right to health. 
· The principles set out above provide guidance to governments as they make decisions about 
the goals, resources, focus and scale of public health law reform activities. Although the precise 
form that the law takes will vary significantly between countries, law has a flexible and enabling 
role in helping to realize the right to health. For example, the law has a role in: eliminating 
discriminatory barriers to the accessibility of health services, ensuring the accountability of health 
service providers, strengthening the components of an effective health system, creating a 
framework for the discharge of core public health functions, and reducing health inequalities. 
 
1.1 Justifications for public health regulation 
A variety of theoretical justifications have been put forward to justify public health regulation. These 
include reducing externalities (such as protecting non-smokers from second-hand smoke or 
improving suboptimal vaccination rates), or increasing the production of public goods (by improving 
air quality, or vector control).1 Regulation may also aim to provide consumers with better 
information about harmful goods (such as health warnings on tobacco and alcohol products), or seek 
to improve their capacity to make healthier choices, for example through front-of-pack food 
labelling that interprets the nutritional content of food. 
Other theoretical justifications for regulation pay greater attention to the persistence of health 
inequalities, to the role that a healthy population plays in economic and social development, and to 
shared agreement around the goal of “health for all”. These ideas, which were powerfully expressed 
in the Alma Ata Declaration (1978)2 and in the Rio Declaration on Social Determinants of Health 
(2011)3 continue to inspire health sector reform efforts, and provide a justification for the role that 
public health law reform plays in health development generally. 
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The approach to public health law reform taken in this report rests on two fundamental human 
rights concepts: the rule of law, and the right of everyone to the enjoyment of the highest attainable 
standard of physical and mental health (hereafter the right to health). The rule of law refers to the 
principle that law-making processes should be transparent, laws should be enforced fairly, courts 
and tribunals should be independent, and the administration of law and its substantive content 
should be consistent with international human rights standards (Box 1.1). 
Box 1.1: Public health and the “rule of law” 
The rule of law is a fundamental concept within the United Nations system. It requires that “laws 
must be publicly promulgated, equally enforced and independently adjudicated and [must be] 
consistent with international human rights norms and standards”.4 Under the rule of law, “all 
persons, institutions and entities, public and private, including the State itself, are accountable to 
just, fair and equitable laws and are entitled without any discrimination to equal protection of the 
law”.5 The United Nations General Assembly has acknowledged that advancing the rule of law at 
national and international levels is “essential for sustained and inclusive economic growth, 
sustainable development, the eradication of poverty and hunger and the full realization of all human 
rights and freedoms, including the right to development”.6 
The right to health is a human right that is well-established in international law (Box 1.2). Most 
countries in the world have ratified at least one international agreement that imposes specific 
obligations on governments regarding the right to health.7 The right to health is recognized in the 
Universal Declaration of Human Rights,8 in the International Covenant on Economic, Social and 
Cultural Rights (ICESCR),9 and in a number of other international human rights treaties including the 
Convention on the Rights of the Child.10 
Box 1.2: What are human rights? 
Human rights are legal guarantees protecting universal values of human dignity and freedom. 
Human rights define the entitlements of all human beings and the corresponding obligations of the 
State as the primary duty-bearer. Human rights have been negotiated by States and agreed upon in 
human rights treaties, such as conventions and covenants, which are legally binding on States that 
are parties to them. 
Although this report focuses mainly on the right to health, as recognized in the ICESCR and a number 
of regional human rights treaties, there are a variety of other health-related rights in international 
law that support actions by government to improve the health of their populations.  These include 
the right to adequate food, clothing and housing, the right to freedom from hunger, and the right to 
environmental and industrial hygiene in the ICESCR (Articles 11 and 12).11 Other rights include the 
right to liberty and security of the person, freedom from coerced labour, liberty of movement, 
freedom of thought, conscience and religion and freedom from discrimination on grounds including 
race, colour, sex, language, religion and political opinion, as recognized in the International Covenant 
on Civil and Political Rights (Articles 4, 8, 9, 12, 18 and 26).12 
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The right to health has also been included in three major regional human rights agreements, in 
Africa,13 Europe14 and the Americas.15 For example, Article 16 of the African Charter on Human and 
Peoples’ Rights states: 
1. Every individual shall have the right to enjoy the best attainable state of physical and mental 
health. 
2. States Parties to the present Charter shall take the necessary measures to protect the health 
of their people and to ensure that they receive medical attention when they are sick. 
In some countries, the right to health has been recognized in the national constitution. For example, 
in Article 6 of the Constitution of the Federal Republic of Brazil, health is designated as a social right. 
The right to health is further reinforced by Article 196, which states: 
Health is the right of all persons and the duty of the State and is guaranteed by means of social and 
economic policies aimed at reducing the risk of illness and other hazards and at universal and equal 
access to all actions and services for the promotion, protection and recovery of health.16 
The Constitution of South Africa guarantees access to health services, including reproductive health 
and emergency services, basic health care for children, and medical services for detained persons 
and prisoners.17 
Similarly, the Constitution of Mongolia declares that citizens shall enjoy the right to a healthy and 
safe environment, and the right to the protection of health and medical care.18 In turn, citizens owe 
a duty to protect their own health.19 
The substantive obligations embodied within the right to health were clarified by the United Nations 
Committee on Economic, Social and Cultural Rights (CESCR) in General Comment 14.20 General 
Comment 14 explains that the right to health is an inclusive right that extends beyond health care to 
the underlying determinants of health, including access to safe and potable water, adequate 
sanitation, an adequate supply of safe food and nutrition, housing, healthy occupational and 
environmental conditions, access to health-related education and information, including on sexual 
and reproductive health, and freedom from discrimination.21 States have an obligation to take 
immediate steps to progressively ensure that services, goods and facilities are available, accessible, 
acceptable and of good quality. These obligations are discussed further in Section 1.1. 
The right to health imposes three distinct obligations on States that are parties to the ICESCR. States 
have an obligation to respect, to protect, and to fulfil the right to health:22 
• Respecting the right to health means not interfering directly or indirectly with the enjoyment 
of the right. For example, States may breach this obligation by unlawfully polluting the air, 
water and soil, by unjustifiably denying or limiting access to health care services, by limiting 
access to contraceptives and by withholding or misrepresenting health information, 
including sexual health information. 
• Protecting the right to health means taking the actions that are necessary to prevent third 
parties from interfering with the right. For example, this requires States to adopt legislative 
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or other measures to ensure that registered medical practitioners and other health 
professionals have achieved appropriate standards of education, professional skill and 
ethics. Protecting the right to health also requires States to take measures to protect 
marginalized and vulnerable groups in society from violence: this includes protecting women 
and children from being coerced into undergoing female genital mutilation and other 
harmful procedures. 
• Fulfilling the right to health means taking actions to facilitate, provide and promote the 
conditions in which the right can be fully realized.23 This requires States to adopt a national 
health policy and to implement legislative measures that seek to realize the right.24 The 
obligation to fulfil the right to health requires States to ensure the provision of adequate 
health services, including immunization programmes, equal access to basic sanitation 
services, nutritious and safe food, and safe drinking water. It requires States to consider the 
infrastructure requirements for the provision of health services, including the provision of an 
adequately trained workforce, as well as hospitals and other health-related facilities that are 
culturally appropriate and respond to the needs of vulnerable and marginalized groups. It 
requires States to ensure the availability of a health insurance system (whether public, 
private, or mixed) that is affordable for all. States must promote medical research and health 
education, and disseminate information to meet the health needs of the population. 
Information campaigns should include information relating to healthy lifestyles and 
nutrition, the availability of health services, harmful traditional practices, HIV/AIDS, sexual 
and reproductive health, domestic violence, the harmful use of alcohol, and the use of 
tobacco and other drugs. States are required to take appropriate actions to respond to 
environmental and occupational health hazards, and other threats that have been 
demonstrated by epidemiological evidence, and to provide a coherent national policy on 
occupational accidents.25 
(a) Obligations of immediate effect under the right to health 
As explained in General Comment 14,26 the right to health requires States to take concrete steps 
towards ensuring the availability and accessibility of quality public health and health care services, 
especially for socially disadvantaged and marginalized groups. Although the right to health 
acknowledges resource constraints and is subject to progressive realization, certain obligations are 
of immediate effect.27 
For example, countries owe an immediate obligation to ensure that the right to access health 
services and other underlying determinants of health (e.g. sanitation and potable water) is not 
undermined by discrimination on grounds recognized in the Covenant. These grounds include 
discrimination on the basis of “race, colour, sex, language, religion, political or other opinion, 
national or social origin, property, birth, physical or mental disability, health status (including 
HIV/AIDS), sexual orientation and civil, political, social or other status”.28 For example, in the case of 
children and adolescents, the principle of non-discrimination precludes preferential feeding or 
medical treatment for boys at the expense of girls.29 In societies that are sharply divided between 
different ethnic groups, it requires health service providers to be blind to these differences and to 
treat everyone with dignity and respect. In some countries, HIV-related stigma and discrimination 
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are widespread: governments may need to take bold measures to confront and reduce this in order 
to overcome the disincentives that prevent people, including mothers and children, from being 
tested and accessing the treatments they need.30 
Another important obligation of immediate effect is the obligation to take “deliberate, concrete and 
targeted” steps towards the full realization of the right to health. A useful starting-point is to adopt 
and implement a national public health strategy and plan of action, based on the specific health 
needs of the population. A national strategy and plan of action are identified elsewhere in General 
Comment 14 as one of a number of “core obligations” that arise from the right to health.31 National 
public health strategies and plans of action should be developed through processes that facilitate 
community participation, with clear goals, targets, health indicators and time frames to enable 
monitoring of progress and evaluation.32 
(b) Core obligations arising under the right to health 
Separate from the obligations of immediate effect discussed above, General Comment 14 identifies 
a number of core obligations that arise under the right to health. These core obligations may be seen 
as priorities for action as States move as quickly as possible towards the full realization of the right 
to health. These core obligations are summarized in Box 1.3. 
Box 1.3: Core obligations arising under the right to health33 
The right to health in Article 12 of the ICESCR, as interpreted by the CESCR in its General Comment 
14, imposes a number of core obligations. These include the obligations to: 
• ensure the right of access to health services without discrimination; 
• ensure access to food that is safe and nutritionally adequate and to ensure freedom from 
hunger; 
• ensure access to basic shelter, housing and sanitation, and an adequate supply of safe and 
potable water; 
• provide essential medicines, as defined by WHO from time to time; 
• ensure equitable distribution of health facilities, goods and services; 
• adopt and implement a national plan of action addressing the health concerns of the 
population. 
In addition to the core obligations above, there are a number of obligations of “comparable 
priority”. These include the obligations to: 
• ensure reproductive, prenatal and postnatal maternal and child health care; 
• provide immunization for priority diseases; 
• prevent, treat and control epidemic and endemic diseases; 
• provide education about the major health challenges facing the community; 
• provide appropriate training for health personnel, including education on health and human 
rights. 
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(c) The right to health and health systems 
In order to respect, protect and fulfil the right to health, States must invest in the components or 
building blocks of an effective health system. WHO’s definition of a health system encompasses all 
the “organizations, people and actions whose primary intent is to promote, restore or maintain 
health”.34 This includes not only the provision of health services by government and the private 
sector, but public policies directed at the determinants of health, regulatory frameworks, health 
legislation and intersectoral efforts by government ministries to support the determinants of better 
health. Table 1.1 summarizes the building blocks of WHO’s health system framework. Laws, fiscal 
strategies and governance frameworks support each of the components of an effective health 
system, and are tools for further strengthening it. 
Table 1.1: Building blocks of a well-functioning health system35 
Leadership and governance: includes policies, 
strategies, laws, incentives, enforcement and 
accountability mechanisms. Includes governance 
structures to improve leadership and to facilitate 
intersectoral action to improve health. 
Health information systems: includes the 
collection, production, management, analysis 
and sharing of information on health status, 
health determinants, and all aspects of health 
system performance (including progress in 
meeting health goals and targets, improving 
equity, and efficient use of resources). 
Health financing: financing structures to raise 
sufficient funds and to share financial risks 
across the population. By removing financial 
barriers and by preventing catastrophic 
expenditure, an effective health financing 
system ensures that the full range of quality 
health services are available to the entire 
population, according to need. 
Human resources for health: includes a 
competent health workforce that is available in 
sufficient numbers, comprises an appropriate 
mix of functions, is fairly distributed, competent, 
responsive and productive. Includes payment 
systems, incentives and regulatory mechanisms 
to ensure the effective and sustainable delivery 
of high-quality services. 
Delivery of health services: both personal and 
population-level services covering disease 
prevention, health promotion, treatment, 
rehabilitation and palliative care. Includes 
standards to ensure access, safety, quality, 
effectiveness and accountability.  
Essential medicines and technologies: universal 
access to health services is not possible without 
policies to assure affordable access to essential 
medicines, vaccines and health technologies. 
Includes a national list of essential medicines, an 
effective distribution system for essential 
medicines and health technologies, and a 
regulatory system for marketing authorization, 
and for the monitoring of medicines and 
therapeutic products. 
The right to health, as explained in General Comment 14, does not create an entitlement to be 
healthy. Nor does it hold States responsible for all the potential causes of poor health, including 
genetic susceptibility or an individual’s choice to adopt an unhealthy lifestyle. On the other hand, the 
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obligation to respect, protect, and fulfil the right to health places health on the agenda of every 
government, and provides a mandate for the legislative and administrative actions that are 
necessary, across all the relevant sectors of government, to create the conditions in which members 
of the population can realize the highest attainable standard of health. The right to health provides 
an over-arching and exacting standard to guide the actions of governments as they seek to 
strengthen their health systems, and to review the health impact of legislation and policies outside 
the health sector. 
The right to health has inherent value for members of the population because it imposes on 
governments an obligation to help to create the conditions for a healthy, productive and flourishing 
life. However, in addition to its inherent value, there are at least two important reasons why the 
right to health – as a guiding value for the law reform process – is more likely to achieve the goal of 
longer and healthier lives. 
Firstly, in some areas, including sexually transmissible infections, and contagious diseases (e.g. 
influenza), it is difficult if not impossible to effectively or efficiently monitor the behaviours that 
result in disease transmission. As a result, the extent of disease transmission will depend, to a 
significant degree, on the voluntary cooperation of individuals. In the case of pandemic or infectious 
diseases, people are more likely to trust the advice of governments, and to follow lawful directions, 
if they are confident that they will be treated fairly and in accordance with the rule of law. Laws that 
take account of the impact of government actions on all members of the population, including those 
who are marginalized and powerless, are likely to be most effective in minimizing disease 
transmission. For example, in the case of sexually transmissible infections, individuals are more likely 
to present for treatment and to follow medical advice if the law protects them from discrimination 
by health professionals and other service providers. 
The second reason why the protection of human rights is central to the effectiveness of public health 
law is because, in circumstances where human rights are ignored or disregarded, significant sections 
of the population risk being marginalized. If this happens, their health will suffer, and this, in turn, 
will defeat the universal goal towards which the right to health aspires: to create the conditions for 
the highest attainable standard of health across the whole population. In most societies, distinct 
patterns of health inequality correlate with socioeconomic status and undermine the achievement 
of other social and economic goals.36 If countries are to make progress towards realizing the right to 
health for their populations, they must address the broad range of social, economic and 
environmental factors that are responsible for health inequalities. 
1.2 Concepts and principles for guiding and 
 evaluating law reform efforts 
Governments owe a duty to ensure that health care facilities, goods and services, as well as public 
health services, facilities and programmes, are available, accessible, culturally acceptable, 
scientifically and medically appropriate and of good quality.37 These principles, which are discussed 
further below, can be used by governments and other stakeholders both to evaluate the adequacy 
of existing laws and to determine the scope of needed reforms. 
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(a) The goal of universal health coverage 
The principles of availability, accessibility, acceptability and quality are not only guiding concepts 
that help to clarify the nature of the responsibility that governments owe under the right to health. 
They also highlight actions to be taken to achieve the goal of universal health coverage (UHC) 
(Box 1.4). UHC, in turn, is a way of making progress towards meeting the various treaty obligations 
that countries have undertaken regarding the right to health.38 
UHC has been defined as “all people receiving quality health services that meet their needs without 
exposing them to financial hardship in paying for them”.39 The priority health services referred to in 
this definition include promotive, preventive, curative, rehabilitative and palliative health services.40 
Defined in this way, the objectives of UHC are: equitable access to priority health services (health for 
all), quality and effectiveness of health services, and financial protection. Like the concept of a 
health system (Table 1.1), UHC includes but is not limited to affordable access to health care 
services; it extends to public policies and actions taken outside the health sector to address the 
determinants of health.41 
Box 1.4: The concept of UHC 
In December 2012, the United Nations General Assembly reaffirmed the goal of UHC, pointing out 
that the concept implies that: 
all people have access, without discrimination, to nationally determined sets of the needed 
promotive, preventive, curative and rehabilitative basic health services and essential, safe, 
affordable, effective and quality medicines, while ensuring that the use of these services does not 
expose the users to financial hardship, with a special emphasis on the poor, vulnerable and 
marginalized segments of the population.42 
UHC is typically presented as a cube (the “UHC cube”) with three dimensions or axes representing 
the population, health services, and health costs (Figure 1.1). The x axis represents the population, 
and shows the proportion of the population who are covered, and who are not covered, by a 
funding mechanism created from pooled funds. 
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Figure 1.1: The UHC cube: services provided, people covered, and cost 
 
The z or services axis represents the range of services that are provided from pooled funds, as a 
proportion of the full set of quality health services that the population needs. The services axis 
encompasses all levels of the health system, including health care services provided to individuals in 
the primary care setting, and in hospitals, preventive services provided in community settings, as 
well as public policies and laws addressing health risks at the population level, such as taxes on 
alcohol and bans on the advertising of tobacco. Since it encompasses priority health care services, 
the services axis encompasses universal access to essential medicines and technologies, a motivated 
and effective health workforce, and health information systems.43 Since it encompasses preventive 
services, the services axis includes immunizations, the provision of family planning and pregnancy 
care services, water and sanitation infrastructure, regulatory frameworks for a safe and sustainable 
food supply, and for controlling epidemics of infectious disease, as well as laboratories and other 
infrastructure for monitoring health risks. 
The y axis relates to the cost and affordability of the services provided. It illustrates the proportion of 
health costs that are met from pooled funds, and the proportion of health costs that impose direct 
costs on individuals and families, as a proportion of the total cost of providing the population with 
the health services that it needs. In low- and middle-income countries, health services may be 
funded in a variety of ways, including through taxes (services provided or funded by government), 
through pre-payment systems (insurance), through direct payments by individuals, and in some 
cases through donor contributions. Since the poor may be unable to meet user fees, or may suffer 
financial hardship in doing so, taxes and insurance systems are vital to increasing health equity. 
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Pooled funds can reduce health inequalities by increasing the affordability of health costs, as well as 
the number of services that do not impose direct costs on users. 
The UHC cube represents a dynamic system. The population axis will continue to expand as the 
population grows; the services axis will expand as new health services, treatments, drugs and 
technologies become available, while the cost axis will expand as treatments and other services 
become more expensive to provide.44 
The purpose of the UHC cube is to encourage countries to expand the provision of priority health 
services, to extend the coverage of those services to more people, and to reduce out-of-pocket 
payments.45 This raises critical questions, including which new services to include in the benefits 
package (services axis), which services to expand to a wider proportion of the population, how to 
define the eligibility criteria for coverage (population axis), and how to finance the expanded range 
of services covered by pre-payment mechanisms (cost axis). Increasing coverage requires an 
understanding of the bottlenecks and weaknesses that prevent health systems from serving the 
entire population and from providing the full suite of priority services at a cost that is affordable and 
sustainable. As explained below, the guiding concepts of availability, accessibility, acceptability, and 
quality focus attention on each of the axes of the UHC cube, and provide a framework for evaluating 
the actions taken by governments to expand UHC. 
(b) Availability 
General Comment 14 emphasized that health care facilities, goods and services, as well as public 
health services, facilities and programmes should be available in sufficient quantity.46 The precise 
nature of the facilities, goods, and services will vary according to many factors, including the level of 
development of each country, the unique set of health challenges it is facing, the available sources 
of financing and the mix of public and private sector service providers. Nevertheless, services, 
facilities and programmes that are essential to an effective health system include: sources of safe 
and potable drinking water, adequate sanitation facilities, health clinics, hospitals and other health-
related buildings, trained medical and professional personnel receiving domestically competitive 
salaries, and essential drugs, as defined by the WHO Action Programme on Essential Drugs.47 
Right to health concepts provide a helpful way of evaluating efforts to move towards UHC. The 
guiding principle of availability links with the services axis of the UHC cube (Figure 1.2). It requires 
governments to assess health needs within the population, and to address the constraints and 
barriers to scaling up the provision of priority services to meet those needs. In many cases, these 
constraints will reflect weaknesses in the building blocks of the health system (Table 1.1),48 including 
lack of investment in the resources that are necessary to provide the appropriate quantity or volume 
of services. Common problems may include: 
• lack of facilities and infrastructure (including bad roads or transport options to enable 
people to travel to places where they can register for insurance coverage or receive health 
services); 
• inadequate distribution systems for essential medicines; 
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• lack of human resources (a skilled and motivated health workforce – especially in rural and 
remote areas); 
• lack of planning and leadership, and 
• the absence of legislative and governance frameworks for managing the provision of services 
and for ensuring accountability. 
Improving availability requires more investment in the resources that make it possible to increase 
the range of health services that can be delivered to the population (i.e. more services), as well as 
the maximum capacity of those services (more of each service).49 
Figure 1.2: Evaluating progress towards UHC using right to health concepts 
 
The commitment of governments and other service providers to increasing the availability of health 
services may be formalized through technical, financial and logistic plans, with assistance from 
development partners, as appropriate. However, law reform is an important and often 
unacknowledged part of the governance reforms that are necessary to implement health plans, to 
scale up the delivery of health services, and to manage resources effectively. For example, legislation 
may be needed to establish a health insurance commission to manage a national health insurance 
scheme, including registering members, accrediting health service providers, processing claims and 
managing a national health insurance fund. Similarly, legislation may be needed to establish a 
national medicines authority to monitor the availability of essential medicines at affordable prices, 
to encourage the appropriate use of generic medicines, and to recommend the reduction of taxes, 
tariffs and mark-ups on essential medicines.50 Legislation may also establish systems for licensing 
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health care establishments, and training and registering classes of health professional that are 
adapted to each country’s particular needs. 
Governments may formalize their commitment to improving the availability of health care and 
public health services through legislation establishing a national health system. For example, South 
Africa’s National Health Act seeks to implement the constitutional right to access health care 
services, and other health-related rights, by establishing a national health system which provides the 
population with the best health services that available resources can afford, in an equitable manner 
(Box 1.5). Ultimately, the guiding principle of availability directs attention to the capacity of 
governments to provide more services from pooled funds and to increase the volume of the services 
that are offered. 
Box 1.5: The goals of South Africa’s National Health Act (Act no. 61 of 2003) 
2. Objects of the Act 
The objects of this Act are to regulate national health and to provide uniformity in respect of health 
services across the nation by: 
a) Establishing a national health system which: 
i) encompasses public and private providers of health services; and 
ii) provides in an equitable manner the population of the Republic with the best 
possible health services that available resources can afford; 
b) Setting out the rights and duties of health care providers, health workers, health 
establishments and users; and 
c) Protecting, respecting, promoting and fulfilling the rights of: 
i) the people of South Africa to the progressive realization of the constitutional right of 
access to health care services, including reproductive health care; 
ii) the people of South Africa to an environment that is not harmful to their health or 
well-being; 
iii) children to basic nutrition and basic health care services contemplated in section 
28(l)(c) of the Constitution; and 
iv) vulnerable groups such as women, children, older persons and persons with 
disabilities. 
(c)  Accessibility 
In addition to investing in the resources that are needed to ensure that health facilities, goods and 
services are more widely available, governments must take steps to ensure that these services are 
accessible to the entire population.51 The concept of accessibility has four overlapping dimensions: 
non-discrimination, physical accessibility, affordability and information accessibility.  
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Non-discrimination 
The guiding principle of non-discrimination relates to the population axis of the UHC cube, since the 
goal of protecting people from discrimination is to ensure that they are not excluded from receiving 
the health services that they need (Figure 1.2). Members of the population should not be denied 
access to health services or medicines because of their racial or cultural identity, their sex, language 
or religion, their physical or mental disability, sexual orientation, political opinions, or their health 
status (including HIV status).52 Discrimination entrenches health inequalities by excluding 
marginalized and vulnerable groups and by treating them less favourably than other individuals and 
groups. For example, some countries have large, permanent populations of migrants who provide a 
cheap labour force and may live for many years in the country without gaining citizenship. If 
governments are to create the conditions in which all members of the population can realize the 
highest attainable standard of health, then public health and health care services must also be 
accessible by these populations. 
General Comment 14 states that countries have an immediate obligation to respect the right to 
health by preventing discrimination in access to curative, palliative and preventive services.53 
Governments can honour these entitlements by passing and enforcing non-discrimination laws. 
Typically, these laws will set out the grounds of prohibited discrimination, or the protected 
attributes or characteristics that cannot lawfully be used as a basis for discriminating against a 
person in the provision of health services, employment and education, and in other areas. These 
laws may also establish a complaints-handling body with power to investigate and conciliate 
complaints, and to pursue other remedies in appropriate cases. 
Physical accessibility 
The guiding principle of physical accessibility also links with the population axis, by directing 
attention to the barriers and obstacles that stand in the way of extending health services to more 
people (Figure 1.2). Health facilities, goods and services will not contribute to the goal of improving 
public health unless they are within the safe physical reach of those who could benefit from them, 
including vulnerable or marginalized groups and others who have difficulty accessing services. These 
may include ethnic or religious minorities, indigenous populations, women, children, the elderly, 
people with disabilities, and people living in slums or in remote or inaccessible locations. 
For example, remote populations will effectively be denied access to health services unless the 
infrastructure exists to enable them to reach and to use those services.54 Physical accessibility 
therefore includes not only physical infrastructure, such as adequate roads and bridges, but also 
forms of transport, such as bus or ferry services, and other forms of needed assistance, such as child 
care or disability support services. 
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Economic accessibility (affordability) 
The guiding principle of economic accessibility directs attention to the cost axis (Figure 1.2). 
Essential health facilities, goods and services should be affordable for all. In many countries, health 
services are delivered through a mix of government, government-funded and privately-funded 
providers. Payment for health care services (including consultations, diagnostic procedures, and 
essential medicines), public health services (such as vaccinations), and services related to the 
underlying determinants of health (such as water, sanitation and the removal of rubbish), should be 
based on the principle of equity. This requires that these services should be affordable to everyone, 
including socially and economically disadvantaged groups, those with no fixed income, or with 
precarious incomes working in the informal sector. Box 1.6 provides an example of how law can 
formalize a national government’s commitment to keeping health services affordable. 
Economic accessibility requires governments to implement funding mechanisms that reduce out-of-
pocket payments imposed at the time the service is delivered, while expanding revenues obtained 
through taxpayer funded health insurance schemes, premiums or other pre-payment mechanisms.55 
By increasing the proportion of health services that are funded from pooled funds, governments can 
reduce the proportion of the population who suffer catastrophic out-of-pocked expenditures, or 
who defer or are denied services due to their inability to pay. 
Box 1.6: Improving economic access to health care services in the Islamic Republic of Iran 
The Constitution of the Islamic Republic of Iran recognizes the rights to the enjoyment of social 
insurance and social security benefits covering retirement, unemployment, old age, disability and 
medical care. These rights provided the basis for additional protections recognized in the 
comprehensive Law of the Fourth Economic, Social and Cultural Development Plan, 2005–2009, 
enacted on 1 September 2004.56 
Article 90 of the Plan was intended to enhance fairness in accessibility to health care services by 
reducing the proportion of low-income households suffering from catastrophic expenditure on 
health (that is, expenditures consuming more than 40% of income after basic subsistence needs 
have been met). Article 90 directed the Ministry of Health, Medicare and Medical Education to 
prepare by-laws ensuring that out-of-pocket payments (the contribution of patients to the costs of 
health care services) do not exceed 30% of the total cost of those services. The goal of Article 90 is 
also to reduce the proportion of vulnerable households suffering from catastrophic health care 
expenditures to 1%. 
Economic accessibility does not mean that all services should be provided by government, nor that 
services should be made available to all individuals free of charge. However, it does require 
governments to take concrete steps to ensure that the poorest and most vulnerable groups in 
society are not “disproportionately burdened with health expenses as compared to richer 
households”.57 For example, this may require government to subsidize the costs of health services in 
remote and rural areas, where the provision of those services is necessarily less cost-effective, and 
where the true cost of those services would put them out of reach of poorer, vulnerable groups. 
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Information accessibility 
The principle of accessibility includes the right to seek, to receive and to express information and 
ideas about health issues to others. Health service providers and health insurance schemes must 
also ensure that personal health data is kept secure, and that privacy and confidentiality are 
respected. Both of these aspects of information accessibility relate to the population axis, by 
directing attention to factors that may undermine demand for health services in the population 
(Figure 1.2). 
Protecting the confidentiality of each person’s health care information is necessary to create trust 
and to encourage all members of the population to access health care services. Protecting the 
confidentiality of particularly sensitive information, such as information relating to HIV infection, 
sexual health or mental health, is especially important in order to avoid creating disincentives to 
people seeking information and treatment in these areas. 
(d) Acceptability 
The principle of acceptability provides that health facilities, goods and services should be delivered 
in ways that are culturally appropriate, sensitive to gender and to different age groups, and 
consistent with ethical obligations. Acceptability relates to the population axis, by directing attention 
to factors that may undermine demand for health services by those who need them. For example, 
there is good evidence that providing clean needles and syringes to persons who are injecting drug 
users will reduce the transmission of HIV.58 However, clean needles must be available in trusted 
locations where injecting drug users feel safe in accessing them (such as outreach centres, vans, 
trust points), without the risk of harassment, arrest or criminal liability. Legislation which 
criminalizes the possession of needles and syringes can undermine efforts to reduce HIV 
transmission among injecting drug users. 
(e)  Quality 
Health facilities, goods and services should be scientifically and medically appropriate and of good 
quality. Ensuring quality in the provision of facilities, goods and services requires a skilled health 
workforce, processes for assuring the supply of officially approved and unexpired drugs and hospital 
equipment, safe and potable water, and adequate sanitation. 
Quality is an independent variable that is central to the capacity of governments to move towards 
UHC.59 Unless the health services that governments provide are effective, and of high quality, they 
cannot contribute to the realization of the highest attainable standard of health. In addition, quality 
is relevant to the population axis of the UHC model (Figure 1.2): if health services are of poor quality, 
this may reduce demand for those services, even by those who need them. 
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PART 2 
THE PROCESS OF PUBLIC HEALTH LAW REFORM 
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 Introduction 
The processes involved in reforming or introducing new public health laws are critical to the 
legitimacy and success of law reform efforts. “Process”, in this report, refers to the practical steps 
that governments and other stakeholders take to advance the goal of law reform, within the political 
context of each country. In addition to discussing these practical steps, this report points to 
principles of good governance that the process of law reform ought to reflect. The law reform 
process provides the opportunity for lawmakers to consult with stakeholder groups and others who 
will be affected by the law and to build public support for the changes that are required. This can 
improve the implementation of the law and compliance with legal requirements. 
Part 2 of this report begins by explaining the context of public health law reform (Chapter 2). 
Although the law reform process will vary greatly between countries, Chapter 2 distinguishes 
between the following three activities: 
• Health legislation review: this is the formal process of reviewing public health laws, either 
generally or in a specific area, and assessing the need for reform. 
• Implementing recommendations from a legislative review: this is the process of designing 
and drafting public health laws. It also includes the political process of passing legislation 
through parliament, as well as arrangements for the implementation and enforcement of 
laws. 
• Designing the review process: ensuring good governance throughout the process of 
reviewing, drafting and amending public health laws. 
One of the first questions a government will consider is whether the goals that it wishes to achieve 
require a legislative or regulatory response, or whether other forms of governance (e.g. self-
regulation or co-regulation) are more appropriate (see Section 2.3). This question may also arise 
when a government is considering how best to implement the recommendations from a health 
legislation review. 
In many cases, the decision to review existing public health laws or to introduce new laws will be 
made for quite specific purposes. As a result, the scope of the legislative review process may be 
narrowly defined. At the same time, the purpose of this report is to encourage governments to 
consider the flexible role that law can play in national efforts to realize the right to health for all 
members of the population. This report therefore takes a broad perspective on the process of public 
health law reform. Section 3.1 considers some common reasons why public health laws may need to 
be revised, and encourages governments to consider the benefits of updating and improving their 
public health laws generally. 
Depending on its scope, the process of reviewing public health laws may provide the opportunity to 
identify priorities for legislative reform, based on evidence of the burden of disease in each country 
and the major health issues that each country is facing. Despite the differences between them, many 
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low- and middle-income countries face remarkably similar health challenges. These include the need 
for legal frameworks to respond effectively to HIV, to epidemics of contagious disease, to the major 
risk factors for the rising burden of noncommunicable disease (including tobacco use, harmful use of 
alcohol, poor diet and obesity), and to the large burden of preventable injuries. These priority areas 
are reviewed in Section 3.2. 
Although law reform is primarily the responsibility of the government, civil society organizations can 
make an important contribution by educating the community about the need for reform, and by 
mobilizing political support for law reform within government (Section 3.3). In some countries, 
political and legislative mechanisms facilitate the direct participation of the community in the 
development of health policy. These mechanisms, as well as public interest litigation, can act as 
triggers or catalysts for the reform of public health laws, as discussed in Section 3.4. 
After it has made a formal commitment to implement recommendations from the legislative review 
process, government will face the challenge of translating those recommendations into effective 
public health legislation. The process of designing and drafting new laws will benefit from a good 
understanding of the range of legal strategies that are available to governments to improve public 
health and to implement policy recommendations. Chapter 4 reviews some of the components or 
characteristics of effective public health laws. Governments that have chosen to amend their public 
health laws should ensure that the law provides a clear mandate for public health actions and sets 
out the powers and responsibilities of public health officials clearly. Other issues for consideration 
include the need for coherence between public health laws and laws administered by other 
ministries, and the need for human rights safeguards (such as protection from discrimination) to be 
built into public health laws. 
The process of formally reviewing public health laws, drafting new ones and gaining parliamentary or 
executive approval for new laws, is complex and will often be subject to political pressures. Law-
makers will need to comply with parliamentary (or other law-making) rules and procedures. 
Chapter 5 emphasizes the importance of good governance throughout the law reform process. This 
includes resisting efforts to corrupt the law-making process, and implementing the principles of 
accountability, transparency and respect for the rule of law. 
In some cases, the public health goals that a government is seeking to achieve will require a 
collaborative approach between the health ministry and other ministries. This may lead to formal 
consideration of how best to facilitate and coordinate an intersectoral approach to addressing public 
health priorities. Globally, there is growing awareness of the importance of coordinated, 
intersectoral action to improve public health and to reduce health inequalities.1 Chapter 6 considers 
how law and governance reforms can support and improve the process of collaboration between 
ministries, and with other stakeholders that are participating in intersectoral health initiatives. 
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Chapter 2: The context of public health law  
reform activities 
 
SUMMARY POINTS 
 
· Laws that protect the health of the population may be organized and administered quite 
differently in different countries, depending on historical and constitutional factors, and the 
specific health challenges each country has faced in the past. The concept of public health law is 
not limited to laws regulating the provision of health care services, but extends to the legal 
powers necessary for the State to discharge its obligation to realize the right to health for all 
members of the population. 
· The scope of any formal review process of public health legislation may vary widely according 
to the political and legal context and priorities of each country. 
· The capacity and willingness of governments to amend or replace public health laws, based on 
the recommendations of a formal legislative review, may be affected by the political ideology of 
the government concerned, the political feasibility of reform proposals, competing legislative 
priorities and available resources. 
· When implementing law reform recommendations, governments should plan to monitor and 
evaluate their impact. This will involve identifying indicators that are suitable for tracking the 
impact of the law on relevant practices and health outcomes. 
· Governments may need to set national priorities and to implement public health law reform 
recommendations in a stepwise manner, dedicating resources tow a smaller number of cost-
effective reforms that will deliver the greatest overall health benefits, and working towards 
implementation of a broader set of reforms as resources allow. 
· Countries may use a variety of different forms of regulation to regulate health risks and other 
health matters. These include legislation, subsidiary regulations, decrees and executive orders, as 
well as guidelines and codes of conduct. Governments may adopt forms of co-regulation that 
formally include the participation of industry or professional bodies and/or civil society 
organizations. Governments may also defer to customary law as a valid source of law, or declare it 
to be the governing source of law in certain contexts. 
· In considering whether public health law reform is appropriate, and whether self-regulatory 
codes and guidelines, or co-regulatory schemes, are failing to achieve public health goals, 
independent monitoring and evaluation are critical. 
2.1 What are public health laws? 
The Constitution of WHO makes it clear that health is not only about the absence of disease or 
infirmity, but is a complete state of physical, mental and social well-being.2 Similarly, the concept of 
public health law, as understood in this report, is not restricted to laws that regulate the provision of 
health care services, but includes the legal powers that are necessary for the State to discharge its 
obligation to realize the right to health for all members of the population. 
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Laws that protect the health of the population may be organized and administered quite differently 
in different countries, depending on historical and constitutional factors, and the specific health 
challenges each country has faced in the past. These may include laws that regulate food safety, 
tobacco control, environmental sanitation, registration of pharmaceuticals, the registration of health 
practitioners, sexually transmissible infections, the management of communicable diseases, 
quarantine, public health emergencies, collection and management of health data, the powers and 
functions of public health officers, and the performance of public health functions by local and 
regional governments. 
Typically, the health ministry will administer laws that affect the provision of health care services 
and address a range of other health risks. Outside the health ministry, other ministries will 
administer laws that may also have a significant influence on health risks and health outcomes. 
Examples include laws relating to pollution and environmental contamination, consumer protection, 
criminal justice, local government, transport, housing and agriculture. Although the health ministry 
will usually lead initiatives to reform public health legislation, collaboration between ministries and 
agencies will be essential where the issue under consideration does not lie within the sole 
operational domain of the health ministry. For example, the reform of laws that aim to prevent 
violence against women will necessarily require the involvement of the justice ministry, while any 
initiative that relates to the taxation of tobacco or alcohol will normally involve the finance ministry. 
Efforts to reduce the health disparities that arise from social disadvantage may involve ministries 
with responsibilities for employment, public housing, transport and social security. 
Where more than one ministry or agency is involved, the process of legislative review necessarily 
becomes more complex. Chapter 6 identifies practical steps for initiating intersectoral initiatives to 
improve public health, and presents several case studies of governance reforms that have supported 
government-wide efforts in this area. 
2.2 Conceptualizing the process of health legislation 
 review 
(a)  Impetus for a review 
The opportunity to review public health laws may arise in many different ways, with many variations 
between countries. The review process may evolve in response to specific concerns about the failure 
of current laws or policies, or from broader discussions about how to improve policies, modernize 
laws or adapt to new challenges. The impetus for a review may come from government itself, from 
stakeholder groups outside government, or from development partners. International factors may 
also have an influence, such as the need to discharge obligations owed under international law (e.g. 
the WHO Framework Convention on Tobacco Control3 or the International Health Regulations 
(2005)4), or to implement recommendations and action plans, such as WHO’s Action Plan for the 
Prevention and Control of Noncommunicable Diseases 2013–2020.5 
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(b)  Scope of the review process 
Assuming that government has formally decided to conduct a review of existing public health laws, 
the scope of that review may vary widely. It may range from reviewing the adequacy of a particular 
section within a statute or code to revising or introducing an entirely new public health act. Even 
more ambitiously, the review process may include consideration of laws and matters administered 
by ministries outside the health ministry. An intersectoral or cross-ministerial review process may be 
necessary in order to respond effectively to persistent health challenges; for example, in order to 
improve food security, to reduce health inequalities, to improve maternal and child health, and to 
reduce the risk factors for noncommunicable diseases (see Chapter 6). 
The scope of the review will often have an influence on the agency or person chosen to undertake 
the review and the formal processes involved. A review may be carried out by independent 
consultants at the request of the health ministry, by health ministry officials, by a parliamentary 
standing committee, by a specially-formed commission or review committee, or by a specialist law 
reform body such as a law reform commission. The person or committee that undertakes the review 
may report back to the health ministry, or report directly to those who have political influence, such 
as the health minister, a group of senior government ministers, or even the prime minister or 
president. The question of who undertakes the health legislation review, and to whom they report, 
may have an important impact on how seriously the recommendations of the review are taken, and 
whether they remain on the political agenda. 
The issues considered during a health legislation review will also vary widely, according to the terms 
of reference of the review. For example, the review may include a consideration of: the specific 
problems that have arisen with the administration of current laws; the opinions of the key 
stakeholder groups (including political parties, business and professional groups, faith-based 
organizations, civil society organizations and development partners); the legislative and 
constitutional powers of the government to reform the law in a particular area; recent international 
developments; and the extent to which law reform is occurring in other countries and jurisdictions. 
(c) Implementing recommendations 
It is helpful to distinguish between the recommendations made during a formal review of public 
health laws, and any subsequent decision by government to amend or replace existing laws. The 
capacity and willingness of a government to implement the recommendations of a review may be 
affected by the political ideology of the government concerned, the political feasibility of the reform 
proposals, competing legislative priorities and available resources. 
The design and drafting of new public health laws raises a wide range of matters for consideration. 
Law reformers will need to consider the most appropriate legislative mechanism for implementing 
the recommended changes, and specify who will administer the new law and what legal powers they 
will require to do so effectively. They should also consider the compatibility of the law with human 
rights principles and the potential role of regional, city and local governments in making the new law 
work. Legislative drafters should consider whether those who will administer the new law have the 
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capacity to understand its requirements, as well as the process of transition from existing laws to 
new laws. 
When implementing law reform recommendations, governments should plan to monitor and 
evaluate their impact. This will involve identifying indicators that are suitable for tracking the impact 
of the law on relevant practices and health outcomes.6 For example, monitoring the impact of 
tobacco control laws may require both baseline and follow-up surveys to determine smoking 
prevalence. Governments may also monitor the impact of mandatory helmet laws in terms of 
infringement notices and road accident fatalities. In many countries, the resources of governments 
to engage in public health law reform are limited. Governments will therefore need to set national 
priorities and proceed in a stepwise manner, dedicating resources to a smaller set of cost-effective 
reforms that will have the greatest overall health benefits, and working towards implementation of a 
broader set of reforms as resources allow.7 
This report includes many case studies and examples of legislation from around the world. These are 
not “model laws”, and in many cases simply reflect the local circumstances of each country. 
However, by sharing the experience of other countries, the report aims to give public health 
authorities a greater understanding of the options for reform, and a determination to use legal 
powers effectively to realize the right to health. 
2.3 Why legislate? 
In many countries, a variety of forms of regulation are used by governments to regulate health risks 
and to create healthier environments. These range from legislation, subsidiary statutory 
instruments, decrees and executive orders to “soft law” instruments such as guidelines and self-
regulatory codes of conduct. In some countries, governments may also defer to customary law as a 
valid source of law, or declare it to be the governing source of law in certain contexts.8 For example, 
Fiji’s Public Health Act states that the Act does not apply to villages (with the exception of those 
provisions governing infectious diseases), although the Minister of Health retains residual power to 
extend the application of any provision of the Act to villages by executive order.9 As a result, 
customary law and forms of social organization remain the operative source of authority for 
managing “minor public health risks, sanitation and general village neatness”.10 As with other 
sources of law, governments should ensure that customary law upholds universal human rights and 
does not legitimate discrimination. 
In addition to statutory regulation, and voluntary forms of regulation, governments may adopt forms 
of co-regulation that draw on the participation of industry, professional or civil society organizations 
(Box 2.1). For example, government may give an industry-administered code or self-regulatory 
process official status within a statutory scheme. Alternatively, it may enhance the status of an 
industry code in other ways, such as through the participation of a government representative on its 
governing board. As Box 2.1 illustrates, in some countries, important matters of health policy – such 
as the regulation of food advertising to children, or regulation of electronic cigarettes – may be 
regulated by industry-based bodies within statutory schemes that lie outside the responsibility of 
the health ministry. Governments should consider carefully whether it is appropriate to delegate 
responsibility for important health issues to industry-based, non-health bodies.  
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Box 2.1: Advertising regulation in the United Kingdom: an example of co-regulation 
In the United Kingdom, both non-broadcast and broadcast advertising are governed by a co-
regulatory system. The Committee of Advertising Practice (CAP) is responsible for writing and 
updating the United Kingdom Code of Non-broadcast Advertising, Sales Promotion and Direct 
Marketing, while the Broadcast Committee of Advertising Practice (BCAP) writes and updates the 
United Kingdom Code for Broadcast Advertising. The membership of both Committees is made up of 
advertising associations, media owners and other industry groups.11 
Although CAP and BCAP are responsible for the standards that govern the content of advertising in 
the United Kingdom, an independent body, the Advertising Standards Authority (ASA) administers 
the codes by acting on complaints and taking action against misleading, harmful or offensive 
advertisements. The ASA Council hears complaints and decides if advertisements have breached the 
advertising codes (two thirds of its members are independent of industry).12 The United Kingdom 
Office of Communications (Ofcom) remains the statutory regulator for the communications 
industries, signs off on major changes to the Codes and has ultimate responsibility for enforcing 
compliance with the Codes.13 
The co-regulatory advertising scheme of the United Kingdom has addressed concerns relating to the 
advertising of unhealthy products in a number of ways. In 2007, Ofcom banned the advertising of 
foods high in salt, sugar and fat (based on a nutrient profile developed by the Food Standards 
Agency) in television programmes commissioned for or directed at audiences below the age of 16.14 
The ASA’s Council has also upheld a number of complaints against advertisers for making misleading 
and deceptive claims about the health effects of electronic cigarettes (e-cigarettes).15 In 2014, the 
CAP and BCAP published new rules for the marketing of e-cigarettes.16 These rules were intended to 
operate during the two year period until the United Kingdom became required to implement the 
requirements of the revised European Union Tobacco Products Directive (2014) into United Kingdom 
law.17 The Directive limits the advertising of e-cigarettes, and extends the same legal restrictions to 
electronic cigarettes as already apply to other tobacco products.18 
The use of statutory regulation and softer, non-mandatory standards is not mutually exclusive. 
Governments frequently adopt a mix of regulatory instruments to address different aspects of a 
health challenge. For example, the government of Mexico has responded to rapidly rising rates of 
obesity with a variety of regulatory and non-regulatory strategies. These include: 
• commissioning voluntary evidence-based guidelines on beverage consumption;19 
• a “National Agreement for Healthy Nutrition” that committed the Mexican Government, the 
food industry and other stakeholders to work together to achieve 10 objectives; 
• statutory regulations to remove foods and beverages with high levels of sugar and saturated 
fat from schools and to improve access to clean water and healthy foods; 
• a voluntary, front-of-pack scheme to identify the healthiest products in each food 
category;20 and 
• a tax of around 10% on sugar-sweetened beverages, and 8% tax on high-calorie foods.21 
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The use of statutory instruments does not always mean that the government is adopting a coercive 
or mandatory approach. For example, legislation can establish institutions that carry out public 
health functions, as in the case of Tonga’s Health Promotion Foundation Act 2007.22 In general, 
however, the benefit of statutory regulation is that it enables governments to impose technical 
standards and requirements that are mandatory, rather than voluntary or discretionary. Statutory 
regulation is therefore suited to contexts where the protection of public health requires widespread 
(and ideally, uniform) compliance with common, minimum standards (e.g. sanitary requirements, 
control of infectious diseases, food safety, tobacco control), or where guidelines and other voluntary 
commitments impose only weak and ineffectual standards. 
Although industries that wish to avoid legislative regulation may point to the existence of a self-
regulatory code as evidence that industry is taking health concerns seriously, statutory regulation 
also has the benefit of creating a level playing field. It prevents businesses from suffering the market 
disadvantages that might otherwise arise if they were left to decide whether or not to adopt 
standards voluntarily. In each case, the central issue is whether the incentives that drive business 
conduct are adequately aligned with the actions and outcomes that are required in order for 
governments to progressively realize the right to health. In some cases, as with the tobacco industry, 
the drivers of business conduct are diametrically opposed to public health goals. 
Governments may be reluctant to impose additional requirements on businesses or individuals 
where there is evidence that voluntary standards or self-regulation are working effectively. Co-
regulation may also benefit the public interest by maintaining an open dialogue with those who are 
subject to regulation, by giving government access to the knowledge and expertise of private sector 
organizations about how to achieve shared goals, and by encouraging a collaborative approach. 
While the monitoring and enforcement of legislative standards may impose substantial costs on 
government, the costs of self-regulation may be shared with or transferred onto industry. In 
evaluating the relative benefits of legislative and non-legislative options, governments must 
remember their obligation to seek to achieve the right to health for their population (see Section 
1.1). 
Independent monitoring and evaluation are critical when evaluating the performance of self-
regulatory codes, guidelines or co-regulatory schemes in achieving public health goals. Where 
credible evidence demonstrates that industry standards are inadequate, governments will need to 
consider the most appropriate and feasible regulatory response. While that may include the 
introduction of new legislation, the form of that legislation may vary depending on the context. For 
example, a government may require the registration of an industry code and make such registration 
conditional on the code meeting specified criteria. These minimum criteria may close off the major 
loopholes and escape clauses in the voluntary code that undermine the health goals that the 
government is seeking to achieve. In addition, the government may specify measurable targets and 
indicators for evaluating the success or performance of industry self-regulation. The government 
may also mandate regular monitoring, with results reported to parliament, or to an appropriate 
regulatory agency, thereby enhancing transparency and public accountability.23 Where an industry 
code fails to achieve these benchmarks, the case for direct statutory controls will be more 
compelling.   
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Chapter 3: Assessing the case for the reform  
of public health law 
 
SUMMARY POINTS 
 
· Countries may review their public health laws for different reasons. For example, public 
health laws may be outdated, inconsistent or incoherent; major health hazards and current 
challenges may require new legislative frameworks, and governments may lack the powers they 
need to discharge their public health responsibilities effectively. Current laws may also fail to 
appropriately balance the rights and interests of individuals with public health, and with other 
public interests. 
· Although the focus of a legislative review process may be quite narrow, it nevertheless 
provides the opportunity for countries to consider updating their public health laws in a more 
systematic way, and to consider priorities for the future. 
· In federal countries, the centralization or decentralization of regulatory power may have 
important impacts on public health. Subject to the division of legislative powers in the national 
constitution, federal governments should carefully consider the advantages and disadvantages 
of centralizing control of a particular issue at the federal level, or alternatively, permitting state, 
city and local governments to introduce additional laws, provided they are consistent with any 
relevant federal laws. 
· Despite their differences, countries need strong legal frameworks to deal with important 
public health challenges that are shared across nations and regions, including HIV, tuberculosis 
and pandemics of infectious disease. 
· Noncommunicable diseases – principally cardiovascular disease, cancer, respiratory diseases 
and diabetes – are responsible for around 68% of global mortality and have led to a double 
burden of disease in many countries. As a result, countries need to develop effective legal 
responses to obesity and dietary risks, and to scale up the implementation of tobacco control. 
· Injuries have been neglected in many countries. Priority areas for governments include 
enforcing laws requiring motor cycle helmets, mandatory seat belts and child restraints. 
Important interventions to reduce violence and intentional injuries include strengthening the 
control of alcohol, and firearms laws. 
· Although the health ministry will often take the lead in public health law reform, 
consultation with other ministries may be critical to effective implementation and enforcement. 
· A variety of events may trigger the reform of public health laws, including disease 
outbreaks, sunset clauses in legislation and obligations under international law. In some 
countries, formal mechanisms may provide opportunities for public health and civil society 
organizations to put health issues on the government’s agenda and to participate in law-
making. In countries where constitutional, health-related rights are justiciable, litigation may 
compel governments to amend their laws and to take action to protect public health. 
 
Advancing the right to health: the vital role of law  Page | 35   
3.1 Common reasons for reviewing and updating 
 public health laws 
 
There are many different reasons why governments may undertake a review of public health laws. 
For example: 
1. Over time, a country’s public health laws may have become outdated, fragmented and even 
incoherent in ways that undermine government efforts to manage health challenges effectively. 
2. Major health hazards and current challenges may require new legislative frameworks, and 
provide the impetus for law reform. 
3. Governments may lack the specific legislative tools that enable them to discharge their 
public health and human rights responsibilities effectively. 
Public health laws tend to develop in a reactive fashion, in response to the specific health challenges 
a country has faced over time. A review of public health laws may be similarly narrow, focusing on a 
specific problem or challenge. Nevertheless, the process of reviewing public health laws provides the 
opportunity for countries to consider updating their laws in a more systematic and proactive way, 
and to identify priorities for the future. This chapter considers some of the reasons that may justify 
carrying out a review of public health laws, either generally or in a specific area. 
(a) The problem of outdated laws 
In some cases, the political impetus for law reform comes about because public health law statutes 
are simply too old and have become outdated. A great deal of public health legislation was framed in 
the late-19th and early-to-mid-twentieth centuries. As a result, public health laws in some countries 
contain provisions that fail to conform to evidence-based approaches to epidemiology and disease, 
or to human rights principles (Box 3.1). Over time, specific provisions and parts of health legislation 
may simply fall into disuse. 
Box 3.1: The legacy of 19th century British public health laws 
Public health laws framed in the 19th century in Britain assumed that disease was transmitted by 
harmful, airborne “miasmas” that were concentrated in rubbish and in damp, poorly ventilated 
buildings.1 Disease was also understood to be transmitted by water, but the agent of infection was 
not understood. Rapid population growth, together with migration from rural to urban areas 
contributed to overcrowded and insanitary living conditions that promoted the spread of disease. 
Public health laws from this period increased the powers of the State over land and premises, 
particularly in poor urban areas, since public health authorities noticed that this was where 
epidemics of disease often arose. 
Legislation empowered public health officials to impose quarantine, to require the removal of filth 
and rubbish, to “cleanse” premises, and to regulate offensive trades. For example, the Public Health 
Page | 36  Advancing the right to health: the vital role of law 
 
Act of 1875 not only required landlords to provide for proper sanitation, ventilation and drainage, 
but to comply with and to enforce a moral code that was associated with cleanliness and good 
health. Landlords operating “lodging houses”, a type of affordable urban housing, were required to 
file “certificate[s] of character”2 and were prohibited from allowing unmarried tenants of the 
opposite sex to cohabit.3 There was little in this legislation to ensure that landowners and occupiers 
were treated fairly, and racial groups sometimes suffered discrimination. 
Public health legislation in those countries that inherited their laws from Britain often reflects the 
legacy of this period. For example, many state public health laws in the United States were 
influenced by a report published in 1850 which reflected the belief that sanitation, health and 
morality were closely intertwined.i  This report has been described as “one of the most farsighted 
and influential documents in the history of the American public health system”, despite the fact that 
late 19th century developments in scientific understanding about the causes of disease disproved 
the notion that immorality was the root of poor health.4 
Outdated public health laws can undermine public health in two main ways. Firstly, due to gaps in 
the legislation, governments and public health officials may lack the mandate and the legal powers 
that they need to respond to established and emerging health threats. In some cases, legislation 
itself may be missing, and the extent of government powers may be ambiguous and uncertain. 
Secondly, outdated legislation may undermine effective public health practice because those powers 
that do exist fail to achieve an appropriate balance between the rights and interests of individuals, 
public health and other public interests. For example, there are significant differences between the 
ways in which sexually transmitted infections, including HIV, and airborne infectious diseases (e.g. 
influenza) are transmitted. The failure to recognize that strategies for the prevention of influenza 
may not be appropriate for HIV can lead to significant injustice, as when HIV is simply added to 
existing schedules in legislation, activating a range of generic powers and obligations that are ill-
suited to HIV prevention. This can lead to situations such as those in which outdated public health 
laws prohibit individuals with HIV from riding on public transport, require them to publicly warn 
others of their infection, or subject individuals to other forms of discrimination that neither reduce 
the spread of disease nor respect basic human rights. Identifying, removing or updating outdated 
provisions is an urgent priority, not only because they may be ineffectual, but because they alienate 
the individuals and communities whose cooperation is required in order to minimize disease 
transmission. 
(b) The problem of multiple layers of law 
Public health laws in many countries are made up of successive layers of statutes, regulations and 
amendments that have accumulated over many decades in response to existing or perceived health 
threats. Public health laws may contain provisions that were introduced in response to a wide range 
of epidemics including smallpox, yellow fever, cholera, tuberculosis, polio, HIV and other sexually 
i For example, Lemuel Shattuck’s Report of the Massachusetts Sanitary Commission, published in 1850, 
adopted the understanding that immorality and disease were closely related: see Institute of Medicine. The 
future of public health. Washington (DC): National Academy Press: 1988:60–1. 
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transmitted infections, West Nile virus, severe acute respiratory syndrome (SARS), and more 
recently, novel forms of influenza. Laws enacted in such an ad hoc, reactive fashion can become 
inconsistent, redundant, ambiguous and confusing. 
(c) The problem of inconsistency 
In addition to multiple layers of law, significant variations can develop over time between the public 
health laws of different jurisdictions. In countries that have state or provincial governments in 
addition to a national government (i.e. federal systems), state or provincial laws may evolve 
independently of each other, with little or no coordination. In some cases, the legislative review 
process can give governments the opportunity to carry out an assessment of inconsistencies, and to 
consider both the advantages and disadvantages of either centralizing regulatory control, or 
alternatively, permitting regulation to continue at the subnational level. 
In federal countries, the division of legislative and regulatory power between the national or federal 
government, and state or provincial governments, is usually set out in the national Constitution. The 
Constitution may grant exclusive regulatory power in a particular area to either the federal or to 
state governments; alternatively, regulatory power may be shared. One benefit of a federal 
structure is that state governments will have their own legislative powers, and thus the flexibility to 
try new approaches. State governments may be able to move ahead with reforms that would be 
impossible to achieve, for political or economic reasons, at the national level. 
In countries where there is an overlap between the legislative powers of federal and state 
legislatures, federal governments can encourage a shared approach to regulation. For example, 
federal laws may make it clear that the federal government does not claim exclusive power to 
regulate, thereby enabling state, city and local governments to introduce additional laws, provided 
they are consistent with any relevant federal legislation. Australia’s Tobacco Advertising Prohibition 
Act, for example, explicitly preserves the right of the states and territories to pass their own laws 
restricting tobacco advertising, provided that they are capable of operating concurrently with 
federal legislation.5 This federal provision has enabled Australia’s states to introduce a number of 
innovative tobacco control laws, including laws prohibiting all tobacco advertising at point of sale, 
laws requiring that tobacco products for sale at retail premises must not be visible from either inside 
or outside the premises, and laws requiring tobacco products to be sold from a single point of sale 
within premises.6 
On the other hand, the existence of inconsistent laws at the state level in a federal country may 
carry disadvantages for health, due to inequality in services provided by states, and inconsistent 
approaches to contentious issues, such as reproductive health. In some areas, the lack of national 
consistency can interfere with a rapid or coherent response to health threats of regional, national or 
even global significance. Lack of consistency in state public health laws may cause particular 
problems when responding to air or water pollution, disposal of toxic waste and the rapid spread of 
infectious diseases such as cholera, West Nile virus, Ebola or pandemic influenza. 
Inconsistencies may also develop over time between the laws and policies administered by different 
ministries or portfolios within the same level of government. This can undermine the coherence of 
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efforts to improve public health and to reduce risk factors for disease. For example, laws and 
programmes that provide production subsidies and other forms of economic support for tobacco 
farmers may encourage domestic production and demand, undermining tobacco control laws and 
increasing the burden of tobacco-related disease. Similarly, policies to stimulate the production of 
palm oil, and other oils that are high in saturated fats, may have a negative impact on rates of 
ischaemic heart disease in countries where these policies result in an increase in consumption, given 
the association between higher palm oil consumption and mortality from ischaemic heart disease.7 
In summary, a review of public health legislation governing a particular issue or health challenge 
should include a review of the problems and limitations of existing laws. It is important to 
understand the historical context in which existing laws were introduced, and to seek out the views 
of those who are responsible for administering and enforcing the legislation and performing core 
public health functions (such as licensing, inspections, investigations, prosecutions and responding 
to health emergencies). The views of professional groups, patient groups, nongovernmental 
organizations, development partners and international and regional organizations may also be 
useful. The following questions may assist in identifying the limitations of existing laws, and in 
making the case for law reform: 
• Do existing laws reflect a modern, evidence-based understanding of the causes of disease, 
routes of transmission (where relevant), and consequences of illness? Or were they framed 
in ignorance of modern understandings of the causes of diseases and mechanisms of 
transmission? 
• Are current laws antiquated, redundant, ambiguous or even incoherent? How well do they 
work in practice? Are there any major gaps, and if so, where are they? 
• Do public health laws give government officials a clear mandate to protect and promote the 
health of the population? Do public health authorities have the specific powers that they 
need to respond effectively to the health challenges that are the focus of the review? 
• Are there inconsistencies between public health laws at local, state, or regional levels, and 
do these inconsistencies threaten a coordinated and coherent approach? Is a national 
approach required, or are there benefits in protecting the ability of regional and local 
governments to regulate in this area? 
• Do existing laws take account of the legitimate interests and rights of individuals and groups, 
impinging on those rights to the minimum extent necessary to achieve their health 
objectives? 
• What changes would be required in order to make current laws consistent with best 
practices? 
3.2 Identifying priorities for public health law reform  
The specific areas that are the subject of a formal legislative review or enquiry will usually reflect the 
health challenges, political priorities and specific experience of each country. National priorities for 
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law reform will typically be identified by government and will be informed by advice from the health 
ministry. Professional groups, development partners and the media may also seek to place particular 
law reform issues on the political agenda (see Section 3.3). 
However, it is not always the case that the major health challenges that a country is facing will be 
high on the political agenda. For example, the impact of disease on poor and marginalized 
populations may be overlooked. Governments may have erroneous views about the causes of 
disease, and ignore evidence about the best way to combat it. Governments may simply lack the 
political will to do what is needed to address public health priorities, such as tobacco or alcohol 
control, due to concerns about the impact that law reform may have on taxation revenues, or the 
influence and interference of industry bodies. In some cases, issues such as violence against women, 
or maternal and child health, may have long been neglected due to power imbalances and other 
inequalities within society. Governments face many challenges that compete for their attention, and 
the opportunity to review a country’s public health laws may only arise infrequently. When it does 
arise, it is vital to ensure that law reform priorities are informed by evidence of the burden of 
disease and the leading health challenges the country is facing. 
This section highlights some major risks to health that are shared across nations and regions. Both 
communicable diseases – such as HIV and pandemic influenza – and noncommunicable diseases – 
such as cancer, heart disease and diabetes – require urgent attention in many countries. Effective 
prevention and control of these diseases requires strong legal frameworks. 
(a) Communicable diseases 
Pandemics of contagious diseases, including novel forms of influenza, pose a powerful threat to 
global health security, with the potential to overwhelm health systems, and threaten economic 
growth and stability (Box 3.2).  
Infectious diseases with pandemic potential 
The SARS epidemic in 2003 was an important catalyst for the completion of the revised International 
Health Regulations (2005),8 which require States to notify WHO if there is the possibility of a “public 
health emergency of international concern”.9 H1N1 circled the globe in 2009 and 2010, becoming 
the first global pandemic of the 21st century.10 SARS, H1N1, and Middle East respiratory syndrome 
coronavirus illustrate that pathogens can be transmitted from one species to another, and 
particularly in the case of SARS and H1N1, spread through casual contact.11 
Box 3.2: Pandemic influenza: a threat to global health and security 
Influenza pandemics have occurred at various points in human history, causing widespread illness, 
death and social disruption.12 In 1918, the “Spanish Flu” pandemic resulted in an estimated 20 to 50 
million deaths worldwide.13 The 1957 “Asian Flu” and the 1968 “Hong Kong Flu” pandemics also 
resulted in significant human and economic harm.14 As global travel, urbanization and overcrowded 
living conditions increase, novel influenza viruses are more likely to spread rapidly around the 
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globe.15 In 2009, WHO declared the H1N1 influenza pandemic to be a public health emergency of 
international concern. Although the H1N1 virus is not highly pathogenic, modern epidemiological 
models predict that a severe pandemic could result in as many as seven million deaths.16 
Law plays a critical role in preventing and mitigating the health consequences of contagious 
epidemics, in two distinct ways. Firstly, law establishes the institutional structures and formal 
processes through which governments respond to disease outbreaks. Secondly, law sets limits for 
the exercise of coercive power over citizens and businesses in order to mitigate the risk of disease 
spread. This is discussed further in Chapters 9–11. 
HIV/AIDS 
HIV infection and HIV-related disease are a critical challenge, both nationally and globally. This is 
especially true in sub-Saharan Africa, where nearly 5% of adults are infected, and the prevalence of 
HIV infection is 25 times higher than the next most affected regions, South, South-East and East 
Asia.17 Sub-Saharan Africa accounts for 70% of people living with HIV, and over 70% of AIDS-related 
deaths.18 Globally, in 2014, nearly 37 million people were living with HIV, nearly half of whom were 
unaware of their infection. In the same year, 1.2 million people died from AIDS-related diseases, and 
around 2 million people became newly infected with HIV (a 35% decline from 2000; see further in 
Box 3.3).19 
Box 3.3: The global impact of HIV infection 
Since the HIV epidemic was first recognized in the early 1980s, 39 million people have died.20 In high-
income countries, a person with HIV has a similar life expectancy to someone without HIV; however, 
this depends on access to antiretroviral medication. The percentage of people with HIV who were 
not receiving antiretroviral therapy fell from 90% in 2006 to 63% in 2013. By June 2015, 15.8 million 
people were receiving antiretroviral therapy.21 Yet globally, this means that around three out of five 
people living with HIV are still not yet receiving the treatment they need.22 
At the end of 2013, over US$ 19 billion was being invested, with more than half of this coming from 
domestic spending.23 However, despite decades of effort, HIV remains one of the most pressing 
global health problems, with many marginalized and vulnerable groups excluded due to poverty, 
legal and social inequalities and harmful gender norms. According to the United Nations 
Development Programme, HIV “has inflicted the ‘single greatest reversal in human development’ in 
modern history”.24 HIV exacerbates health inequalities both within countries and between countries 
and regions, with socioeconomically disadvantaged communities bearing the brunt of suffering and 
early death. HIV has serious economic as well as health consequences. HIV primarily affects 
otherwise young and productive workers, interrupting income-generating activities, exhausting 
family savings, reducing taxation revenues and interfering with schooling, because families can no 
longer afford school fees or because children are required to look after sick relatives.25 
The scale of the HIV pandemic, its capacity to rob countries of young and productive people, and the 
economic and health inequalities it perpetuates, have spurred a number of international initiatives 
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to support prevention and treatment. Evidence of global political support ranges from the United 
Nations General Assembly’s Declaration of Commitment on HIV/AIDS in 2001,26 to the creation of 
the United States President’s Emergency Plan for AIDS Relief,27 and the Global Fund to Fight AIDS, 
Tuberculosis and Malaria.28 The international community has focused on achieving several shared 
goals, including universal access to comprehensive prevention programmes, treatment, care and 
support.29 However, these goals cannot be achieved at the national level without strong 
government, supported by adequate resources and rational laws to optimize the delivery of 
comprehensive HIV programmes. 
Significant work has been done to assist countries to identify the kinds of laws that are best suited to 
preventing and controlling the spread of HIV, as well as existing laws that create obstacles to 
effective treatment and prevention.30 But major challenges remain. For example, in 2012 the Global 
Commission on HIV and the Law reported that while 61% of countries reported having laws to 
protect people living with HIV from discrimination, these laws are “often ignored, laxly enforced, or 
aggressively flouted”.31 The Commission also pointed out that laws explicitly criminalizing the 
transmission of HIV, and laws criminalizing key populations, including commercial sex workers, men 
who have sex with men, and injecting drug users, ignore evidence and undermine efforts to prevent 
transmission and encourage treatment.32 
Tuberculosis 
Tuberculosis (TB) remains a persistent threat to global health. TB is a contagious, airborne infection, 
second only to HIV in terms of global mortality from a single infectious agent. In 2014, an estimated 
9.6 million people developed TB, including more than 1.1 million new cases among people with 
HIV.33 Although mortality from TB has fallen by 47% since 1990, 1.5 million people died from TB in 
2014; around 25% of these deaths were in people co-infected with HIV.34 Although TB can be 
effectively treated, mortality rates are high in the absence of treatment. This problem is exacerbated 
by the fact that more than one third of new TB cases each year remain undiagnosed.35 
In addition to the challenge of improving access to antiretroviral therapy and anti-TB drugs for 
people who are coinfected with HIV and TB is the escalating crisis of multidrug-resistant TB (MDR-
TB), defined as resistance to both rifampicin and isoniazid, two first-line anti-TB drugs. Globally, in 
2015, around 3.3% of new TB cases and 20% of previously-treated cases were of MDR-TB.36 Of these, 
nearly 10% were estimated to have extensively drug-resistant TB (XDR-TB), due to resistance to 
second-line drugs.37 By the end of 2014, 105 countries had reported cases of XDR-TB.38 
MDR-TB and XDR-TB not only jeopardize progress in TB control, they also illustrate the global 
importance of strengthening health systems, including universal coverage, and in this case universal 
access to diagnosis, care and treatment for people with TB and MDR-TB. Progress towards universal 
coverage requires improvements in diagnostic and surveillance capabilities, and uninterrupted, 
timely access to quality-assured anti-TB medicines, supported by adequate financing.39 Bottlenecks 
to improved management of MDR-TB include weak drug procurement and supply systems, limited 
laboratory capacity, lack of trained staff and adequate treatment facilities, the absence of secure 
funding, and problems with programme management.40 In addition to the role that law plays in 
strengthening the components of the health system, the global challenge of TB draws attention to 
Page | 42  Advancing the right to health: the vital role of law 
 
the need for adequate legal powers to encourage treatment adherence by those with TB in ways 
consistent with the human rights and dignity (see Section 10.3). 
(b)  Noncommunicable diseases 
Noncommunicable diseases (NCDs) – principally cardiovascular disease, cancer, respiratory diseases 
and diabetes – are responsible for around 68% of global mortality (in 2012, around 38 million 
deaths).41 The global transition from communicable to noncommunicable diseases is the result of 
several factors. These include longer life spans due to the relative success of efforts to address 
communicable diseases, the growth of risk factors for NCDs within populations, and the promotion 
of harmful products. Important risk factors for NCDs include tobacco use, harmful use of alcohol, 
excess saturated fat, salt and sugar in the diet, overweight and obesity, inadequate physical activity 
and high blood pressure. WHO has estimated that if current trends continue, by 2030 there will be 
52 million deaths per year caused by noncommunicable diseases.42 
Obesity 
Obesity is now recognized as a major risk factor for heart disease, cancer and diabetes. Between 
1980 and 2013, the global prevalence of overweight and obesity increased by 27.5% for adults and 
47.1% for children.43 In 2014, the age-standardized global prevalence of obesity was nearly 11% in 
men and nearly 6.5% in women; if current trends persist, by 2025 it will reach 18% in men and more 
than 21% in women.44 Although in developed countries rates of overweight and obesity are higher in 
men than in women, the reverse is true in developing countries.45 In low- and middle-income 
countries, the rapid increase in rates of obesity has created a double burden of communicable and 
noncommunicable diseases, with obesity, micronutrient deficiencies, underweight and stunting seen 
side by side within communities and even within the same household.46 In 2014, more than 600 
million adults were obese, and more than 1.9 billion were overweight.47 The number of adults with 
diabetes has been projected to rise from 382 million to 592 million between 2013 and 2035, with a 
108% increase in low-income countries.48 Childhood obesity has also become a serious concern, 
given the higher risks that obese children will face in adult life (see Box 3.4). 
Box 3.4: The epidemic of childhood obesity 
In 2013, around 8% of children and adolescents in developing countries were overweight or 
obese. In developed countries, the rate was around 23%.49 However, rates of increase of child 
overweight and obesity are around 30% higher in low- and middle-income countries than in high-
income countries.50 Overweight and obese children are likely to remain obese into adulthood and 
are more likely to develop NCDs such as diabetes and cardiovascular diseases at a younger age.51 
To reduce levels of obesity among children, governments need to confront the factors that are 
rapidly changing the food and physical activity environments in many countries. Governments 
need to moderate the advertising and promotion of foods and beverages that contain high levels 
of fat and sugar but lack nutritional value. Fresh produce and healthy food options should be 
available, accessible and affordable, especially in low-income neighbourhoods. Communities need 
safe areas where children can play and engage in physical activity, both indoors and outdoors. The 
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meals children eat at school should be healthy and nutritious. In many countries, efforts to reduce 
childhood obesity should be integrated with policies for improving food security and preventing 
undernutrition. In addition to population-wide policies and local community initiatives, 
governments need to allocate resources in order to monitor NCD risk factors, to plan for 
workforce needs, to develop guidelines and policy advice, and to support partnerships with 
professional groups, nongovernmental organizations and other stakeholders.52 
Cardiovascular disease, cancer and tobacco-related diseases 
Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for 17 million 
deaths each year.53 This number is expected to increase to more than 22 million by 2030.54 Over 
three quarters of CVD deaths, and nearly 90% of deaths from chronic obstructive pulmonary disease, 
occur in low- and middle-income countries.55 Cancers caused by infections – such as human 
papillomavirus, Helicobacter pylori and hepatitis B and C – also have a disproportionate impact on 
low- and middle-income countries, accounting for 26% of all cancer cases.56 
In 2012, cancers were responsible for over 8 million deaths; by 2030, WHO estimates that there will 
be more than 12 million cancer deaths each year.57 Tobacco use, lack of physical exercise, obesity, 
harmful use of alcohol, air pollution, infections and ultraviolet exposure are some of the leading 
modifiable risk factors. However, tobacco use stands apart in terms of the sheer scale of harm 
caused by a single, preventable risk factor.58 
Tobacco is responsible for around 6 million deaths each year and nearly 9% of global mortality, 
including 71% of global lung cancer deaths.59 Seventy per cent of these deaths occurred in low- and 
middle-income countries. Due to population growth and aggressive marketing tactics, tobacco 
consumption is rising in many low- and middle-income economies. By 2030, tobacco is likely to be 
responsible for 8 million deaths each year, and 10% of global mortality.60 
The international community has responded to the epidemic of tobacco deaths with the WHO 
Framework Convention on Tobacco Control (WHO FCTC).61 The WHO FCTC commits its Parties to 
passing national laws that address both demand for, and supply of, tobacco products (see 
Chapter 13). Implementing and enforcing the obligations contained in the WHO FCTC is not only the 
first priority for reducing mortality from NCDs, but a sure strategy for extending healthy life 
expectancy and improving productivity. 
WHO’s Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–
202062 sets out a menu of policy options for the prevention and control of the leading NCDs and 
their risk factors.63 Law has a significant role to play in implementing many of these interventions, 
and in strengthening health systems to treat and manage NCDs effectively (see Chapter 7).64 At the 
national level, governance reforms will also be required to facilitate cross-sectoral engagement of 
relevant ministries to reduce risk factors.65 
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(c) Injuries 
Injuries from violence, suicide and accidents – including falls, drowning, burns and poisoning – claim 
more than 5 million lives each year (9% of global deaths), and leave millions more disabled.66 Around 
90% of fatal accidents occur in low- and middle-income countries.67 Where injury-related disability 
affects the head of the household, the impact on family income may lead to reductions in family 
expenditures on food, education, medical care and to greater vulnerability to illness.68 While injuries 
affect all age groups, some groups are more at risk: for those between the ages of 15 and 29 years, 
three of the top five leading causes of death are injury-related.69 
WHO classifies injuries into two groups: intentional (or violence-related) injuries and unintentional 
(accidental) injuries. Each year, over 1.3 million people die from violence, and many more are 
affected by physical, sexual, reproductive and mental health problems as a result of experiencing 
and witnessing violence.70 Violence has a negative impact on national economies, costing billions of 
dollars each year in health care costs, law enforcement and lost productivity.71 In the second group, 
road traffic injuries cause over 1.2 million deaths each year, with a further 20–50 million non-fatal 
injuries.72 
There are a number of powerful interventions that could save lives and reduce unintentional injury-
related disabilities.73 These include: 
• mandatory use of motorcycle helmets, seat belts, and child restraints; 
• physically separating pedestrians from motor vehicles and motor cycles; 
• enforcing controls on speed limits and on driving while under the influence of alcohol; 
• use of safer stoves for cooking; 
• child resistant containers for storing poisons; 
• barriers to separate children from water. 
These interventions rely on improvements in the local environment, the introduction and 
enforcement of legislation, public education and improved product safety.74 
Similarly, interventions are available to reduce intentional injuries from violence and self-harm. 
Specific legislative measures include increasing excise taxes on alcoholic beverages, amending liquor 
licensing laws to restrict the time of sale and location of retail alcohol outlets, minimum age 
purchasing laws and restrictions on the promotion and advertising of alcohol.75 In countries where 
gun ownership is lawful, violence and accidental injuries can be reduced by requiring background 
checks on licence applications for all categories of firearm, by imposing licence restrictions that 
regulate where it is lawful to possess a firearm, and by banning military-style weapons and other 
firearms, including automatic and semi-automatic weapons, which have a massive and rapid 
destructive force. Rates of death and disability from both intentional and unintentional injuries can 
be reduced by improving the availability and quality of emergency care. 
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3.3 Who can initiate public health law reform? 
With so many global health challenges and priorities, who sets the agenda for public health law 
reform? In many countries, the health ministry will initiative the process of legislative review. 
However, legislative review and law reform activities can also originate in other ministries or 
departments, requiring careful collaboration with the health minister. The prime minister or 
president, the cabinet or a law reform commission may also be instrumental in public health law 
reform. The leadership or support of senior ministers and other executives within government can 
be crucial to ensuring that government and parliamentary resources are made available for the 
drafting and debating of the proposed changes, the conduct of community consultation, and for 
ensuring that public health law reform retains its place among the other priorities competing for the 
government’s attention. 
Even where a formal proposal for the introduction of a new law has taken place, it may need to be 
submitted several times before it is accepted within government as a credible option that deserves 
serious consideration. Advocacy for law reform may need to continue through several parliamentary 
and budgetary cycles before new laws are successfully passed. Throughout this process, the 
advocacy and support of senior government officials remains crucial. 
Whichever agency provides leadership, it is important for consultation to occur with other agencies 
and departments that play a role in the implementation or administration of the law. Consultation 
with other ministries can lead to a better understanding of the obstacles that need to be resolved in 
order to implement the law successfully. The experience of Papua New Guinea illustrates this point 
(see Box 3.5). 
Box 3.5: The development of Papua New Guinea’s Provincial Health Authorities Act 
Papua New Guinea’s experience with the Provincial Health Authorities Act illustrates the importance 
of intensive consultation during the process of drafting new public health laws. This Act reflected the 
policy decision, by the National Department of Health, to unify the delivery of public health and 
hospital services at the provincial level. The effective implementation of the new Act required the 
Department to alter its arrangements for the payment of budgeted health funds in order to 
accommodate the newly-created provincial health authorities. Treasury planning and budgeting 
processes required that the payment of funds from the central government to the provincial 
government (for health services delivery) be redirected to the provincial health authorities in order 
to avoid loss of funds to non-health purposes. Since the central budget and financial systems were 
controlled by the treasury, frequent discussions were required in order to fully explain the new 
policy, and to gain the understanding and support that was necessary for the modification of the 
budgetary process and implementation of the legislation. One outcome of this consultation process 
was that treasury guidelines were amended to make explicit reference to the new provincial health 
authorities and to the need for funds to be paid directly to them. 
Outside government, proposals for the reform of public health laws may be improved by 
consultation with other major stakeholders, including the health professions, the private sector, civil 
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society, philanthropic organizations, academia and the media. Government can encourage feedback 
by publishing discussion papers that set out draft proposals and invite comment. 
In some cases, civil society organizations may become directly involved in law reform. A dramatic 
illustration of this occurred in Brazil during the period of constitutional reform in the latter half of 
the 1980s, when the text of the constitutional amendments dealing with health was developed by a 
group of nongovernmental organizations working in the health sector. The text of these popular 
amendments was adopted, with only minor changes, by the Constituent Assembly and now appears 
in the Federal Constitution of the Brazilian Republic (1988).76 These provisions confirm the right to 
health and recognize a corresponding duty at all levels of government to protect and promote it. 
They also established a public health system (Sistema Único de Saúde, or “SUS”), financed from the 
social security budget, with contributions from other levels of government, that encompasses the 
control of health risks and the “promotion, protection and recovery” of health.77 
Although stakeholder input can influence the design of new laws, governments should take care to 
ensure that lobbyists and sectional interests do not undermine the public health goals that they are 
seeking to achieve.  The risk of industry interference has been widely recognized. For example, the 
guidelines for implementation of the WHO FCTC, adopted by Parties to the Convention, emphasize 
the importance of resisting the tobacco industry’s attempts to influence the development and 
implementation of tobacco control laws and policies.78 Other industries, including the alcohol, food 
and pharmaceutical industries, have a strong commercial interest in influencing laws and policies 
that affect them. In all cases, policy-makers will need to determine whether, and for what specific 
purposes, consultation or collaboration is appropriate, bearing in mind the possibility that industry 
groups may seek to weaken regulation and to undermine the goals that the government is seeking 
to achieve. 
3.4 What factors can act as triggers for public health 
 law reform 
(a) Triggers for public health law reform within government 
Within government, there will be a variety of political opportunities for prioritizing public health 
policies and for initiating the process of law reform. These may arise within the context of 
developing a poverty reduction strategy, a national public health strategy, or reporting to 
development partners. Disease outbreaks and national public health emergencies may also provide 
opportunities for advocacy to government by professional and nongovernment organizations, and 
for leadership by government in the area of public health law reform. Sunset clauses may also 
require the government to formally consider re-authorizing, extending or reforming current laws. 
International instruments can draw attention to particular health challenges arising at the country 
level and serve as a catalyst for national law reform. Examples include the WHO FCTC,79 the 
International Health Regulations (2005),80 the International Code of Marketing of Breast-milk 
Substitutes,81 the set of recommendations on the marketing of foods and non-alcoholic beverages to 
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children,82 and the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 
2013–2020.83 In the case of treaties and regulations, countries have an obligation under 
international law to implement these instruments by amending their domestic laws and developing 
their national capabilities. 
(b) Community participation as a trigger for public health law reform and 
policy-making 
In some countries, formal mechanisms for community participation in government processes may 
assist civil society organizations to put health issues on the agenda of government and to participate 
in law-making. For example, citizen-initiated referenda may allow citizens to petition government on 
a popular issue. In Brazil, legislation enacted in 1990 establishes the National Health Council as a 
“permanent collegiate deliberative body” representing government, service providers, health 
workers and health service users, which participates in the development of health policies and 
monitors their implementation.84 At the state and municipal levels, the establishment of health 
councils is a precondition to the receipt of federal funds from the National Health Fund.85 By 2008 
there were over 5500 municipal health councils in Brazil.86 
Policy conventions and health congresses provide opportunities for citizens to identify national 
health priorities, to monitor progress in implementation, and to advocate for law reform. In Brazil, 
the National Health Conference is required to meet every four years to evaluate the health situation 
in Brazil and to propose health policy directives.87 In Thailand, the National Health Act of 2007 
formalizes community participation in the formation of health policy through the National Health 
Assembly (NHA).88 Topics that are successful in reaching the agenda of the NHA are supported by 
briefing papers and debated. Although resolutions passed at the NHA are non-binding, they are re-
shaped by the National Health Commission for consideration by relevant ministries. 
(c) Litigation and public health law reform 
Civil society organizations have often turned to the courts as a remedy for injustice and 
discrimination within the health sector, litigating the absence of tobacco control laws, lack of access 
to health care services, clean water, sanitation and housing, and adequate food.89 National 
constitutions frequently protect individuals from legislative and executive actions that interfere with 
the civil and political rights of the individual. Some constitutions also recognize social and economic 
rights and oblige the State to take positive actions to secure these rights for the benefit of the 
population. This section focuses on legal claims which assert that the fundamental protections 
contained in a national constitution, a bill or charter of rights, or a ratified international agreement, 
require governments to alter their policies or practices – in ways that advance the realization of the 
right to health. In some cases, successful litigation may prove to be the catalyst for the subsequent 
introduction or amendment of public health laws. 
Around two thirds of countries have constitutional provisions recognizing a right to health or health 
care services.90 Typically, these provisions require the legislature, the executive and other organs of 
State to take reasonable measures to secure the enjoyment of the right within the limits of available 
Page | 48  Advancing the right to health: the vital role of law 
 
resources. For example, in several cases the South African Constitutional Court has ruled that the 
government has a positive obligation to take reasonable measures to fulfil basic socioeconomic 
rights, including the right to health care, food and water, and housing or land.91 
In South Africa, the existence of social and economic rights in the Constitution obliges government 
to protect these rights not only through legislation, but also through the effective implementation of 
policies designed to improve public health. For example, when ruling that the Constitution imposes a 
positive obligation on the government to take action to fulfil the right to housing, the South African 
Constitutional Court stated that legislation alone – without effective change – would not satisfy this 
duty.92 Box 3.6 presents a case study of litigation whose substantive effect was to require the South 
African government to implement a national plan of action to provide HIV-positive pregnant women 
with reasonable access to nevirapine, a drug for preventing the perinatal transmission of HIV from 
mother to child. 
Box 3.6: The right to health and reasonable access to nevirapine in South Africa 
In Minister of Health v Treatment Action Campaign (No. 2),93 a coalition of civil society organizations 
challenged the decision of the South African Government to impose restrictions on the availability of 
nevirapine within the public health sector. 
WHO recommended nevirapine for the prevention of mother-to-child HIV transmission in January 
2001, and the Medicines Control Council formally approved its use in South Africa in April of the 
same year. As a result, medical practitioners in the private sector became entitled to prescribe 
nevirapine in appropriate cases. The risk of HIV transmission from a pregnant, HIV-positive woman is 
substantially reduced through a single dose of nevirapine during pregnancy, and by the 
administration of a few drops to the baby within 72 hours of delivery. According to government 
estimates at the time, around 70 000 children became infected with HIV perinatally each year. 
Despite the fact that the manufacturers of nevirapine had offered it to the South African 
Government without charge, for a period of five years, the ability to prescribe nevirapine within the 
public health system was limited to two sites per province, while research continued for a further 
period of two years into the safety and efficacy of the drug and the operational challenges of making 
it more widely available. These included the challenges of making confidential counselling and HIV 
testing services widely available to pregnant women. 
The South African Bill of Rights provides that everyone has the right to access “health care services, 
including reproductive health care”.94 Every child has the right to “to basic nutrition, shelter, basic 
health care services and social services”.95 The State is required to use legislative and other 
measures, to progressively realize these rights, within its available resources.96 
The South African Supreme Court held that the safety concerns about nevirapine were no more than 
“hypothetical”, and that the cost of nevirapine was not at issue. It held that the government was not 
justified in restricting the availability of nevirapine to those sites where it could be provided as part of a 
broader “comprehensive package” of services for preventing mother-to-child transmission and that 
the restrictions on public sector availability unreasonably excluded women who could not access the 
chosen sites. The Court said: “To the extent that government limits the supply of nevirapine to its 
research sites, it is the poor outside the catchment areas of these sites who will suffer”.97 
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The Court concluded that the government’s “inflexible” policy of limiting the availability of a 
“potentially lifesaving drug” was in breach of both the right to health care in Article 27 and the rights 
of children as set out in Article 28. As the Court pointed out, this finding required a change in 
government policy: “The policy will have to be that nevirapine must be provided where it is 
medically indicated at those hospitals and clinics within the public sector where facilities exist for 
testing and counselling”.98 
The orders made by the Court emphasized the positive obligations imposed on the government by 
the constitutional right to health. These included the delivery, within available resources, of a 
comprehensive health care programme to progressively realize the rights of pregnant women and 
their children to services to prevent the transmission of HIV, including reasonable measures for 
testing and counselling of women to reduce the risk of perinatal transmission. 
In Colombia, the Ministry of Social Protection initiated a sweeping reform of its health system – 
including changes in the coverage of health care services – following a finding by the Constitutional 
Court that systemic problems within the public health system constituted failure to fulfil the right to 
health.99 Other courts have mandated that states reallocate funds to secure access to treatment for 
all, regardless of expense. Peru and the Bolivarian Republic of Venezuela also adjusted their public 
health spending following such rulings.100 
Even in countries where the constitution does not protect the right to health, other constitutional 
rights may nevertheless provide indirect protection. For example, although there is no right to 
health in the Indian Constitution, the Supreme Court has interpreted the constitutional right to life 
(Article 21) to impose a duty on the government to safeguard life, which extends to providing for 
emergency health care services.101 
In Murli Deora v Union of India,102 the Supreme Court of India held that smoking in public violates 
the right to protection of life and personal liberty contained in the Constitution. It issued an order 
requiring the federal and state governments to ensure implementation of the prohibition on 
smoking in a number of public settings. These restrictions were included in subsequent national 
tobacco control legislation, passed in 2003 (Box 3.7). 
Box 3.7: Protection from exposure to second-hand smoke through the constitutional right to life 
and to personal liberty in the Indian Constitution 
Part III of the Constitution of India sets out a number of fundamental rights and liberties, including 
Article 21, which states: “No person shall be deprived of his life or personal liberty except according 
to procedure established by law”. Under Article 32 of the Constitution, individuals may petition the 
Supreme Court to enforce these rights, and the Supreme Court may issue appropriate orders. 
In Murli S. Deora v Union of India,103 the petitioner relied on Article 21 of the Constitution to seek an 
order protecting non-smokers from harm caused by exposure to tobacco smoke in public places. At 
the time the case was heard, India’s federal Tobacco Act contained no restrictions on smoking in 
public places, although a bill had been introduced into Parliament and was awaiting consideration by 
a Select Committee. The Attorney-General of India and counsel for the various states agreed that it 
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was in the interests of citizens for the Court to make an order protecting citizens from 
environmental tobacco smoke until the federal Act could be amended. 
Referring to the rights guaranteed under Article 21, the Court asked why a non-smoker should be 
threatened with fatal diseases, including cancer or heart disease, as a result of exposure to tobacco 
smoke in public: “Is it not indirectly depriving [a person] of his life without any process of law? The 
answer is obviously – ‘yes’.”104 
After considering the effect of smoking on both smokers and non-smokers, the Court issued an order 
prohibiting smoking in public places and requiring federal and state governments to “take effective 
steps to ensure [the prohibition of] smoking” in “auditoriums, hospital buildings, health institutions, 
educational institutions, libraries and court buildings, and public conveyances including railways”.105 
The effect of this order was to give constitutional protection against exposure to second-hand smoke 
in public places in India. In 2003, the Parliament of India passed the Cigarettes and Other Tobacco 
Products Act, which prohibits smoking in a “public place”, defined to include the places identified in 
the order of the Supreme Court.106 
Similarly, in 2001, a public interest applicant, the Environmental Action Network, sought a 
declaration in the High Court of Uganda that public smoking violated a number of constitutional 
rights including the right to life (Article 22) and the right to a healthy and clean environment (Article 
39). In one of several judgments relating to this application, Justice Ntabgoba commented that 
“unregulated smoking in public places constitutes a violation of the rights of non-smoking members 
of the public”, depriving them of a clean and healthy environment.107 As a result of this litigation,108 
the National Environment Management Authority issued regulations in 2004 banning smoking in a 
range of public places.109 
Cases like this illustrate that litigants, and public health organizations, can be powerful agents for 
change. The history, and legal and constitutional context of each country is unique. It follows that 
stakeholders will need to identify allies, and to consider how the available political, legal and 
constitutional processes might be used most effectively to build momentum towards the 
improvement of public health policies and the introduction of effective public health laws. The 
environment for reform is likely to be most favourable where deficiencies in a country’s public 
health laws have been recognized and demonstrated, where law reform proposals have been 
identified and discussed with major stakeholders, and where political champions are ready and able 
to take the issue forward.110 Civil society organizations and the media play a vital role throughout the 
public health law reform process. 
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Chapter 4: Building blocks for effective  
public health laws 
 
SUMMARY POINTS 
 
· Public health legislation should clearly set out the mandate, powers and responsibilities of the 
government and of public health officials. This not only ensures that public health officials have 
the powers they need; it also helps to ensure that governments remain accountable for the 
discharge of their statutory duties and functions. 
· The responsibilities of regional, local and city councils should be explicitly set out in legislation. 
However, countries that have devolved public health functions to regional and local levels should 
ensure that national coordination is not jeopardized, and that the availability, accessibility and 
quality of public health services is not thereby compromised. 
· Public health legislation should establish clear mechanisms for coordinating the activities of 
different levels of government during public health emergencies. 
· Governments may consider imposing a general duty on persons not to create a serious risk to 
public health (as defined), and a general power that permits the minister or chief health officer to 
take action and to make such orders as are reasonable and necessary to deal with a risk to public 
health. However, except in cases of genuine emergency, legislation should authorize the courts to 
review the exercise of executive powers. 
· Governments have an obligation to frame public health laws in ways that are consistent with 
human rights obligations. In some countries, a human rights commission or equivalent body can 
investigate complaints of discrimination occurring on the basis of protected attributes set out in 
legislation. These protected grounds may include sex, religious belief, colour, race or ethnic 
origins, disability, age, political opinions and marital or family status. 
· Governments should seek to ensure coherence between public health laws and criminal laws. 
For example, criminal penalties for the transmission of HIV may have unintended effects, 
discouraging women from being tested or from having their babies tested for fear of prosecution. 
Introduction 
This chapter considers some building blocks for good public health laws that may assist law 
reformers as they design legislation and implement the recommendations of a legislative review 
process. Effective legislation must be built on a solid understanding of the specific legal powers and 
safeguards that are needed in order to respond effectively to the situation at hand. Where they exist, 
model laws may provide helpful guidance. However, law reform is a country-owned process that will 
reflect the legal history, legal and constitutional structure and political context of each country. As a 
result, the legal mechanisms used to implement law reform recommendations may vary 
considerably, even between countries that share a similar culture, language and geography. 
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4.1 Legislative goals, mandates and principles 
The public health functions of government cover a wide range of activities (Table 4.1). In considering 
public health law reform, governments need to consider the way in which these functions can best 
be supported by legislation. It is important for public health laws to explicitly set out the mandate, 
powers and responsibilities of government, and of public health officials. This not only ensures that 
health ministries and public health officials have the powers they need, but also helps to ensure that 
they remain accountable for the discharge of their statutory duties and functions. It also ensures that 
health ministries do not overlook critical functions or responsibilities or adopt an unduly narrow 
definition of public health. 
Table 4.1: The core public health functions of government 
Generating 
evidence for 
action 
Surveillance and monitoring of the health status of the population, and of health 
risks. 
Taking action Public health protection and assurance, including through the performance of 
regulatory functions and the discharge of legislative responsibilities relating to the 
investigation of health risks and the prevention of disease and injury. 
Taking action Health promotion, including education and partnerships to support community-
based health programmes and to empower individuals to live healthy lives. 
Financing Financing of public health interventions, including financing essential medicines 
and technologies and health care services. 
Training Training and capacity-building, including accreditation and renewal of the public 
health workforce. 
Supporting 
research 
Research and evaluation, including funding research and developing research 
capacity. 
There is no single way of expressing the goals and objects of public health legislation, since these 
goals will reflect the specific needs of each country and the distribution of powers and 
responsibilities between ministries and levels of government. In the Australian state of Victoria, the 
Public Health and Wellbeing Act 2008 states that the objective of the Act is: “to achieve the highest 
attainable standard of public health and wellbeing by: 
(a) protecting public health and preventing disease, illness, injury, disability or premature death; 
(b) promoting conditions in which people can be healthy; 
(c) reducing inequalities in the state of public health and wellbeing”.1 
This legislative mandate encompasses three important themes. Firstly, governments have a duty to 
protect and promote the health of the population as a whole. This duty extends to those who, for 
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example, live in remote parts of the country, or who cannot afford to pay for services. Secondly, 
governments have a duty to work to reduce health inequalities. This means giving special attention 
to the health needs of the disadvantaged and vulnerable: those people whose health needs might be 
forgotten if government focused only on improving the average level of health. Both of these ideas 
are encompassed by the obligation of governments to ensure that health facilities, goods and 
services are accessible – economically, physically and without discrimination – to all members of the 
population.2 Thirdly, by recognizing the goal of promoting the conditions for healthy living, the 
legislation recognizes the concept of sustainability, understood here to mean that people should 
possess the resources that enable them to lead a healthy life, now and into the future. Sustainability 
also has an important intergenerational dimension: governments have a duty to develop policies to 
protect the health of future generations from emerging threats, such as the health consequences of 
climate change.3 
The legislative goals set out in South Africa’s National Health Act (see Box 1.5 in Section 1.2) provide 
another example. This Act establishes a national health system with the goal of providing equitable 
access to the “best possible health services that available resources can afford”.4 In view of the 
enormous and persistent health inequalities suffered by large parts of the population as a result of 
the policies of apartheid, the Act draws attention to the goal of providing “uniformity in respect of 
health services across the nation”. The Act acknowledges that the achievement of this goal is assisted 
by the obligation of the State to protect, respect, promote and fulfil key constitutional rights 
affecting health. These include the right to health care services, including reproductive health care, 
an environment that does not harm health or well-being, and basic nutrition for children. The Act 
gives powerful expression to the need for government to protect vulnerable groups, including 
women, children, the elderly and those with disabilities. 
In some countries, public health legislation includes statutory principles that are intended to provide 
guidance to those who administer the legislation. For example, Victoria’s Public Health and Wellbeing 
Act, discussed above, provides that decisions about public health interventions, and the use of 
resources to promote and protect public health, should be evidence-based. However, when faced 
with a serious public health threat, “lack of full scientific certainty should not be used as a reason for 
postponing measures to prevent or control the public health risk”.5 Balancing the need to act on the 
basis of evidence with the need to prevent significant threats to public health is an important 
function of government. In order to ensure accountability, members of the public should have access 
to reliable information about risks to public health and the opportunity to participate in the 
development of policies and programmes. 
4.2 Powers and responsibilities of the health ministry, 
 and coordination with other agencies 
Public health legislation should clearly state the functions and responsibilities of the relevant 
Minister. In many countries, these Ministerial or departmental functions are exercised through a duly 
appointed chief health officer (or equivalent). The chief health officer’s functions will usually include 
advising the Minister, and ensuring compliance with public health legislation. These functions may 
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also include the preparation of public health plans, proposals for improving services and submitting 
periodic reports to the Minister on the state of public health within the jurisdiction. 
The factors that influence health, both positively and negatively, are complex, ranging across a 
number of sectors and – as a result – government agencies and ministries. For this reason, an 
effective response to a particular risk or health challenge may require the carefully coordinated 
exercise of statutory powers by a number of agencies – often referred to as an “all-of-government” 
approach. For example, while many countries will have an agency or department that regulates 
tobacco products, misleading and deceptive claims about the health impact of particular products 
may be more appropriately dealt with by the agency that regulates consumer affairs and business 
conduct, rather than a health agency. Legislation can facilitate intersectoral and interdepartmental 
responses to health risks in a variety of ways. For example, public health legislation may explicitly 
authorize the chief health officer or health ministry to seek the assistance and collaboration of other 
government agencies in responding to a specific issue. 
Regional, municipal, local and city councils play an important role in public health administration, by 
enforcing legislation within local government boundaries, and by contracting for or ensuring the 
direct provision of core public health services, such as immunizations, postnatal health checks of 
mothers and children, and the removal of waste and rubbish. The responsibilities of local 
government and of local public health officials should be explicitly stated in the legislation. 
Legislation may require local councils to prepare public health plans, and to report on their progress 
in meeting local area objectives.6 
Subject to local circumstances, the delegation of public health functions to the local level may create 
the risk that these functions will not be performed, a risk which may be exacerbated by lack of 
resources. To minimize this risk, legislation may set out a process for local councils to cooperate 
jointly in a broader regional response to public health risks, for a council to transfer its functions to 
the chief health officer, or for the minister to direct the chief health officer to perform the functions 
that a local council has failed to perform. Countries that have devolved key public health functions to 
the local level should ensure that the capacity and obligation of the national government to ensure 
the availability, accessibility and quality of public health services is not thereby compromised (see 
Section 1.2). 
Coordination is critical during public health emergencies. For example, coordination may be required 
between different levels of government (national, state, local, and city governments), and between 
agencies and ministries with specialized responsibilities in the areas of customs, border control, 
passenger surveillance, human quarantine, contact tracing, travel advisories and the reporting of 
notifiable and quarantinable diseases. At the global level, the International Health Regulations (2005) 
require countries to designate a National Focal Point for coordinating the flow of information 
between WHO and relevant parts of the government of each country.7 At the national level, law 
reformers may consider a formal legislative mechanism for ensuring coordination between relevant 
national, regional, local and city administrations. Formal intergovernmental agreements may also 
achieve the same result. 
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4.3 Legal tools and strategies for discharging public 
 health responsibilities 
Government officials and other stakeholders engaged in the revision of public health laws need to 
approach the process of implementing law reform recommendations with a good working knowledge 
of the variety of legal strategies that the law makes available. The wide range of matters regulated in 
public health statutes can be understood in terms of these basic strategies, which are summarized in 
Table 4.2 and discussed in detail below. 
Table 4.2: Some important strategies and targets for public health law8 
Public health infrastructure and governance structures: A government can use law to establish 
agencies with legal mandates, and to establish the infrastructure, processes and capabilities that 
enable the government to discharge its public health functions. 
Economic policies: Governments have the power to impose taxes and to spend taxation revenues on 
funding or subsidizing the provision of health-related goods and services (e.g. health care services, 
immunizations and subsidized pharmaceuticals). Governments can make grants, offer subsidies and 
create economic incentives and disincentives to encourage healthier behaviours, choices and 
purchases. 
The informational environment: Governments can use law to shape the informational environment 
in order to encourage healthier behaviours, to inform consumer choices, to protect the population 
from misleading and deceptive communications and to moderate exposure to the commercial 
marketing of unhealthy products. The mandatory collection of information by governments creates 
information assets that can inform the allocation of resources and ensure a timely response to health 
risks, including during public health emergencies. 
Regulation of businesses, professionals and individuals: Governments can mitigate risks to health by 
imposing specific technical requirements, and performance standards on businesses, employers and 
providers of goods and services. 
Environmental policies: Law is a powerful tool for improving the environments in which people live, 
work, eat and play. Governments can use law to mitigate risks to health in the natural environment 
(in relation to water, air and soil, natural disasters), while shaping the built environment in ways that 
minimize risks to health and encourage healthy behaviours. 
Health inequalities: In considering the use of law in each of the areas noted above, governments 
have a responsibility to ensure that there is equality of opportunity in access to health services and 
to other resources that are needed to live a healthy life. 
Indirect regulation through the tort system: While government is the key actor in protecting public 
health, national constitutions and legal systems may also permit individuals to vindicate private 
rights in ways that benefit the health of the public.  
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The basic strategies listed in Table 4.2 are described in more detail below. 
Public health infrastructure and governance structures 
As discussed above, public health law reform begins by establishing the public health infrastructure: 
setting out the legal mandate of the Minister of Health, and of key public health officials. Legislation 
supports the administration of the public health system by creating the structures and pathways for 
communication and coordination between ministries, and between different levels of government. 
Economic policies 
Secondly, governments can use economic policies in a variety of ways to support public health and 
the costs of public health administration. For example, governments can impose excise taxes in order 
to suppress demand for tobacco and for other products whose consumption may carry health risks, 
such as alcohol and sugar-sweetened beverages. It can impose licensing fees on food establishments 
in order to offset the costs of performing food safety inspections and other health-related functions.9 
Compliance with legal requirements that prohibit certain kinds of conduct (e.g. dumping toxic waste, 
polluting a waterway or selling tobacco to children) is often encouraged through the imposition of 
fines and other penalties. Governments can make grants to lower levels of government to support 
public health programmes and the delivery of services. These grants may be subject to conditions 
that recipients must meet, including the provision of matching funds.10 For example, in the United 
States, as a condition for receiving federal grants for mental health and substance abuse 
programmes, the federal government imposed a legislative condition requiring the states to pass 
laws prohibiting the sale of tobacco products to children.11 Conditional grants are an important 
strategy that national governments can use to encourage regional and local governments to 
discharge their public health obligations. 
The informational environment 
Thirdly, good information is a foundation for healthy policies and behaviours. Governments have a 
role in educating the public about health risks, and encouraging healthy behaviours. For example, 
governments can influence the informational environment through the regulation of food labelling, 
or by requiring the provision of warnings to consumers about the risks of particular products (e.g. 
tobacco), or activities (e.g. use of sunbeds).12 The provision of information by government to support 
individuals to make informed choices about their health forms part of the obligation of governments 
to fulfil the right to health.13 Subject to constitutional considerations, governments can also restrict 
the advertising of certain goods, including tobacco and alcohol.14 
Regulation of businesses, professionals, and individuals 
Fourthly, governments can regulate businesses and other providers of goods and services in order to 
mitigate risks to health (e.g. through occupational health and safety standards, emission standards, 
manufacturing standards, regulations on working conditions and other controls on manufacturers 
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and retailers).15 Conventionally, statutory regulation takes the form of technical requirements that 
are identified and described by the State, and set out in legislation, regulations or codes of practice. 
However, legislation may also require businesses to meet specific targets and performance 
standards, while permitting a degree of flexibility in how these will be achieved. This may create 
incentives for businesses to innovate and find new ways of reducing pollution, improving the 
nutritional quality of food, or reducing risks associated with their products. 
Environmental policies 
The capacity to lead a healthy life is powerfully influenced by the physical environment, which 
encompasses both the natural and the built environment. Public health regulation has long 
recognized that the quality of the natural environment has direct impacts on health, whether 
through contaminated air, water or soil or through the health consequences of natural disasters. 
Governments can use law to shape the built environment in ways that reduce health risks and 
encourage healthy behaviours, for example by improving access to healthy food, improving safety 
and security in urban areas, and creating safe, well-lit open spaces that facilitate physical activity.16 
Health inequalities 
In order to discharge their responsibility to provide “equality of opportunity for people to enjoy the 
highest attainable level of health”,17 governments must address the socioeconomic factors that 
contribute to health inequalities. Law is a powerful tool for ensuring that the poor and vulnerable are 
not deprived of access to health care services and other resources for leading a healthy life. The 
context of government interventions in this area is likely to vary significantly from country to country, 
and to cover a wide range of economic and regulatory interventions. Examples include: government-
subsidized school lunches and breakfasts for the children of low-income families, the subsidized 
provision of pharmaceuticals to aid smoking cessation, the provision of long-lasting insecticide-
treated mosquito nets to high-burden areas (see Section 8.2), and cash transfers to alleviate poverty 
and stimulate economic growth.18 
One way that legislation can help to reduce health inequalities is by recognizing the right of 
individuals to challenge policies and actions that undermine the freedoms and entitlements that 
comprise the right to health. Box 4.1 draws on the conclusions of a study of constitutional provisions 
recognizing the right to health in east and southern Africa, and illustrates the variety of forms that 
these provisions take.19 Legislative recognition of the entitlement of everyone to a basic system of 
health protection (encompassing health care services, vaccination and essential medicines) is likely to 
increase pressures for these entitlements to be realized, through effective planning and resource 
allocation by governments. It can also provide the basis for more effective advocacy by civil society 
organizations, and litigation to challenge denial of these rights. 
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Box 4.1: Legal recognition of the right to health and to other health-related rights: some best 
practice examples from eastern and southern Africa 
Constitution of the Republic of Mozambique, Article 116: non-discriminatory access to health 
facilities20 
1. Medical and health care for citizens shall be organized through a national health system, which 
shall benefit all Mozambican people. 
2. To achieve the goals of the national health system, the law shall establish the ways in which 
medical and health care is delivered. 
3. The State shall encourage citizens and institutions to participate in raising the standard of 
health in the community. 
4. The State shall promote the expansion of medical and health care and the equal access of all 
citizens to the enjoyment of this right... 
Constitution of the Republic of South Africa, Section 27: the right to health care, food, water and 
social protection21 
1. Everyone has the right to have access to 
a. health care services, including reproductive health care; 
b. sufficient food and water; and 
c. Social security, including, if they are unable to support themselves and their dependants, 
appropriate social assistance. 
2. The state must take reasonable legislative and other measures, within its available resources, to 
achieve the progressive realization of each of these rights. 
3. No one may be refused emergency medical treatment. 
Constitution of the Republic of Uganda: national objectives and directive principles of State 
policy22 
XIV. General social and economic objectives 
The State shall endeavour to fulfil the fundamental rights of all Ugandans to social justice and 
economic development and shall, in particular, ensure that- 
… 
(ii) all Ugandans enjoy rights and opportunities and access to education, health services, clean and 
safe water, work, decent shelter, adequate clothing, food security and pension and retirement 
benefits. 
XXII: Food security and nutrition 
The State shall: 
(a) take appropriate steps to encourage people to grow and store adequate food; 
(b) establish national food reserves; and 
(c) encourage and promote proper nutrition through mass education and other appropriate 
means in order to build a healthy State. 
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Indirect regulation through the tort system 
Although the strategies discussed above are principally legislative, governments can also promote 
the health of the population indirectly by ensuring that individuals who have suffered harm can 
access the courts and pursue private remedies. Successful claims for compensation, injunctions, 
declarations and other remedies can create pressure on businesses, employers and others to change 
their products and practices in ways that reduce health risks. In addition, supporting the capacity of 
individuals and groups to pursue public interest litigation, and to make effective use of the health-
related rights set out in national constitutions, is an important strategy for advancing the right to 
health.23 The capacity for public interest litigation to serve as a trigger for public health law reform 
was discussed in Section 3.4(c). 
Governments can also promote public health by properly resourcing an independent agency to 
protect consumers from harmful, deceptive and manipulative claims and practices that create risks 
to health. Consumer protection agencies have a unique mandate to protect the public interest by 
preventing businesses from exploiting the vulnerability and trust of consumers. For example, without 
regulation, tobacco companies may advertise that “light” or “mild” cigarettes are less harmful than 
others, pharmaceutical companies may advertise the health benefits of untested or harmful 
compounds, and food businesses may undermine breastfeeding by making claims about the benefits 
or superiority of breast-milk substitutes. 24 
4.4 Building flexibility into public health laws 
Knowledge and understanding of the determinants of health and disease have evolved rapidly over 
the past few decades. New risks and hazards continue to emerge and the predominant causes of 
death and disability are also changing at the country level. These factors support the need for 
flexibility in the operation of legal powers to enhance the law’s capacity to respond to new and 
emerging health risks. For example, by framing legal powers in generic terms, and by permitting the 
health ministry to add new diseases or risks through subsidiary regulations or executive orders, 
lawmakers can dramatically reduce the time involved in responding to new threats (Box 4.2). 
Box 4.2: Building flexibility into public health legislation 
The threats and risks to public health that require regulation are likely to evolve over time. 
Legislatures have developed a wide variety of statutory mechanisms for building flexibility into 
public health laws. Examples include: 
• Communicable diseases: Despite some exceptions (e.g. HIV), it will usually be impractical to 
enact new laws that are designed specifically to meet each new disease or threat. Typically, 
communicable diseases are regulated through generic provisions in public health laws. These 
provisions may impose reporting requirements, and new diseases or threats can be declared by 
executive order to be “notifiable diseases” as soon as there is an adequate case definition. Similarly, 
an emerging, highly transmissible disease may be declared to be a “quarantinable disease” under 
legislation dealing with public health emergencies, thus triggering a range of additional powers. 
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• Noncommunicable diseases: In British Columbia (Canada), the Public Health Act (2008) provides 
that a “condition, thing or activity” that causes or is associated with a “health impediment” may be 
prescribed and thereafter regulated in regulations. The concept of a health impediment refers to 
something that adversely affects public health over a period of time, that causes “significant chronic 
disease or disability in the population”, or that interferes with public health initiatives for the 
prevention of chronic disease and disability. British Columbia has used this legislative mechanism to 
prescribe transfats as a health impediment, and thereafter to impose limits on transfats originating 
from partially hydrogenated vegetable oil and margarine within food service establishments. This 
mechanism has also been used to authorize the screening of children for vision and hearing 
impairments, and tooth and gum decay, with test results being communicated to parents. 
• Power to regulate “public health risk activities” and “public health risk procedures”: In the 
Australian Capital Territory, the Public Health Act (1997) gives the Minister of Health the power to 
declare an activity (or a procedure forming part of that activity) that may result in disease 
transmission or harm to health as a “public health risk activity”. Thereafter, the Minister can impose 
licensing conditions on that activity. An “improvement notice” can be issued to a person carrying on 
a public health risk activity or performing a public health risk procedure. A “prohibition notice” can 
also be issued. This mechanism has been used to regulate water utilities and businesses performing 
skin penetration procedures, including tattooing and body piercing. The same Act contains powers 
allowing the Minister to issue Codes of Conduct for the performance of particular activities. Codes 
issued by the Minister must be put before Parliament in the same way as other regulations made 
under the Act. 
Flexibility is an important attribute in public health legislation because it preserves the capacity for 
judgments to be made by public health officials about whether or not a regulatory response is 
necessary or appropriate in the circumstances. At the international level, the International Health 
Regulations (2005) preserve flexibility by requiring countries to respond to any “public health 
emergencies of international concern”, rather than only to specific diseases.25 In order to determine 
whether an event may constitute a public health emergency of international concern, within their 
territories, countries apply an algorithm that requires consideration of whether the outbreak is 
serious, unexpected and carries significant risk of international spread, and whether there is a 
significant risk of international restrictions to travel and trade as a result. Within countries, legislation 
can preserve flexibility by authorizing public health officials to exercise powers that are triggered by 
the assessment, on reasonable grounds, that a particular outbreak, event or occurrence creates a 
serious risk to public health. 
Flexibility is also important because of the difficulty of predicting emerging health risks or even 
providing a comprehensive list of current ones. This explains why public health statutes may also 
contain a general duty not to create a “significant risk” or a “serious risk” to public health (as 
defined).26 Legislation may also contain a general power that permits the Minister to take action and 
to make orders that are reasonable and necessary to deal with a risk to public health. Legislation 
should clearly define the conditions that must be met before such powers are exercised, and, 
wherever feasible, authorize the courts to review the exercise of executive powers. 
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4.5 Integrating human rights protections into public 
 health law 
The process of reforming public health laws provides an important opportunity for lawmakers to 
integrate human rights safeguards into health legislation. Human rights encompass both civil and 
political rights, such as non-discrimination and privacy, as well as the right to health itself and other 
social and economic rights (see Box 1.2 in Section 1.1). While human rights have inherent value, they 
also have an important instrumental value within public health legislation. 
The right to health, as recognized in international law, provides a foundation for development. 
General Comment 14,27 discussed in Section 1.1, frames the right to health in terms of the “facilities, 
goods, services and conditions” that are necessary to realize the highest attainable standard of 
health.28 In addition to non-discriminatory access to appropriate health care services, the right to 
health encompasses rights to a range of underlying determinants of health. These include: access to 
safe water, an adequate supply of uncontaminated food, adequate sanitation and housing, healthy 
working conditions and a healthy environment, as well as access to health-related education, 
including on sexual and reproductive health.29 
Viewing the public health law reform process through the lens of a country’s obligation to 
progressively realize the right to health carries some important benefits. For example, it ensures that 
States do not define their responsibilities too narrowly; it also draws attention to the broader social 
determinants of health and to the importance of considering the health impacts of policies and laws 
across many sectors of government.30 
Self-evidently, the violation of human rights (e.g. slavery, torture, violence against women and 
children, hazardous working conditions, and the maiming and disfigurement of the body) can lead to 
lifelong ill-health. Failure to protect the human rights of vulnerable groups can also lead to ill-health 
as a result of the denial or discriminatory provision of services and resources. This is a particular 
problem for marginalized groups who experience deprivation as a result of absent or inadequate 
access to basic infrastructure, including water, electricity, adequate sanitation, transport, housing 
and health care (see Section 1.1). Human rights violations can also harm health in more indirect 
ways. For example, children deprived of education are less likely to acquire the knowledge and skills 
that are necessary to lead a healthy lifestyle and to make healthy choices. Discrimination against 
marginalized groups can affect mental health and well-being, leading to harmful lifestyles, violence 
and self-harm. 
Discrimination against women and children is an important area for countries to address, given the 
health inequalities that women and children can suffer because of discrimination based on their sex 
or age. The Convention on the Elimination of All Forms of Discrimination against Women targets 
discrimination in services affecting women.31 In particular, Article 12(1) recognizes that States must 
“take measures … to ensure, on a basis of equality of men and women, access to health care services, 
including those related to family planning”.32 
The Convention on the Rights of the Child also highlights the importance of protecting children from 
discrimination.33 Article 2.1 requires States to respect the protections set out in the Convention, 
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without reference to the “race, colour, sex, language, religion, political or other opinion, national, 
ethnic or social origin, property, disability, birth or other status” of the child or of his/her parents or 
legal guardians. The Convention recognizes the right of children to the “enjoyment of the highest 
attainable standard of health and to facilities for the treatment of illness and rehabilitation of 
health”34 (Box 4.3). 
Box 4.3: The right to health for children 
International recognition: Article 24 of the Convention on the Rights of the Child requires States 
Parties to implement the right of the child to the highest attainable standard of health by taking 
appropriate measures, including the following: 
(a) to diminish infant and child mortality; 
(b) to provide medical assistance and health care to all children, with an emphasis on primary 
health care; 
(c) to combat disease and malnutrition, including through the provision of adequate nutritious 
food and clean drinking water; 
(d) to provide prenatal and postnatal health care for mothers; 
(e) to ensure that parents and children can access education and are supported in their use of 
knowledge about child health and nutrition, the advantages of breastfeeding, hygiene and 
environmental sanitation, and accident prevention; 
(f) to develop preventive health care, guidance for parents and family planning education and 
services. 
National recognition: Many countries recognize the rights of children in their national Constitutions. 
For example, the Constitution of Brazil states that: 
“It is the duty of the family, the society and the State to ensure children and adolescents, with 
absolute priority, the right to life, health, nourishment, education, leisure, professional training, 
culture, dignity, respect, freedom and family and community life, as well as to guard them from all 
forms of negligence, discrimination, exploitation, violence, cruelty and oppression”.35 
Significantly, Article 227 also recommends that the State allocate a percentage of its public health 
care funds to mother and child assistance. 
Public health legislation can and should protect individuals from discrimination, and ensure fair 
access to health services for everyone. However, the precise legal mechanisms for achieving 
protection from discrimination, and for vindicating human rights protections, may vary between 
countries. For example, discrimination on the basis of a person’s health status may be prohibited in 
disability rights legislation, health legislation, a principal act or statute, or subsidiary legislation. In 
some countries, specific anti-discrimination laws provide a complaints mechanism for individuals 
who have been subjected to direct or indirect discrimination on a range of prohibited grounds. For 
example, under New Zealand’s Human Rights Act, the Human Rights Commission hears complaints of 
discrimination in a range of areas including: employment, the provision of goods and services 
(including health care services), access to education, housing and accommodation, and by 
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professional associations and vocational training bodies. The Act provides protection from 
discrimination on the basis of a range of protected attributes, including a person’s sex, marital status, 
religious or ethical belief, colour, race or ethnic origins, disability (including physical illness or 
impairment, psychiatric illness, and intellectual impairment), age, political opinions and family status. 
In some countries (or parts of countries), individuals and groups can appeal directly to the courts to 
vindicate their constitutional rights. For example, in Colombia, the Constitution provides for the 
protection of specific groups, including women and newborn children,36 and enables an individual to 
petition any judge to protect his or her constitutional rights using a special writ known as a tutela. All 
such decisions are referred to the Constitutional Court, which can review them at its discretion. In 
one case initiated under this process, the Court recognized a woman’s right to equal opportunity in 
the workforce, holding that dismissal from employment of a pregnant or lactating woman without 
cause amounts to a violation of the human right to dignity and self-fulfilment.37 In another case, the 
Court held that the State owes pregnant or lactating women special protection in terms of job 
security, particularly women who are the head of a household. The Court declared that the 
termination of employment during pregnancy or within three months of birth creates a presumption 
of gender discrimination, placing the burden of proof on the employer if a tutela is filed.38 The 
Constitutional Court has also recognized a duty to provide special protection to women affected by 
forced displacement or civil war.39 
4.6 Creating coherence between public health laws 
 and other laws 
The process of reforming public health laws and implementing the recommendations of a legislative 
review does not occur in a vacuum, but should include an assessment of the extent to which existing 
laws are consistent with public health goals. In addition to gaps, there may be inconsistencies in a 
country’s public health laws, and even contradictory approaches to reducing risks from disease and 
injuries. 
One area where inconsistencies may arise is between public health laws and criminal laws. The poor 
health of vulnerable populations and minorities, including undocumented migrants, men who have 
sex with men, drug users and sex workers, can be exacerbated by criminal laws that create barriers 
to the effective delivery of health services. For example, the Global Commission on HIV and the Law 
has warned that specific criminal offences for the transmission of HIV, and laws imposing compulsory 
HIV testing and disclosure of HIV status, can be counterproductive.40 In addition to entrenching 
stigma and discrimination against people living with HIV, individuals who fear criminal penalties may 
be less likely to seek testing, to access counselling services or to disclose their HIV status to partners 
(see Section 10.2(c)). Similarly, criminal penalties for transmission may dissuade pregnant women 
and mothers from undergoing testing, while leaving them little choice but to continue breastfeeding 
where breast milk substitutes and clean water are not available.41 
Inconsistencies may also arise with laws affecting children. For example, laws that prevent persons 
under 18 years of age from accessing advice about contraception have been described as a 
manifestation of discrimination on the grounds of both age, and sex:42 their practical effect may be to 
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expose young people to sexually transmitted infections and unwanted pregnancies. Laws restricting 
the availability of abortion may force women to seek unsafe methods for terminating a pregnancy, 
leading to serious injury or death.43 
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Chapter 5: Good governance in the process of public 
health law reform 
 
SUMMARY POINTS 
 
· To maximize the success and legitimacy of the public health law reform process, countries 
should integrate the following six principles into the law reform process: stewardship, 
transparency, participation, fairness, accountability and following the rule of law. 
· Like other forms of corruption in the health sector, corruption in the development and 
implementation of public health laws threatens progress towards national health goals. Civil 
society organizations and an independent media play important roles when powerful industries or 
other vested interests seek to weaken legislation or to subvert the will of Parliament through the 
corruption of public officials who are charged with enforcing legislation. 
Previous chapters in this Part of the report considered some of the issues that may arise for 
governments as they review their public health laws, and following review, as they seek to 
implement recommendations for law reform. This section emphasizes the importance of good 
governance throughout the law reform process. “Governance” can be understood to refer both to 
the capacity of a government to develop and implement policies, and to the ways in which power is 
exercised for the purposes of managing a country’s economic and social resources.1 “Good 
governance” refers to governance processes that reflect the values and principles that will contribute 
most effectively to economic and social development, including the progressive realization of the 
right to health. The World Bank has pointed out that: 
Good governance is epitomized by predictable, open and enlightened decision-making (that is, 
transparent processes); a bureaucracy imbued with a professional ethos; an executive arm of 
government accountable for its actions; and a strong civil society participating in public affairs; all 
behaving under the rule of law.2 
Good governance maximizes the capacity of States to develop and implement policies for the public’s 
benefit, to manage resources in a prudent manner, and to provide services efficiently and 
effectively.3 Understood in this way, the “good” in governance refers to those distinctive features 
that characterize how governments formulate and implement policies, rather than the content of 
policies themselves. 
5.1 Public health law reform, good governance and 
 human rights 
Good governance is essential to a successful law reform process. Like any other policy process, the 
process of public health law reform may be inappropriately influenced by those pursuing their own 
economic or political interests. Attempts to undermine public health law may take the form of 
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lobbying efforts and other attempts to influence the content of the law or to undermine its 
implementation and enforcement. By ensuring transparency, and by providing opportunities for 
community participation, governments can improve the quality of the information available to 
lawmakers while also protecting the process from attempts to undermine the public good. 
Within the context of public health law reform, there are close connections between the principles of 
good governance and human rights. For example, ensuring the participation of those who are 
affected by public health laws is both an important principle of good governance4 and a well-
recognized dimension of the right to health.5 Similarly, the principle of fairness, if honoured in the 
law reform process, will help to ensure that law does not legitimate the discriminatory treatment or 
exclusion of individuals or vulnerable groups, in violation of the right to health. The process of 
reforming a country’s public health laws also illustrates the obligation of States to fulfil the right to 
health.6 Without good governance, however, the State cannot discharge its obligation to respect, 
protect or fulfil that right in a systematic and sustainable manner.7 
5.2 Good governance and corruption 
In some cases, the process of developing, passing, implementing or enforcing the law will be 
vulnerable to corruption. Like other forms of corruption in the health sector, corruption in the 
process of public health law reform threatens progress towards national health goals (see Box 5.1). 
Civil society organizations and an independent media can play an important role when powerful 
industries or other vested interests seek to weaken legislation, or to subvert the will of parliament 
through the corruption of public officials who are charged with enforcing legislation. For example, by 
investigating and documenting corruption, and publicizing the findings, civil society organizations 
may be able to generate the necessary political pressure for an independent investigation into 
inappropriate actions or activities. Similarly, by publicizing the results of investigations and keeping 
the issue of corruption before the public, media organizations can help to keep governments 
accountable and generate political pressure for police or prosecutors to investigate corruption and 
take action against corrupt officials. 
Box 5.1: Good governance and corruption in the health sector 
Generally, corruption can be understood as “the abuse of entrusted public power for private 
benefit”.8 The principles of good governance help to strengthen the law reform process against 
corruption and other failures by governments or government officials to faithfully serve the public 
interest. Whereas the attributes of good governance are stewardship, transparency, participation, 
fairness, accountability, and adherence to the rule of law, “corrupt governance fails to offer citizens 
adequate and accurate information about government and policies, curtails the public’s 
opportunities for participation, violates the public’s right to be informed about government activities 
and procedures, and compromises the right to political participation. Thus, corruption weakens the 
accountability of State officials, reduces transparency in the work of State institutions and allows 
human rights violations to go unpunished”.9 
Corruption can be problematic in the health sector, especially in low-income countries.10 Prominent 
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examples of corruption in the health sector include poor health facility construction, absenteeism of 
health professionals, improper spending and diversion of funds, theft of drugs, soliciting of informal 
payments to improve levels of service, and accreditation and licensing bribery.11 
5.3 Principles of good governance 
There are a variety of conceptual frameworks that seek to identify the attributes of good 
governance.12 This section draws on the attributes of good governance identified by the United 
Nations Development Programme (UNDP),13 and adds the concept of stewardship, which is a core 
public health function of government.14 To maximize the success and legitimacy of the public health 
law reform process, countries should integrate the following six principles into the law reform 
process: stewardship, transparency, participation, fairness, accountability and following the rule of 
law. 
(a) Stewardship 
Stewardship refers to the “careful and responsible management of something entrusted to one’s 
care”.15 Those who exercise the authority to make policy – the minister of health and others who 
work to reform public health laws – must exercise stewardship, putting aside personal desires and 
working to maximize the health interests of the people they serve. Unless law reformers approach 
the task of law reform with the public’s benefit in mind, public health laws cannot maximize their 
potential to assist countries to progressively realize the right to health for all members of the 
population. 
(b) Transparency 
Transparency is “built on the free flow of information”.16 It requires that, as far as possible, the 
process of developing, implementing and enforcing the law should be open and visible to the public. 
Transparency helps to build public understanding about the law, and confidence that legal powers 
will be exercised for the benefit of society as a whole. 
A variety of processes can help to ensure transparency during the law reform process. These include 
public forums, parliamentary debates and a political environment that permits media scrutiny and 
public reporting of government actions. Transparency supports the human right to participation 
because it allows members of the public to provide feedback on law reform proposals and draft laws. 
Once new laws have been passed, governments can enhance transparency by ensuring that 
legislation, regulations, executive orders and other laws remain accessible to members of the public 
and to representative groups. This principle also applies to the judgements of courts and tribunals. 
(c) Participation 
In cases where the law is intended to influence and alter behaviour, it is important that those who 
are directly affected by the law should be aware of it, understand it and also appreciate the goals 
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that the law is seeking to achieve. To achieve public support for a new public health law, lawmakers 
should consult affected communities, civil society groups, public health organizations and other 
stakeholders. When the community is given a seat at the negotiating table, it is more likely to 
support and comply with a new law. On the other hand, engaging with those who have a vested 
interest in defeating or weakening the law may be harmful to public health. For example, the 
Guidelines for the implementation of Article 5.3 of the WHO Framework Convention on Tobacco 
Control recommend that government officials should avoid conflicts of interest and “interact with the 
tobacco industry only when and to the extent strictly necessary to enable them to effectively 
regulate the tobacco industry and tobacco products”.17 
There are a variety of other ways that governments and health ministries can ensure community 
participation in the law reform process. For example, by publishing discussion papers and making 
draft legislation available (including on the Internet), governments can ensure that members of the 
public and representative organizations can give comments and other feedback. Where a 
commission or government committee considers options for law reform, it is customary for these 
bodies to accept submissions and to consult extensively. An example of this occurred in South Africa, 
where the Ministry of Justice conducted a “road show” as part of the process of amending the 
Marriage Act, sharing information and building community support for the proposed changes.18 As 
discussed in Section 3.4(b), formal mechanisms for community participation can also serve as the 
trigger for public health law reform. 
(d) Fairness 
The principle of fairness makes a significant contribution to good governance because it 
encompasses the related human rights of equality and non-discrimination. Article 26 of the 
International Covenant on Civil and Political Rights states: 
All persons are equal before the law and are entitled without any discrimination to the equal 
protection of the law. In this respect, the law shall prohibit any discrimination and guarantee to all 
persons equal and effective protection against discrimination on any ground such as race, colour, 
sex, language, religion, political or other opinion, national or social origin, property, birth or other 
status.19 
Discrimination entrenches health inequalities and undermines the capacity of governments to pursue 
the right to health for all members of the population. Governments have an obligation to take 
immediate action to eliminate discrimination; doing so will help to ensure equality of access to 
health services and to the resources needed to lead a healthy life.20 This does not necessarily mean 
that the State must provide health services and other social services to everyone free of charge. On 
the other hand, the State does have an obligation to ensure that individuals and vulnerable groups 
do not miss out on health care and health services because of their inability to pay. Law is a powerful 
tool for establishing the principle of “equality of opportunity for people to enjoy the highest 
attainable level of health”.21 
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(e) Accountability 
Accountability means taking responsibility for the success and failure of laws and policies, and 
putting processes in place to ensure that changes are made to improve decision-making and the 
performance of public health functions in future. In the context of public health law reform, 
accountability requires that legislation should set out the responsibilities and functions of public 
health officials so that it is clear who is accountable for enforcing the law and for exercising powers 
to protect the public’s health. 
In countries where resources and administrative capacity are limited, even the best laws and policies 
may be poorly implemented. As part of normal budgetary processes, therefore, governments should 
allocate resources to ensure that laws are administered effectively at both national and local levels. 
In circumstances where the activities and behaviour of businesses and individuals are subject to legal 
requirements, the law should set out the consequences for non-compliance, including the penalties 
imposed for offences. 
Many of the factors that influence the health of the population may fall outside the authority of the 
health ministry. As a result, accountability for the progressive realization of the right to health must 
be shared across government as a whole. Discharging this responsibility will require coordination 
between ministries, as discussed in Chapter 6. 
(f) The rule of law 
Good governance is based on the rule of law. The principle of the rule of law means that all persons, 
officials and institutions, including the State itself, are accountable under laws that are publicly 
disseminated, equally enforced, independently adjudicated, and consistent with international human 
rights standards (see Box 1.1 in Section 1.1). The rule of law ensures that the law reform process 
itself is clear, fair and that it remains focused on the public interest. 
In summary, each of the principles of good governance create an enabling environment for the 
effective management of the law reform process so that it can best achieve its goal of realizing the 
right to health for all members of the population. Where opportunities exist for civil society to 
participate in the law reform process, through a transparent and well managed process, there is a 
greater chance that a consensus will form around the need for reform. This improves the chances of 
success in the implementation and administration of public health laws. 
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 Chapter 6: Coordinated, intersectoral action to 
improve public health 
 
SUMMARY POINTS 
 
· The factors that influence health outcomes are complex and extend well beyond the provision 
of health care services. Many also fall outside the authority of the health ministry. As a result, 
accountability for the progressive realization of the right to health must be shared across 
government as a whole. Coordinated, intersectoral action to improve health, including between 
ministries, between different levels of government, and with stakeholders outside government, is 
necessary in order to address complex and persistent health challenges. 
· Legal and regulatory reform can support intersectoral action in health in a variety of ways, 
including by establishing new governance structures and processes for advancing shared goals, by 
establishing an accountability framework that sets out the responsibilities of participants, and by 
providing a clear mandate for intersectoral actions by relevant government agencies and 
authorities. 
· The processes and structures that are used to formalize intersectoral and intergovernmental 
collaboration will vary between countries and will be influenced by existing institutions, traditions 
and constitutional arrangements, as well as the specific priorities that are being pursued. 
Governments may choose to invest in a number of structures and processes that vary in scale and 
focus in order to address different health priorities. Some intersectoral initiatives may be framed 
largely in terms of the health benefits they aim to achieve, while others may aim to achieve a 
number of related economic and social objectives. 
· Securing high-level political commitment to an intersectoral initiative is vital, and may help to 
reduce resistance from ministries whose goals may conflict with public health. 
· A successful partnership across sectoral boundaries requires the active participation and 
goodwill of all partners. The political commitment of partner ministries may be strengthened by 
formalizing the partnership in a declaration, memorandum of understanding or other framework 
document that sets out shared goals and the key responsibilities of each partner. 
· Where different levels of government are involved, the unique legal status, legislative powers 
and comparative advantage of each level should be assessed. 
· WHO has identified a number of practical steps that may assist health ministries as they seek 
to work with other ministries to realize the benefits of an intersectoral approach. 
· Governance reforms have played an important role in many successful intersectoral initiatives, 
including in the areas of disease prevention, reducing health inequalities and improving food and 
nutritional security. 
 
The factors that influence health outcomes are complex and extend well beyond the provision of 
health care services.1 The physical, economic, social and political environments in which people live 
have a profound impact on the health of individuals and populations. They affect life opportunities, 
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exposure to health risks, knowledge and access to information, preferences, choices and the capacity 
for self-protective behaviour, as well as access to – and the affordability of – health care services. 
The wide range of factors influencing the health of the population creates profound challenges for 
governments and public health policy-makers. These include the need to work with a broader range 
of health stakeholders than has traditionally been the case, and to develop new structures for 
collaborating across portfolio boundaries. The need for a coordinated, intersectoral approach to 
health policy-making has been called many things, including an “all-of-government” approach, 
“health in all policies”, and “joined-up government”. This chapter discusses how legal and regulatory 
reforms can help to create an enabling environment for intersectoral action on health. For example, 
regulation can: 
• provide a clear mandate for engaging with other sectors and stakeholders, both within and 
beyond government; 
• establish new governance structures and processes for advancing shared social goals 
(including health); and 
• establish a framework for accountability that sets out the responsibilities of all participants 
for achieving shared goals, and requires the evaluation of progress. 
6.1  The purpose and scale of intersectoral reforms to 
 improve public health 
The structures and processes that are used to formalize intersectoral and intergovernmental 
collaboration will vary between countries and will be influenced by existing institutions, traditions 
and constitutional arrangements, as well as the specific priorities that are being pursued. Policies 
tend to evolve incrementally, rather than through a dramatic process of re-invention. For this reason, 
there may be benefits to building on existing structures and processes, while shaping and adapting 
them in new directions.2 
There is no single blueprint for intersectoral action in health. Governments may choose to invest in a 
number of structures and processes that vary in scale and focus in order to address different goals 
and priorities. Some intersectoral initiatives may be framed largely in terms of the health benefits 
they aim to achieve, such as obesity prevention or active living. More ambitious, cross-sectoral 
partnerships may aim to achieve a number of economic and social objectives, including 
improvements in health and well-being. Examples of broader, intersectoral partnerships include: 
• initiatives to reduce road traffic injuries; 
• initiatives to improve the safety and security of the food supply; 
• initiatives to improve child health, well-being and educational attainment; and 
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• integrated approaches to improving the quality of the local environment encompassing, for 
example, improved housing, infrastructure, social services, crime prevention and 
environmental remediation.3 
Intersectoral structures may also provide a solution when governments have already passed multiple 
pieces of legislation that overlap and share common goals, but which are administered across a 
number of ministries. For example, the Republic of Korea has passed 25 Acts, administered by six 
ministries, which seek to improve the physical health and nutrition of children, and to reduce 
obesity. While the overlapping tasks mandated under these Acts could be merged within a single 
ministry, another alternative is to create an intersectoral committee to facilitate collaboration among 
ministries.4 
Intersectoral initiatives may generate benefits that extend well beyond health. Public health leaders 
should consider how best to present the case for intersectoral action, remembering that 
collaboration with other sectors and ministries may be easier to achieve when initiatives are framed 
in terms of language, concepts, goals and values that are familiar or appropriate to that sector. For 
example, an integrated approach to reducing rates of violence in disadvantaged urban communities 
is relevant to the goals and values of policing and the justice sector. In addition, however, 
intersectoral action on the underlying social determinants of violence could include policies and 
programmes to respond to drug and alcohol problems, mental illness, poverty and unemployment. 
Laws, policies and programmes to create safer and healthier communities, in turn, will contribute to 
broader, societal goals; for example, reducing reliance on government welfare payments, creating a 
more socially cohesive environment that attracts local businesses, attracts tourism and reduces the 
pressure on over-burdened health systems and health care workers.5 
Public health leaders can help to overcome inertia and to generate political support for intersectoral 
action by highlighting the health benefits that could result from coordinated action. For example, the 
threats to health and health equity are not the only grounds for action on climate change. 
Nevertheless, mitigating the impacts of climate change on health is an important argument 
supporting an all-of-government approach to improving environmental sustainability and reducing 
greenhouse gas emissions.6 
Intersectoral action in health: the evolution of an idea 
This subsection briefly reviews highlights in the evolution of intersectoral action in health, and 
identifies some priority areas where intersectoral governance structures could be used to advance 
the right to health. 
In the Alma Ata Declaration (1978),7 intersectoral action was recognized as a key to improving 
primary health care, through coordinated action across a range of sectors, including agriculture, 
animal husbandry, food, industry, education, public works and communications. In 1986, the Ottawa 
Charter for Health Promotion recognized that intersectoral action is fundamental to reducing 
inequalities in health status within the population.8 The Charter emphasized health promotion both 
as a concept and strategy for re-orienting health systems in order to improve health equity and to 
achieve greater control by individuals and communities over the determinants affecting their health. 
 
Advancing the right to health: the vital role of law  Page | 81   
The Charter emphasized that health promotion includes building healthy public policy. This means 
putting health “on the agenda of policy-makers in all sectors and at all levels, directing them to be 
aware of the health consequences of their actions and to accept their responsibilities for health” (see 
Box 6.1). Like the Alma Ata Declaration, the Ottawa Charter emphasized the importance of 
community and individual self-reliance, and drew attention to health impact assessment as a 
strategy for making healthier public policies. 
Box 6.1: Intersectoral action in the Ottawa Charter for Health Promotion9 
The prerequisites… for health cannot be ensured by the health sector alone. More importantly, 
health promotion demands coordinated action by all concerned: by governments, by health and 
other social and economic sectors, by nongovernmental and voluntary organizations, by local 
authorities, by industry and by the media. People in all walks of life are involved as individuals, 
families and communities. Professional and social groups and health personnel have a major 
responsibility to mediate between differing interests in society for the pursuit of health…. 
Health promotion goes beyond health care. It puts health on the agenda of policy-makers in all 
sectors and at all levels, directing them to be aware of the health consequences of their decisions 
and to accept their responsibilities for health. 
Health promotion policy combines diverse but complementary approaches including legislation, 
fiscal measures, taxation and organizational change. It is coordinated action that leads to health, 
income and social policies that foster greater equity. Joint action contributes to ensuring safer and 
healthier goods and services, healthier public services and cleaner, more enjoyable environments. 
In 2008, the WHO Commission on Social Determinants of Health emphasized that disparities in 
health between rich and poor countries, and between rich and poor people within the same country, 
are fundamentally linked to disparities in power and income, goods and services. These factors are 
reflected, in turn, in disparities in living and working conditions, in the quality of the surrounding 
natural environment, and in access to health care, education, leisure and other opportunities for a 
flourishing life (Box 6.2). The Commission called for a new approach to development that involves 
the participation of all levels of government, civil society, business and local communities.10 It also 
emphasized the importance of political leadership: 
Policies and programmes must embrace all the key sectors of society, not just the health sector. That 
said, the minister of health and the supporting ministry are critical to global change. They can 
champion a social determinants of health approach at the highest level of society, they can 
demonstrate effectiveness through good practice, and they can support other ministries in creating 
policies that promote health equity.11 
Box 6.2: Conclusions of the WHO Commission on the Social Determinants of Health12 
“The poor health of the poor, the social gradient in health within countries, and the marked health 
inequities between countries are caused by the unequal distribution of power, income, goods and 
services, globally and nationally, the consequent unfairness in the immediate, visible circumstances 
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of people’s lives – their access to health care, schools and education, their conditions of work and 
leisure, their homes, communities, towns or cities – and their chances of leading a flourishing life. 
This unequal distribution of health-damaging experiences is not in any sense a ‘natural’ 
phenomenon but is the result of a toxic combination of poor social policies and programmes, unfair 
economic arrangements and bad politics. Together, the structural determinants and conditions of 
daily life constitute the social determinants of health and are responsible for a major part of health 
inequalities between and within countries.” 
In 2010, the Adelaide Statement on Health in All Policies pointed out that the interdependence of 
public policy requires not only an integrated response across government departments, but 
partnerships with the business sector and civil society.13 The Statement identified important 
attributes that are reflected in successful approaches to intersectoral action in health, as well as 
examples of regulatory tools and processes that governments can consider when designing an 
intersectoral response (Box 6.3). 
Box 6.3: Adelaide Statement on Health in All Policies 
“Health in All Policies works best when: 
• a clear mandate makes joined-up government an imperative; 
• systematic processes take account of interactions across sectors; 
• mediation occurs across interests; 
• accountability, transparency and participatory processes are present; 
• engagement occurs with stakeholders outside of government; 
• practical cross-sector initiatives build partnerships and trust. 
Tools and instruments that have [been] shown to be useful at different stages of the policy cycle 
include: 
• inter-ministerial and inter-departmental committees; 
• cross-sector action teams; 
• integrated budgets and accounting; 
• cross-cutting information and evaluation systems; 
• joined-up workforce development; 
• community consultations and Citizens’ Juries; 
• partnership platforms; 
• Health Lens Analysis; 
• impact assessments; 
• legislative frameworks.” 
In 2011, the World Conference on Social Determinants of Health in Rio de Janeiro considered how 
intersectoral action and structures could reduce health inequalities by tackling the social 
determinants of health. Participants discussed strategies for institutionalizing intersectoral action 
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and emphasized the need to integrate intersectoral governance at all levels, from the level of United 
Nations agencies to local communities. At all levels, effective intersectoral engagement and action 
requires “a long-lasting sustainable process rather than a single event or programme”.14 
At the international level, partnerships for multisectoral action have been recognized as an essential 
strategy for improving global health, in order to reduce fragmentation, conserve resources and 
maximize impact and influence at the country level. For example, a key feature of the global 
response to chronic, noncommunicable diseases is the emphasis on partnerships between 
governments, WHO and other United Nations agencies, development assistance agencies, civil 
society organizations and, where appropriate, the private sector.15 This has been formalized in the 
United Nations Task Force on noncommunicable diseases, which is led by WHO and coordinates the 
activities of United Nations organizations and intergovernmental organizations in implementing the 
Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020.16 A 
separate global coordination mechanism established by WHO facilitates engagement and 
partnerships between a broader group of stakeholders including WHO Member States, United 
Nations funds, programmes and agencies, civil society groups and the private sector, while protecting 
against conflicts of interest.17 
The Rio conference on social determinants of health highlighted the importance of ensuring the 
participation of civil society in intersectoral structures, and of civil society’s role in keeping 
governments accountable. Evaluation and accountability require both good information and 
“permanent structures and forums (such as intersectoral committees) that [facilitate] comparison of 
data”.18 
6.2 Practical steps for initiating intersectoral action 
Intersectoral action can be initiated at a variety of levels, depending on its scope and purpose. In 
many cases, political leaders at national, regional, city or local level, in consultation with public health 
leaders will have a vision or a preliminary plan of what could be achieved through an intersectoral 
partnership. In some cases, a parliamentary interest group (such as a cross-party parliamentary 
diabetes support group)19 may provide the initial impetus, support and advice. Securing high-level 
political commitment to an intersectoral initiative is vital: it gives legitimacy to the open-ended 
process of negotiating a partnership with relevant sectors, and can help to reduce opposition from 
ministries whose goals may conflict with public health. Where different levels of government are 
involved, the unique legal status, legislative powers and comparative advantage of each level should 
be considered. 
A successful partnership across sectoral boundaries requires the active participation and goodwill of 
all partners. The political commitment of government to intersectoral action on health may be 
strengthened by formalizing the partnership in a declaration, memorandum of understanding or 
other framework document. Such a commitment may even be formalized in the national 
constitution. For example, Thailand’s Constitution (2007) provides that if a public programme might 
have a serious impact on natural resources or the environment, a participatory health and 
environmental impact assessment must be carried out before the programme can begin (Box 6.4).20  
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Box 6.4: Constitution of the Kingdom of Thailand (2007), Article 6721 
Article 67 states, in part: 
Any project or activity which may seriously affect the quality of the environment, natural resources 
and biological diversity shall not be permitted, unless its impacts on the quality of the environment 
and on the health of the people in the communities have been studied and evaluated, and 
consultation with the public and interested parties has been organized, and opinions of an 
independent organization, consisting of representatives from private environmental and health 
organizations and from higher education institutions providing studies in the field of the 
environment, natural resources or health, have been obtained prior to the operation of such a 
project or activity. 
Civil society organizations, professional associations, academia and the private sector are important 
partners for achieving shared health goals. In Brazil, governments and civil society organizations 
signed a Declaration for the Prevention and Control of Noncommunicable Diseases, which commits 
the parties to implementing the WHO Framework Convention on Tobacco Control, the WHO Global 
Strategy on Diet, Physical Activity and Health and other strategies. Signatories committed to placing 
these policies on the work agendas of national, state and local governments, ensuring integrated 
action between sectors, access to resources and broad community participation.22 The Declaration 
constitutes an important statement of intent which supports the implementation of a coordinated, 
intersectoral approach to noncommunicable diseases encompassing surveillance, prevention and 
treatment. 
Although helpful, declarations and statements of intent are not a substitute for action by 
governments. Governments must ensure that they take the concrete steps that are required to 
deliver on their promises, by enforcing public health laws, reforming and improving them and 
honouring human rights obligations. Governments should ensure that partnerships with the private 
sector, where appropriate, do not undermine their capacity to use legal and regulatory powers 
effectively to protect public health. For example, the Guidelines for the implementation of Article 5.3 
of the WHO Framework Convention on Tobacco Control recommend that: “The tobacco industry 
should not be a partner in any initiative linked to setting or implementing public health policies, given 
that its interests are in direct conflict with the goals of public health”.23 
Despite the importance of high-level political support, health ministries, rather than other ministers 
or heads of government, will often be the leaders of intersectoral initiatives for health, with practical 
responsibility for moving them forward. WHO has identified a number of practical steps that may 
assist health ministries as they seek to realize the benefits of an intersectoral approach.24 For 
example, health ministries should: 
• Build understanding among health sector personnel of the need for an intersectoral 
approach to implement health priorities or to advance shared societal goals; 
• Strengthen the capacity of health sector personnel to interact with and develop alliances 
with other Ministries; 
• Use health impact assessment as a tool to identify how health department priorities will have 
an impact on the goals and interests of other ministries and their constituencies.  
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• Identify areas where interests are aligned, but be aware of areas where disagreements and 
rivalries could also arise. Create alliances where possible without undermining health goals; 
• Identify existing structures and processes for cross-ministerial, intersectoral action and 
cooperation. Are these appropriate? Review existing laws and mandates for intersectoral 
action. Are they adequate? Identify new potential mechanisms for intersectoral cooperation. 
Seek high-level political support for these to be formalized and used; 
• Be responsive to initiatives led by other sectors that provide opportunities for improving 
health and achieving health goals. For example, initiatives to improve food security, led by 
the agricultural sector, may also provide opportunities for improving diets, diversifying away 
from tobacco cultivation and supporting the cultivation of healthier oils; 
• Explain the health impact of policies administered by other ministries, and the health 
benefits of a collaborative approach to policy development. Share relevant health data with 
other ministries; 
• Choose the best method of collaboration for implementing each initiative, remembering that 
the most appropriate implementation strategies may vary according to the priority in 
question.  
• Develop a strategy for engaging other sectors and ministries, and a common framework that 
assists all sectors and partners to understand the issues and the required actions; 
• Support community participation in the development and implementation of health 
initiatives through public consultation, preparation of discussion papers, web-based tools 
and mass media; 
• Look for ways to ensure political accountability through reporting requirements and access 
to information. Reporting mechanisms mandated by international agreements provide 
opportunities for reporting on government commitments and progress made in intersectoral 
activities; 
• Monitor and evaluate the progress of intersectoral efforts to advance priority health goals, 
and identify and promote good practices. 
6.3 Case studies of governance reforms supporting 
 intersectoral action on health 
This section presents three case studies of intersectoral structures and processes designed to 
advance health in three important areas: firstly, health promotion and disease prevention; secondly, 
reducing health inequalities through action on the social determinants of health; and thirdly, 
reducing hunger and improving nutritional security. The discussion highlights key features of the 
governance structures adopted in each case. 
(a) Disease prevention and health promotion 
Effective disease prevention strategies require action to be taken outside the health sector in order 
to promote healthy living, to improve access to information, to reduce risk factors for disease, and to 
improve the quality of the environments in which people live. National leadership can take a variety 
of forms. 
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In Mexico, a National Council for the Prevention and Control of Chronic, Noncommunicable Diseases 
was established by presidential decree.25 The National Council acts as the permanent coordinating 
body for national action on noncommunicable diseases and their risk factors, linking Secretariat of 
Health officials with their counterparts in the finance, agriculture, education and trade ministries. 
The Council coordinates activities both among federal government agencies, and between the 
federal government and the states under the National Health Council. 
A similar model operates in the United States of America. In 2009, Congress passed legislation calling 
on President Barack Obama to establish an intersectoral National Prevention, Health Promotion and 
Public Health Council.26 The Council now comprises the heads of 20 federal government agencies, 
and is supported by an Advisory Group of experts appointed by the President (Box 6.5). Legislation 
required the Council to develop a national prevention and health promotion strategy, setting out 
specific goals for improving health through federally funded prevention and health promotion 
programmes.27 The Council is also required to publish an annual report setting out corrective actions 
that federal agencies can take to achieve national goals for reductions in tobacco use, harmful use of 
alcohol, physical inactivity and poor diet.28 
Box 6.5: The National Prevention, Health Promotion and Public Health Council (United States)29 
The Council: The National Prevention Council, established by executive order of President Obama, 
10 June 2010, comprises: 
• The Surgeon-General (Chair) 
• Secretary, Department of Health and Human Services 
• Secretary, Department of Agriculture 
• Secretary, Department of Education 
• Chairperson, Federal Trade Commission 
• Secretary, Department of Transportation 
• Secretary, Department of Labour 
• Secretary, Department of Homeland Security 
• Administrator, Environmental Protection Agency 
• Director, Office of National Drug Control Policy 
• Director, Domestic Policy Council 
• Assistant Secretary, Indian Affairs, Department of the Interior 
• Attorney-General, Department of Justice 
• Acting Chief Executive Officer, Corporation for National and Community Service 
• Secretary, Department of Defence 
• Secretary, Department of Veterans Affairs 
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• Secretary, Department of Housing and Urban Development 
• Director, Office of Management and Budget 
• Secretary, Department of the Interior 
• Administrator, General Services Administration 
• Director, Office of Personnel Management 
The Advisory Group: The Council is supported by an Advisory Group on Prevention, Health 
Promotion and Integrative Public Health. Members of the Advisory Council include a diverse group 
of licensed health professionals with expertise in: 
• worksite health promotion; 
• community services, including community health centres; 
• preventive medicine; 
• health coaching; 
• public health education; 
• geriatrics; and 
• rehabilitation medicine. 
• Key duties of the Council include: 
• providing coordination and leadership among federal agencies on disease prevention, health 
promotion practices, and integrative health care; 
• developing a national strategy for disease prevention and health promotion that includes 
the most effective and achievable strategies for reducing preventable illness and disability in 
the United States. This strategy must set out specific goals for improvements in health, 
together with specific, measurable actions and timelines for implementing the strategy; 
• providing recommendations to the President and to Congress on changes in federal policy 
required in order to achieve national goals for reducing tobacco use, reducing sedentary 
behaviour, and improving nutrition; 
• reporting annually on corrective actions recommended to federal agencies to meet the goals 
and actions taken by relevant agencies. This annual status report must contain a list of 
national priorities for improving lifestyles, covering: smoking cessation, proper nutrition, 
appropriate exercise, mental health, behavioural health, substance abuse and domestic 
violence. It must contain “specific, science-based initiatives” to achieve national goals for 
nutrition, exercise and smoking cessation and for preventing the five leading disease killers 
in the United States. 
Four features of this model for intersectoral action deserve emphasis. As a national council 
comprising the heads of federal executive agencies, the Council has a clear mandate for shaping and 
implementing new programmes and policies. In order to discharge these responsibilities, the Council 
is served by an Advisory Group of experts in preventive health. Although the legislative mandate is 
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imposed directly on heads of government agencies, the presence of the Advisory Group ensures that 
the policy-shaping process is less vulnerable to entrenched departmental cultures and goals, which 
may run contrary to public health objectives. 
Secondly, the authorizing legislation by Congress seeks to ensure accountability for the 
implementation of the national prevention strategy by ensuring that it contains specific indicators for 
measuring progress, and by requiring preparation of an annual status report which enables Congress 
and the President, to monitor progress. 
Thirdly, in addition to encouraging collective action by federal agencies, the National Strategy 
envisages that the National Prevention Council and the Advisory Group will engage with a broad 
range of partners to ensure implementation of the national prevention strategy.30 These include 
state and local governments, businesses, community organizations and faith-based organizations. 
Fourthly, the authorizing legislation illustrates how rising health care costs are a driver for 
government investment in intersectoral initiatives for preventive health. In this case, the legislation 
established a Prevention and Public Health Fund to provide sustained funding for preventive health 
programmes, reaching US$ 2 billion per year by 2015, in order to reduce the rate of growth in health 
care costs.31 
(b)  Promoting health equity and reducing health inequalities 
The WHO Commission on Social Determinants of Health found that health inequalities arise from the 
“societal conditions in which people are born, grow, live, work and age”. These social determinants 
include “early years’ experiences, education, economic status, employment and decent work, 
housing and environment and effective systems of preventing and treating ill-health”.32 It follows 
that reducing health inequalities within the population requires an intersectoral approach that 
addresses areas of sustained disadvantage in social and economic living conditions. The priority areas 
for government action to promote health equity vary between countries, but often include policies 
to address the following kinds of problems: 
• inadequate income; 
• unemployment; 
• substandard housing; 
• fuel poverty; 
• lack of sanitation and lack of access to clean water; 
• low levels of education; 
• hunger; 
• lack of access to fresh fruit and vegetables and to nutrients required for a healthy diet at 
reasonably affordable prices; 
• high rates of risk factors including smoking, binge drinking and substance abuse; 
• poor access to health care services, including prenatal and mental health services; 
• high rates of crime and violence; 
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• high rates of teenage pregnancy; 
• high rates of suicide and self-harm; 
• lack of access to safe public areas for recreation and physical activity; 
• lack of public transport; 
• dangerous and contaminated physical environments; 
• social isolation and lack of social supports. 
Making progress on a complex set of issues like these calls for an integrated response that 
coordinates the work of all relevant ministries, coordinates actions by different levels of government, 
and provides opportunities for partnerships between government, community groups, businesses 
and other stakeholders. 
In England, the foundation for government action to reduce health inequalities was an independent 
scientific review that documented the widening gap between the health outcomes of different social 
groups and made policy recommendations covering a range of sectors.33 By the 1990s, the mortality 
rate of working age men in England was almost three times as high for those in the lowest 
socioeconomic quintile (unskilled workers) as it was for the highest quintile (professionals).34 A 
subsequent joint review by the Department of Health and the Treasury identified a set of priority 
interventions for public spending. This review provided the basis for the government’s national 
strategy for tackling health inequalities.35 
In 2001, the government adopted a national health inequalities target: to reduce inequalities in 
health outcomes by 10%, as measured by infant mortality and life expectancy at birth.36 Additional 
targets were added in 2004, including a target to reduce (by 10%) the gap between the most 
deprived 20% of local area authorities and the population as a whole. The government used 
indicators for health and for deprivation in different local government areas to measure the gap and 
progress towards the target. 
The national health inequalities strategy was adopted in 2003. It grouped policies and services under 
four themes: supporting families, mothers and children; engaging communities and individuals; 
preventing illness and providing effective treatment through the National Health Service (NHS); and 
addressing the underlying, long-term determinants of health (Box 6.6). 
Box 6.6: A programme for action for reducing health inequalities in England37 
In 2003, the Department of Health in England outlined a strategy for tackling health inequalities. The 
strategy focused on four themes: 
• supporting families, mothers and children: in order to provide children with the best possible 
start in life, and to break the intergenerational cycle of poor health; 
• engaging communities and individuals: the strategy recognized the need for the government 
to respond to local problems and “pools of deprivation” through specific and targeted 
interventions. These would operate alongside the delivery of mainstream services to local 
communities and socially excluded groups; 
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• preventing illness and providing effective treatment and care through the NHS. The strategy 
included policies to reduce tobacco use, to tackle cancer and coronary heart disease, and to 
improve primary care through the government-funded NHS; 
• addressing the underlying determinants of health. The strategy included long-term activities 
undertaken by the government, at national and local levels, to address the underlying social 
determinants of health; for example: by reducing poverty and improving employment 
opportunities and living conditions for disadvantaged groups. 
One important feature of the government’s strategy was the recognition that government services 
needed to be tailored to local circumstances in order to meet local needs. The strategy envisaged 
that this would occur through “local strategic partnerships” between local government authorities, 
primary care trusts (which commission the provision of health services from health care providers on 
behalf of the NHS), as well as communities, businesses and the voluntary sector. Under the 
government’s strategy, local government authorities were required to negotiate Local Public Service 
Agreements with the central government, to include performance targets covering a range of 
sectors, as well as the national health inequality targets. Local governments were invited to use the 
local strategic partnership process to review local challenges together with other stakeholders and to 
agree on additional outcome-focused targets for local performance, with a reward grant paid to 
those authorities that met their target.38 The entire strategy was supported by a set of health and 
social indicators for measuring local area performance, national performance and the difference 
between national performance and performance in deprived local areas. 
(c) Improving food and nutritional security in Brazil 
Institutions, laws and governance reforms have played an important part in Brazil’s efforts to reduce 
hunger and improve food security. Brazil is the world’s seventh largest economy and a large 
agricultural producer and food exporter. Nevertheless, a significant segment of the population lives 
in conditions of hunger and food insecurity, due to lack of income to purchase adequate food, 
exacerbated by variations in food production between geographical regions. 
Despite these problems, Brazil has achieved significant reductions in poverty, hunger and food 
insecurity over the past decade. In 2003, using the methodology developed to track poverty and food 
insecurity across all regions in Brazil, there were 50 million people, including nearly 11 million 
families, living below the poverty line (now frequently defined as US$ 1.25 per day).39 By 2009, over 
20 million people (nearly 4 million families), had been removed from poverty.40 
When Luiz Inácio Lula da Silva became the President of Brazil in 2003, he made hunger and food 
insecurity a priority of his Presidency, stating in his first speech that “If at the end of my mandate 
every Brazilian can eat three times a day, I will have fulfilled my life’s mission”.41 President da Silva 
immediately launched Fome Zero (Zero Hunger), a national programme that combined emergency 
activities to increase income and access to food with longer-term structural activities to reduce 
poverty and increase the supply of food at affordable prices.42 This section highlights the key 
governance reforms involved in the implementation of Fome Zero, together with a brief description 
of the programme’s leading policies. 
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Intersectoral governance reforms 
Fome Zero was supported by a number of governance reforms that made it possible for civil society 
to originate and participate in policy proposals, and which also facilitated coordination between 
different federal ministries and different levels of government. Together, these reforms created the 
National System for Food and Nutritional Security (SISAN), which was formalized in the Federal Law 
on Food and Nutrition Security (2006).43 SISAN comprised: 
• the National Conference on Food and Nutritional Security; 
• the National Council of Food and Nutritional Security; 
• the Inter-ministerial Chamber for Food and Nutritional Security; 
• agencies and entities implementing policies and programmes for food and nutritional 
security at federal, state and municipal levels; and 
• private institutions that respected the goals of SISAN and wished to participate in it. 
“Food and nutritional security” was defined in 2004, during Brazil’s Second National Conference on 
Food and Nutrition Security, and this definition was subsequently included in federal law (Box 6.7). 
The concept draws attention to a number of underlying variables including: sufficient quantity of 
food; the quality of food, including its safety and nutritional balance; regularity of access to food; as 
well as choice and dignity: freedom to choose food that is culturally appropriate without 
compromising other needs.44 
As reflected in Article 4 of the Federal Law, the achievement of food and nutritional security rests on 
intersectoral policies and programmes addressing a range of underlying factors which affect the 
capacity of low-income families to participate in the domestic food market, both as food producers 
and consumers. Effective policies on food and nutritional security must seek to: 
• expand access to food through support for traditional and family farming; 
• ensure biodiversity and the sustainable use of resources; 
• promote good health and nutrition, especially among vulnerable social groups; 
• ensure the safety and quality of food; 
• improve access to information; and 
• implement participatory public policies to improve food production, commercialization and 
consumption. 
Box 6.7: Food and nutritional security in Brazil: a multifaceted concept 
Organic Law of Food Security and Nutrition, Brazil45 
Article 3. Food and nutritional security consists of the realization of the human right to regular and 
permanent access to good-quality food, in sufficient quantity, without compromising the fulfilment 
of other basic needs, having as its basis healthy nutritional habits that respect cultural diversity and 
that are environmentally, culturally, economically and socially sustainable. 
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Article 4 Food and nutritional security comprises: 
I. Expansion of access to food through its production, particularly via family and traditional 
farming, food processing, industrialization and commercialization, including international 
agreements; better food supply and distribution, including of water; job creation and redistribution 
of wealth; 
II. The conservation of biodiversity and the sustainable use of resources; 
III. The promotion of health, food, and nutrition for the population, including specific population 
groups and those more socially vulnerable; 
IV. The guarantee of the biological, sanitary, nutritional and technological qualities of the food, as 
well as its good use, which stimulates healthy food practices and lifestyles that respect the ethnic 
and racial diversity of the population; 
V. The production of knowledge and the access to information; and 
VI. The implementation of public policies and sustainable and participatory strategies of food 
production, commercialization and consumption, respecting the diverse cultural characteristics of 
the country. 
At the federal level, three governance reforms played a critical role in shared efforts to achieve these 
goals. Firstly, Fome Zero was initially administered by a new, Extraordinary Ministry for Food Security 
and the Fight against Hunger, which subsequently became the Ministry for Social Development and 
the Fight against Hunger. The functions of this Ministry included “formulating and coordinating the 
implementation of the National Food and Nutrition Security Policy for the purpose of ensuring the 
human right to food”, and creating links between policies and programmes administered by federal, 
state and municipal governments, as well as those of civil society.46 The creation of a ministry 
devoted to the coordination of hunger and food security initiatives reflected the high level of political 
commitment to hunger prevention within the da Silva administration, and maintained the relative 
political priority of Fome Zero among other programmes competing for attention and resources. 
Secondly, President da Silva re-established the National Council of Food and Nutritional Security 
(CONSEA), a unique body which is attached to the Presidency and ensures the participation of civil 
society in national policy-making on food security. One third (currently 19) of the delegates to 
CONSEA are ministers and secretaries from portfolios related to food and nutritional security. The 
remaining two thirds of delegates come from civil society and represent nongovernmental 
organizations, social movements and professional and religious organizations.47 
CONSEA is required to convene the National Conference on Food and Nutrition Security every four 
years. The national conferences are a unique aspect of participatory democracy in Brazil, proposing 
and prioritizing policies and guidelines that form the foundation of the National System for Food and 
Nutrition Security (SISAN). The national conference is preceded by state conferences convened by 
the 27 state CONSEAs, which debate issues of food security relevant to their geographical 
constituencies, nominate delegates to the national conference, and submit proposals which are 
included in the base document for the national conference. A similar process occurs at the municipal 
level. For example, the Fourth National Conference on Food and Nutrition Security, held in 2011, was 
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attended by 1626 delegates representing the 26 states, and carried forward the work of over 75 000 
people from 3000 municipalities.48 
Thirdly, CONSEA’s legal role includes considering and framing resolutions and guidelines adopted by 
the national conference into specific proposals that take account of the politics and institutions of 
government.49 These proposals, which include budgetary requirements for their implementation, are 
submitted to the Inter-ministerial Chamber for Food and Nutritional Security (CAISAN), a purely 
governmental body that comprises over a dozen Ministers and Secretaries who participate in 
CONSEA. CAISAN is charged, in turn, with transforming the proposals received from CONSEA into 
government programmes (with supporting directives, goals, budgets and resources), and with 
implementing and monitoring them.50 CAISAN is chaired by the General Secretary of CONSEA and its 
Executive Secretariat is maintained by the Ministry for Social Development and the Fight against 
Hunger. 
Fome Zero: leading policies 
Fome Zero was a political programme that began with the government of President da Silva but 
developed over time. The first set of policies aimed to increase access to food by boosting the 
purchasing power of the unemployed and those on low wages. The largest initiative here was the 
family grants programme, Bolsa Família, which consolidated a range of income assistance payments. 
In 2010, these payments reached over 12.7 million families living in poverty and extreme poverty 
(nearly 50 million people).51 The conditions for receipt of the Bolsa Família – that children are 
vaccinated, receive regular health checks and attend school – are monitored by municipal and state 
secretariats within the Ministries of Education and of Health, which communicates the data to the 
Ministry for Social Development and the Fight against Hunger. Since 2006, municipalities have 
received economic incentives to improve their monitoring of these conditions and for maintaining 
up-to-date data on municipal enrolees. 
A second set of policies aimed to increase access to food by strengthening family farming, which 
(unlike Brazil’s export-oriented agribusiness sector) accounts for production of most of the domestic 
food supply.52 Family farmers represent the majority of the rural population, but many live in 
conditions of food insecurity. The Family Farming Food Acquisition Programme, funded jointly by the 
Ministry for Social Development and the Fight against Hunger and the Ministry of Agrarian 
Development, involves direct procurement of food from family farmers, traditional peoples and 
groups resettled under agrarian reform programmes. Under one set of initiatives, the National Food 
Supply Company purchased products from farmers at market prices, and used these to re-establish 
public food security stocks. Under another set of initiatives, based on agreements with states, cities 
and local family farmers’ associations, products purchased from farmers’ associations are donated to 
municipal food security programmes, including subsidized restaurants and school meal programmes 
which, by law, must purchase 30% of food from family farmers.53 A further set of initiatives aimed to 
boost milk production and distribution in semi-arid regions. 
Other programmes supporting food production included agrarian reforms to resettle displaced 
groups, regularization of land tenure, expansion of credit to family farmers, harvest insurance, the 
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building of rainwater cisterns to encourage self-sufficiency and independence from water utilities, 
and technical assistance. 
A third set of policies aimed to directly increase access to food. Under President da Silva’s 
administration, the school meals programme was expanded to include all students in kindergarten, 
elementary and high school. Other initiatives included the federally-funded workers’ food 
programme for low-income workers, as well as the Network of Public Utilities for Food Security and 
Nutrition (RedSAN), administered by the Ministry for Social Development and the Fight Against 
Hunger. RedSAN activities include subsidizing restaurants and food banks and distributing emergency 
food baskets, which include products produced by family farmers. 
Strengthening the National System for Food and Nutrition Security  
Brazil’s National System for Food and Nutrition Security (see Figure 6.1) is both intersectoral and 
decentralized. Since Brazil has a highly decentralized political system, the federal government relies 
for implementation on governance relationships with over 5500 municipalities. The National System 
for Food and Nutrition Security has been strengthened through the establishment, by presidential 
decree, of the National Food and Nutritional Security Policy, together with a National Food and 
Nutritional Security Plan which reflects that policy (Box 6.8). This law clarifies the roles and 
obligations of the bodies that make up the National System for Food and Nutrition Security. This 
includes the establishment and resourcing of CONSEAs at the state and municipal levels to ensure 
comprehensive engagement with civil society at all levels. It also includes the establishment of 
CAISANs at state and municipal levels to coordinate the actions of state and municipal agencies in 
food security at each level (Figure 6.1). 
Box 6.8: Key goals of Brazil’s National Food and Nutritional Security Policy54 
Brazil’s National Food and Nutritional Security Plan is based on the following goals and principles: 
• The promotion of universal access to adequate and healthy food, especially for those living 
in conditions of food and nutritional insecurity; 
• Sustainable, decentralized systems for food production, extraction, processing and 
distribution; 
• Permanent processes for education, research and training in relation to food and nutritional 
security and the human right to adequate food; 
• The coordination of actions to secure food and nutritional security for quilombolas and other 
traditional communities, and indigenous peoples; 
• Integrating activities on food and nutritional security with activities undertaken at all levels 
of health care; 
• Ensuring universal access to a sufficient quantity of water, with priority for those living in 
conditions of water insecurity, and for family food production, fisheries and aquaculture; 
• Support to initiatives to promote food sovereignty, food and nutritional security, and the 
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human right to adequate food in the international arena; 
• Monitoring of the realization of the human right to adequate food. 
The articulation of policies and programmes for food security between the federal, state and 
municipal levels of government occurs through tripartite forums, convened by CAISAN, which 
provide the link between the intersectoral coordinating agencies of each level of government.55 
These structures are intended to facilitate the administration of programmes which, like the Bolsa 
Família, depend upon a range of actions being taken by government agencies at every level. The 
presidential decree specifies the criteria to be met by states and municipalities, and non-profit 
organizations that wish to become members of SISAN, as well as the financing responsibilities of each 
level of government.56 In 2010, Brazil’s efforts to improve food and nutritional security were further 
strengthened through a constitutional amendment recognizing the right to food.57 Brazil’s model for 
addressing hunger has become an important model for other countries that wish to ensure 
community participation while integrating government actions across sectors and between different 
levels of government. 
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Figure 6.1: Brazil’s national food and nutrition security system and policy58 
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PART 3 
PRIORITIES FOR PUBLIC HEALTH LAW REFORM 
 
Introduction 
Public health laws provide governments with the tools to protect their populations from avoidable 
injury and disease, to encourage and support healthy behaviours, and to respond to public health 
emergencies. Part 3 of this report provides guidance about the content of effective public health 
laws, together with examples of how governments in different countries are using public health laws 
to address key challenges affecting their populations. 
This Part includes discussion of the legislative powers and duties that often form the core parts of 
public health laws at national or regional level. The core public health functions of government 
include: ensuring sanitation, hygiene and vector abatement; conducting surveillance and monitoring 
of risks to health; controlling infectious diseases; dealing quickly and effectively with public health 
emergencies; and implementing policies and laws to encourage safe and healthy behaviours. 
This Part also describes how public health law can make a substantial contribution to public health in 
five additional areas. These are: tobacco control, the migration and retention of health care workers, 
access to essential medicines, obesity and malnutrition, and maternal and child health. These areas 
were identified during the expert consultation as being critically important to national efforts to 
realize the right to health. An overarching goal for governments in discharging their obligations 
under the right to health is to deliver universal access to quality health care and public health 
services, supported by an effective health system. Chapter 8 outlines the relationship between law 
and this overarching goal. 
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Chapter 7: Achieving universal access to quality  
health services 
 
SUMMARY POINTS 
 
· Universal health coverage is the goal of ensuring that all members of the population and their 
communities have access to promotive, preventive, curative, rehabilitative and palliative health 
services that are of sufficient quality to be effective, without being exposed to financial hardship. 
· To expand health insurance systems towards achievement of universal health coverage, 
governments need to make progress along three axes: to “expand priority services, include more 
people and reduce out-of-pocket payments”.1 
· Making progress towards universal health coverage requires governments to strengthen those 
building blocks of the health system that make it possible to deliver services of high quality. This 
includes investing in basic infrastructure, human resources and financing systems; developing an 
effective health information system; systems for procuring and distributing essential medicines, 
vaccines and technology, and systems for governance and accountability. 
· Different countries will take different pathways towards universal health coverage. Priorities 
for law reform are likely to emerge incrementally as countries identify particular problems with 
the performance of their health systems and seek to remedy them. However, many of the 
regulatory issues that governments will need to consider relate to: (i) defining membership and 
entitlements under a health insurance scheme; (ii) regulating health service providers; (iii) 
financing health services; and (iv) and establishing governing institutions. 
· Governments scaling up health insurance systems may wish to formally recognize the right of 
members of the population to access a defined set of benefits or services. Governments may 
strengthen the implementation of this right – as well as the quality of the health services provided 
– by creating a formal complaints scheme for those who are not treated in accordance with their 
entitlements under the scheme. 
· The right to health imposes an immediate obligation on governments to protect members of 
the population from discrimination, including discrimination in access to benefits under a health 
insurance scheme. Governments may consider creating statutory protection for the privacy, 
confidentiality and security of the health information of members of a health insurance scheme. 
· Governments should pursue financing systems for health services that avoid two important 
risks. The first is the risk of catastrophic expenditure (leading to improverishment), caused by the 
need for large out-of-pocket payments for medical services when a person falls ill. The second is 
the risk that even modest user fees may dampen demand and create barriers to access for the 
poorest members of the population. Governments can mitigate these risks by raising funds for 
expanded coverage through compulsory pre-payment mechanisms, such as taxation and/or 
compulsory insurance contributions, and by providing an exemption from contributions for those 
who cannot afford to contribute at any level. 
· Legal regulation of the financing of health services includes the regulation of revenue 
collection, legal control of the funding pools that are used to pay for health services, and 
regulation of the purchasing of health services provided to covered populations. 
· WHO has recommended that governments consider new ways of increasing their revenues, 
including by imposing or increasing excise taxes on tobacco and alcoholic beverages, sugary drinks, 
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airline tickets or currency transactions. 
· Depending on the structure of the health insurance system, governments may regulate 
funding pools to ensure capital adequacy and to impose controls over the investment of funds. 
They may also impose requirements to report to the central government, and impose governance 
requirements on the entities (health insurance schemes) that administer insurance schemes based 
on pooled funds. 
· Private health insurance schemes often coexist with the public schemes that are the vehicle 
used by governments to scale up coverage. In the case of private insurers, governments typically 
regulate a wide range of matters including registration and prudential requirements, competition, 
advertising, premiums, adverse selection and reporting requirements. 
· In scaling up the health services that are provided from pooled funds, governments have been 
advised by WHO to place particular emphasis on primary care. Robust primary health care systems 
are associated with reduced morbidity and premature mortality as well as lower costs. 
· The health workforce is a crucial input in strategies to scale up the coverage of health services. 
In addition to regulating the purchasing of services and the remuneration of health care providers, 
legislative frameworks perform important gateway functions. These include licensing health care 
providers to practice their profession in the jurisdiction, and accrediting service providers under 
the health insurance scheme. Governments may also establish quality agencies to support the 
improvement of quality standards and governance processes across all facilities. 
· Formal recognition of new professional categories and roles may be required as countries 
scale up the training and education of the health workforce and adapt to the changing burden of 
disease. 
· By imposing licensing requirements on the practice of medicine and other health professions, 
governments can protect the public from unskilled and poorly skilled individuals who claim the 
right to provide medical services. Some countries have introduced national councils that oversee 
registration, continuing professional education and professional conduct across a range of health 
professions. 
· Licensing requirements for health professionals should be sufficiently flexible to permit the 
delivery of emergency health services by authorized personnel following a natural disaster or 
other public health emergency. This may include foreign health professionals contracted to 
international agencies or to accredited nongovernmental organizations. 
· Legislation may create a range of offences for inappropriate medical practice; for example, 
forging documents, using unapproved medicines, carrying out experimental treatment without 
consent, and soliciting or illegally accepting money and gifts from patients. 
· Governments may consider requiring accredited health care providers to contribute to 
premium-based compensation schemes for individuals who are injured through medical 
negligence or substandard care, or who are victims of criminal offences committed by health 
professionals. 
· Establishing governing institutions is an important part of the law reform process as countries 
scale up towards universal health coverage. Two important institutions commonly seen in health 
insurance systems are a national health insurance authority, and a medicines regulation authority. 
In some countries, the functions of both agencies may be merged into a single institution. 
· The key functions of a national health insurance authority charged with improving population 
coverage include registering members, collecting health insurance contributions, managing pooled 
funds, accrediting, contracting and reimbursing health service providers, and complying with 
government reporting requirements. 
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· The functions of a medicines regulatory authority include assessing and authorizing the entry 
of medicines into the country (drug registration), monitoring safety and effectiveness, regulating 
domestic manufacturing, importation and distribution of drugs, and regulating pharmaceutical 
advertising. In order to perform these functions, regulatory authorities commonly perform a wide 
range of more specific functions set out in legislation. 
· The experience of Ghana illustrates the role of legislation in establishing and expanding a 
national health insurance scheme. 
Universal health coverage (UHC) has emerged as a unifying concept and goal for governments as 
they seek to strengthen their health systems and to discharge their obligations under the right to 
health.2 UHC is the goal of ensuring that all members of the population have access to promotive, 
preventive, curative, rehabilitative and palliative health services that are of sufficient quality to be 
effective, without being exposed to financial hardship.3 In 2015, the United Nations General 
Assembly adopted a global target for UHC as part of the Sustainable Development Goals. This target 
states: “Achieve UHC, including financial risk protection, access to quality essential health care 
services and access to safe, effective, quality and affordable essential medicines and vaccines for all” 
(Target 3.8).4 The right to health, as recognized in international human rights law, directs attention 
to a wide-ranging set of features that may assist governments to strengthen their health systems 
and to accelerate their progress towards UHC.5 
7.1  The concept and scope of universal health 
 coverage  
The quality services that governments are obliged to make universally accessible include health 
services delivered to individuals in hospitals, in primary care facilities and in other community 
settings. These include diagnostic services, medical procedures, the provision of essential medicines, 
palliative care and preventive services such as immunizations and perinatal health assessments. In 
addition, UHC encompasses the delivery of services to the population as a whole, or targeted 
segments of it, through information campaigns, vector control, the performance of public health 
regulatory functions, and other public policies addressing the determinants of health. 
Making progress on the overarching goal of UHC requires governments to strengthen those building 
blocks of the health system that make it possible to deliver services of high quality (see Table 1.1). 
Health financing is a critical component, since all functions of the health system depend upon 
adequate and sustainable financing. Other vital components of the delivery of quality health services 
include the training, development and retention of the health workforce; strategies for achieving 
universal access to essential medicines, vaccines and technology; the development of an effective 
health information system; management of infrastructure and capital investments; mechanisms for 
governance and accountability, and effective leadership at senior levels.6 Health systems are 
complex: making progress with each of the building blocks is necessary to make progress towards 
the overall goal of UHC. For example, it will not be feasible to expand the range of health services 
available under a health insurance system, or to extend the coverage of services to more people, 
unless countries simultaneously invest in the development of their health workforce. Countries that 
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have made strong progress towards UHC have prioritized their health workforce needs, investing in 
workforce planning, training, improving remuneration systems and in governance frameworks.7 
In addition to investing in the health system itself, the goal of UHC requires governments to 
implement public policies to address the broader determinants of health, many of which lie outside 
the health sector.8 This is partly why the goal of UHC requires a government-wide commitment, 
supported by governance mechanisms and other practical ways of achieving cooperation between 
government sectors (see further, Chapter 6). 
This report provides examples of the law’s role in both strengthening health systems and addressing 
the broader determinants of health that lie outside the health sector, as governments seek to move 
towards UHC (see Table 7.1). Progress towards UHC will be reflected in efforts to: 
• expand the range of health services that are accessible by individuals and populations (a 
generous benefits package); 
• expand the proportion of the population who are covered by those services (by scaling up 
the capacity of service providers to deliver a sufficient volume of services to meet the needs 
of the covered population); 
• increase the quality of health services; and 
• improve the affordability of health services (financial protection). 
Table 7.1: Important ways that law can support progress towards universal health coverage  
Strengthening the building blocks of the health 
system 
Implementing public policies to reduce health 
risks affecting the population 
Examples: 
• Reducing financial exposure when accessing 
health services: Section 7.2(b); Section 7.3 
• Establishing legal frameworks for 
surveillance, and the management and use of 
health information: Chapter 9 
• Retention and regulation of the health 
workforce: Chapter 14 
• Facilitating universal access to essential 
medicines at affordable prices: Chapter 15 
• Strengthening leadership and coordination 
within government, including through 
processes to facilitate intersectoral action on 
health risks: Chapter 6 
Examples: 
• Establishing legal frameworks for clean 
water, sanitation and vector abatement: 
Chapter 8 
• Controlling infectious diseases: Chapter 10 
• Establishing legal powers and agreed 
processes for dealing with public health 
emergencies: Chapter 11 
• Reducing the occurrence of injuries: Section 
12.2 
• Reducing the burden of disease from tobacco 
use (Chapter 13), obesity and undernutrition 
(Chapter 16), and other risks for 
noncommunicable diseases: Section 12.1. 
• Preventing violence, discrimination, and 
other risks to maternal and child health: 
Chapter 17 
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7.2 Legislative frameworks supporting the provision 
 of health services 
Legal frameworks are an essential part of the fabric or structure of an effective health system. Seen 
from outside, the function and purpose of legal and regulatory structures may not always be visible, 
but without them, roles, powers and responsibilities may be unclear, accountability absent, 
institutions may be missing, and vital functions may be performed haphazardly, or not at all. 
However, laws are neither self-executing, nor sufficient by themselves. Laws must be enforced, and 
legislative frameworks function as parts of broader, integrated systems for the financing, 
administration and delivery of health services. 
This section adopts a very simple framework for presenting some examples of legal and regulatory 
issues that may arise as governments move towards expanding national health insurance systems. 
Building on the UHC cube discussed in Section 1.2, governments may use legislation and regulatory 
processes to: 
• define membership and coverage under a health insurance scheme (the population axis); 
• introduce funding mechanisms and regulate for greater affordability (cost axis); 
• regulate health service providers and service provision (the service axis); and 
• establish governing institutions and processes. 
(a)  Memberships, coverage and entitlements 
Recognizing the legal entitlement of all members of the population to have access to essential health 
services, vaccinations, essential medicines and technologies – without discrimination based on 
inability to pay – provides a foundation for planning and resource allocation as governments move 
towards UHC. Recognition of such a right does not require the government to become the sole 
provider of all health services. However, it does commit the government to pursuing those 
intermediate objectives that will help to achieve the broader goal of UHC. 
The process for expanding coverage under a health insurance scheme will usually involve formally 
defining the parameters of programme entitlements, including any means-tested exemptions, co-
payments, safety nets and rights of access for those who cannot afford to pay. Registration systems 
for government-subsidized health insurance schemes may involve systems for ensuring proof of 
identity and membership (e.g. identity cards or other identifiers), in order to enable the monitoring 
of claims submitted by health providers and utilization of the scheme by enrolled members. 
In order to facilitate access to the scheme by those it is intended to benefit, governments may 
consider building a right of access into the design of the scheme, such as through a patient charter of 
rights, coupled with a complaints system for the investigation and conciliation of complaints by 
those who are not treated in accordance with their entitlements. The right to health imposes an 
immediate obligation on governments to prevent discrimination in access to services on a range of 
prohibited grounds. These grounds include race, colour, sex, language, religion, political opinion, 
national or social origin, property, physical or mental disability, health status and sexual orientation.9 
Protection from unlawful discrimination implies that individuals will have adequate access to a 
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mechanism for making complaints about discrimination, such as an ombudsman or discrimination 
commissioner. Discrimination may occur not only by excluding an individual from coverage or by 
refusing to provide services covered by the scheme on grounds prohibited by law, but by failing to 
treat an individual with dignity, through inferior levels of service, or by imposing unjustified 
additional requirements. The regulation of membership and coverage under a health insurance 
system extends to statutory protection for the security, privacy and confidentiality of health 
information about enrolled members. 
(b) Financing of health services 
There are vast discrepancies between countries in the amount of total spending on health per 
person, in total government spending on health per person, and in the share of private expenditure 
on health as a percentage of total expenditure. For example, in 2012, Norway, a high-income 
country with a well-developed social security net spent US$ 9312 on health, although US$ 7919 of 
this total was made up of government spending, meaning that private spending was about 15%. By 
contrast, in a number of low-income countries around the world, total health spending per capita is 
only a few tens of dollars, and a high percentage of this is private spending (exceeding 70% in some 
countries).10 
Access to a set of priority health care services for all members of the population requires a financing 
system that avoids two important risks. The first is catastrophic expenditure (leading to 
improverishment),11 caused by the need for large out-of-pocket payments when a person falls ill. 
The second is the risk that even modest user fees, and other bureaucratic requirements (eg the need 
for annual re-enrolment) will dampen demand and create barriers to access for the poorest 
households in low-income countries.12 
Countries that have come closest to achieving UHC raise funds to pay for health and medical services 
through compulsory pre-payment mechanisms, such as taxation, compulsory insurance 
contributions or, frequently, a combination of both.13 At the same time, universal access to priority 
health services cannot be achieved unless governments cover the cost of services for those who 
cannot afford to contribute at any level.14 There is strong evidence that both community-based 
health insurance schemes, and social health insurance schemes (typically based on mandatory, 
salary-based contributions), can improve financial protection as well as the use of health care 
services by insured persons.15 
For example, Rwanda first introduced community-based health insurance schemes (known as 
mutuelles) in 1999, with participation and annual premiums organized on a household basis. 
Enrolled households are affiliated with a local health care centre, which provides referral for hospital 
services covered by their mutuelle.16 In 2012–2013, 86% of the population was covered under this 
scheme. The government pays premiums for 25% of the population, consisting of people who are 
classified as vulnerable, subsidizing the provision of services through payment of block grants to 
administrative districts.17 
In nearly all OECD countries, public sector financing accounts for the majority of health care 
financing.18 The World Health Assembly has urged Member States to develop their health financing 
systems in order to reduce out-of-pocket payments at the time of service delivery and to pool risks 
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among the population in order to avoid catastrophic health care expenditure by those in need of 
care.19 
Legal regulation of the financing of health services includes the regulation of revenue collection, 
legal control of the funding pools that are used to pay for health services, and regulation of the 
purchasing of health services provided to covered populations.20 WHO has recommended that 
governments increase the public funds that are available for health financing by improving revenue 
collection, and by giving greater priority to health within national budgets.21 WHO has also 
encouraged governments to consider innovative ways of increasing revenue, such as imposing or 
increasing excise taxes on tobacco and alcohol products, sugary drinks, airline tickets or currency 
transactions.22 
The regulation of revenue collection is conceptually distinct from the regulation of fund pooling. 
Revenue collection includes the mobilization of funds through general taxes, voluntary or 
compulsory insurance premiums paid by employers or households, and donations from 
development partners. Fund pooling refers to the control of those monies for the benefit of the 
beneficiaries of the health insurance system, and includes the governance of institutions that control 
fund pools.23 Fund pooling permits governments to reduce duplication and to create economies of 
scale, and to require that revenues from higher income contributors are used to cross-subsidize the 
provision of services to those on lower incomes. 
Depending on the structure of the health insurance system, the government may regulate funding 
pools to ensure capital adequacy and to impose controls over the investment of funds. It may also 
impose requirements to report to the central government, and impose governance requirements on 
the health insurance entities that administer insurance schemes based on pooled funds.24 
Governments may also make scheme membership mandatory for eligible households, prohibit 
medical underwriting (risk-adjusted premiums based on medical history), and link premiums to 
household income. In many countries, private health insurance schemes pre-date social health 
insurance schemes, community-based health insurance schemes and other vehicles used to pursue 
the goal of UHC.25 In the case of private insurers, governments may need to address a wide range of 
issues, including prudential requirements, consumer protection, competition, advertising, adverse 
selection, premiums and mechanisms for government oversight.26 
The regulation of purchasing refers to the regulation of the financial relationship between providers 
of health services and government agencies, health insurance schemes or other entities purchasing 
health services on behalf of enrolled populations.27 For example, providers may be employed on 
salary, or remunerated on the basis of fee-for-service, but strong demand, cost escalation and/or the 
risks of over-servicing often require governments to trial other approaches, such as capitation or use 
of fixed rate reimbursement based on diagnosis-related groups.28 A number of countries have 
considered performance-based financing as a way of expanding child immunization and coverage of 
other health services (Box 7.1). 
Box 7.1: Improving health systems through performance-based financing 
While performance-based financing can take many forms, the common theme is to formalize the 
relationship between a central government or funder of health services and the different 
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organizational units of the health system. Payment is then based on organizational units meeting 
the performance criteria set out in a contract or agreement with the funder, rather than being 
based on inputs, such as salaries and pharmaceuticals.29 Well-designed performance-based 
financing systems can attract a high level of commitment from health professionals, through 
incentives or additional funding for those organizational units that exceed basic performance 
standards. 
Health service providers that are subject to performance-based funding may be more likely to 
demand performance and accountability from other parts of the health system that they depend 
upon (for example, for data collection, the supply of pharmaceuticals, or the roll-out of national 
programmes) and to respond to the populations they serve in more flexible ways (e.g. with home 
visits, community outreach programmes, subcontracting to community organizations and more 
flexible workings hours). Performance-based financing may be useful not only for the funding of 
child immunization, and the provision of antenatal and postnatal health care, but for improving 
diabetes management, smoking cessation and other risk factors for noncommunicable diseases.30 
(c) Health services and health service providers 
UHC requires governments not only to expand the range of services provided in the benefits 
package, but also to expand the capacity or volume of the services provided in order to achieve 
greater population coverage. The service axis therefore requires a focus both on the services 
themselves, and on the production and regulation of service providers and on other inputs that are 
needed in order to expand service provision. 
WHO has advised governments that are moving towards UHC to place particular emphasis on 
primary care, taking account of the health inequalities that exist within countries based on 
disparities in income, education, employment status, geographical location and membership of 
different ethnic, racial or religious groups.31 Some key features of primary health care, as this term is 
used by WHO, are set out in Box 7.2. Providing a minimum package of integrated services, based 
upon population health needs, that ensures continuity of care and affordable access to all members 
of the population, including those in rural and remote areas, should be the overriding goal. 
Box 7.2: Distinctive features of people-centred, primary health care systems32 
A responsive, people-centred primary health care system: 
• focuses on the health needs of the population and aims to provide a comprehensive package 
of health services for all ages, rather than targeting particular groups, or a limited set of 
priority diseases; 
• provides continuity of care, through well-articulated referral systems, rather than 
fragmented and episodic relationships, or disease or programme-specific interventions; 
• makes health care available to all, irrespective of ability to pay; 
• resists all forms of discrimination that create obstacles to access and equity; 
• places the emphasis on “close-to-client” care provided locally, rather than on hospitals or 
specialist practitioners; 
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• uses the primary care team as a coordinating centre for referral to specialist health care 
services when required; 
• is responsive to the population it serves, providing both curative and palliative care, as well 
as preventive services and health promotion; 
• works in partnership with people to improve their health and the health of the wider 
community, builds bridges to the wider community, and addresses the social determinants 
of ill-health. 
The health workforce is a crucial input – but all too often a limiting factor – in strategies to scale up 
the coverage of health services.33 In addition to regulating purchasing and remuneration, legislative 
frameworks perform important gateway functions: licensing health care providers to practice their 
profession in the jurisdiction and accrediting health clinics and health service providers under a 
health insurance scheme. Licensing and accreditation play an important role in safeguarding quality 
of care and in improving accountability for the delivery of health services. In addition, they may 
enable countries to innovate and to adapt their health workforce to meet new challenges. For 
example, in 2014, Tonga graduated its first cohort of nurses specializing in the prevention, detection 
and management of noncommunicable diseases.34 Tonga’s noncommunicable disease nurses 
illustrate the fact that new professional categories and designations may be required as countries 
both expand the production of health care workers and adapt to the changing burden of disease. 
Licensing requirements allow authorities to impose prerequisites for those who wish to practise 
medicine, the allied health professions and other technical roles. For example, medical practitioners 
are typically required to complete a medical training course or degree at a recognized medical 
school, to successfully pass State medical exams, to complete a period of practical training in a 
medical facility (a medical internship), to fulfil ethical and character requirements and to maintain 
their knowledge of their field. Additional requirements apply to medical specialists. In some 
countries, a national council oversees and supports the operations of professional boards 
representing the different professions (Box 7.3). By imposing licensing requirements on the practice 
of medicine, or by formally recognizing the entry requirements imposed by respected professional 
bodies, governments can protect the public from unskilled and poorly skilled individuals who claim 
the right to provide medical services. Licensing requirements may be imposed upon medical 
practitioners, nurses, and other allied health professionals at national or state level. 
Box 7.3: Gateway requirements for the practice of medicine: an example from South Africa 
The Health Professions Council of South Africa (HPCSA), a national body established by the Health 
Professions Act 1974, regulates the medical and allied health professions in matters including 
registration to practice, education and training and professional conduct.35 The South African 
Nursing Council, established by the Nursing Act 2005, performs a similar function for the nursing 
profession. Registration by the HPCSA is a prerequisite for practising as a medical practitioner or in 
one of the other professional categories recognized by each of the 14 professional boards.36 The 
HPCSA accredits medical programmes and aspiring doctors are required to attend an accredited 
university and participate in an internship at an accredited facility. The Medical and Dental Board 
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registers practitioners who meet specified criteria under a range of professional categories. Each of 
the boards that operate within the framework of the HPCSA may enquire into allegations of 
unprofessional practice by health practitioners and impose penalties in appropriate cases, including 
fines, suspension from practice or removal of registration.37 
Under China’s law on medical practitioners, adopted in 1998, health administration departments at 
the county level and above are responsible for regulating medical practitioners within their 
respective regions, overseen by the health administration department under the State Council.38 
Those with bachelor degrees in medicine who have completed a one year internship may sit the 
state exam; those who pass may apply to their local health administration department for 
registration, and following registration, may practice at medical institutions in accordance with the 
location, category and scope of their registration.39 Doctors with five years’ experience at medical 
institutions may apply for approval for private practice. Local health administration departments 
have a variety of responsibilities, including maintaining a list of registered and deregistered doctors, 
assessing the continuing professional performance of practising doctors, and providing continuing 
medical education.40 The law specifies a number of legal responsibilities of practicing doctors and 
provides for warnings, suspension or revocation of registration for those who fail to meet these 
requirements. Grounds for prosecution (including criminal prosecution) include malpractice, forging 
documents, using unapproved medicines, carrying out experimental treatment without consent, 
soliciting or illegally accepting money and gifts from patients, and making improper use of one’s 
position.41 The law authorizes local health administration departments to close unapproved medical 
treatment facilities and to confiscate illegally-obtained income, medicines and equipment.42 
When framing licensing requirements, governments should be aware of the need for flexible 
arrangements for authorizing the delivery of emergency health services by authorized personnel 
following a natural disaster, pandemic or other public health emergency. Creating a process to 
expedite approval by executive order during an emergency ensures that communities will not be 
deprived of medical care at the time they most require it. Where appropriate, medical and health 
care services may be delivered by health professionals contracted to international agencies, 
accredited nongovernmental organizations, or attached to the security forces of a friendly 
government that is performing disaster relief functions in partnership with national authorities. 
Governments may also consider requiring accredited health care providers to contribute to 
premium-based compensation schemes for individuals who are injured through medical negligence 
or substandard care, or who are victims of criminal offences committed by health professionals. 
Although individuals can seek legal remedies through court actions, governments in some countries 
have established health care complaints agencies as alternative dispute resolution systems to 
investigate and conciliate complaints about medical care and to uphold compliance with codes of 
conduct adopted by the profession. Legislation may also support health care complaints schemes by 
defining what constitutes inappropriate care or medical misconduct. 
In addition to licensing health professionals, governments may also impose licensing requirements 
and accreditation criteria upon hospitals, nursing homes and other health care establishments, not 
only to improve accountability and to identify the best-performing institutions, but to support the 
improvement of quality standards across all facilities.43 In some countries, government agencies or 
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an independent agency perform accreditation functions. In Argentina, the Technical Institute for 
Accreditation of Health Care Organizations – a nongovernmental non-profit organization – provides 
voluntary accreditation to both public and private hospitals according to Pan American Health 
Organization standards.44 In performing these functions, regulatory agencies must avoid any conflict 
of interest with businesses that own or run health care establishments for profit. 
(d) Governing institutions 
The capacity of governments to expand the range, coverage, affordability and quality of health 
services will depend on their capacity to manage, coordinate and expand the underlying resources 
(inputs) needed to deliver those services. Underlying resources include physical infrastructure, 
human resources, health information, medicines, vaccines, health technology, funding streams and 
payment systems.45 Expanding towards UHC requires simultaneous investments in each of these 
areas, as well as governing institutions to coordinate and integrate their functions. In some 
countries, this coordinating role may be performed by a single national health insurance commission 
or authority; in others, a large number of community or employment-based health insurance 
schemes may share governance functions. Key functions include registering members, collecting 
health insurance contributions, managing pooled funds, accrediting, contracting and reimbursing 
health service providers, and complying with government reporting and other legislative 
requirements. 
However the system is organized, governments nevertheless retain an overarching stewardship role, 
which may be partly delegated to purpose-built institutions.46 Stewardship functions include the 
overall design of the health insurance system, assessment of its performance, advocacy for the 
policies and coverage goals of the system within the political structures of government, the 
performance of regulatory functions, and accountability for progress towards the realization of the 
right to health for all members of the population. 
Improving the performance of institutions is an important part of the law reform process as 
countries move towards UHC. In turn, institutions will themselves be subject to administrative and 
financial requirements. For example, governing legislation may include requirements relating to: the 
appointment, tenure and removal of senior executives, the establishment of principal committees, 
units and directorates, and provisions relating to meetings and conflicts of interest. Governing 
legislation may also specify a level of direct government control over the organization (e.g. through 
ministerial directives), and include provisions relating to accounts, auditing requirements and annual 
reports. 
Two important institutions commonly seen in health insurance systems include a national health 
insurance authority (discussed in the following section), and a drugs and medicines regulation 
authority. A drug regulation agency performs three important roles. The first is drug registration, 
including assessing and authorizing the entry of medicines into the market, and monitoring their 
safety and effectiveness. The second is regulation of manufacturing, importation and distribution of 
drugs. The third is regulation of pharmaceutical advertising and the provision of information.47 In 
order to fulfil these roles, regulatory authorities may perform a range of more specific functions (see 
Box 7.4). In order to fulfil all of these roles effectively, and to negotiate contracts for the bulk 
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purchasing of essential medicines, drug regulatory authorities should be centralized at the national 
level.  
Box 7.4: Some regulatory functions of a national medicines administration authority48 
• Establishing a national list of essential medicines that responds to country-specific needs and 
disease burden, with a focus on primary care; 
• Licensing drug manufacturers, wholesalers and other drug dispensers, and monitoring good 
manufacturing practices; 
• Establishing evidence-based clinical guidelines for rational use of prescription medicines; 
• Monitoring demand for essential medicines and monitoring prices in the public and private 
sectors; 
• Educating prescribers and establishing financial incentives for prescribers to substitute 
generic brands; 
• Preferential registration and quality assurance of generic medicines; 
• Working with donors to reduce duplication of distribution systems; 
• Investigating counterfeit medicines and referring cases to law enforcement authorities; 
• Negotiating prices and licences on behalf of government-funded or subsidized health 
insurance schemes; 
• Monitoring safety and quality of medicines and investigating safety issues – using legal 
powers to inspect premises, to remove, test and recall products, and to restrain misleading 
and fraudulent practices; 
• Negotiating prices on behalf of government-funded and subsidized schemes; 
• Advising the government on use of flexibilities in the Agreement on Trade-Related Aspects of 
Intellectual Property Rights (TRIPS). 
7.3 The role of legislation in defining a national 
 health insurance scheme: case study from Ghana 
Ghana’s National Health Insurance Scheme provides a helpful case study of the role of legislation in 
creating the governing institutions and formalizing the funding mechanisms for UHC. Ghana’s 
experience may be relevant to other countries where responsibility for the provision of health 
services is decentralized, where a large proportion of the uninsured population works in the informal 
sector, and where many of those covered by the scheme cannot afford to contribute through 
premiums or user fees. The national health insurance model Ghana introduced in 2003 was based on 
service provision through a network of semi-autonomous, district-based mutual health 
organizations, strengthened by national governance and financing mechanisms. A decade later, 
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however, Ghana passed legislation that created a single agency (the National Health Insurance 
Authority) with district offices.49 
(a) Legislative regulation of Ghana’s National Health Insurance Scheme 
Governing institutions 
Ghana’s National Health Insurance Act 2003 established the National Health Insurance Authority 
(NHIA), with the goal of replacing a user pays policy with a national health insurance scheme 
providing basic health care services to all residents.50 The Act required each district to establish a 
mutual health insurance scheme for residents of that district, which was registered as a company 
limited by guarantee under Ghana’s Companies Act.51 The Act authorized three kinds of health 
insurance schemes: district mutual health insurance schemes, private mutual health insurance 
schemes, and private commercial health insurance schemes.52 However, it was the district schemes 
that provided the basis for a system of national coverage. The NHIA’s functions included registering, 
licensing and regulating health insurance schemes, granting accreditation to health care providers, 
monitoring their performance and ensuring the quality of services delivered to beneficiaries of 
schemes. The NHIA maintained a register of licensed health insurance schemes and accredited 
health care providers53 and was authorized to inspect and investigate schemes and issue enforceable 
directives.54 The NHIA also managed the National Health Insurance Fund, which subsidized the 
provision of health services by district mutual health insurance schemes.55 
Membership and coverage 
The 2003 Act made district schemes responsible for enrolling residents of each district as members, 
obtaining membership contributions, issuing health insurance identity cards, and administering a 
means test for indigent persons.56 The legislation prohibited schemes from discriminating against a 
person with respect to their admission as a member of a scheme on the basis of “race, sex, disability, 
marital status, ethnicity, social origin, nationality, religion or creed”.57 The Act also stipulated that 
the subsidy that mutual health insurance schemes received from the National Health Insurance Fund 
would not be paid unless the Council (the governing body of the NHIA) was satisfied that persons 
had not been excluded from membership based on their physical disability, social, economic or 
health status.58 
Regulation of health services and health service providers 
The 2003 Act required health insurance schemes to use the services of health facilities and health 
care providers that had been accredited by the NHIA.59 The Regulations set out the accreditation 
requirements for defined classes of health care facilities and for health professionals.60 
The 2003 Act also required all licensed schemes to provide the minimum health care benefits set out 
in the Regulations, thus ensuring a nationally applicable set of priority services.61 These included 
outpatient services (including laboratory, X-ray and ultrasound services), inpatient services, oral 
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health and eye care services, maternity care (antenatal and postnatal care, deliveries – including 
caesarean sections), and all emergencies.62 Minimum benefits also include the prescription 
medications included in the National Health Insurance Scheme Medicines List.63 The Regulations set 
out a list of public health services that were to be paid for by the government and were to be free to 
all members of the population, including immunization, family planning, treatment of mental illness, 
HIV testing, and treatment of tuberculosis, onchocerciasis, Buruli ulcer and trachoma.64 Health care 
services excluded from the scheme were also defined.65 
Except in emergencies, the Regulations required primary health care facilities to act as gatekeepers, 
referring patients to secondary and tertiary care services as appropriate.66 All health care facilities 
were required to adopt the referral protocols, practice guidelines and health resource sharing 
arrangements approved by the Council as a requirement for accreditation.67 Accredited facilities 
were required to submit quarterly reports containing specified data to enable the Council to monitor 
the performance of health care facilities and pharmaceutical service providers.68 The Regulations 
also set out the circumstances in which health insurance schemes were authorized to refuse 
payment for services provided by health care facilities.69 
Financing 
The 2003 Act required members of district mutual health insurance funds to make membership 
contributions. However, several classes of people were exempt, including dependent children under 
18, pensioners, persons aged 70 years or older, and (subject to a means test) indigent persons with 
no fixed place of residence or source of income.70 Unlike private schemes, district mutual health 
insurance schemes were paid a subsidy from the National Health Insurance Fund, at a level 
determined by the Council and approved by Parliament.71 The Fund was financed from a number of 
sources. These included: 
• membership contributions (subject to exemptions including those mentioned above); 
• a health insurance levy of 2.5% on selected goods and services (with exemptions on medical 
services, pharmaceuticals, water, education, and mosquito nets);72 
• a 2.5% deduction from formal sector contributions to Ghana’s Social Security and Pensions 
Scheme Fund; 
• parliamentary allocations, and investment income.73 
No co-payments or up-front fees were required at point of service for services covered by the 
scheme.74 Under the 2003 Act, the Council, as the governing board of the NHIA, determined the 
tariffs or levels of reimbursement for health services, in consultation with health care facilities and 
schemes. The Act authorized payment on the basis of fee-for-service, capitation payments or on any 
other basis that the Council determined.75 
Evolution of the scheme under the 2012 Act 
Community-based, mutual health insurance schemes have the advantage of being flexible, 
responsive to their members and based on the values of solidarity and mutual assistance. 
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Community-based schemes may therefore have greater capacity to generate trust and to enrol 
members from among those who were previously excluded from health coverage for financial or 
administrative reasons. However, in order to harmonize National Health Insurance Scheme 
operations, improve service delivery, and address a number of problems (including inefficiencies, 
difficulties in achieving portability, and irregular billing practices), Ghana repealed its 2003 Act and 
introduced a centralized health insurance scheme through the National Health Insurance Act 2012.76 
The 2012 Act created a single-payer system, overseen by the NHIA, with the stated goal of universal 
health insurance coverage and access to health care services for all residents of and visitors to 
Ghana.77 The Act established a multidisciplinary governing board for the NHIA,78 and three specialist 
committees with specific oversight functions. These included the Finance and Investment 
Committee, overseeing the management of the National Health Insurance Fund, and the National 
Health Insurance Oversight Committee. This last committee advises the Board with respect to 
systems for registration of members in the national scheme, the benefits package available under 
the scheme, the credentialing of health service providers, tariffs payable to health care providers, 
and mechanisms for submission and adjudication of claims by service providers.79 The Act provides 
for the appointment of executives of the Authority, and members of the board, and authorizes the 
board to establish directorates for the performance of functions of the Authority. The key functions 
of the Authority under the 2012 Act are set out in Box 7.5. 
Box 7.5: Key functions of Ghana’s National Health Insurance Authority 
In order to achieve its objective of attaining universal health insurance coverage for all residents, the 
National Health Insurance Act 2012 (Act 852) authorizes the Authority to: 
(a) implement, operate and manage the National Health Insurance Scheme; 
(b) determine in consultation with the Minister contributions that should be made by members of 
the National Health Insurance Scheme; 
(c) register members of the National Health Insurance Scheme; 
(d) register and supervise private health insurance schemes; 
(e) issue identity cards to members of the National Health Insurance Scheme; 
(f) ensure 
(i) equity in health care coverage; 
(ii) access by the poor to health care services; 
(iii) protection of the poor and vulnerable against financial risk; 
(g) grant credentials to health care providers and facilities that provide health care services to 
members of the National Health Insurance Scheme; 
(h) manage the National Health Insurance Fund; 
(i) provide a decentralized system to receive and resolve complaints by members of the National 
Health Insurance Scheme and health care providers; 
(j) receive, process and pay claims for services rendered by health care providers; 
(k) undertake public education on health insurance on its own or in collaboration with other bodies; 
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(I) make proposals to the Minister for the formulation of policies on health insurance; 
(m) undertake programmes that further the sustainability of the National Health Insurance Scheme; 
(n) develop guidelines, processes and manuals for the effective implementation and management of 
the National Health Insurance Scheme; 
(o) ensure the efficiency and quality of services under the national and private health insurance 
schemes, 
(p) protect the interest of members of private health insurance schemes; 
(q) identify and enrol persons exempt from payment of contributions to National Health Insurance 
into the National Health Insurance Scheme; 
(r) monitor and ensure compliance with this Act and any Regulations, guidelines, policies, processes 
and manuals made under this Act; and 
(s) perform any other function conferred on it by this Act or that are ancillary to the object of the 
Authority. 
Under the 2012 Act, membership of the scheme is mandatory for all residents, although residents 
must still apply for registration to the Authority, which issues membership cards.80 The Act requires 
the Minister to prescribe the health care benefits package provided under the National Health 
Insurance Scheme, and the Authority must assess the continued suitability of the benefits package 
every six months.81 The Authority must also develop a list of the medicines that may be prescribed 
under the scheme and the prices that can be charged for these medicines, and review these 
annually. Similarly, the Authority must review the list of health services and service tariffs that may 
be charged by health care providers, and may add or remove diagnoses, procedures and 
examinations and review prices.82 The 2012 Act also sets out a variety of offences that apply to 
officers of the Authority, to members of the National Health Insurance Scheme, and health care 
providers who provide services under the scheme.83 
(b) Ghana’s National Health Insurance Scheme and the dimensions of universal 
health coverage 
Ghana’s experience illustrates the central role of legislation in implementing a national health 
insurance scheme. This includes creating governing institutions and providing for their 
administration and financial accountability. It also includes formalizing the roles and responsibilities 
of the government and of health service providers, and the entitlements of members of the scheme. 
This section briefly reviews how Ghana’s legislation addressed each of the three axes or dimensions 
of UHC, as discussed in Section 1.2. WHO’s UHC model directs attention to ways of: 
• expanding the population covered by the scheme; 
• expanding the services provided under the scheme; and 
• improving affordability, by reducing out-of-pocket payments and moving towards pre-
payment.84 
The key institutions created by or under the 2003 Act included the NHIA itself, and the district-
based, mutual health insurance schemes. Other significant governance mechanisms included the 
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establishment of the National Health Insurance Fund and the National Health Insurance Levy. Under 
the 2012 Act, the network of mutual health insurance schemes became branch offices of the NHIA. 
Population axis 
Under the 2003 Act, district schemes were responsible for expanding the covered population by 
enrolling new members. This was supported by legislation prohibiting discrimination on a number of 
grounds. Under the 2012 Act, the NHIA assumed responsibility for registering members, and its 
functions included educating the population about the benefits of the scheme. Employers were also 
required to ensure that employees are registered under the scheme.85 
Expanding membership includes registering new members and verifying identities, in order to 
reduce the risks of over-servicing and inappropriate billing. There is also a human dimension to 
expanding population coverage: members must be treated with dignity and respect at point of care, 
regardless of their economic or social circumstances. Ghana is moving towards biometric registration 
and on-the-spot issuance of identity cards to new members. Other challenges include identifying and 
enrolling those who, although not exempt from paying premiums, exist on low and precarious 
incomes in the informal sector.86 
Services axis 
Under the 2003 Act, the range of covered health services was defined in the Regulations, and the 
licensing of schemes and the accreditation of health facilities and health care providers was 
stipulated as a central function of the NHIA. The inspection and accreditation of health care 
providers and health facilities continued under the 2012 Act. The NHIA reviews the benefits package 
regularly, and conducts an annual review of the medicines that providers are entitled to prescribe 
under the scheme, and of the services and supplies for which providers are entitled to charge.87 
The provision of health services and the administration of the health insurance system both depend 
on human resources. The scaling up of Ghana’s national health insurance scheme therefore 
depended on parallel strategies to increase the production of health workers.88 
Cost axis 
The 2003 Act sought to eliminate out-of-pocket payments by switching from fee-for-service to pre-
paid membership contributions paid by enrolled members with defined exemptions, including for 
indigent persons. Mutual health insurance organizations were subsidized by the National Health 
Insurance Fund, which was financed from a variety of sources. Arrangements for the regulation of 
the Fund, and the administration of the National Health Insurance Levy that partly funds it, were 
continued under the 2012 Act.89 Like its predecessor, the 2012 Act provides for oversight of private 
commercial and private mutual health insurance schemes that operate independently of the 
national health insurance scheme. Private schemes are not permitted to be subsidized from the 
National Health Insurance Fund.90 
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As population coverage increases, the cost of paying for cover under the scheme is also likely to 
increase. Revenue sources to support financial sustainability could include higher excise taxes on 
tobacco and alcoholic beverages, a tax on sugary drinks or electronic communications services, a 
levy on extractive industries, or an increase in the National Health Insurance Levy.91 Raising 
membership contributions and reviewing exemptions is also possible, but carries the risk of further 
excluding those on low incomes and in precarious employment. 
A single-payer health insurance scheme also creates risks of over-servicing. Administering authorities 
need the capacity to monitor claims, strong clinical and internal audit capabilities, and the capacity 
to investigate inappropriate billing practices and to refer appropriate cases for prosecution. No 
insurance scheme can remain financially sustainable if a culture of inappropriate billing practices 
takes root among health service providers, or if additional fees are gouged from members in ways 
that drive indigent and low-income persons away from the scheme. In response to cost pressures, 
Ghana’s NHIA has trialled capitation payment systems, strengthened its clinical and internal audit 
divisions, introduced a centralized, consolidated account for collecting premiums, centralized its 
claims processing and payment functions, strengthened the enforcement of the Ministry’s 
gatekeeper policy, improved the rational prescribing of medicines by linking diagnosis to treatment, 
and introduced electronic claims submission.92 Like several other African countries, Ghana is also 
moving towards innovative, mobile systems for registering members and collecting premiums.93 
Quality 
The 2003 Act sought to address service quality in a number of ways; for example, by requiring health 
care facilities to adopt quality assurance standards,94 by requiring schemes to pay accounts 
submitted by service providers within four weeks, and by requiring licensed schemes to provide a 
procedure for settling complaints.95 The 2012 Act requires the Minister to appoint an Adjudication 
Committee, with membership from a range of professional associations, to hear complaints made by 
a member of the scheme or by a health care provider accredited to the scheme, or complaints 
referred to it by the Board.96 Members of the National Health Insurance Scheme must also be 
informed about complaint and dispute resolution mechanisms at the time of registration.97 The 
Authority is also required to ensure that health care providers “implement policies that guarantee 
quality health care to members … and carry out clinical audits”.98 
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Chapter 8: Clean water, sanitation  
and vector abatement 
 
SUMMARY POINTS 
 
· Safe, clean drinking water and sanitation facilities are essential to the enjoyment of life and to 
the right to health. Water and sanitation laws are also fundamental components of a modern 
public health system. 
· Water management laws may impose general duties on local governments and town councils 
to provide, protect and conserve sources of clean drinking water. Discharging this duty will require 
a range of supporting powers. These may include the power to enter and acquire land, to access 
sources of water on just terms, to purchase water rights, to construct reservoirs and water storage 
tanks, to inspect waterworks and maintain pumping and other equipment, to test water supplies, 
and to enter into contracts for the supply of water sourced from within or beyond the relevant 
local government area. 
· Health inspectors should be empowered to test water quality and to control or regulate any 
activities that are reasonably likely to contaminate public water supplies. These powers should 
extend to the disposal of waste and refuse, including animal remains. Subject to constitutional 
considerations, governments should consider ways to ensure that the health ministry retains 
oversight and ultimate responsibility for the provision of clean drinking water. 
· Water management and sanitation laws should include duties on landowners and occupiers of 
premises to ensure adequate drainage of waste and flood water, to dispose of domestic waste 
appropriately, as well as a general duty not to pollute or contaminate sources of drinking water 
and water catchment areas. 
· Although imposing user fees may help to conserve scarce water supplies, the privatization of 
water provision services may potentially result in inequitable levels of access or increase disease 
rates. Governments should only proceed with privatization if this is accompanied by a closely 
monitored strategy to safeguard access by those who are most disadvantaged. Governments may 
consider legislation that prohibits the disconnection of water services to private dwellings, or 
consider pricing policies that only permit user fees to apply for water use that exceeds basic 
needs. 
· In order to plan for future needs, public health laws should authorize governments to collect 
and analyse data on water resources, take samples, monitor quality and install and remove 
monitoring equipment. 
· Public health laws may set out the kinds of premises that must have water supplies and 
functioning sanitation facilities that are connected to a sewerage system or septic tank. Public 
health laws may also authorize health and sanitation inspectors to direct an owner or occupier of 
premises to install sanitary facilities, to dispose of sewerage and contaminated waste, and to take 
such actions as are necessary to prevent a wastewater system from causing a risk to public health. 
· Public health laws may require local and city governments to install public toilets, washing 
facilities and associated septic tanks or sewerage systems in public areas where members of the 
public travel and congregate. These include train and bus stations, sporting facilities and petrol 
stations. 
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· Governments should consider gender when planning sanitation reforms. Women and girls 
should have access to clean water and sanitation facilities that protect their health, safety and 
privacy. 
· Effective malaria control requires universal access to measures for the prevention, diagnosis 
and treatment of malaria. Public health laws should mandate vector surveillance and authorize 
public health authorities to take all such actions as necessary to implement evidence-based 
control strategies. Key malaria control interventions include providing long-lasting insecticide-
treated mosquito nets to high-burden populations, and indoor residual spraying. 
· Governments should prohibit the marketing, sale and use of oral, artemisinin-based 
monotherapies and promote the use of artemisinin-based combination therapy for treatment of 
malaria. 
· Indoor residual spraying with DDT remains an important intervention for malaria control, in 
accordance with WHO recommendations and the Stockholm Convention on Persistent Organic 
Pollutants. WHO has published operational guidelines for safe and effective indoor residual 
spraying. 
· Public health laws can support vector control through statutory offences for causing or 
permitting a nuisance that applies to owners or occupiers of premises. 
· Public health laws should authorize public health authorities to issue an abatement notice that 
requires the owner or occupier to take such actions as reasonably necessary to abate or prevent 
the nuisance. Typically, public health laws authorize local authorities to enter and inspect 
premises, and to take actions themselves to abate a nuisance when an owner or occupier fails to 
do so. 
8.1 Sanitation and hygiene 
The right to safe and clean drinking water and sanitation facilities is a human right that is essential 
for the full enjoyment of life and all human rights.1 Access to safe and potable water and adequate 
sanitation are also underlying determinants of health which form part of the right to the highest 
attainable standard of health contained in the International Covenant on Economic, Social and 
Cultural Rights.2 Between 1990 and 2015, the percentage of the world’s population with access to an 
improved source of drinking water – such as a protected well, hand pump or public tap – rose from 
76% to 91%.3 Despite this, in 2015, an estimated 663 million people still lacked access to a safe and 
reliable source of drinking water; nearly half of these people lived in sub-Saharan Africa.4 
In 2015, around one in three of the global population lacked access to sanitation facilities. In 47 
countries, fewer than 50% of the population had access to improved sanitation,5 and open 
defecation was still practiced by more than 900 million people.6 Lack of hygiene and access to clean 
drinking water, including inadequate management of water distribution systems,7 are significant 
causes of avoidable mortality.  Unequal levels of access to these services are also significant causes 
of health inequalities.8 Improving access to adequate sanitation and clean drinking water are 
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foundational strategies for reducing health inequalities and for fulfilling the right to health (Box 
8.1).9 
Box 8.1: Clean drinking water and sanitation: foundations of a modern public health system 
• Faecal-oral transmission of disease, caused by unsafe water and inadequate sanitation, are 
the primary drivers of diarrhoeal diseases – the second leading cause of death in children 
under five, killing around 760 000 children annually.10 
• Contaminated water and poor sanitation cause a range of other diseases that affect millions 
of people each year, including cholera, hepatitis A, fluorosis, dracunculiasis, intestinal 
worms, malaria, schistosomiasis, trachoma, arsenic poisoning and typhoid fever.11 
In 2008, ministers and heads of delegations responsible for health, sanitation and water 
programmes in 32 African countries signed the eThekwini Declaration, aspiring to commit at least 
0.5% of gross domestic product to new budget lines created expressly for improved sanitation and 
hygiene development.12 In 2010, the United Nations General Assembly called on States to provide 
financial resources, capacity-building and technology transfer, particularly to developing countries, 
in order to scale up the provision of clean, accessible and affordable drinking water and sanitation 
for all.13 In 2015, the General Assembly adopted the goal of ensuring the “availability and sustainable 
management of water and hygiene for all”, as part of the Sustainable Development Goals (SDGs). 
This goal is supported by six technical targets relating to drinking water, sanitation and hygiene, 
wastewater management, water efficiency, integrated resource management and protection of 
aquatic ecosystems. (Box 8.2).14 Since the right to health encompasses safe and potable water, and 
adequate sanitation, governments must also consider the availability, accessibility, acceptability and 
quality of these services (see Section 1.2). Investment in infrastructure to improve access to water 
and sanitation should also be accompanied by education about hygiene. For example, handwashing 
with soap is a powerful public health intervention that has been estimated to reduce diarrhoea by 
around 48%.15 
Box 8.2: Goals and targets for clean drinking water and sanitation in the Sustainable Development 
Goals  
Goal 6: Ensure availability and sustainable management of water and sanitation for all 
Targets for Goal 6: 
• 6.1 By 2030, achieve universal and equitable access to safe and affordable drinking water for 
all. 
• 6.2 By 2030, achieve access to adequate and equitable sanitation and hygiene for all and end 
open defecation, paying special attention to the needs of women and girls and those in 
vulnerable situations. 
• 6.3 By 2030, improve water quality by reducing pollution, eliminating dumping and 
minimizing release of hazardous chemicals and materials, halving the proportion of 
untreated wastewater and substantially increasing recycling and safe reuse globally. 
• 6.4 By 2030, substantially increase water-use efficiency across all sectors and ensure 
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sustainable withdrawals and supply of freshwater to address water scarcity and substantially 
reduce the number of people suffering from water scarcity. 
• 6.5 By 2030, implement integrated water resources management at all levels, including 
through transboundary cooperation as appropriate. 
• 6.6 By 2020, protect and restore water-related ecosystems, including mountains, forests, 
wetlands, rivers, aquifers and lakes. 
• 6.a By 2030, expand international cooperation and capacity-building support to developing 
countries in water- and sanitation-related activities and programmes, including water 
harvesting, desalination, water efficiency, wastewater treatment, recycling and reuse 
technologies 
• 6.b Support and strengthen the participation of local communities in improving water and 
sanitation management 
(a) Clean water supplies 
Public health laws in relation to clean water should address three key areas: water management, 
sanitation facilities and water contaminants. Water management laws may impose general duties on 
local governments and town councils to provide sources of clean drinking water, to carry out water 
assessments in order to identify, protect and conserve drinking water catchment areas and to 
mitigate potential sources of contamination. The duty to provide a sufficient supply of clean water 
requires planning and monitoring by local authorities on an ongoing basis, due to the impact of 
population growth and changing land-use patterns as well as the impact of agriculture on traditional 
sources of water supplies. In order to discharge this duty effectively, local governments and town 
councils may require a range of additional powers. These may include the power to enter and 
acquire land, to access sources of water on just terms, to purchase water rights, to construct 
reservoirs and water storage tanks, to inspect water management facilities, to maintain pumping 
and other equipment, to test water supplies, and to enter into contracts for the supply of water 
sourced from within or beyond their local government area. 
Where resource constraints prevent the construction of public storage tanks, governments may 
encourage point-of-use water treatment and safe storage through education and funding 
strategies.16 Low-cost and effective treatments include boiling, solar disinfection (exposing clear 
containers of water to sunlight for at least six hours), ceramic or biosand filtration systems, and use 
of sodium hypochlorite or chlorinated isocyanurates.17 Laws can encourage self-sufficiency in water 
supplies by requiring landowners to collect, store and conserve rainwater (Box 8.3). Governments 
can encourage compliance by subsidizing water storage containers and chemicals for water 
purification.18  
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Box 8.3: Regulating the quality of drinking water: an example from Belize 
Public Health Act19 
Section 52. Surface drains. Every Town Council may, and when required by the Director of Health 
Services shall, construct and maintain in proper order in convenient places drains for the removal of 
surface and floodwater and for the proper drainage of swamplands situated within its jurisdiction. 
Section 53. Draining of houses and lots, etc. 
(1) Where any lot, house or premises is without a drain sufficient for the effectual drainage of flood 
water or domestic wastewater a Medical Officer of Health may by written notice require the owner 
or occupier of the lot, house or premises within a reasonable time therein specified to make a drain 
or drains emptying, in the case of flood water, into any public drain, and in the case of domestic 
wastewater, emptying into such sump or pit or place as a Medical Officer of Health may direct. 
(2) A Medical Officer of Health may require any such drain or drains to be of such material, 
construction and size and to be laid at such level and with such fall as may appear to [him or her] to 
be necessary and proper and may require any sump to be of a size and type approved by the 
Director of Health Services. 
(3) If such notice is not complied with the Medical Officer of Health may after the time specified in 
the notice do the work required and may recover in a summary manner the expenses incurred by 
[him or her] in so doing from the owner, or may declare the same to be private improvement 
expenses. 
Section 54. Public Tanks. Every Town Council may, and when required by the Minister shall, 
construct and maintain tanks and reservoirs for the storage of rain or fresh water as may be 
necessary, and may sell the water so stored or permit the free use thereof. 
Section 55. By-laws regulating issue of water. Every Town Council may make by-laws for regulating 
the issue of water from any tank or reservoir under its charge. 
Section 61. Dwelling houses to be provided with tanks. 
(1) Every owner of a dwelling-house, the roof of which is not a thatched one, shall erect and 
maintain in good order a tank or tanks in connection with the dwelling-house, for the storage of rain 
water, and in respect of every new building to be used as a dwelling-house erected on or after the 
coming into force of this Act, the tank or tanks shall be capable of storing not less than five gallons of 
water for each square foot of floor space contained within such dwelling-house. 
(2) No tank required to be maintained under this section shall be deemed to be in good order- 
(a) If it is not connected by suitable pipes to gutters attached to a sufficient surface of roof or 
platform exposed to the weather or if such gutters or pipes are not in good order; or 
(b) If the tank is not fitted with apparatus for draining off water there from without waste; or 
(c) If the tank is not watertight; or 
(d) If the tank is not provided with a suitable covered or screened opening for conveniently 
inspecting and repairing the inlet and outlet, and for cleaning. 
Section 63. Inspection of premises and receptacles for water. Any health officer may from time to 
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time with or without assistance enter into, visit and inspect for the purposes of sections 60 to 63 
inclusive all or any premises, tanks and receptacles for water. 
Water management and sanitation laws may impose additional duties on landowners and occupiers 
of premises. These may include the duty to ensure adequate drainage of waste and flood water 
(thereby minimizing standing water, an optimal breeding ground for mosquitoes), to dispose of 
domestic waste appropriately, as well as a general duty not to pollute or contaminate sources of 
drinking water and water catchment areas. 
Local councils may vary in their financial and administrative capacity to manage the supply of clean 
drinking water and to enforce water laws. Subject to the constitutional division of powers in each 
country, government officials considering the revision of public health laws may consider ways of 
ensuring that the health ministry shares some oversight and responsibility for the provision of clean 
drinking water, in order to ensure universal access to disadvantaged groups. 
Factors that may contribute to poor coverage of clean water services include lack of capital for the 
infrastructure investments that are needed for the distribution and management of water, as well as 
inefficient management and lack of accountability on the part of governing agencies.20 When 
countries struggle with water scarcity problems, governments often face pressure to privatize water 
systems to discourage wasteful use. While attaching user fees to water may conserve supplies and 
prevent wasteful use, in some circumstances privatization may result in inequitable access or 
increase disease rates.21 When considering the privatization of water services, governments should 
carefully weigh the potential risks of privatization, and ensure that any privatization of supplies is 
accompanied by a closely monitored strategy to safeguard access. After privatization led to price 
increases in the United Kingdom, increasing numbers of households were disconnected from water 
lines after failing to make payments.22 In response to growing public health concerns, the 
government passed legislation prohibiting disconnection or the use of limiting devices to reduce use 
for non-payment reasons.23 Governments can also establish financing schemes to support 
investment in the provision of clean water to low-income communities, or impose pricing standards 
that only permit user fees for water use that exceeds basic needs.24 
In order to ensure the ongoing quality and sufficiency of drinking water, and to plan for future 
needs, governments need information about the volume, flow and quality of water sources. Public 
health laws should therefore authorize governments to collect and analyse water resources data, to 
take samples, and to construct, install, repair and remove recording and monitoring equipment (Box 
8.4). 
Box 8.4: Laws authorizing the monitoring and investigation of water supplies: an example from 
Australia 
Water Act (Northern Territory)25 
Section 34. Water resources investigation 
To enable effective planning for water resource development and environmental protection, it is the 
duty of the [Controller of water resources] to ensure as far as possible that a continuous program for 
the assessment of water resources of the Territory is carried out, including the investigation, 
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collection, collation and analysis of data concerning the occurrence, volume, flow, characteristics, 
quality, flood potential and use of water resources, and for that purpose the Controller may: 
 (a) systematically gauge stream flow, record climatic data and monitor groundwater levels; 
 (b) construct, operate, repair, maintain, alter and remove gauging, recording and monitoring 
stations and investigation and monitoring bores; 
 (c) sample and analyse water and waste. 
(b)  Sanitation facilities 
Laws that regulate the provision and maintenance of sanitation systems, including toilets and 
washing facilities, make a vital contribution to public health infrastructure by minimizing faecal-oral 
transmission of disease. The WHO/UNICEF Joint Monitoring Programme for Water Supply and 
Sanitation has provided guidance on the range of facilities that provide a basic level of health 
protection.26 An important component of protecting water supplies is to specify the kinds of 
premises, including hotels and lodging houses, workplaces, schools, homes and building sites, that 
must have functioning toilets or sanitation facilities connected to a sewerage system or septic tank. 
Public health laws may also authorize health and sanitation inspectors to direct an owner or 
occupier of premises to install sanitary facilities, to dispose of sewerage and contaminated waste, 
and to take such actions as are necessary to prevent a wastewater system from causing a risk to 
public health (Box 8.5). 
For example, the Public and Environmental Health Regulations of the Northern Territory, in 
Australia, authorize the Chief Health Officer to direct an owner or occupier of premises to install 
sanitary facilities within a specified period, and create an offence for failure to do so.27 The Chief 
Health Officer may also give directions about the management or disposal of “biosolids, septage, or 
sludge”, as defined in the regulations. Box 8.5 illustrates the power of the Chief Health Officer to 
give directions to an owner or occupier of premises in order to ensure that a wastewater system 
does not create a risk to public health. 
Box 8.5: Power to give directions in relation to wastewater systems: an example from Australia 
Public and Environmental Health Regulations, Northern Territory, Australia28 
Section 89 CHO [Chief Health Officer] may give directions 
(1) This regulation applies if the CHO has reasonable grounds to believe that a wastewater system at 
a place is causing, or is likely to cause, a serious public health risk. 
(2) The CHO may direct an owner or occupier of a place to do any thing the CHO considers 
reasonably necessary to prevent the wastewater system from causing, or continuing to be, a serious 
public health risk. 
(3) A person commits an offence if the person: 
 (a) is an owner or occupier of the place; and 
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 (b) is given a direction by the CHO under subregulation (2); and 
 (c) does not comply with the direction within the time specified in the notice. 
(5) If the person does not comply with the direction, the CHO may take any action the CHO considers 
necessary to prevent the wastewater system from causing, or continuing to be, a serious public 
health risk. 
Where resource constraints prevent the construction of a sanitary facility in every place of 
accommodation, the law may instead provide for public or shared facilities until the State develops 
the capacity to provide sanitary services in every dwelling. Governments considering law reform may 
require local government authorities and city councils to plan for the provision of public toilets, 
washing facilities and associated septic tanks or sewerage systems in public areas where members of 
the public travel and congregate. These include train and bus stations, sporting facilities and petrol 
stations. As noted above, hand washing is an important strategy for avoiding diarrhoea; 
governments may consider funding education programmes on hygiene and subsidizing the provision 
of soap for poor populations.29 
Access to improved sanitation can increase productivity by minimizing absences from work and 
school as a result of faecal-oral transmission of disease. Sanitation facilities must be acceptable to 
the communities they are intended to serve (see Section 1.2). For example, sanitation reforms may 
be more effective where public health laws require schools and workplaces to install separate 
facilities for men and women, since women and girls are less likely to use these facilities when doing 
so compromises their safety or privacy.30 Belize’s public health law empowers the health ministry to 
require an employer or school to provide separate facilities for men and women (Box 8.6). 
Box 8.6: Providing for sanitation facilities for both sexes: an example from Belize 
Public Health Act31 
Section 23. Schools and factories to be provided with privies for both sexes 
(1) Where it appears to the Director of Health Services, that any house or building is used or 
intended to be used as a factory or school by persons of both sexes he may if he thinks fit by written 
notice require the owner or occupier to construct a sufficient number of water-closets, earth-closets 
or privies, for the separate use of each sex within a time specified therein. 
A fundamental principle of public health is that sources of water intended for drinking, bathing and 
washing by humans should be protected and separated from drains and run-off, floodwater and 
watercourses potentially contaminated by animals. In addition to waterborne diseases caused by 
inadequate sanitation, poisoning and illness can also occur when groundwater is contaminated with 
industrial waste, fertilizers and pesticides. Public health laws should empower health inspectors to 
test water quality and to control or regulate any activities that are reasonably likely to contaminate 
public water supplies. These powers should extend to the disposal of waste and refuse, including 
animal remains. With due regard to religious beliefs and customs, human burials should be 
restricted to cemeteries that are safe from scavenging and physically separated from water courses. 
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Modern public health laws often create general offences that cover different kinds of actions that 
may contaminate watercourses and sources of drinking water, causing environmental harm or a risk 
to human health. 
8.2 Vector abatement 
Vector control measures aim to reduce the transmission of disease by reducing the number of 
animals and insects that act as vectors for disease transmission, or by reducing interactions between 
animal and disease vectors, and people. Vector-borne diseases, such as malaria, are preventable and 
curable, and yet malaria caused more than 580 000 deaths in 2013, mostly among African children 
(Box 8.7).32 This section focuses on mosquito and rodent control, although region-specific health 
threats may also require attention to vectors such as cockroaches, or sand and tsetse flies. 
Box 8.7: Progress in malaria control 
• In 2015 there were an estimated 214 million new cases of malaria, and 438 000 deaths.33 
Although the estimated malaria mortality rate has fallen by 60% since 2000, a child still dies 
from malaria every two minutes.34 
• In recent years, a number of countries have been certified as malaria-free. These include the 
United Arab Emirates (2007), Morocco (2010), Turkmenistan (2010) and Armenia (2012).35 
Nevertheless, in 2015, 95 countries and territories had cases of malaria transmission.36 
• In the WHO African Region, between 2000 and 2015, malaria mortality declined by 48%.  
Nevertheless, in 2015, most cases of malaria (88%), and most deaths (90%) still occurred in 
this region.37 The longer lifespan and stronger tendency of African mosquito species to bite 
humans explains why around 90% of malaria deaths occur in this region.38 
(a) Malaria and other mosquito-borne diseases 
WHO’s Global Technical Strategy for Malaria 2016–2030 encourages countries to move towards 
malaria-free status by adopting a strategy based on three pillars.39 The first pillar involves universal 
access to measures for the prevention, diagnosis and treatment of malaria. This means universal 
coverage of malaria control interventions for all populations at risk, including indoor residual 
spraying (IRS), and the distribution of long-lasting insecticide-treated nets (LLINs) in high-burden 
areas. IRS and LLINs are the “two core, broadly-applicable vector control interventions” for effective 
malaria control.40 Better outcomes have been achieved when LLINs are distributed for free or at 
subsidized cost.41 In areas with seasonal transmission patterns, distribution of LLINs should be 
focused on areas at highest risk due to climatic conditions or lack of access to health services. Public 
education on LLINs is critical to reduce improper and sporadic use (or no use at all), re-selling, 
improper washing practices, and/or failure to replace damaged nets. IRS is also an effective means 
of vector control in areas where the majority of the population sleeps and rests indoors and where a 
high percentage of homes have spray-able surfaces. In areas where this is not the case, other 
strategies include larviciding (where vectors breed in permanent or semi-permanent bodies of 
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water), environmental management, window screens and area spraying during peak vector activity 
time. 
Effective vector control should be complemented by preventive courses of antimalarial medication 
for the most vulnerable groups (including pregnant women and infants), universal diagnostic testing 
for all suspected cases, and quality-assured treatment of all confirmed cases. In order to prevent 
drug resistance, the World Health Assembly has urged Member States to cease progressively the 
provision in both the public and private sectors of oral, artemisinin-based monotherapies and to 
promote the use of artemisinin-based combination therapy.42 The WHO strategy urges regulatory 
authorities to ensure that artemisinin-based monotherapies are removed from health facilities, 
pharmacies and the private market.43 
The second pillar of WHO’s malaria strategy involves accelerating efforts towards malaria-free status 
and elimination of malaria in low-transmission settings. This includes strengthening the 
epidemiological surveillance of malaria, with compulsory notification of all confirmed cases (see 
Chapter 9), and a ban on the sale of over-the-counter antimalarial medicines to prevent 
inappropriate use. The elimination of malaria requires a multisectoral approach, with renewed 
political commitment and enhanced regional collaboration. The third pillar involves upgrading 
malaria surveillance within all national and subnational malaria strategies, and investing in health 
information systems to support surveillance. 
The Roll Back Malaria Partnership, hosted by WHO between 1998 and 2015, is made up of more 
than 500 partners including malaria-endemic countries, OECD donor countries, multilateral 
development partners, foundations, the private sector, nongovernmental organizations and 
researchers.44 Since 2013, these efforts have been strengthened by the Multisectoral Action 
Framework for Malaria, which recognizes that malaria is a symptom of low levels of human 
development, and aims to accelerate malaria control by integrating it within strategies for social and 
economic development.45 Financing plays an important role in the Multisectoral Action Framework, 
including the provision of financial support for the costs of malaria interventions incurred directly by 
households.46 
Public health law can support national programmes to control mosquito-borne illnesses in several 
important ways. For example, legislation can mandate vector surveillance and the provision of public 
education programmes, and give local health authorities a clear mandate to take all such actions as 
are necessary to fully implement national malaria control strategies. There may be benefits in 
incorporating environmental management strategies directly into public health regulations, and 
including a requirement for provincial health officers to educate local populations about vector 
control requirements. Provincial health officers should have a duty to report annually in an 
independent manner, and to issue reports at other times as necessary. 
Despite its effectiveness in malaria control, some countries may face pressure to reduce IRS in order 
to eliminate the use of DDT. DDT is a closely regulated and cost-effective insecticide that has been 
controversial in malarial control efforts. The Stockholm Convention on Persistent Organic Pollutants 
expressly allows the use of DDT for disease control purposes (subject to reporting to the 
Secretariat).47 In some countries, the replacement of DDT with other insecticides has compromised 
malaria control programmes.48 Following a risk assessment,49 WHO published an updated position 
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statement that confirms the necessity of the use of DDT, in accordance with the requirements of the 
Convention and WHO recommendations (Box 8.8).50 WHO has published operational guidance for 
IRS programmes.51 Governments should consider adopting national standards for safe storage and 
use of pesticides in IRS and incorporating these within public health legislation, including the use of 
warning labels on insecticides, childproof dispenser designs, by creating offences for leakage and 
misuse of pesticides, and by mandating the reporting of DDT use to the Secretariat of the Stockholm 
Convention. 
Box 8.8: WHO’s position statement on the use of DDT in malaria control 
Indoor residual spraying (IRS) using DDT is an important intervention for malaria control. From 12 
insecticides recommended by WHO for IRS, DDT has the longest residual efficacy against malaria 
when sprayed on walls and ceilings (6–12 months). WHO’s position statement concludes: 
DDT is still needed and used for disease vector control simply because there is no alternative of both 
equivalent efficacy and operational feasibility, especially for high-transmission areas. The reduction 
and ultimate elimination of the use of DDT for public health must be supported technically and 
financially. It is essential that adequate resources and technical support are rapidly allocated to 
countries so that they can adopt appropriate measures for sound management of pesticides in 
general and of DDT in particular. There is also an urgent need to develop alternative products and 
methods, not only to reduce reliance on DDT and to achieve its ultimate elimination, but also to 
sustain effective malaria vector control.52 
For dengue control, WHO encourages national control programmes based on environmental 
management strategies and insecticides.53 Public health laws should provide a clear mandate for the 
development of national strategies, and for locally led surveillance, monitoring and enforcement of 
regulatory requirements. These include requirements to ensure that water storage containers are 
covered and cleaned regularly, that large waste items (such as used tires) are disposed of, and 
avoidance of the use of hollow building materials (such as bamboo).54 Improving the delivery of 
potable water (e.g. through installation of piped water systems) will reduce reliance on storage bins 
and thus reduce potential vector breeding grounds.55 Chemical control strategies may also be 
incorporated into dengue control programmes. WHO has recommended substituting the use of DDT 
with organophosphate insecticides for dengue control,56 and has issued guidelines for the safe use of 
pesticides.57 Incorporating controls for safe use into national public health laws or regulations 
improves clarity around the specific standards that public health officers should implement and 
enforce in order to discharge their mandate in this area. 
(b)  Rodent control 
Rodents are vectors for the transmission of disease, particularly in urban or overcrowded areas. 
Rodent control measures include improving environmental sanitation practices, securing the storage 
of food, grain and animal feed, washing dishes and removing food scraps, removing household 
rubbish and waste, and removing deceased animals from areas near living spaces.58 In emergency 
situations, use of rodenticides may be necessary to control outbreaks. Rodenticides should be 
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targeted narrowly towards areas of greatest infestation, which can be identified through use of 
traps.59 As with the chemical control strategies discussed above, public health law should require 
adherence to stringent safety guidelines. 
Public health law has a long history of using environmental management strategies to reduce 
diseases transmitted by rodents. These include strict compliance with (and auditing of) food storage 
and hygiene requirements in food establishments, as well as contractual requirements in landlord-
tenant laws to remove waste and to keep premises free of vermin. Due to their flexibility, most 
public health statutes include nuisance abatement provisions authorizing public health officers to 
inspect premises and to order owners or occupiers of premises to take such actions as are 
reasonably necessary to reduce the health risks posed by rats or other vectors. A public nuisance 
may be broadly defined to include any act or omission that is harmful or that is likely to be harmful 
to the public’s health, and also includes acts or omissions that may jeopardize a public good, such as 
a potable water supply, that is needed to maintain public health.60 
Public nuisance laws are a critically important public health tool, and can be framed in both general 
and specific ways. In many countries, nuisance laws give a wide range of examples to illustrate the 
broad coverage of the concept of a public health nuisance. For example, Jamaica’s Public Health 
(Nuisance) Regulations create an offence for causing or permitting a nuisance that applies to owners 
or occupiers of premises. The regulations authorize public health authorities to issue an abatement 
notice that requires the owner or occupier to take such actions as reasonably necessary to abate or 
prevent the nuisance. The schedules include a list of examples that are included within the concept 
of a nuisance (Box 8.9). Typically, public health laws authorize local authorities to enter and inspect 
premises, and to take actions themselves to abate a nuisance when an owner or occupier fails to do 
so. 
Box 8.9: Using public health nuisance laws for vector control: an example from Jamaica 
Public Health (Nuisance) Regulations 199561 
Section 3(1) No person shall cause or permit a nuisance on any premises owned or occupied by him. 
(2) No person shall cause a nuisance on any premises or aid and abet any other person to cause or 
permit a nuisance on any premises. 
Section 4(1) A Medical Officer (Health), a Public Health Inspector or any person authorized by the 
Minister in writing in that behalf (hereinafter referred to as an "authorized person") or a Local Board 
may, on becoming aware of the existence of a nuisance on any premises, serve on the owner or 
occupier of the premises or on the person causing or permitting the nuisance, a notice in writing in 
the form set out in the Second Schedule requiring the owner, occupier, or person- 
(a) to abate the nuisance within such reasonable time not being more than thirty days, as may be 
specified in the notice; 
(b) to perform such act as the Medical Officer (Health), the Public Health Inspector, an authorized 
person or Local Board considers to be reasonably required to abate or prevent the recurrence of the 
nuisance. 
(2) Where a person, without reasonable cause, fails to comply with the requirements specified in the 
notice under paragraph (1), the Medical Officer (Health), the Public Health Inspector or authorized 
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person shall make a report in writing to the Local Board and the Local Board may authorize in writing 
any person to enter upon the premises and do such things as are necessary to abate or prevent a 
recurrence of the nuisance. 
First Schedule 
Nuisances 
1–(1) A building or structure which, because of structural defects or insanitary conditions, is or is 
likely to become a health hazard. 
(2) Any premises or other place which because of insanitary conditions is or is likely to become a 
health hazard. 
2. An accumulation or deposit of solid waste of human or animal excreta. 
3. Dust, smoke, fumes, gases or effluvia emitting from any manufacturing process or caused by the 
carrying on of any trade or business or otherwise by the action of any person. 
4–(1) Any animal which is kept in such a manner as to become hazardous to health. 
(2) The carcass of any animal which is not buried or destroyed within twenty-four hours of the 
animal's dying. 
5. A tree, bush or structure which interferes with the flow of air or the letting in of sunlight into any 
building or premises. 
6–(1). The lack of water or a water supply system. 
(2) A water supply system that is not maintained in a sanitary condition. 
(3) The running to waste of water from a tap, pipe or pump or from any other device from which 
water is obtained. 
(4) The accumulation of stagnant water. 
7. Any sanitary convenience which is so designed, located or kept which is or is likely to become a 
health hazard. 
8. The infestation of flies, fleas, cockroaches, lice, rats, mosquitoes, mosquito larvae and other 
vermin on any premises. 
9. Excess vegetation or overgrowth of bush on any building, land or structure which harbours or is 
likely to harbour vermin. 
10–(1) The discharge of any sewage, industrial waste or any other noxious matter into the sea or any 
watercourse or onto any land. 
(2) In paragraph (1) “watercourse” includes any river, stream, creek, canal, drain, natural channel or 
any permanent and defined course for water or flood-water. 
11. Offensive smells. including the emission of noxious fumes, gases or powerful smells, as a result of 
agricultural, domestic or industrial processes or otherwise. 
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Chapter 9: Monitoring, surveillance, and investigation 
of health threats 
 
SUMMARY POINTS 
 
· Monitoring, surveillance and investigation of health threats are vital capabilities for an 
effective health system. The International Health Regulations (2005) require countries to maintain 
an integrated, national system for public health surveillance and response, and set out the core 
capabilities that countries are required to achieve. 
· Systematic monitoring of serious infectious diseases and other conditions is typically achieved 
through notifiable diseases legislation based on clinical observation and laboratory confirmation. 
Clinical and laboratory-based surveillance also provides the basis for systematic collection of vital 
statistics (births, deaths, causes of death), and may extend to the reporting and analysis of risk 
factors for noncommunicable diseases and injuries. Systematic collection of these data informs 
the allocation of resources and facilitates evaluation of community-based and population-level 
prevention strategies. 
· Clinical and laboratory surveillance are passive systems that may be enhanced by sentinel 
surveillance and/or community-based surveillance strategies that rely on a wider range of people, 
including non-medical personnel. Suspected cases identified in this way must be treated with 
respect, protected from discrimination, with diagnosis confirmed by qualified health workers at 
the earliest opportunity. 
· A significant degree of stigma may attach to some diseases, such as HIV, sexually transmitted 
infections and diabetes. Notifiable diseases legislation should require the protection of personal 
information, and clearly define any exceptions. Concerns about discrimination and breach of 
privacy may be addressed by requiring certain diseases to be reported on an anonymous or de-
identified basis. 
· In some countries, legislation or regulations may be used to establish or enhance a 
comprehensive public health surveillance system. In federal systems, intergovernmental 
agreements, federal grants and conditional funding agreements may be useful strategies for 
achieving an integrated system where public health surveillance is, in practice, coordinated at the 
regional (state or provincial) level. 
· The cases of disease or harm captured by effective surveillance systems may reflect a wide 
variety of public health hazards. Countries may find it useful to establish an intersectoral 
committee to consider whether existing legislation, regulations and other instruments are 
adequate to ensure a rapid and effective public health response and to fulfil the obligations set 
out in the International Health Regulations (2005). 
Surveillance and monitoring are critical components of a well-functioning public health system. 
Public health professionals use surveillance to assist them in performing many of their key functions. 
These include monitoring, vector control, responding to outbreaks of infectious disease, identifying 
the source of foodborne illnesses, ensuring the safety of drinking water and national blood supplies, 
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and tracking modifiable risk factors for noncommunicable diseases in order to develop and evaluate 
preventive policies. 
Public health laws support effective surveillance systems by identifying the diseases and conditions 
for which reporting is required and designating the persons to whom these reporting requirements 
apply – with sufficient flexibility so that these requirements can be applied rapidly to emerging 
diseases and conditions when appropriate. Factors that affect the design of surveillance laws include 
the purpose of notification requirements, the frequency and severity of disease incidence, the 
reliability of the diagnosis, and the need for a rapid response. This section briefly identifies different 
kinds of surveillance strategies, and gives examples of how public health law can establish and 
maintain these systems. The collection of health information that identifies individuals carries the 
risk of discrimination and loss of privacy. The management of these risks, through legal 
requirements to maintain the security, privacy, and confidentiality of personal information, and 
through legal protection from discrimination, provide the foundation for effective control of 
communicable diseases. This is discussed further in Chapter 10. 
9.1 Clinical and laboratory-based surveillance 
A critical function of clinical surveillance is to provide early warning of disease outbreaks that require 
rapid response at the regional, national or international level. On the front line of surveillance 
systems are health care providers, who examine patients and diagnose diseases based on signs and 
symptoms, with or without assistance from laboratory-based tests, rapid test kits or other diagnostic 
aids. 
Public health laws typically establish a list of “notifiable diseases” and other conditions that health 
care providers, hospitals and/or laboratories are required to report to the relevant local or national 
public health authority. Notifiable diseases generally include infectious diseases that can quickly 
spread throughout communities and regions via water, food, contact with animals, mosquitoes, 
airborne droplets, or through sexual contact and other forms of human interaction. Examples of 
notifiable diseases include diseases preventable by vaccination (e.g. influenza, hepatitis B), sexually 
transmitted diseases (e.g. HIV, herpes), nosocomial infections (e.g. methicillin-resistant 
Staphylococcus aureus (MRSA)), foodborne illnesses (e.g. botulism), waterborne diseases (e.g. 
cholera), contagious diseases caused by airborne particles (e.g. tuberculosis), and diseases 
transmitted by vectors or parasites (e.g. rabies, malaria). The list of notifiable diseases mandated by 
legislation may vary over time, according to a country’s stage of development and the capacity of its 
health workforce. In some countries, risk factors for noncommunicable diseases may also become 
notifiable (Box 9.1). 
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Box 9.1: Mandatory reporting of noncommunicable disease risk factors: an example from New 
York City 
The surveillance of noncommunicable diseases and their risk factors tends to occur through 
community-based or voluntary clinical reporting systems, rather than through formal, legislative 
notification systems.1 In appropriate circumstances, however, the mandatory reporting of risk 
factors for noncommunicable diseases may assist in identifying cases and ensuring that affected 
individuals are offered treatment to prevent the progression of disease. For example, in 2006, New 
York City expanded notifiable disease reporting obligations to include haemoglobin A1c (glycated 
haemoglobin), in order to create a registry to map the epidemiology of hyperglycaemia and to 
identify and offer treatment to the estimated one in three diabetics who are unaware of their 
disease.2 
Effective surveillance systems must respond rapidly to cases of emerging epidemic diseases and 
ensure that they are identified and reported to authorities. Legislative drafters can facilitate this by 
ensuring that notifiable diseases and other conditions to which reporting obligations apply are 
included in the schedules or appendices of legislation, or that these can be updated rapidly by 
executive action. In the early stages of a new epidemic, confirmatory laboratory tests may be 
unavailable and the best available case definition may be both complex and nonspecific. 
In addition to detecting disease outbreaks, clinical surveillance systems perform an epidemiological 
surveillance function by capturing vital statistics (births, deaths, causes of death), and by monitoring 
the incidence of other reportable conditions over time, such as perinatal deaths, deaths from 
specified diseases (e.g. cancer, malaria) and deaths from preventable causes (e.g. burns, drownings, 
road traffic injuries). Longitudinal surveillance performs a vital role in public health, informing the 
allocation of resources and facilitating the evaluation of community-based and population-level 
prevention strategies. In some cases, public health laws may require notification to be made to 
particular hospitals or other centres of excellence that lead national surveillance and research efforts 
and host disease-specific registers. Disease registers may record diagnosis, clinical data and 
outcomes data that facilitate the evaluation and improvement of diagnostic strategies and clinical 
treatments. 
One limitation of clinical surveillance systems is that they are passive systems that only identify cases 
when patients seek medical assistance or come into contact with the health care system. In 
countries where large numbers of people lack affordable access to health care services, clinical 
surveillance systems may underestimate the burden of disease, while also failing to achieve their 
primary goal of identifying disease outbreaks. The goal of achieving universal access to health 
services therefore supports efforts to improve clinical surveillance capabilities. One legal strategy for 
improving surveillance capability in low-resource settings is to impose reporting requirements for 
suspected cases of epidemic diseases on a wider range of people, including school principals, 
employers, and village chiefs (Box 9.2). Care should be taken to ensure that suspected cases are 
treated with dignity, that confidentiality is respected, and that the diagnosis of suspected cases is 
reviewed by qualified health care workers at the earliest opportunity. 
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Box 9.2: Improving the front line diagnosis of acutely infectious diseases: an example from 
Zimbabwe 
Public Health Act (Ch 15:09)3 
Zimbabwe’s Public Health Act provides that the Minister may, by statutory instrument, declare a 
disease to be a “formidable epidemic disease” for the purposes of the Act. Section 27 of the Act 
provides that: 
Medical practitioners, principals of schools, heads of families or householders, employers of labour, 
owners or occupiers of land or premises, chiefs, headmen and others shall report to the local 
authority or district administrator, as the case may be, the occurrence of any case of illness or death 
coming to their notice and suspected to be due to any formidable epidemic disease, or with a history 
of presenting symptoms or post-mortem appearances which might reasonably give grounds for such 
suspicion. 
Where available, laboratory confirmation of clinical diagnoses is important to improve the accuracy 
of surveillance systems. Public health laws typically impose reporting requirements on laboratories 
in order to confirm clinical diagnoses, or in circumstances where accurate diagnosis requires 
laboratory investigations. In higher-income countries, legislation may apply the same compulsory 
notification requirements to laboratories as to physicians; however, this may not be a cost-effective 
use of limited laboratory resources in lower-income countries. In cases where both clinical and 
laboratory reporting obligations are imposed, accurate patient identification will be necessary to 
avoid double counting. 
A significant degree of stigma may attach to some diseases, including HIV, sexually transmitted 
infections, and diabetes. Diagnosis may carry the risk of discrimination, especially when there is 
weak protection for privacy and confidentiality. Notifiable diseases legislation should require the 
protection of personal information, and clearly define any exceptions. In order to reduce 
disincentives for testing, and to improve compliance with treatment regimes, legislation may also 
require the reporting of certain diseases to health authorities on an anonymous or de-identified 
basis. This approach may enhance rates of testing among vulnerable groups, including sex workers, 
injecting drug users, ethnic minorities, and, in some cases, women. 
9.2 Sentinel surveillance 
Sentinel surveillance provides public health authorities with data on the prevalence of a disease in a 
particular area or among a particular subgroup. For example, carefully chosen sentinel sites may 
provide early warning of disease outbreaks as well as prospective monitoring of rates of infectious 
disease or other health conditions, such as child malnutrition.4 Like other passive surveillance 
strategies, sentinel surveillance only provides authorities with approximate figures, but may be a 
critical component of an early warning system that triggers an urgent response to public health 
events of national significance. 
Page | 144  Advancing the right to health: the vital role of law 
 
9.3 Community-based surveillance and investigations 
Since clinical and laboratory-based surveillance is passive (identifying cases of disease only among 
those who present for treatment), it must be complemented by strategies to identify missing cases, 
confirm diagnoses and investigate outbreaks within community settings. Rare and new events may 
not be included in regular, clinical and laboratory-based surveillance systems. In addition, outbreaks 
of serious or contagious diseases require immediate investigation so that appropriate public health 
measures (e.g. isolation, contact tracing) can be implemented.5 
As illustrated in Box 9.2, community-based surveillance may rely on non-medical personnel to 
identify potential outbreaks. These may include other health care workers, community groups, 
community services (e.g. schools, police, and religious organizations) as well as the media. In 
developing a reporting strategy, governments will need to identify the appropriate balance between 
sensitivity (identifying all important events), and sustainability (maintaining the reporting capability 
without undermining other public health functions).6 Since it may have a higher error rate than 
other types of surveillance, community surveillance is best used where symptoms are easily 
recognizable and likely to clearly identify a given disease. Governments should ensure that event 
assessment teams responding to community reports have appropriate powers to carry out event-
based surveillance in community settings, and where necessary, to implement public health 
measures urgently (see Chapter 11). 
9.4 Comprehensive surveillance systems 
Laws that establish surveillance systems may enable different kinds of surveillance strategies to be 
implemented simultaneously. This may help to overcome the limitations of each strategy and 
provide a clearer picture of the burden of disease and the extent of disease spread. For example, 
Argentina’s Resolution no. 1715/2007, enacted in order to bring its national surveillance capabilities 
into conformity with the International Health Regulations (2005) (IHR), authorizes and explains the 
case for each surveillance strategy (Box 9.3). Comprehensive surveillance systems that combine 
multiple strategies will require coordination between local, regional and national health authorities. 
For example, clinician and laboratory reporting of a serious outbreak must trigger national – and, 
following notification to WHO – international response systems to minimize the spread of disease. 
The surveillance capabilities required at local, regional and national levels are not purely matters of 
domestic policy but are prescribed in the IHR.7 
Box 9.3: Different surveillance strategies used to track and investigate notifiable events 
Resolution 1715/2007 of the Ministry of Health of Argentina, on rules for the surveillance and 
control of diseases or events subject to compulsory notification8 
3. Surveillance strategies for events subject to compulsory notification. Different strategies will be 
used to monitor notifiable diseases, including multiple strategies for the same event. They are: 
3-1. Clinical surveillance: shall be universal. Cases are notified on the suspicion of the treating 
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physician, based on the corresponding definition of a suspect case. This provides the system with 
sensitivity and timeliness. Suspected cases are confirmed or amended upon laboratory or 
epidemiologic investigation. Clinical surveillance includes syndromic surveillance, in cases where a 
number of diseases share similar clinical manifestations. 
3-2. Laboratory surveillance: is complementary to clinical surveillance, it provides specificity and 
supplies diagnoses of etiologic agents, natural reservoirs, and/or vectors. Its main objective is to 
contribute to knowledge of health events caused by the disease agent, determining the frequency of 
various microorganisms, their geographical and temporal distributions, and identifying patterns of 
behaviour of different agents. 
3-3. Sentinel surveillance: three variants of this strategy have been implemented within the country: 
units, physicians, and sentinel groups. The sentinel site strategy is not currently in use. 
3-4. Special studies: epidemiological studies are performed periodically to monitor trends in 
reportable events. These are generally cross-sectional studies of prevalence used to obtain baseline 
data and then conducted at a particular frequency to track changes in relation to implementation of 
control measures. Examples include a survey tracking risk factors for noncommunicable diseases, or 
Chagas seroprevalence in children under 5 years of age (and in other age groups), etc. 
9.5 Developing integrated national capabilities for 
 surveillance and response 
The IHR9 require countries to meet a number of “core capacity requirements” for surveillance and 
response at local, intermediate and national levels (Box 9.4). At the local community or primary 
public health response level, core capacity requirements include the ability to detect events 
involving disease or death above expected levels for the particular time and location in all areas 
within the territory of the country, and to report all available essential information to local 
community health care institutions or the appropriate health personnel, or to the intermediate or 
national response level, depending on organizational structures.10 At the national level, core capacity 
requirements include assessing all reports of urgent events within 48 hours, and notifying WHO 
immediately of all events that may constitute a “public health emergency of international concern”, 
via a national IHR focal point.11 States Parties to the IHR must also inform WHO within 24 hours of 
receipt of evidence of a public health risk identified outside their territory that may cause 
international disease spread, as manifested by human cases, vectors carrying infection or 
contaminated goods that have been exported or imported by that State Party.12 
Box 9.4: Core capacity requirements for surveillance and response under the International Health 
Regulations (2005)13 
A. Core Capacity Requirements for Surveillance and Response 
4. At the local community level and/or primary public health response level 
The capacities: 
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(a) to detect events involving disease or death above expected levels for the particular time and 
place in all areas within the territory of the State Party; and 
(b) to report all available essential information immediately to the appropriate level of healthcare 
response. At the community level, reporting shall be to local community health-care institutions or 
the appropriate health personnel. At the primary public health response level, reporting shall be to 
the intermediate or national response level, depending on organizational structures. For the 
purposes of this Annex, essential information includes the following: clinical descriptions, laboratory 
results, sources and type of risk, numbers of human cases and deaths, conditions affecting the 
spread of the disease and the health measures employed; and 
(c) to implement preliminary control measures immediately. 
5. At the intermediate public health response levels 
The capacities: 
(a) to confirm the status of reported events and to support or implement additional control 
measures; and 
(b) to assess reported events immediately and, if found urgent, to report all essential information to 
the national level. For the purposes of this Annex, the criteria for urgent events include serious 
public health impact and/or unusual or unexpected nature with high potential for spread. 
6. At the national level 
Assessment and notification. The capacities: 
(a) to assess all reports of urgent events within 48 hours; and 
(b) to notify WHO immediately through the National IHR Focal Point when the assessment indicates 
the event is notifiable pursuant to paragraph 1 of Article 6 and Annex 2 and to inform WHO as 
required pursuant to Article 7 and paragraph 2 of Article 9. 
Public health response. The capacities: 
(a) to determine rapidly the control measures required to prevent domestic and international 
spread; 
(b) to provide support through specialized staff, laboratory analysis of samples (domestically or 
through collaborating centres) and logistical assistance (e.g. equipment, supplies and transport); 
(c) to provide on-site assistance as required to supplement local investigations; 
(d) to provide a direct operational link with senior health and other officials to approve rapidly and 
implement containment and control measures; 
(e) to provide direct liaison with other relevant government ministries; 
(f) to provide, by the most efficient means of communication available, links with hospitals, clinics, 
airports, ports, ground crossings, laboratories and other key operational areas for the dissemination 
of information and recommendations received from WHO regarding events in the State Party’s own 
territory and in the territories of other States Parties; 
(g) to establish, operate and maintain a national public health emergency response plan, including 
the creation of multidisciplinary/multisectoral teams to respond to events that may constitute a 
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public health emergency of international concern; and 
(h) to provide the foregoing on a 24-hour basis. 
Ensuring an integrated, national system that meets the core capacity requirements for surveillance 
and response is an important part of each country’s obligation to fully implement the IHR. Some 
countries have used legislation or executive orders to establish or to enhance a national public 
health surveillance system (Box 9.5). However, federal countries may need to ensure that the 
division of regulatory power between national, state and local/city governments does not create 
impediments to the rapid sharing of information between different levels of government, or to 
national coordination of surveillance activities throughout the country. Even when federal 
governments have adequate legislative powers that could be used, intergovernmental agreements 
may be a more practical way of establishing a national system in countries where public health 
surveillance is, in practice, coordinated at the regional (state or provincial) level.14 
Box 9.5: Establishing Colombia’s public health surveillance system 
In Colombia, the public health surveillance system was established by Presidential decree. The 
decree identifies the Ministry of Social Protection, departmental, district, and municipal health 
directorates, and a number of other agencies as the entities that are responsible for the 
implementation and development of the system, and sets out their respective functions. The 
functions of the Ministry of Social Protection include analysing information from the surveillance 
system to identify public health priorities and to guide public health responses.15 The functions of 
the municipal health directorates include ensuring the infrastructure and human resources required 
to carry out surveillance at the municipal level, organizing the community in appropriate 
community-based surveillance activities, identifying cases and contacts and investigating disease 
outbreaks within the municipal area.16 The functions of reference institutions and entities 
generating primary data, including laboratories, blood and organ banks, and health service 
providers, are also set out. The decree establishes a National Intersectoral Commission for Public 
Health Surveillance to provide high-level guidance to national ministries overseeing the system.17 
Public health surveillance committees are also established to assist the health directorates at 
departmental, district and municipal levels.18 
In some countries, the most pressing difficulty is likely to be that surveillance and response 
capabilities are degraded or non-functioning in particular regions of the country. Options available 
for federal governments include the provision of financial assistance to strengthen regional 
surveillance systems, or more generally, the provision of conditional funding. For example, federal 
grants to regional governments may contain conditions that require the harmonization of regional 
surveillance systems in order to meet the core capabilities set out in the IHR.19 
The cases of disease or harm that are captured by effective surveillance systems may reflect a wide 
variety of public health hazards. WHO has pointed out that “different public health risks (e.g. 
infectious disease, food safety, risks of chemical accidents or contamination, radionuclear safety, or 
animal health issues which may affect humans) are addressed in different laws or regulations, and 
often by different ministries, departments and governmental levels”.20 For this reason, WHO has 
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recommended that countries establish an intersectoral committee for legislative assessment that 
includes representation from all government sectors and, if appropriate, other interest groups 
affected by the IHR.21 The task of such a committee would be to assess whether “existing legislation, 
regulations and other instruments cover all the subject areas and functions of the IHR (2005)”.22 For 
example, identification of cases of a serious foodborne illness (e.g. botulism) through a clinical and 
laboratory surveillance system should trigger an urgent investigation of the likely source. In turn, this 
will require public health personnel to have adequate powers to enter food businesses, remove 
samples, recall products and require the removal of products from sale, temporarily close 
businesses, and issue public health alerts. 
The IHR have a particular focus on the international spread of disease. They therefore require 
countries to meet core capacity requirements for managing international traffic and responding to 
potential health risks at designated airports, ports and ground crossings.23 WHO has published a 
toolkit to assist countries to assess their national legislation and regulations against the specific 
requirements of the IHR.24 These matters are discussed further in Chapter 11. 
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Chapter 10: Controlling the spread  
of infectious diseases 
 
SUMMARY POINTS 
 
· Minimizing the transmission of infectious diseases is a core function of public health law.  The 
appropriate exercise of legal powers will vary according to the seriousness of the disease, the 
means of transmission, and how easily the disease is transmitted. 
· Law can contribute to the prevention of infectious diseases by improving access to 
vaccinations and contraceptives, and by facilitating screening, counselling and education of those 
at risk of infection.  Law also has a reactive role: supporting access to treatment, and authorizing 
public health authorities to limit contact with infectious individuals and to exercise emergency 
powers in response to disease outbreaks. 
· Where public health laws authorize interferences with freedom of movement, the right to 
control one’s health and body, privacy, and property rights, they should balance these private 
rights with the public health interest in an ethical and transparent way.  Public health powers 
should be based on the principles of public health necessity, reasonable and effective means, 
proportionality, distributive justice, and transparency. 
· Immunization is a successful and cost-effective public health strategy that saves millions of 
lives each year.  Governments can support vaccination coverage by ensuring that vaccination is 
free or affordable, by ensuring that all children are vaccinated (with limited exceptions for medical 
or religious reasons), and that vaccinations are documented. 
· Screening individuals to determine if they have been infected with or exposed to an infectious 
disease is a core public health strategy.  Early treatment has important public health benefits; for 
example, people receiving treatment for tuberculosis and HIV infection are less likely to transmit 
the infection to others.  Routine, voluntary HIV testing benefits both affected individuals and their 
intimate partners by facilitating early access to prevention, care and treatment services. 
· Health laws can improve the success of voluntary screening programmes by including 
counselling requirements, ensuring the confidentiality of test results, and protecting individuals 
diagnosed with particular diseases from discrimination.  Public health laws should protect the 
confidentiality of a person’s HIV status, authorizing disclosure to third parties only in limited 
circumstances where a third party is at significant risk of HIV transmission and where other 
statutory preconditions are met. 
· Governments should carefully consider the appropriate role of criminal law when amending 
laws to prevent the transmission of infectious and communicable diseases.  For example, criminal 
penalties for transmission of HIV may create disincentives to individuals to come forward for HIV 
testing and treatment, or may provide the pretext for harassment and violence against vulnerable 
groups.  Encouraging personal responsibility and self-protection is critical, especially in countries 
where rates of HIV infection are high. 
· Public health laws should authorize compulsory treatment only in circumstances where an 
individual is unable or unwilling to consent to treatment, and where their behaviour creates a 
significant risk of transmission of a serious disease.  Compulsory treatment orders should restrict 
individual liberty only to the extent necessary to most effectively reduce risks to public health. 
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· Public health laws may authorize the isolation of individuals and groups who may have been 
exposed to an infectious disease, as well as the closure of businesses and premises and the 
confiscation of property.  The exercise of these powers must be based on public health 
considerations, without discrimination on grounds of race, gender, tribal background, or other 
inappropriate criteria.  Public health laws should provide for the fair compensation of those who 
have suffered economic loss due to a public health order affecting their property or facilities. 
 
Minimizing the transmission of infectious diseases is a core function of public health law.  Clearly-
defined legal powers are needed to respond to outbreaks of contagious and serious diseases at 
national level.  The appropriate exercise of legal powers will vary according to the seriousness of the 
disease, the means of transmission, and how easily the disease is transmitted.  Some diseases are 
entirely preventable by vaccination (e.g. measles and polio), or by access to improved sanitation and 
clean drinking water (e.g. diarrhoeal and parasitic diseases).  Others are treatable when detected in 
a timely manner (e.g. tuberculosis and malaria).  The epidemic of HIV can be substantially reduced 
through laws supporting access to treatment, combined with measures to educate and support 
individuals and communities to implement proven strategies for preventing transmission. As 
discussed in Section 11.1, States Parties to the International Health Regulations (2005) have an 
obligation to assess and notify WHO of all events occurring within their territories that may 
constitute a public health emergency of international concern.1  The legal framework for responding 
to public health emergencies is discussed further in Chapter 11. 
In circumstances where a disease or infection is transmitted by sexual contact or other forms of 
human behaviour that are private and difficult to monitor, the priority for governments is to create 
an enabling legal environment that supports those behaviours that are most successful in preventing 
further transmission.  This is the challenge of HIV and the law.  High rates of infection with HIV, 
particularly in sub-Saharan Africa, combined with inadequate access to treatment, have resulted in a 
heavy burden of disease from AIDS, dramatically reducing average life expectancy, productivity, and 
creating major obstacles to the progressive realization of the right to health (see Section 3.2(a)).  
These problems have been exacerbated by a lack of resources.  In 2009, the Regional HIV Prevention 
Experts Think Tank and Multisectoral Stakeholder meeting convened by the East African Community 
recommended that Partner States commit at least 15% of their national budgets to health, and 15% 
of the national health budget to HIV and AIDS interventions – beyond the 5% currently committed.2  
They also recommended that Partner States scale up by at least 50% the allocation of the total HIV 
and AIDS budget devoted to HIV prevention interventions.3 
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10.1 Building ethical principles into infectious  
 disease legislation 
Public health laws can support the control of infectious diseases in two important ways.  Firstly, law 
has a proactive or preventive role: improving access to vaccinations and contraceptives, together 
with screening, education, counselling and other strategies that aim to minimize exposure to 
disease.  Secondly, law has a reactive role: supporting access to treatment, and authorizing health 
departments and health care providers to limit contact with infectious individuals and to exercise 
emergency powers in response to disease outbreaks.  Because infectious disease control and 
prevention laws may involve interference with freedom of movement, the right to control one’s 
health and body, and with privacy and property rights, public health laws should embody a decision-
making process that balances these personal rights with the public’s health in an ethical and 
transparent way.  Table 10.1 identifies a set of ethical principles that are relevant and sets out what 
they mean in terms of the exercise of coercive power over individuals, within a legal framework for 
control of infectious diseases.4 
Table 10.1: Building ethical principles into legislation that restricts personal rights and freedoms 
Ethical principle Putting the principle into practice 
Public health necessity Coercive powers should be exercised on the basis of a demonstrable threat 
to public health.  Mandatory physical examination, treatment or isolation 
should require a reasonable suspicion that the person is contagious or could 
pose harm to others. 
Reasonable and 
effective means 
The specific measures adopted by governments must be appropriate to 
prevent or reduce the threat.  Governments should monitor the 
effectiveness of public health interventions and ensure that they are based 
on sound science. 
Proportionality Governments must strive to ensure that there is a reasonable fit between 
the coercive measures imposed on individuals, and the public health benefit 
that they seek to achieve.  Governments should adopt the least 
burdensome measure from among the measures that are available and 
reasonably appropriate to mitigate the risks in question.  Restrictions that 
are “gratuitously onerous or unfair” may “overstep ethical boundaries”.5 
Distributive justice The risks, benefits and burdens of public health interventions should be 
shared fairly.  For example, vulnerable populations should not be targeted 
with restrictive measures, nor excluded or given lower priority in the 
allocation of treatment, vaccines, or other benefits. 
 
Advancing the right to health: the vital role of law  Page | 153 
 
Trust and transparency The public should have an opportunity to participate in the formulation of 
public health policies, and governments should give reasons for policies and 
decisions that restrict individual freedoms.  Openness and accountability 
are essential to generating public trust, and are likely to improve public 
health decision-making.  Without public trust and voluntary cooperation, 
governments will find it harder to achieve their goals and to act in the 
public interest. 
10.2 Preventing the transmission of infectious 
 diseases 
(a) Immunization 
“Overwhelming evidence demonstrates the benefits of immunization as one of the most successful 
and cost-effective health interventions known”.6  Immunization avoids about 2–3 million deaths 
each year, as well as serious disability from vaccine-preventable diseases including Yellow fever, 
diphtheria, tetanus and pertussis, rubella, rotaviruses, polio, pneumococcal diseases, mumps, 
measles, human papillomavirus, polio, hepatitis B, and Haemophilus influenzae type b.7  To maximize 
immunization coverage, national vaccination plans should provide for free or affordable 
immunizations that are available from most health care providers, public education campaigns to 
illustrate the importance and safety of vaccinations, monitoring of vaccination rates and their impact 
on health outcomes, and limited exceptions for individuals who for medical or religious reasons wish 
to avoid vaccinations. 
Belize’s Public Health Act 2000 illustrates some important features of a national vaccination strategy: 
all children are to be vaccinated, vaccinations are to be documented, any person (including any 
adult) may be vaccinated free of charge, and public health officials may require any person to be 
vaccinated or revaccinated if an outbreak occurs (Box 10.1). Governments may determine that 
certain highly infectious diseases warrant compulsory vaccination, although such a requirement may 
be subject to constitutional protections relating to the right to be free from non-consensual medical 
treatment, or to freedom of religion. 
Box 10.1: National requirements for child vaccination in Belize 
Public Health Act8 
Section 150. Child to be vaccinated within three months. 
(1) Every parent of a child in Belize shall, within three months after the birth of the child, or within 
three months after receiving into custody the child, take or cause the child to be taken to a public 
vaccinator of the district in which such child is then resident, to be vaccinated according to this Act, 
unless the child has been previously vaccinated by a [medical practitioner]. 
Section 151. Inspection after vaccination. 
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(1) On the eighth day after the vaccination, the parent shall again take or cause the child to be taken 
to the public vaccinator for inspection at such time and place as may have been appointed by him at 
the time of vaccination. 
(2) If on inspection it is ascertained that the vaccination has been unsuccessful, the parent shall, if 
the vaccinator so directs, cause the child to be forthwith again vaccinated and afterwards inspected 
as on the previous occasion. 
(3) If the vaccination has been successful the public vaccinator or surgeon forthwith shall give to the 
parent a certificate ... and within seven days shall transmit a certified copy of the certificate to the 
Registrar of the district within which the child’s birth was registered ... or if the birth of the child has 
not been registered, then he shall give it to the Registrar of the district where the child resides. 
Section 152. Where child is unfit 
(1) If any public vaccinator or surgeon is of opinion that the child is not in a fit and proper state to be 
successfully vaccinated, he shall forthwith deliver to the parent a certificate under his hand 
according to the form of the Sixth Schedule or to the like effect, that the child is then in a state unfit 
for successful vaccination, which certificate shall remain in force for two months only but shall be 
renewable for a like period from time to time, until a public vaccinator or surgeon thinks the child to 
be in a fit state for successful vaccination, when the child shall with all reasonable dispatch be 
vaccinated and a certificate of successful vaccination according to the form of the Fifth Schedule 
duly given if warranted by the result and a certified copy sent to the Registrar of the district where 
the child resides. 
S 154. Public Vaccination gratis. 
(1) Any public vaccinator shall, on application, vaccinate or re-vaccinate without charge any person 
at any time and place appointed for the attendance of such public vaccinator, and on the performing 
of the same the public vaccinator shall appoint a time and direct such person to attend at the same 
place, the time being as far as practicable the eighth day after vaccination. 
National vaccination strategies should include contingency plans for outbreaks of highly contagious 
or serious diseases (e.g. pandemic influenza).  In these circumstances, shortages of vaccine may 
occur.  Priority of access to limited supplies of vaccine should occur in accordance with regulations 
developed through a transparent process that provides the opportunity for meaningful public 
discussion about the principles of fair allocation.  In many cases, priority is likely to be given to health 
care workers, emergency responders (e.g. fire and police personnel) and others responsible for 
ensuring the continuation of key services and societal functions.9 
(b)  Screening 
Screening individuals to determine if they have been infected with or exposed to an infectious 
disease is a core public health strategy.  Screening enables health care providers to begin treatment 
in a timely manner, to manage co-morbidities more effectively, to encourage patients to reduce 
high-risk behaviour and, in certain cases, to identify the need for compulsory treatment.  In addition 
to reducing the severity of illness, early treatment may also reduce transmission rates.  For example, 
early treatment with antiretroviral drugs lowers the viral load of people with HIV and significantly 
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reduces the risk of sexual transmission.10  WHO supports the expansion of HIV testing and 
counselling in order to identify people with HIV early on in their infection and to “link them 
successfully to prevention, care, and treatment services”.11 
In addition to authorizing screening, including mandatory screening in appropriate circumstances, 
public health laws can improve the success of screening programmes by including counselling 
requirements, by ensuring the confidentiality of test results, and by protecting individuals diagnosed 
with particular diseases (e.g. HIV) from discrimination.  Laws drafted in accordance with human 
rights principles increase the likelihood that individuals will voluntarily seek out testing and 
treatment services.12 
Global strategies for controlling infectious diseases advise against placing heavy reliance on criminal 
laws and penalties.  For example, the Joint United Nations Program on HIV/AIDS has advised against 
the criminalization of unintentional HIV transmission and non-disclosure of HIV infection to sexual 
partners,13 and the HIV and AIDS Prevention and Management Bill, passed in 2012 by the East 
African Legislative Assembly, integrates human rights principles into law in the region14  (Box 10.2). 
Box 10.2: Incorporating human rights principles into infectious disease screening policies in the 
East African Community 
The East African Community HIV and AIDS Prevention and Management Bill15 
9. HIV and AIDS education and information as a health care service. 
(1) The provision of HIV and AIDS education and information shall form part of the delivery and 
health care services by all health care providers at public and private health care facilities.  
15. Prevention of mother-to-child transmission.  In order to prevent or reduce the risk of mother-
to-child transmission of HIV, the Minister shall ensure that –  
… 
(b) HIV counselling and testing is made available and offered to all pregnant women and their 
partners, as part of ante-natal care services.  
19. Contents of post-test counselling. 
… 
(3) Where the result of a test is HIV positive, a counsellor shall –  
(a) provide post-test counselling which shall include at a minimum –  
(i) the medical consequences of living with HIV; 
(ii) the modes of prevention and transmission of HIV and other opportunistic infections; 
(iii) the importance of disclosure of the person’s status to the person’s spouse or spouses or sexual 
partner or partners; 
(iv) the medical treatment and other social facilities available; 
(v) the need to continuously seek professional services relating to HIV; and 
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(b) refer the tested person to an appropriate health service provider for follow up testing or 
treatment. 
21. Provision of testing facilities. The Minister shall ensure that facilities for HIV testing are made 
available –  
(a) free of charge, to persons who voluntarily request an HIV test in respect of themselves; and 
(b) to persons who are required to undergo an HIV test under this Act or any other written law. 
22. Prohibition of compulsory testing.  
(1) Subject to this Act, no person shall compel another person to undergo an HIV test. 
(2) Unless otherwise provided under this Act, every HIV test shall be confidential.  
(3) Without prejudice to the generality of subsections (1) and (2), no person shall compel another to 
undergo an HIV test as a precondition to, or for continued enjoyment of – 
(a) any employment; 
(b) marriage; 
(c) admission into any educational institution; 
(d) entry into or travel out of a Partner State; or 
(e) the provision of health care, insurance cover or any other service. 
23. Consent to testing.  
(1) Unless otherwise provided by this Act, the informed consent of the person to be tested shall be 
obtained prior to any HIV test. 
Under the East African Community law, which applies within Burundi, Kenya, Rwanda, Uganda and 
the United Republic of Tanzania, HIV screening remains voluntary and routine, meaning that all 
patients are offered an HIV test when they come into contact with the health system.  This approach 
has become the norm within infectious disease control strategies and settings where antiretroviral 
drugs are available and accessible,16 and is a proven way of both increasing uptake of screening and 
increasing the number of women who are aware of their HIV status and receive interventions to 
reduce mother-to-child transmission.17  Where access to treatment is limited, HIV screening policies 
should not require routine testing, but rather require health care providers to screen symptomatic 
patients, patients who request testing, and all blood collected for transfusion or for the manufacture 
of blood products.18  The East African Community bill provides that the results of HIV tests shall be 
confidential and encourages persons diagnosed with HIV to voluntarily disclose their status to 
spouses or sexual partners.  The disclosure of a person’s HIV status to a third party without consent 
is authorized in strictly limited circumstances where a third party is at significant risk of HIV 
transmission and where other statutory preconditions are met (Box 10.3). 
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Box 10.3: HIV test results, post-test counselling and disclosure of HIV status in the East African 
Community  
The East African Community HIV and AIDS Prevention and Management Bill19 
Section 24. HIV test results. 
(1) Subject to subsection (3) and (4), the result of an HIV test shall be confidentially and directly 
communicated to the person concerned ... 
(2) A person providing treatment, care or counselling services to a person living with HIV shall 
encourage that person to inform the person’s spouse ... or sexual partner or partners or any other 
third party who is at significant risk of HIV transmission from the person living with HIV, of the 
person’s HIV status. 
(3) Except where subsection (4) is applicable, a person providing treatment, care or counselling 
services to a person living with HIV may notify a third party of the HIV status of that person only 
where the notifying person is requested by the person living with HIV to do so. 
(4) A person providing treatment, care or counselling services to a person living with HIV may notify 
a third party of the HIV status of that person if –  
(a) In the opinion of the person providing treatment, care or counselling services, after 
discussion of the matter with the person living with HIV, that person is not at risk of serious harm 
from the third party or from other persons as a consequence of such notification;  
(b) The third party to be notified is at significant risk of HIV transmission from the person living 
with HIV; 
(c) The person living with HIV, after appropriate counselling, does not personally inform the 
third party at risk of HIV transmission; and 
(d) The person providing treatment, care or counselling services has informed the person living 
with HIV of the intention to notify the third party;  
or 
(e) The person living with HIV is dead, unconscious or otherwise unable to give consent to the 
notification and is unlikely to regain consciousness or the ability to give consent; and 
(f) In the opinion of the person providing treatment, care or counselling services, there was a 
significant risk of transmission of HIV by the person living with HIV to the third party. 
Routine HIV testing services are likely to be most effective when combined with outreach 
programmes that target those populations most at risk of transmission.  These include sex workers, 
men who have sex with men, injecting drug users, military personnel, transport workers, and 
prisoners.  For example, Thailand’s National AIDS Committee adopted a strategy targeting 
commercial sex workers, which resulted in an increase in condom use by sex workers by over 70% in 
three years20 and a fivefold decrease in new HIV infections.21 
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(c) Criminal law and mandatory disclosure laws 
The appropriate role of criminal law in national efforts to prevent transmission of HIV and other 
sexually transmissible infections is often controversial.  Public health laws often contain penalties for 
failing to comply with public health orders made by authorities, or for engaging in behaviours that 
place public health at risk.  However, policy-makers should not ignore the potential for unintended 
consequences arising from laws that create criminal offences for recklessly exposing another person 
to HIV, or for failing to disclose one’s HIV status to a sexual partner (mandatory disclosure laws).22 
Laws like these may be intended to encourage personal responsibility in the hope that individuals 
will modify their behaviour in order to avoid criminal penalties.  They may also be motivated by the 
belief that those who fail to protect others from HIV transmission, or from the risk of transmission, 
deserve punishment.  On the other hand, the broader impact of these laws on transmission rates 
and public health can be negative.  The final report of the Global Commission on HIV and the Law 
pointed out that criminal laws against HIV in many countries are overly broad, carry draconian 
penalties, and are “virtually impossible to enforce with any semblance of fairness”.23  For example, 
sex workers and women in abusive relationships may face violence if required to disclose their HIV 
status to sexual partners.24  To the extent that criminal penalties have any effect on sexual behaviour 
at all,25 they may create disincentives to individuals to come forward for HIV testing and treatment, 
for fear of criminal penalties or official investigation.  This is counter-productive, since it is important 
to encourage individuals to monitor their HIV status and to seek treatment as soon as they are 
diagnosed, both because those who acquired the virus recently will have a higher viral load and will 
be more likely to transmit it,26 and because effective treatment with antiretroviral therapy lowers 
viral load and makes it less likely that HIV positive individuals will pass on the virus to others.27 
An additional concern that relates to mandatory disclosure laws is the potential for such laws to 
subtly undermine disease control efforts by weakening the assumption that individuals are primarily 
responsible for protecting themselves from the risks of transmission of HIV and other sexually 
transmissible diseases.  In countries where large numbers of the population are infected, relying on 
voluntary disclosure by sexual partners is unrealistic.  Individuals may not know their status, or may 
be ashamed, fearful, or otherwise unwilling to reveal information about themselves.  In these 
circumstances, personal responsibility and self-protection remain critical. 
The Joint United Nations Programme on HIV/AIDS (UNAIDS)28 and, more recently, the Global 
Commission on HIV and the Law, have recommended that countries should only prosecute HIV 
transmission in cases of intentional and actual transmission, and require a high standard of evidence 
and proof.  The Global Commission recommended that countries repeal provisions that explicitly 
criminalise HIV transmission, and rely on existing laws against assault, laws against causing bodily 
harm, or laws that permit public health officials to intervene when a person’s behaviour creates a 
serious risk of transmission of communicable disease.29 
10.3 Compulsory treatment orders 
Although the right to consent to medical treatment is a fundamental individual human right, there 
are circumstances in which public health authorities may be justified in ordering the compulsory 
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diagnosis and treatment of individuals.  Public health laws should authorize compulsory treatment 
orders only in circumstances where the person in question is unable or unwilling to consent to a 
diagnostic procedure or treatment, and where their behaviour creates a significant risk of 
transmission of a serious disease.  For example, South Africa’s National Health Act states that a 
health service may not be provided to a user without the user's informed consent, unless “failure to 
treat the user, or group of people which includes the user, will result in a serious risk to public 
health”.30 
A treatment order should clearly state the grounds on which it has been made, should set out any 
restrictions or limitations on behaviour, and should take into account the principle that individual 
liberty should only be restricted to the extent necessary to most effectively reduce risks to public 
health (see Section 10.1).  Public health laws should also include procedural rights to protect the 
interests of individuals subject to treatment orders.  This may include the requirement for a court to 
review each compulsory treatment order within a defined period of time.  Public health officials 
must ensure that laws authorizing treatment without consent are never used to discriminate against 
or to marginalize vulnerable individuals and groups. 
10.4 Limiting contact with infectious persons 
Isolating persons who have or may have been exposed to a serious contagious disease, in order to 
prevent transmission, is a long-established public health strategy that may be applied to both 
individuals and groups.  Where an outbreak of a serious, contagious disease occurs, it will often be 
impractical or impossible to accurately identify cases and carriers of disease.  For this reason, public 
health laws should authorize officials to evacuate or to order the closure of premises (e.g. markets, 
schools and movie theatres) and to prevent access to public spaces where people would otherwise 
gather.  Since the closure of premises can affect businesses and livelihoods, it is important for the 
operation of public health orders to be reviewed regularly and to be based on public health 
considerations, without discrimination on grounds of race, gender, tribal background or other 
inappropriate criteria. 
Public health orders for the evacuation or closure of premises may be coupled with orders to 
disinfect and decontaminate premises, or to remove noxious articles (including objects, birds and 
animals) that are contaminated with an infectious agent. Where the confiscation or destruction of 
private property causes more than trivial economic loss, public health laws should require 
reasonable compensation to be paid to the owner.  This principle can have an important benefit for 
public health: laws that provide for just compensation are more likely to secure the trust and 
voluntary cooperation of those who are poor and economically vulnerable, and who for that reason 
are most likely to be adversely affected by a public health order. 
Public health laws should authorize public health officials to make orders for the isolation of infected 
individuals, and the quarantine of those who have been exposed to a serious contagious disease.  As 
with treatment orders, however, these restrictions on autonomy should only be used as a last resort 
and should be minimally restrictive (see Section 10.1).  For example, an infectious individual who 
does not require medical attention may be effectively quarantined within his or her home, rather 
than being confined in a hospital or other facility used as a detention centre.  Laws authorizing 
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mandatory confinement must also ensure that basic needs are met, including adequate shelter, 
food, water and sanitation.  They should also provide for appropriate treatment and health care, and 
respect the cultural or religious expectations of quarantined or isolated individuals to the greatest 
possible extent (Box 10.4).  National laws should also include procedural safeguards, by giving 
individuals who are the subject of a quarantine or isolation order the right to seek review by a court 
within a reasonable time. 
Box 10.4: Incorporating human rights protections into quarantine and isolation laws: an example 
from the United States 
Model Public Health Act31 
Section 5-108: Quarantine and Isolation. 
(a) Authorization. A state or local public health agency may isolate or quarantine an individual or 
group of individuals pursuant to rules or regulations promulgated by the state public health agency 
consistent with the provisions of this section. 
(b) Conditions and Principles.  The state or local public health agency shall adhere to the following 
conditions and principles when isolating or quarantining individuals or groups of individuals: 
(1) Isolation and quarantine must be by the least restrictive means necessary to prevent the spread 
of a contagious or possibly contagious disease to others and may include, but are not limited to, 
confinement to private homes or other private and public premises. 
(2) Isolated individuals must be confined separately from quarantined individuals.  
(3) The health status of isolated and quarantined individuals must be monitored regularly to 
determine if they continue to require isolation or quarantine.  
(4) If a quarantined individual subsequently becomes infected or is reasonably believed to have 
become infected with a contagious or possibly contagious disease he or she must promptly be 
removed to isolation.  
(5) Isolation and quarantine must be immediately terminated when an individual poses no 
substantial risk of transmitting a contagious or possibly contagious disease to others. 
(6) The needs of individuals who are isolated or quarantined shall be addressed in a systematic and 
competent fashion, including, but not limited to, providing adequate food, clothing, shelter, means 
of communication with those in isolation or quarantine and outside these settings, and competent 
medical care.  
(7) Outside premises used for isolation and quarantine shall be maintained in a safe and hygienic 
manner and be designed to minimize the likelihood of further transmission of infection or other 
harms to individuals isolated and quarantined.  
(8) To the extent possible, cultural and religious beliefs shall be respected in addressing the needs of 
individuals, and establishing and maintaining isolation and quarantine premises.  
(c) Entry into Isolation or Quarantine Premises.  The state or local public health agency may 
authorize physicians, health care workers, or others access to individuals in isolation or quarantine 
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as necessary to meet the needs of isolated or quarantined individuals.  Any individual entering 
isolation or quarantine premises with or without authorization of the state or local public health 
agency may be isolated or quarantined where needed to protect the public’s health. 
(d) Temporary Isolation and Quarantine without Notice. The state or local public health agency may 
temporarily isolate or quarantine an individual or groups of individuals through a written directive if 
delay in imposing the isolation or quarantine would significantly jeopardize the agency’s ability to 
prevent or limit the transmission of a contagious or possibly contagious disease to others.  
(e) Isolation or Quarantine with Notice. The state or local public health agency may make a written 
petition to a court for an order authorizing the isolation or quarantine of an individual or groups of 
individuals.  
(f) Relief from Isolation and Quarantine.  An isolated or quarantined individual or group of 
individuals may apply to a court for an order to show cause why isolation or quarantine should not 
be terminated. The court shall rule on the application to show cause within 48 hours of its filing. 
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Chapter 11: Public health emergencies 
 
SUMMARY POINTS 
 
· Disaster management is a core function of public health law. National laws and emergency 
plans must take account of international obligations for the management of public health 
emergencies, including the International Health Regulations (2005) (IHR). The purpose of the IHR is 
to prevent and manage the public health risks arising from the international spread of disease, 
while avoiding “unnecessary interference with international traffic and trade”. 
· Important obligations that arise under the revised IHR include the following: 
· Each country is required to establish a National IHR Focal Point accessible at all times for 
communications with WHO. 
· Each country must develop and maintain the capacity to assess health risks within its 
territory and to notify WHO of all events that may constitute a public health emergency of 
international concern. The IHR contain a decision instrument to assist countries to identify events 
requiring notification. 
· The IHR impose a legal requirement on countries to strengthen and maintain their 
surveillance and response capabilities at local, intermediate and national levels, and at designated 
airports, ports and ground crossings. At national level, countries are expected to develop the 
capacity to assess all reports of urgent events within 24 hours. 
· Following a determination by WHO that a public health emergency of international 
concern is occurring, the Director-General may issue temporary recommendations, after receiving 
advice from the Emergency Committee. These recommendations may include the requirement to 
carry out medical examinations and vaccinations, to place suspect persons under public health 
observation, to quarantine, isolate or require the contact tracing of contacts of affected persons, 
to carry out exit screening, and to refuse entry to suspect or affected persons. 
· The IHR require countries to exercise their health powers in a transparent and non-
discriminatory manner, with full respect for the dignity, human rights and fundamental freedoms 
of persons.  When issuing temporary recommendations, the Director-General shall consider health 
measures that are neither more restrictive of international traffic and trade nor more intrusive to 
persons than reasonable and appropriate alternative measures. The IHR contain a number of more 
specific human rights protections that apply to the exercise of specific powers. 
· In addition to the IHR, the Pandemic Influenza Preparedness (PIP) Framework provides 
guidance in relation to the sharing of influenza viruses with human pandemic potential through 
the WHO-coordinated Global Influenza Surveillance and Response System. The framework 
includes a benefit-sharing system that gives commercial entities access to PIP biological materials 
in exchange for providing assistance to developing countries. 
· National authorities should develop a national emergency plan that sets out a clear chain of 
command and takes account of all relevant levels of government. The legal authority and roles of 
key officials during an emergency should be defined in legislation. These powers may include the 
authority to take such actions as are reasonably required to deal with a serious risk to public 
health. Public health laws should establish clear triggers for the application of emergency powers, 
with clear time limits. Disaster management laws should enable individuals to seek an 
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independent review of decisions that restrict their fundamental rights. 
· In order to ensure an adequate health workforce during an emergency, public health laws may 
grant temporary practice licenses to health professionals who are inactive, retired or licensed in 
other jurisdictions. 
· National emergency plans should establish a national stockpile of essential medicines, 
vaccines and medical supplies to meet emergency needs. 
· In some circumstances, public health laws authorize government authorities to take control of 
premises, facilities and supplies, including health facilities and medical supplies, provided that 
reasonable compensation is paid. 
· Public health laws should authorize public health officials to take such actions as reasonably 
necessary to investigate the causes, sources and means of transmission of disease agents, to 
authorize diagnostic testing, compulsory medical treatment, and to make orders for isolation 
and/or quarantine. These powers should not be exercised in an arbitrary or discriminatory way, 
and should be exercised in accordance with the principle of proportionality. 
Disaster management is a core function of public health law. Public health emergencies can arise 
from a wide range of causes, including outbreaks of contagious, life-threatening disease, natural 
disasters, as well as chemical contamination of the environment and the release of radiation. In 
emergencies, large numbers of people may require medical attention, health care systems may be 
over-stretched, and public order may be threatened. This chapter identifies some of the legal issues 
that may arise for national authorities in the course of responding to a public health emergency. 
11.1 International management of public health 
 emergencies 
(a) The International Health Regulations (2005) 
The revised International Health Regulations (2005) (IHR), adopted by the World Health Assembly in 
2005, are binding on all WHO Member States and provide a regulatory framework for international 
management of public health emergencies.1 The purpose of the IHR is to prevent and manage the 
public health risks arising from the international spread of disease, while avoiding “unnecessary 
interference with international traffic and trade”.2 Critical features of the IHR include: 
• the legal obligation imposed on each country to notify WHO of events that may constitute a 
“public health emergency of international concern within its territory”;3 
• the obligation of countries to “develop, strengthen and maintain” their national capacities to 
detect, assess, report and respond effectively to public health risks and emergencies;4 and 
• the ability of the WHO Director-General to make non-binding, temporary recommendations 
to countries in whose territory a public health emergency of international concern has 
arisen.5 
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This report does not provide a technical review of obligations owed by countries under the IHR.6 
WHO has published a range of resources to assist countries to implement their obligations under the 
IHR through national legislation (Box 11.1).7 
Box 11.1: Implementation of the International Health Regulations (2005): selected priority areas8 
• National International Health Regulations (2005) (IHR) Focal Points: designation and 
operation 
• Detection, reporting, verification and control of events, as well as related communications, 
domestically and internationally 
• Communications and collaboration with WHO 
• Implementation of IHR documents: 
o Ship Sanitation Certificate (Annex 3) 
o International Certificate of Vaccination and Prophylaxis (Annex 6) 
o Maritime Declaration of Health (Annex 8) 
o Health Part of Aircraft General Declaration (Annex 9) 
• Designation of Points of Entry (ports, airports and ground crossings) for development of core 
public health capacities 
• Identification (and informing WHO) of ports authorized to issue Ship Sanitation Certificates 
and provide related services. 
National IHR Focal Points 
In order to facilitate global surveillance and response capabilities, the IHR require each country to 
establish a National IHR Focal Point. The Focal Point shall be accessible at all times for 
communications with corresponding WHO IHR Contact Points, established by WHO to assist 
communications with each country.9 The IHR envisage a number of important forms of 
communication between national focal points and WHO; in addition, the focal points are expected 
to function as coordinating centres for surveillance and reporting within their countries, and for 
communications between government departments.10 Countries must ensure that 
telecommunications systems enable the focal point to be contacted and to communicate with WHO 
at all times. 
Reporting obligations 
The IHR require each country to assess health risks within its territory and to notify WHO of all 
events that may constitute a public health emergency of international concern, together with the 
health measures it has taken in response to those events.11 Following notification, each country shall 
continue to provide timely, accurate and detailed information about the notified event, including 
(where possible), “case definitions, laboratory results, source and type of risk, number of cases and 
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deaths, conditions affecting the spread of the disease and the health measures employed”, and any 
difficulties faced and support needed in order to respond effectively.12 
The concept of a “public health emergency of international concern” is not limited to epidemic-
prone diseases, but extends to biological, chemical and nuclear hazards, including the chemical or 
nuclear contamination of the environment, and contaminated food and pharmaceuticals.13 The IHR 
contain a decision instrument to assist countries to identify events requiring notification (Box 11.2). 
Countries are required to notify WHO within 24 hours (or immediately in the case of nuclear-related 
events), through their National IHR Focal Point.14 Prior to this point, countries are encouraged to 
consult with WHO about emerging health threats and the appropriate health response.15 
Determining the existence of a public health emergency of international concern under the IHR is 
the prerogative of the Director-General, who acts on the advice of Emergency Committees.16 
Box 11.2: Notification of events that may constitute a public health emergency of international 
concern under the International Health Regulations (2005) 
Article 6 of the International Health Regulations (2005) (IHR) imposes an obligation on countries to 
notify WHO, via the National IHR Focal Point, of “all events which may constitute a public health 
emergency of international concern within its territory”.17 The IHR define a “public health 
emergency of international concern” as an extraordinary event that is determined to “constitute a 
public health risk to other States through the international spread of disease and to potentially 
require a coordinated international response”.18 The algorithm in Annex 2 of the IHR identifies two 
categories of reportable events.19 Under the first category, countries are required to assess domestic 
public health events against the four criteria below and to notify WHO when at least two of the four 
criteria are met: 
• Is the public health impact of the event serious? (yes/no) 
• Is the event unusual or unexpected? (yes/no) 
• Is there any significant risk of international spread? (yes/no) 
• Is there any significant risk of international travel or trade restrictions? (yes/no) 
Under the second category, one or more cases of the following four specific diseases are considered 
by definition to constitute a public health emergency of international concern: 
• smallpox; 
• severe acute respiratory syndrome (SARS); 
• human influenza caused by a new subtype; 
• poliomyelitis due to wild-type poliovirus. 
WHO has published guidance to assist countries to identify events that are reportable under Annex 2 
of the IHR.20 
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Surveillance and response capabilities 
The IHR impose a legal requirement on countries to strengthen and maintain their surveillance and 
response capabilities at local, intermediate and national levels, and at designated airports, ports and 
ground crossings.21 At the local community level, this includes the capacity to identify outbreaks of 
disease or death above expected levels for the particular time and place and for all areas within that 
country.22 At national level, countries are expected to develop the capacity to assess all reports of 
urgent events within 24 hours. In addition, countries are required to inform WHO of public health 
risks identified outside their territory that may result in the international spread of disease, as 
manifested by human cases, vectors for infection or contaminated goods.23 Countries are expected 
to establish and maintain core capacities for responding to the risks presented by ill travellers who 
present at designated airports, ports and ground crossings. These include providing prompt medical 
assessment of those who are ill, transporting ill persons to appropriate medical facilities, and 
assessing and if necessary imposing quarantine restrictions on persons who may have been exposed 
to disease.24 
Temporary recommendations 
Following a determination by WHO that a public health emergency of international concern is 
occurring, the Director-General may issue temporary recommendations, after receiving advice from 
an Emergency Committee.25 These recommendations may include health measures for 
implementation both by countries experiencing the public health emergency, and other countries. 
Depending on the circumstances, the recommendations may include the requirement to carry out 
medical examinations and vaccinations, to place suspect persons under public health observation, to 
quarantine, isolate or require the contact tracing of contacts of affected persons, to carry out exit 
screening and to refuse entry to suspect or affected persons.26 
Human rights protections within the IHR 
Countries are required to implement the IHR with “full respect for the dignity, human rights and 
fundamental freedoms of persons”,27 and to exercise their health powers “in a transparent and non-
discriminatory manner”.28 When issuing temporary recommendations, the Director-General shall 
consider health measures that are neither more restrictive of international traffic and trade, nor 
more intrusive of persons than “reasonably available alternatives that would achieve the 
appropriate level of health protection”.29 More specific human rights protections are summarized in 
Box 11.3. 
Box 11.3: Protecting human rights under the International Health Regulations (2005) 
• Countries may require travellers, on arrival or departure, to provide information about their 
destination and itinerary, and may conduct a “non-invasive medical examination which is the 
least intrusive examination that would achieve the public health objective”. On the basis of 
this assessment, countries may also require a suspect or affected traveller, on a case-by-case 
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basis, to undergo a medical examination, provided it is the “least intrusive and invasive 
medical examination that would achieve the public health objective of preventing the 
international spread of disease”.30 
• Countries may require travellers to undergo invasive medical examinations, vaccination or 
other prophylaxis and deny entry to a traveller who refuses to consent to such a measure. 
However, where there is evidence of an imminent public health risk, travellers may be 
compelled to undergo “the least invasive and intrusive medical examination that would 
achieve the public health objective”. In these circumstances, countries may also require 
vaccination or other prophylaxis, and impose additional health measures in order to control 
the spread of disease, including isolation, quarantine and public health observation.31 
• Countries shall treat all travellers with “respect for their dignity, human rights and 
fundamental freedoms”. In order to minimize discomfort or distress associated with public 
health measures (including medical examinations, quarantine, and isolation), countries shall: 
o take into consideration the “gender, sociocultural, ethnic or religious concerns” of 
travellers; and 
o provide adequate food and water, accommodation and clothing, protection for 
possessions, appropriate medical treatment and linguistic assistance.32 
(b) Pandemic Influenza Preparedness Framework 
The Pandemic Influenza Preparedness Framework (“PIP Framework”) adopted by the World Health 
Assembly in 2011 provides important international guidance in relation to H5N1 and “other 
influenza viruses with human pandemic potential”.33 Negotiation of the PIP Framework was 
precipitated by the decision of Indonesia in January 2007 to withhold H5N1 influenza virus samples 
from WHO for surveillance or vaccine development purposes, following advice that samples were 
provided to pharmaceutical companies without its consent. Indonesia’s position was that efforts to 
develop patentable diagnostics, vaccines and therapeutic drugs derived from use of biological 
samples sourced from Indonesia, without its consent, reflected the inequity of global arrangements 
for virus sharing, which benefit richer countries that can afford to pay for patented products at the 
expense of those which cannot.34 
The PIP Framework encourages WHO Member States to share PIP biological materials from influenza 
viruses with human pandemic potential in a “rapid, systematic and timely manner” through the 
WHO-coordinated Global Influenza Surveillance and Response System (GISRS).35 In doing so, 
countries are taken to consent to the onward transfer and use of PIP biological materials to other 
institutions, organizations and entities, subject to the terms of two standard material transfer 
agreements. These agreements apply to transfers of viruses and PIP biological materials within the 
GISRS system, and outside the GISRS system, respectively.36 
The framework requires WHO to establish an electronic traceability system to enable the tracking in 
real time of all PIP biological materials. Under the first material transfer agreement, between 
providers and recipient laboratories within the GISRS, both parties are encouraged not to seek to 
obtain any intellectual property rights in the materials.37 The second material transfer agreement, 
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between WHO and recipients outside the GISRS, creates a benefit-sharing system that gives 
commercial entities access to PIP biological materials in exchange for assistance to developing 
countries (Box 11.4). Among other provisions, the PIP Framework commits the Director-General to 
work with multilateral agencies and donors to establish stockpiles of vaccines and antivirals, and 
asks countries to urge manufacturers to implement tiered pricing in order to increase the 
affordability of influenza vaccines and antivirals in developing countries.38 Manufacturers of 
influenza vaccines, as well as diagnostic and pharmaceutical manufacturers receiving samples 
through the GISRS system are also required to pay annual contributions equivalent to half the 
running costs of the GISRS network.39 
Box 11.4: Benefit-sharing provisions applicable to commercial entities receiving influenza viruses 
under the Pandemic Influenza Preparedness Framework 
A. Benefit-sharing options for manufacturers of vaccines and/or antivirals. Manufacturers shall 
commit to at least two of the following: 
• donate 10% or more of real-time pandemic vaccine production to WHO; 
• reserve 10% or more of pandemic vaccine production for WHO at affordable prices; 
• donate at least X [amount to be negotiated] courses of antiviral treatment for the pandemic 
to WHO; 
• reserve at least X courses of antiviral treatment for the pandemic at affordable prices; 
• grant licences to manufacturers in developing countries on fair and reasonable terms for 
products in which the recipient holds intellectual property rights (influenza vaccines, 
adjuvants, antivirals, and/or diagnostics); 
• grant royalty-free licences to manufacturers in developing countries, or alternatively, 
royalty-free licences to WHO for production of pandemic influenza vaccines, adjuvants, 
antivirals and diagnostics; 
B. Benefit-sharing options for manufacturers of products other than vaccines or antivirals. 
Manufacturers shall commit to at least one of the following: 
• donate to WHO at least X [amount to be negotiated] diagnostic kits for use in a pandemic; 
• reserve at least X diagnostic kits for use in a pandemic, at affordable prices; 
• in coordination with WHO, support the strengthening of influenza specific laboratory and 
 surveillance capacity in developing countries; 
• in coordination with WHO, support the transfer of technology and know-how for pandemic 
influenza preparedness to developing countries. 
C. In addition to the above commitments, recipients shall consider contributing to the following 
measures: 
• donations of vaccines; 
• donations of pre-pandemic vaccines; 
• donations of antivirals; 
• donations of medical devices; 
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• donations of diagnostic kits; 
• affordable pricing; 
• transfer of technology and processes; 
• granting of sublicences to WHO; 
• laboratory and surveillance capacity-building. 
(c) Strengthening WHO’s emergency response capacity 
The Ebola virus disease outbreak in 2014–2015, which resulted in the establishment and deployment 
of the United Nations Mission for Ebola Emergency Response (UNMEER),40 has been a catalyst for a 
number of developments in the global management of public health emergencies. These include the 
establishment of a global health emergency workforce, and a contingency fund to support WHO’s 
emergency response capacity. 
National governments bear the primary responsibility for developing their domestic health systems 
and establishing an effective health emergency workforce. However, in order to support national 
efforts, WHO has committed to scaling up the global health emergency workforce, both by 
expanding partnerships with United Nations agencies, funds and programmes, and by improving the 
coordination of other international responders, including through its leadership of the Global Health 
Cluster of international humanitarian health organizations.41 The process of operationalizing the 
global health emergency workforce includes developing processes for pre-deployment (establishing 
rosters, quality assurance and training), deployment (including logistic planning and medical 
evacuation), and decommissioning of personnel, together with governance and finance 
arrangements. In order to support its role in coordinating the global response to public health 
emergencies, WHO has established a contingency fund with a target capitalization of US$ 100 
million.42 Financed through voluntary contributions, this fund can support all aspects of WHO’s 
emergency response work, including the mobilization of the global health emergency workforce, and 
surveillance in high-risk areas. 
11.2 National public health emergency plans 
The following sections identify some of the legal issues that countries may face during the process of 
strengthening their national laws and operational plans for responding to public health emergencies. 
Countries should prepare and regularly review a national emergency plan that sets out a clear 
command structure for decision-making and for activating and coordinating resources. Emergency 
plans should specify the officials and agencies that will have operational control during the 
emergency, and identify relevant advisory bodies, such as national emergency councils and standing 
committees advising in specialist areas. The roles and powers of officials performing key operational 
or executive roles during an emergency, including the health minister, chief health officer, director 
of human biosecurity (and similar officials), should be defined in legislation. 
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Since overlapping authority, and gaps in authority may cause uncertainty and disputes during an 
emergency, national emergency plans should take account of all levels of government (national, 
state/regional/provincial, and local/city), ensuring that the response to localized emergencies can be 
scaled up as required.43 In order to ensure that countries meet their obligations under the IHR, 
national governments may need to formalize agreements about operational control and chains of 
command through memoranda of understanding. Similarly, the roles and responsibilities of different 
ministries, as well as statutory and executive bodies, should be considered and specified.44 
Public health laws contribute to effective disaster management by authorizing rapid and decisive 
government responses, and by temporarily suspending the operation of laws and processes that 
would otherwise disrupt an effective emergency response. Public health laws should establish clear 
triggers for the application of emergency powers, such as the scale or seriousness of the emergency, 
or a formal declaration of emergency as well as a specific time period for the application of these 
powers (e.g. 30 days, renewable if necessary). Since the emergency powers required for disaster 
management may require interferences with individual human rights, disaster management laws 
should include accountability mechanisms, such as the right to seek review of decisions that affect a 
person’s fundamental rights by an independent, external body, within a time frame that is 
reasonable in the circumstances. 
Emergency powers may include the power to rapidly marshal the physical and human resources that 
are needed to provide health care and other services. As discussed in the following sections, public 
health laws may authorize public health officials to: 
• expand the health care or disaster management workforce by co-opting personnel from 
other agencies and jurisdictions under a unified command structure; 
• seize property in order to establish emergency response centres and to ensure the 
availability and rapid distribution of pharmaceuticals and supplies; or 
• conduct surveillance and mandate vaccinations, treatment, isolation or quarantine of 
infected or potentially infected individuals. 
11.3 Emergency health workforce 
Health care workers may be in short supply following a natural disaster or event causing mass 
casualties. Public health laws may provide that health professionals must assist in the provision of 
emergency assistance, grant temporary practice licences to medical professionals and nurses who 
are inactive, retired, or licensed in other countries or jurisdictions, or allow health professionals to 
perform functions beyond their licensed scope of practice (Box 11.5). The United States Model State 
Public Health Act illustrates how emergency health care workers may be protected from civil 
lawsuits that arise from treatment provided during an emergency in a given jurisdiction, except in 
circumstances where their actions or omissions demonstrated a reckless disregard for the life and 
health of the patient. 
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Box 11.5: Maintaining the health care workforce during a public health emergency: an example 
from the United States 
Model State Public Health Act45 
Section 6-104. Protection of individuals. 
(d) Licensing and appointment of health personnel. During a state of public health emergency, the 
state or local public health agency is authorized: 
(1) Health care providers. To require in-state health care providers to assist in the performance of 
vaccination, treatment, examination, testing, decontamination, quarantine, or isolation of any 
individual as a condition of licensure, authorization, or the ability to continue to function as a health 
care provider in this state. 
(2) Health care providers from other jurisdictions. To appoint and prescribe the duties of out-of-
state emergency health care providers (with proof of current licensure in their state) as may be 
reasonable and necessary to respond to the public health emergency. 
(i) The appointment of out-of-state emergency health care providers shall not exceed the 
termination of the declaration of a state of public health emergency. The state or local public health 
agency may terminate the out-of-state appointments at any time or for any reason provided that 
any such termination will not jeopardize the health, safety, and welfare of the people of this state. 
(ii) The state public health agency may waive any or all licensing requirements, permits, or fees 
required by state code and applicable orders, rules, or regulations for health care providers from 
other jurisdictions to practice in this state. 
(iii) Any out-of-state emergency health care provider appointed pursuant to this Section shall not be 
held liable for any civil damages as a result of medical care or treatment related to the response to 
the public health emergency unless such damages result from providing, or failing to provide, 
medical care or treatment in the event of gross negligence or willful misconduct. 
Colorado State Governor’s Expert Emergency Epidemic Response Committee Draft Executive Order 
5.0, United States of America46 
Authorizes Colorado licensed physician assistants and emergency medical technicians to practice 
outside of their normal supervision but under the supervision of another physician to meet the 
emergency epidemic. 
11.4 Control of premises, facilities and supplies 
Natural disasters as well as emergencies resulting from human actions, may create dangerous or 
contaminated areas that present a risk to public health and must be immediately closed off to the 
public. Public health laws may authorize public health authorities to compel the evacuation and 
closure of any premises or public area, and include the power to enter premises and private 
property in order to dispose of infectious waste or contaminated material (Box 11.6). 
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A public health emergency may create an urgent need for vaccinations, treatments and emergency 
response sites. Emergency plans should provide for the stockpiling of essential pharmaceuticals and 
medical supplies, and should consider the logistics of distributing essential supplies to areas of 
greatest need following an emergency event. For example, in the United States, federal law requires 
the Centers for Disease Control and Prevention (CDC), in coordination with the Secretary of 
Homeland Security, to maintain a strategic national stockpile of essential medicines, vaccines, 
medical devices and other supplies “in such numbers, types and amounts” as the Secretary 
determines to be necessary.47 The contents of the stockpile are required to be kept within their 
shelf-life limits and made available, free of charge, to meet the needs of states and communities 
within 12 hours of determination of emergency need.48 The Secretary is required to review the 
contents of the stockpile and to make plans for the management of the stockpile in consultation 
with federal, state and local officials.49 In 2009, the stockpile was used to assist state health 
departments to respond to the H1N1 influenza outbreak (antiviral drugs such as oseltamivir and 
zanamivir were distributed to states to replenish supplies).50 Public health laws can support these 
plans by authorizing public health officials to purchase or acquire essential medicines, vaccines and 
other medical supplies from public or private sources, on reasonable terms (Box 11.6). In addition to 
authorizing the specific actions set out in Box 11.6, public health laws may contain general 
authorizing provisions permitting government officials to exercise executive powers following the 
declaration of an emergency, and authorizing health departments to take such actions as are 
reasonably required to deal with the risk to human health. 
Box 11.6: Laws authorizing the emergency use of facilities and pharmaceuticals: an example from 
the United States 
Model State Public Health Act51 
Section 6-103. Management of property. 
(a) Emergency Measures Concerning Facilities and Materials. During a state of public health 
emergency, the state or local public health agency is authorized: 
(1) Close facilities. To close, direct, and compel the evacuation of, or decontaminate or cause to be 
decontaminated any facility of which it has reasonable cause to believe that it may endanger the 
public’s health. 
(2) Use of materials and facilities. To procure, by condemnation or otherwise, construct, lease, 
transport, store, maintain, renovate, or distribute materials and facilities as may be reasonable and 
necessary to respond to the public health emergency, with the right to take immediate possession 
thereof. Such materials and facilities include communication devices, carriers, real estate, fuels, 
food, and clothing. 
(3) Use of health care facilities. To require a health care facility to provide services or the use of its 
facility if such services or use are reasonable and necessary to respond to the public health 
emergency as a condition of licensure, authorization or the ability to continue doing business in the 
state as a health care facility. The use of the health care facility may include transferring the 
management and supervision of the health care facility to the state or local public health agency for 
a limited period of time. 
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(4) Destruction of materials. To decontaminate or cause to be decontaminated, or destroy, any 
material of which it has reasonable cause to believe that it may endanger the public’s health. 
(5) Control of materials. To inspect, control, restrict, and regulate by rationing and using quotas, 
prohibitions on shipments, allocation, or other means, the use, sale, dispensing, distribution, or 
transportation of food, fuel, clothing and other commodities, as may be reasonable and necessary to 
respond to the public health emergency. 
(e) Control of Health Care Supplies. 
(1) Procurement. During a state of public health emergency, the state or local public health agency 
may purchase and distribute anti-toxins, serums, vaccines, immunizing agents, antibiotics, antidotes, 
and other pharmaceutical agents, medical supplies, or personal protective equipment to prepare for 
or control a public health emergency. 
(2) Rationing. Where a state of public health emergency results in a state-wide or regional shortage 
or threatened shortage of any product under subsection (1), whether or not such product has been 
purchased by the agency, the agency may control, restrict, and regulate by rationing and using 
quotas, prohibitions on shipments, allocation, or other means, the use, sale, dispensing, distribution, 
or transportation of the relevant product. In making rationing or other supply and distribution 
decisions, the agency may give preference to health care providers, disaster response personnel, and 
mortuary staff. 
(3) Distribution. During a state of public health emergency, the agency may store or distribute any 
anti-toxins, serums, vaccines, immunizing agents, antibiotics, antidotes, and other pharmaceutical 
agents, personal protective equipment, or medical supplies located within the state as may be 
reasonable and necessary to respond to the public health emergency, with the right to take 
immediate possession thereof…. 
Section 6-106. Compensation 
(a) Just Compensation. The State shall pay just compensation to the owner of any facilities or 
materials that are lawfully used or appropriated by a state or local public health agency for its 
temporary or permanent use during a state of public health emergency according to the procedures 
and standards set forth in this Article. 
11.5 Health care services during a public health 
 emergency 
In order to deal effectively with a public health emergency, emergency powers can include the 
power to authorize compulsory medical treatment, and to make orders for isolation and quarantine. 
However, laws that directly restrict the freedom of individuals during a disaster or public health 
emergency should comply with the human rights protections set out in the IHR (see Section 11.1(a)), 
with the United Nations’ Siracusa Principles (see Box 11.7),52 and with any domestically applicable 
fundamental rights protection regime. 
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Box 11.7: Requirements for laws directly restricting individual freedom during a public health 
emergency: the Siracusa Principles 
Emergency laws that place limitations on individual freedoms must: 
(1) Respond to a pressing public or social need; 
(2) Pursue a legitimate aim; 
(3) Be proportionate to the legitimate aim; and 
(4) Be no more restrictive than required to achieve the purpose sought by restricting the right.53 
Laws that restrict rights should not be applied or implemented in an arbitrary or discriminatory 
manner.54 Furthermore, where limitations are placed upon fundamental rights, such as freedom of 
movement, they must be substantiated by scientific evidence and implemented in ways that take 
account of the values of participation, transparency and accountability.55 
In addition to authorizing medical treatment, emergency powers should authorize urgent 
investigations to determine the causes, sources and means of transmission of disease agents. 
Conducting swift and accurate surveillance during a public health emergency enables authorities to 
design and implement effective responses. Public health laws can authorize state or local health 
departments to enter premises, to collect specimens and perform diagnostic tests on living or 
deceased persons, and to access previously collected samples or test results as necessary in order to 
respond effectively. 
Disasters may threaten public order and public health due to violence and crime. Reproductive 
health needs are often especially great in the aftermath of a disaster. Displaced women are often 
victims of rape and sexual violence, and may have an urgent need for emergency contraception and 
treatment for sexually transmissible infections. WHO’s Interagency Emergency Health Kit,56 which 
includes emergency contraception and midwifery supplies, and WHO’s Model List of Essential 
Medicines,57 can serve as a benchmark in operational planning for a public health emergency. 
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Chapter 12: Enabling environments to support healthy 
and safe behaviours 
 
SUMMARY POINTS 
 
· Noncommunicable diseases (NCDs) kill more than 38 million people every year. Three quarters 
of these deaths occur in low- and middle-income countries, entrenching poverty, cutting into the 
productive years of life and undermining the benefits of the lower dependency rates enjoyed by 
developing countries with younger populations. 
· Members of the World Health Assembly have committed to a 25% relative reduction in 
premature mortality from cardiovascular diseases, cancer, diabetes and chronic respiratory 
diseases by 2025, and to a set of supporting targets covering key risk factors: harmful use of 
alcohol, physical inactivity, salt intake, tobacco use, raised blood pressure, and overweight and 
obesity. The WHO Global Action Plan for the Prevention and Control of NCDs identifies a suite of 
policy options to assist countries to meet these targets. 
· Many of WHO’s recommended “best buys” for reducing risk factors for NCDs will require legal 
and regulatory controls for effective implementation. To ensure that these measures are 
implemented, with adequate budgets for monitoring and enforcement, high-level leadership will 
be required from presidents, prime ministers, health ministers and other senior cabinet ministers. 
The involvement of non-health ministries is vital, since many of the most important interventions 
will be implemented outside the health sector. Examples include raising taxes on alcohol and/or 
unhealthy food and beverages, reducing the amount of smuggled and counterfeit tobacco 
products, and restricting the marketing of unhealthy foods to children. 
· When implementing effective measures to prevent and control NCDs, governments can expect 
resistance from manufacturers and retailers of tobacco, alcohol and unhealthy foods, and their 
allies. The tobacco and alcohol industries should have no role in the formation of tobacco and 
alcohol control laws and policies. 
· Where voluntary partnerships with the food industry are ineffective in achieving national 
targets, governments may consider strengthening their level of oversight of the industry, and 
implementing a co-regulatory approach. 
· Governments have a responsibility to disseminate accurate information about health risks to 
their populations and to promote healthy lifestyles. Independent health promotion agencies, 
established by legislation, are one model for providing national leadership in health promotion. 
· Injuries claim nearly 5 million lives each year and are a neglected global health priority. Ninety 
per cent of fatal injuries occur in low- and middle-income countries. 
· Law has an important role to play in reducing road traffic injuries, including through setting 
and enforcing speed limits on roads, regulating the licence system, implementing drink-driving 
counter-measures (e.g. random breath testing), and requiring seat belts to be used by all 
occupants of motor vehicles and helmets to be worn on motorcycles and bicycles. 
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Introduction 
Enabling individuals to make healthy choices and to engage in safe behaviours is a core function of 
public health law. Individual behaviour is a significant contributor to avoidable death and disability, 
both from noncommunicable diseases (NCDs) and injuries. The most prominent NCDs 
(cardiovascular disease, cancer, diabetes and chronic respiratory diseases) are linked to a cluster of 
behavioural risk factors including tobacco use, harmful use of alcohol, unhealthy diets and lack of 
physical activity. In 2012, NCDs caused 38 million deaths. Nearly three quarters of these deaths (28 
million), and over 80% of premature deaths, occurred in low- and middle-income countries.1 Injuries 
and violence accounted for a further 5 million deaths.2 
To the extent that they have the knowledge and resources to do so, individuals share responsibility 
for the choices they make about their health and lifestyles. At the same time, governments have an 
over-riding responsibility to seek to realize the right to health for the populations they represent 
(see Section 1.1). Public health laws can significantly reduce the occurrence of injuries and the 
preventable component of NCDs by helping to create environments that are safer and that support 
healthier behaviours. This section identifies priority areas where law can support governments and 
individuals to reduce risks from NCDs and injuries. 
12.1 Enabling behaviours that reduce risks  
  for NCDs  
WHO has identified four modifiable behavioural risk factors that are responsible for most NCDs: 
tobacco use, lack of physical activity, unhealthy diet and harmful use of alcohol.3 These risk factors 
contribute to metabolic and physiological risk factors including raised blood pressure (which alone 
was responsible for over 9 million deaths in 2010),4 overweight and obesity, high blood glucose 
levels (hyperglycaemia), and high cholesterol. NCDs and their risk factors occur at higher rates 
among those with lower levels of income and education,5 entrenching poverty,6 cutting into the 
productive years of life and undermining the benefits of the lower dependency rates enjoyed by 
developing countries with younger populations.7 
NCDs impose heavy economic costs on households, health systems and economies due to a range of 
factors including reduced labour supply, reduced productivity, higher demand for medical 
treatments, and higher social welfare expenditures.8 According to a study prepared for the World 
Economic Forum, under a “business as usual” scenario, NCD morbidity and mortality will cost low- 
and middle-income countries US$ 500 billion per year over the period 2011–2025 (roughly 4% of 
average gross domestic product).9 On the other hand, cost-effective interventions are available. 
WHO has estimated that the cost of implementing a core set of population-level and individual-level 
interventions for preventing and treating NCDs (including the cost-effective “best buys” indicated in 
Table 12.1), would require an annual investment of US$ 1 per person in low-income countries, 
US$ 1.50 in lower middle-income countries, and US$ 3 in upper-middle-income countries.10 
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(a) Global targets for reducing mortality from NCDs 
In 2012, at the World Health Assembly (WHA), WHO Member States adopted a global target of a 
25% relative reduction in mortality from cardiovascular diseases, cancer, diabetes and chronic 
respiratory diseases by 2025.11 In 2013, the WHA adopted a global monitoring framework that 
included eight additional voluntary targets for reducing risk factors and improving the response of 
national health systems, and 25 indicators for measuring progress towards each target.12 These 
targets include a 10% relative reduction in the harmful use of alcohol; a 10% relative reduction in the 
prevalence of insufficient physical activity; a 30% reduction in mean population salt intake; a 30% 
relative reduction in prevalence of current tobacco use; and a halt in the rise of diabetes and 
obesity. A progress report was submitted to the WHA in 2015, and further reports will be submitted 
in 2020 and 2025.13 
Following the high-level meeting on the prevention and control of NCDs held by the United Nations 
General Assembly (UNGA) in September 2011,14 the UNGA has also become a forum for global 
action on NCDs. For example, in 2014, members of the UNGA made a number of time-bound 
commitments; these included the commitment to consider setting national targets and process 
indicators, taking into account the nine voluntary targets adopted by the WHA, and to consider 
developing or strengthening a national multisectoral coordinating mechanism to achieve these 
national targets.15 Members of the UNGA have also assumed reporting obligations to facilitate the 
preparation, by WHO, of reports to the UNGA on progress achieved in the prevention and control of 
NCDs.16 Separately, members of the UNGA have adopted 17 Sustainable Development Goals (SDGs) 
and 169 supporting targets in order to accelerate sustainable development over the period 2015–
2030. The Sustainable Development Goals include the following target: to “reduce by one third 
premature mortality from non-communicable diseases through prevention and treatment and 
promote mental health and well-being” (Target 3.4).17 
(b) Implementing “best buys” for NCDs 
The WHO Global Action Plan for the Prevention and Control of NCDs 2013–2020 identified a suite of 
policy options to assist countries to meet these targets. A number of these policies are “best buys”, 
meaning that they are very cost-effective and affordable in low- and middle-income countries.18 As 
Table 12.1 illustrates, the implementation of priority actions for the prevention and control of NCDs 
may require fiscal policies by governments (e.g. raising taxes) or new legislation or regulations that 
prescribe standards, mandate required actions and authorize government agencies to carry out 
monitoring and enforcement.19 Specific legal strategies for reducing tobacco use and obesity are 
discussed in Chapters 13 and 16 of this report. 
Fully implementing the legal and regulatory priorities included in Table 12.1 is likely to be 
challenging in some countries, due to the political influence of tobacco, alcohol and processed food 
manufacturers and retailers. In order to secure the passage of the laws, policies and budgets that are 
needed, high-level leadership will be needed from presidents, prime ministers, health ministers and 
other political leaders.20 While leadership within the health ministry will be vital, the involvement of 
other ministries is also necessary, since many of the priority interventions will be implemented 
outside the health sector. Governance processes will be required to coordinate the work of all 
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relevant ministries, including health, agriculture, finance and taxation, education, recreation and 
sport, media and communications, transport and urban planning. Coordinating mechanisms are 
necessary to mediate tensions between ministries and to ensure that all ministries work 
constructively towards common goals (see Section 6.3).21 
Table 12.1 Selected legal and regulatory priorities for reducing risk factors for NCDs22 
(Best Buy = ) 
Tobacco 
Comprehensive implementation of the WHO Framework Convention on Tobacco Control (WHO 
FCTC),23 especially: 
● Reducing the affordability of tobacco products by increasing tobacco excise taxes (WHO FCTC, 
Article 6)  
● Banning smoking in in public places, including workplaces, public transport, bars and restaurants 
(WHO FCTC, Article 8)  
● Health warnings on tobacco products, and at point of sale; labelling controls (WHO FCTC, Articles 
11 and 12)  
● Comprehensive bans on all forms of tobacco advertising, promotion and sponsorship, including 
in all media, in community settings, and in retail establishments (WHO FCTC, Article 13)  
● Bans on sales of tobacco by and to persons under the age of 18 years, or the age set by domestic 
law, with monitoring and enforcement (WHO FCTC, Article 16) 
● Penalties for smuggled and counterfeit tobacco, with adequate resources for monitoring and 
enforcement (WHO FCTC, Article 15; Protocol to Eliminate Illicit Trade in Tobacco Products)i 
● Affordable treatment for tobacco dependence: supporting interventions for smoking cessation in 
primary care; affordable pharmacological therapies (WHO FCTC Article 14) 
Alcohol 
Implementation of the WHO Global Strategy to Reduce the Harmful Use of Alcohol,24 especially: 
● Increasing excise taxes on alcoholic beverages (paras 32–34)  
● Strengthening tracking systems for illicit alcohol, with penalties for smuggled and informal 
alcohol, and adequate resources for monitoring and enforcement (paras 37–39) 
● Restricting or banning alcohol advertising and promotion through the media, including social 
media, in community settings and retail establishments; restrictions on alcohol sponsorship of 
cultural and sporting events (paras 29–31)  
● Controls on access to retailed alcohol, including minimum age purchasing laws, licensing and 
other controls on days and hours of retail sale, location and density of retail outlets (paras 27–28) 
 
● Health warnings on alcohol products and at point of sale; enforce laws against serving to 
intoxication, and legal liability for harm that results from intoxication following the service of 
alcohol (paras 19 and 36) 
● Drink-driving counter-measures, including random breath testing, a maximum 0.5 g/l blood 
alcohol concentration limit for adult drivers, with a reduced or zero limit for younger drivers 
(paras 24–26) 
i The Protocol was adopted on 12 November 2012 at the fifth session of the Conference of the Parties to the 
WHO FCTC, but at the time of writing had not yet entered into force. 
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Diet, and 
physical 
activity 
Building on the WHO Global Strategy on Diet, Physical Activity and Health:25 
● Institutional and governance reform to enable development of a comprehensive and 
multisectoral approach to policy development for diet, nutrition and physical activity, with input 
from key sectors (agriculture, transport, education, environmental and urban planning, sport, 
youth, industry, finance, and media and communications). City and local governments should have 
a legal mandate to play a leading role (paras 38–44) 
● Review agricultural policies to ensure they contribute to a healthy and sustainable food supply  
(para. 41) 
● Encourage or require food reformulation in order to reduce levels of salt , saturated fat and 
added sugar (para. 41) 
● Requiring food manufacturers to replace trans-fats with polyunsaturated fats (para. 41)  
● Place restrictions on the marketing of foods and beverages high in salt, sugar and fats (especially 
to children): WHO, resolution WHA 63.14 (adopted in May 2010) on marketing of foods and non-
alcoholic beverages to children) 
● Implement a framework for food labelling and health claims on food products to support healthy 
choices and to prevent misleading claims about food (para. 40) 
● Manage food taxes and subsidies to encourage a healthy diet; for example, by imposing higher 
taxes for foods and beverages to be consumed in lower quantities, and consider using revenues to 
support greater access to healthy foods among disadvantaged communities (para. 41) 
● Legislation to protect women’s right to breastfeed, without harassment or discrimination 
Other 
strategies 
● Hepatitis B vaccination 
(c) Engaging with the private sector 
The implementation of legal and regulatory priorities for NCDs will necessarily affect the interests of 
the private sector, including manufacturers and retailers of tobacco products, alcoholic beverages, 
and nutritionally-poor foods and beverages. As discussed in Section 13.6, Article 5.3 of the 
Framework Convention on Tobacco Control (WHO FCTC) requires parties to protect the setting and 
implementation of their tobacco control policies from the commercial and vested interests of the 
tobacco industry.26 The Conference of the Parties to the WHO FCTC has issued guidelines to assist 
parties to implement their recommendations under Article 5.3.27 
Similarly, in light of evidence that the alcohol industry seeks to use partnerships to weaken national 
policies for alcohol control,28 WHO has emphasized that “the development of alcohol policies is the 
sole prerogative of national authorities”29 and that governments should take care to “protect the 
formulation of health policies from distortion by commercial or vested interests”.30 
In some countries, food manufacturers, retailers, government and public health stakeholders are 
engaged in voluntary partnerships to reformulate food products and to reduce levels of salt, 
saturated fat and sugar over time.31 In circumstances where voluntary processes fail to make timely 
progress towards public health goals and targets, governments may consider adopting a responsive 
regulatory approach that includes strengthening their level of oversight of the industry, “scaffolding” 
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voluntary processes with formal targets, or supplementing voluntary standards with legislation (see 
Section 2.1(c)).32 
(d) Supporting health promotion 
Health promotion campaigns to build adult literacy and public awareness about healthy behaviours 
are an important component of a comprehensive response to NCDs and their risk factors. The right 
to health imposes a duty on states to disseminate “appropriate information relating to healthy 
lifestyles and nutrition, harmful traditional practices and the availability of services”, and to support 
people in making informed choices about their health.33 Similarly, the WHO Global Strategy on Diet, 
Physical Activity and Health encourages governments to develop national dietary and physical 
activity guidelines and to ensure the availability of health promotion and education programmes.34 
Evidence-based recommendations include the following: 
• limit energy intake from total fats and shift fat consumption away from saturated fats to 
unsaturated fats and towards the elimination of trans-fatty acids; 
• increase the consumption of fruits and vegetables, and legumes, whole grains and nuts; 
• limit the intake of free sugars; 
• limit salt (sodium) consumption from all sources and ensure that salt is iodized; and 
• engage in at least 30 minutes of regular, moderate-intensity physical activity on most days.35 
Independent agencies dedicated to health promotion can provide an important institutional base for 
national campaigns to quit smoking, reduce the harmful use of alcohol, reduce dietary risk factors 
and promote physical activity. For example, in 2007, in response to a rapidly escalating NCD crisis, 
Tonga passed legislation to establish a national Health Promotion Foundation (also known as 
TongaHealth).36 The Foundation is an independent body that works with communities, 
nongovernmental organizations and government departments to promote healthy lifestyle changes 
throughout Tonga. It acts as a catalyst for the development of new policies, programmes and 
environments, designs and conducts social marketing campaigns, and administers a competitive 
grant scheme that funds research, programmes and facilities to promote health and reduce NCD risk 
factors.37 Members of the Board of the Foundation are appointed by an appointment committee 
that consists of the Minister for Health, the Chair of the National Noncommunicable Diseases 
Committee and its sub-committees.38 The existence of an independent statutory agency may be 
helpful in ensuring that health promotion receives the budgetary resources it needs within the 
overall health portfolio. Tonga’s example has been helpful in influencing other South Pacific 
countries to establish similar agencies. 
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12.2 Discouraging behaviour that contributes  
 to injuries 
Injuries claim nearly 5 million lives each year: around 9% of global deaths. One quarter of these 
deaths are caused by road traffic injuries, the ninth leading cause of death in 2012, and the leading 
cause of death for people aged 15–29 years.39 Road traffic injuries cost low- and middle-income 
countries over US$ 100 billion annually (between 1% and 2% of gross national product), and are 
increasing in many countries due to rapid motorization coupled with the failure to invest in proven 
road safety interventions. 40 
WHO has recommended that countries develop national strategies for preventing road traffic 
injuries, and designate a single agency or focal point with responsibilities in this area. These 
responsibilities should include collaborating with other ministries and stakeholders, including 
transport companies and the community.41 Law plays an important role in improving road safety. 
Key areas for law reform may include: setting and enforcing speed limits on roads, introducing 
traffic-calming measures, introducing and enforcing offences for driving while intoxicated, 
introducing a graduated licensing system (with mandatory speed restrictions) for novice drivers, 
prohibiting drivers from using hand-held electronic devices while driving, requiring motorcycles to 
use running lights during daytime, and mandating the use of seat belts and child restraints in cars, 
and helmets by people using motorcycles and bicycles.42 In countries where alcohol use is not 
condoned, significant hidden consumption may nevertheless occur, and paradoxically there may be 
limited public awareness of the hazards of drink-driving. 
The Islamic Republic of Iran experienced a significant decline in fatal traffic accidents and injuries 
between 1997 and 2007, following the passage of a law that required the government to develop 
road safety legislation within a period of six months (see Box 12.1).43 Laws requiring the use of safety 
belts for drivers and all passengers of four wheeled vehicles save lives during traffic accidents, are 
highly cost-effective, and can be successfully implemented in rapidly motorizing low and middle-
income countries.44 
Box 12.1: Reducing the risk to health from traffic accidents: an example from the Islamic Republic 
of Iran 
Law of the Fourth Economic, Social, and Cultural Development Plan: Enhancement of Health and 
Improvement of the Quality of Life.45 
The Government is charged with preparation of a bill for protection and enhancement of health of 
the individual members of society and reduction of the risks to health, including through the 
following points, and to present the said bill to the Islamic Consultative Assembly for approval, 
within six months of enactment of this law: 
• Reducing traffic accidents, through reconnaissance of accident-generating points and axes 
along roads and highways … and reducing the number of such points by 50% by the end of 
the fourth plan. 
• Placing emphasis on the principles of safety and safe driving regulations. 
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• Regulating and completing the pre-hospital and hospital medical emergency networks of the 
country and reducing the death tolls resulting from traffic accidents by 50% by the end of 
the fourth plan. 
• Enhancing the safety plan for motor vehicles and enforcing human and safety engineering 
standards. 
In one intervention carried out in the Chinese city of Guangzhou, four strategies for reducing road 
traffic injuries were implemented over a 12-month period. These included enhanced police training, 
highly visible police patrols, as well as static, covert operations at different locations throughout the 
city and social marketing (radio and television commercials, billboards, bus signs). Courses or 
materials concerning the requirement to fit and use seat belts, and the safety benefits, were 
provided to taxi company managers, instructors in driving schools and primary school teachers. Over 
the period of the intervention, the prevalence of seat-belt use by drivers and passengers increased 
by 12%, reducing serious injuries and fatalities by 7%.46 Interventions like this are highly cost-
effective in reducing the cost of road traffic accidents in rapidly motorizing societies. 
Among motorcyclists, research shows that mandatory helmet laws are highly effective in reducing 
deaths from traffic accidents as well as non-fatal traumatic brain injury. In Viet Nam, a national 
helmet law in effect from December 2007 increased helmet use up to 99% and avoided 1557 deaths 
and 2495 serious injuries in its first year of operation (Box 12.2).47 In Romagna, Italy, hospital 
admissions for traumatic brain injury decreased by 31% in the year following introduction of the 
mandatory motorcycle helmet law.48 Experience has shown that the repealing of mandatory 
motorcycle helmet laws is associated with sharp increases in rates of motorcycle fatalities.49 
Box 12.2: Reducing death and disability from motor vehicle accidents in Viet Nam through a 
national motorcycle helmet law 
Reasons for the success of Viet Nam’s law included the following: 
• Significant penalties were set for failing to wear a helmet; 
• Public education and social marketing increased public awareness prior to the introduction 
of the new law. Civil service employees and members of the armed services wore helmets three 
months before the law took effect; 
• The law was strictly enforced from the date it came into effect; 
• The obligation imposed was simple to understand: the helmet law applied to all motorcycle 
riders and all passengers on all roads; 
• Supported by government product standards to prevent substandard products entering the 
market, high-quality, climatically appropriate helmets were widely available for sale at an 
affordable price, and 50 000 helmets were distributed to low-income families; 
• The mandatory helmet law was issued by the Prime Minister. This ensured the highest level 
of political support. A multisectoral National Traffic Safety Committee, chaired by the Minister of 
Transport, with representatives from 15 ministries, led the development and implementation of 
the law on behalf of the Vietnamese government. 
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Chapter 13: Tobacco control 
 
SUMMARY POINTS 
 
· The foundation for effective national tobacco control policies lies in comprehensive 
implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC). 
· Once it enters into force, the Protocol to Eliminate Illicit Trade in Tobacco Products could 
provide a comprehensive framework for national legislation to eliminate smuggled, counterfeit 
and illicit tobacco products that increase the accessibility and affordability of tobacco and 
undermine government revenues. 
· The Conference of the Parties to the WHO FCTC has issued detailed guidelines to assist Parties 
to implement specific provisions of the WHO FCTC in an effective, evidence-based manner. 
· In entering trade and investment agreements, countries should ensure that they do not unduly 
restrict their health sovereignty or unduly diminish their capacity to implement and enforce 
effective tobacco control measures. 
· Countries should coordinate the activities of their health, trade and finance ministries in order 
to ensure that they do not undertake trade and investment obligations that unduly conflict with 
their health goals, including their capacity to effectively regulate tobacco, alcohol and unhealthy 
food products. 
· Tax policy is a powerful instrument for raising the price and reducing the affordability of 
tobacco products. Uniformly high tobacco prices help to discourage initiation, encourage quitting, 
and reduce the amount of tobacco consumed by those who do not quit. Countries can use tobacco 
excise tax increases, applied to all brands and forms of tobacco, whether imported or locally 
produced, to achieve the public health goal of reducing the death and disease caused by tobacco 
use. 
· Other priority policies for implementing the WHO FCTC at national level include large, text-
based and graphic health warnings on tobacco packages, comprehensive bans on all advertising, 
promotion and sponsorship of tobacco products, and legislative measures to ensure protection 
from exposure to tobacco smoke, including in all workplaces, public transport and indoor public 
places. 
· The interests of the tobacco industry are in irreconcilable conflict with public health. 
Governments should limit their interaction with the tobacco industry, ensure that any interactions 
that do occur are transparent, avoid conflicts of interest and ensure that the industry is excluded 
from law reform and law-making processes. 
Introduction 
There are currently around 1.3 billion smokers in the world, mostly living in low- and middle-income 
countries. Unless they quit, up to half of them will die prematurely from tobacco-related diseases, 
including lung cancer, heart disease and stroke and chronic obstructive pulmonary disease.1 Tobacco 
killed 100 million people during the twentieth century, and currently causes around 6 million deaths 
each year, including over 600 000 deaths among non-smokers that are attributable to exposure to 
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second-hand tobacco smoke.2 Globally, tobacco is responsible for 12% of all male deaths and 6% of 
all female deaths.3 Due to population growth, and the aggressive marketing activities of tobacco 
companies, tobacco-related deaths are projected to increase, rising from 6 million deaths to around 
12 million deaths per year for the period 2025–2050.4 
13.1 Global tobacco control 
(a) The Framework Convention on Tobacco Control 
Tobacco use is an “industrially created epidemic” that is sustained by the activities of the tobacco 
industry.5 The burden of death and disease caused by tobacco is preventable, but preventing them 
requires governments to honour their commitments to implement evidence-based and cost-
effective legal measures to regulate the tobacco industry.6 The foundation for effective national 
tobacco control policies lies in comprehensive implementation of the WHO Framework Convention 
on Tobacco Control (WHO FCTC).7 The WHO FCTC was adopted by the World Health Assembly in 
2003 and entered into force in 2005. It requires Parties to implement measures to reduce both 
demand for, and supply of, tobacco products (Box 13.1). The Conference of the Parties to the WHO 
FCTC has issued detailed guidelines to assist Parties to implement specific provisions of the 
Convention in an effective and evidence-based manner.8 Under Article 2.1, Parties are encouraged 
to implement tobacco control measures that go beyond the requirements of the Convention and its 
protocols and that are consistent with international law.9 
In many countries, significant law reform efforts are still needed in order to fully implement the 
provisions of the WHO FCTC. For example, in 2015, 103 countries (and nearly 2.8 billion people) 
were fully covered by at least one or more tobacco control measures as recommended by WHO in 
the MPOWER package of recommendations for countries implementing the WHO FCTC. These 
measures include tobacco taxes, tobacco advertising bans, warning labels and smoke-free controls. 
Nevertheless, only 49 countries (with 20% of the global population) were covered by two or more 
such measures.10 
Box 13.1: Using public health law to reduce supply of and demand for tobacco: the WHO 
Framework Convention on Tobacco Control 
Supply reduction provisions: 
• Enact legislation to reduce illicit trade in tobacco products (including for offences in relation 
to counterfeit and contraband cigarette and authorizing seizure of illicit tobacco and of 
proceeds derived from commerce in illicit tobacco products) (Article 15). 
• Implement legislative or other measures to prevent sales of tobacco to and by minors. These 
measures may include: prohibiting the manufacture and sale of sweets or other objects in 
the form of tobacco products that may appeal to minors, prohibiting the distribution of free 
tobacco products to the public, prohibiting the sale of cigarettes individually or in small 
packets, ensuring that tobacco vending machines are not accessible to minors, and banning 
the sale of tobacco products in ways that make them directly accessible to members of the 
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public (Article 16). 
• Provide support for economically viable alternative activities for tobacco workers, growers, 
and sellers (Article 17). 
• Demand reduction provisions: 
• Adopt tax and/or price policies aimed at reducing consumption of tobacco (including 
restrictions on tax- and duty-free tobacco products) (Article 6). 
• Ban smoking in indoor workplaces, public transport, indoor public places, and as 
appropriate, other public places (Article 8). 
• Adopt measures for the testing, measuring and regulation of the contents and emissions of 
tobacco products (Article 9). 
• Require tobacco manufacturers and importers to disclose to governmental authorities 
information about the contents and emissions of tobacco products. Implement measures for 
the public disclosure of information about the toxic constituents of tobacco products, and 
the emissions they produce (Article 10). 
• Prohibit false, misleading and deceptive labelling and advertising of tobacco products, 
including descriptors, trademarks or other signs suggesting that a particular product is less 
harmful than others (e.g. labelling products as “low tar”, “light”, “ultra-light”, or “mild”) 
(Article 11.1(a)). 
• Require each tobacco package to include clearly visible and rotating warnings about the 
harmful effects of tobacco use, approved by a competent national authority. Warnings 
should cover 50% or more of the principal display areas, but shall be no less than 30% of the 
principal display areas (Article 11.1(b)). 
• Implement public awareness campaigns to promote access to information regarding the 
addictive nature of tobacco use, the health effects of smoking and of second-hand smoke, 
the benefits of tobacco cessation, and the economic and environmental consequences of 
tobacco production and consumption (Article 12). 
• To the extent permitted by each country’s constitution, ban or restrict all tobacco 
advertising, promotion, and sponsorship. Subject to the legal environment and technical 
means available to each Party, this shall include a comprehensive ban on cross-border 
advertising, promotion and sponsorship of tobacco originating from its territory (Article 13). 
• Promote cessation of tobacco consumption and treatment for tobacco dependence. This 
shall include the diagnosis and treatment of tobacco dependence within national health and 
education programmes (Article 14). 
Some countries, particularly those with limited capacity, may find that the most rapid way to make 
progress in combating the tobacco epidemic is to prioritize the implementation of their obligations 
under the WHO FCTC in a stepwise manner. WHO’s MPOWER package11 is not a substitute for the 
obligations that countries have assumed under the WHO FCTC. However, it may assist Parties to 
prioritize their actions towards full implement the WHO FCTC by identifying six priority areas for 
policy action and by explaining their rationale and evidence base. These six areas are: 
1. monitor tobacco use and prevention policies; 
2. protect from tobacco use; 
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3. offer help to quit tobacco use; 
4. warn about the dangers of tobacco; 
5. enforce bans on tobacco advertising and sponsorship; and 
6. raise taxes on tobacco. 
In 2012, Turkey became the first country in the world to protect its entire population with all six of 
the MPOWER measures implemented at the highest level of achievement.12 After ratifying the WHO 
FCTC in 2004, the Ministry of Health formed a National Tobacco Control Committee to prepare a 
national implementation plan. Between 2008 and 2012, larger, pictorial warning labels were 
introduced on tobacco packs, taxes on tobacco increased to in excess of 80% of the retail price, a 
total ban on all tobacco advertising, promotion and sponsorship was implemented, and smoke-free 
laws were strengthened to cover restaurants, bars and cafés.13 During this four-year period, smoking 
rates fell from 30.1% to 25.7% – a reduction of 14.6%.14 Turkey’s achievement illustrates how rapid 
changes are possible through sustained political commitment to implementing the core obligations 
of the WHO FCTC. 
The comprehensive tobacco control law passed in 2013 by the Russian Federation illustrates the kind 
of urgent action still needed in many countries.15 The law established smoke-free environments in 
medical, educational, sports and cultural facilities, government buildings, public playgrounds, 
beaches, apartment stairwells, airports and public transportation. From June 2014, smoking bans 
were extended to cover hospitality venues including hotels, cafés, bars and restaurants.16 The retail 
sale of tobacco products is also banned in many of these places.17 The law bans retail cigarette 
displays and prevents retailers from displaying price lists containing colours or logos.18 Television 
programmes and movies depicting smoking must also broadcast a public service announcement 
warning viewers about the health risks of smoking.19 
During the period of economic transition that occurred in the Russian Federation between 1990 and 
2000, cigarette consumption increased by 81%.20 The Global Adult Tobacco Survey, conducted in 
2008–2010, found that 40% of Russians smoke, including 60% of Russian males, giving Russia the 
highest smoking rates in Europe.21 Russia’s comprehensive approach could dramatically reduce the 
future burden of tobacco-related disease, and provide an important model for other countries to 
follow. 
A major obstacle to the implementation of effective tobacco control laws at national level is the 
influence and activities of transnational tobacco companies.22 As discussed below, two of the major 
strategies used by transnational tobacco companies are the use of international trade rules and 
commitments to challenge national tobacco control laws and to gain access to markets, and the use 
of smuggling and other forms of illicit trade in tobacco products.23 Like all forms of illicit tobacco 
trade, smuggling reduces government revenues from the taxing of legitimately produced and 
imported products. By reducing government revenues, illicit trade in tobacco may also undermine 
spending on social programmes, including tobacco control programmes.24 
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(b) The Protocol to Eliminate Illicit Trade in Tobacco Products 
In 2007, the Conference of the Parties to the FCTC established an Intergovernmental Negotiating 
Body to negotiate a protocol on illicit trade in tobacco products.25 Following several years of 
negotiations, the Protocol to Eliminate Illicit Trade in Tobacco Products was adopted by the Parties 
to the WHO FCTC in 2012. The Protocol aims to eliminate all forms of unlawful activity relating to the 
production, shipment, receipt, possession, distribution, sale or purchase of tobacco products.26 The 
Protocol requires ratification or formal acceptance by 40 Parties before it enters into force.27 
Illicit production and smuggling of tobacco products encourage tobacco use and undermine public 
health policies by reducing prices and increasing access. In turn, lower prices encourage smoking 
initiation and higher levels of tobacco consumption, particularly among young people, the poor and 
low-income groups.28 Illicit trade in tobacco deprives governments of taxation revenues, while also 
undermining tobacco control laws and policies such as large pictorial warnings and retail controls. 
The smuggling of tobacco may also threaten national security by providing a lucrative source of 
income for criminal groups, providing financing for terrorist acts and by facilitating other forms of 
criminal activity such as money laundering and smuggling of weapons, drugs and counterfeit 
goods.29 
The key provisions of the Protocol require Parties to take measures to improve their control of the 
tobacco supply chain. The Protocol requires Parties to prohibit the manufacture, import or export of 
tobacco products and manufacturing equipment except in accordance with a licence granted by a 
national authority.30 To the extent that it is appropriate, Parties must also licence persons engaged 
in growing, wholesaling, warehousing, distribution and retailing tobacco products and 
manufacturing equipment. Parties must establish a designated national authority to administer 
tobacco licences,31 and within five years must establish a tracking and tracing system to permit 
Parties to trace the origin, movement and legal status of all tobacco products within their territory.32 
National and regional tracking systems provide the basis for a global tracking and tracing regime and 
global information-sharing focal point (located at the Secretariat of the WHO FCTC) which Parties 
have agreed to establish within the same five-year period. The obligations of Parties to establish a 
national tracking system must not be delegated to the tobacco industry, although Parties may 
require the industry to bear the costs of its administration.33 The Protocol requires each Party to 
consider banning retail sales of tobacco products over the Internet or using telecommunications 
devices.34 In some countries, including the United States, legislation restricts the retail sale of 
tobacco through the mail, since mail-order sales may evade excise taxes and make it easier for 
children and adolescents to purchase tobacco.35 
(c) World Trade Organization agreements and domestic tobacco control laws 
In many countries, the implementation of obligations under the FCTC takes place against the 
backdrop of the obligations they have assumed as members of the World Trade Organization (WTO). 
WTO Agreements of potential relevance to domestic tobacco control laws include the General 
Agreement on Tariffs and Trade (GATT),36 as well as the Agreement on Technical Barriers to Trade 
(the TBT Agreement),37 and the Agreement on Trade-Related Aspects of Intellectual Property Rights 
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(TRIPS).38 In implementing all such agreements, countries should ensure that they do not unduly 
restrict their health sovereignty or unduly diminish their capacity to implement and enforce effective 
tobacco control measures. 
Trade agreements seek to foster a predictable, competitive global marketplace that eliminates 
discriminatory practices and reduces unnecessary regulatory obstacles to international trade in 
goods and services and to the global protection of intellectual property rights.39 These goals are not 
inherently opposed to the protection of public health. For example, where trade liberalization 
measures result in economic growth, this may reduce poverty and raise living standards, permitting 
higher levels of spending on health, education and social services. On the other hand, governments 
should ensure that the implementation of trade liberalization measures takes account of public 
health considerations, and that governments preserve the policy space to adopt policies that will 
best protect the health of the population.40 
Some aspects of trade agreements require particular scrutiny in terms of their potential impact on 
public health. For example, reductions in tariffs (customs duties) and the elimination of non-tariff 
barriers, such as quotas, licences and monopolies, may help to create a more contestable market for 
tobacco products, increasing the availability of global brands, reducing prices and stimulating 
demand. Complaint mechanisms in trade agreements provide opportunities for national 
governments to challenge domestic tobacco control laws in other countries, including import bans, 
labelling requirements and product regulation. Bilateral and regional investment agreements may 
also give tobacco companies the right to make complaints against national governments for harm to 
the value of their investment in a host country. Transnational tobacco companies strongly support 
trade liberalization agreements giving them greater access to developing country markets, and have 
lobbied national governments to support investor–State dispute settlement rights in regional trade 
and investment agreements.41 
In addition to defining the obligations that countries owe under international law, trade and 
investment agreements can have a broader, political function, as tools used by transnational 
tobacco companies to place pressure on national governments to weaken their domestic tobacco 
control laws. The risks are greatest for smaller countries, and for developing and least developed 
countries, which may lack the financial resources to defend complaints, or the human resources to 
provide accurate advice about the scope of global trade laws and global trade and investment 
agreements.42 Article 5.3 of the FCTC states that “In setting and implementing their public health 
policies with respect to tobacco control, Parties should act to protect these policies from commercial 
and other vested interests of the tobacco industry in accordance with national law”.43 It is clear from 
this article that the tobacco industry is not a trustworthy or reliable source of information for 
governments about the scope of their obligations under the FCTC, under WTO Agreements or any 
other trade or investment agreement.44 
WTO Agreements impose several different kinds of obligations on WTO members. Firstly, under the 
GATT, WTO members must not impose customs duties that exceed the “bound” tariff rates set out 
in each member’s GATT schedule.45 The aspiration of the WTO system is for countries to eliminate 
non-tariff barriers, and to progressively lower their tariff barriers.46 Although lower tariffs may result 
in cheaper tobacco imports, greater competition and increased domestic consumption, national 
authorities are not precluded from raising taxes on both imported and domestic tobacco products in 
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order to counter this effect. On the other hand, since the WTO Agreements prohibit the 
discriminatory treatment of imports, the risk remains that high domestic tax rates applied equally to 
both imported and domestic goods will be difficult to achieve in political terms.47 Thailand’s 
remarkable achievement in progressively raising tobacco taxes until they reached 71.5% of retail 
price in 1999 was an important factor in enabling it to reduce smoking rates, despite an adverse 
WTO ruling in 1990 that required it to wind back its government monopoly on tobacco and to permit 
tobacco imports.48 
Secondly, a core principle underlying the WTO Agreements is trade without discrimination.49 WTO 
members are prohibited from adopting laws and policies that have the effect of treating imported 
goods less favourably than “like” domestically produced goods (the principle of national treatment), 
and from discriminating between “like” goods imported from third countries (principle of most 
favoured nation treatment). These principles are reflected in Articles I and III of the GATT,50 which 
applies to international trade in tobacco products, and in Article 2.1 of the TBT Agreement),51 which 
applies to tobacco product requirements, such as tobacco packaging and labelling requirements, and 
restrictions on flavoured tobacco products.52 
In circumstances where a WTO member’s tobacco control laws are considered to have a 
discriminatory effect, that member may nevertheless seek to justify them on the basis of Article 
XX(b) of GATT, which provides an exception for measures that are “necessary to protect human, 
animal or plant life or health”. Article XX(b) provides that such measures must not be applied in a 
manner that constitutes unjustifiable discrimination between countries, or a disguised restriction on 
international trade.53 
In contrast to GATT, there is no human health exception for measures that are considered to be in 
breach of the principles of national treatment and most favoured nation treatment under Article 2.1 
of the TBT Agreement. However, in the United States – Clove Cigarettes case, the Appellate Body 
drew attention to the sixth recital to the TBT Agreement, which recognizes that no country should 
be prevented from taking measures necessary “for the protection of human, animal or plant life or 
health, of the environment or for the prevention of deceptive practices, at the levels it considers 
appropriate”, provided that they are not applied in a way that constitutes discrimination or are a 
disguised restriction on international trade.54 A tobacco control measure that has a negative impact 
on the competitive opportunities for tobacco exports of another member is not, for that reason, 
prohibited, provided that the detrimental impact “stems exclusively from a legitimate regulatory 
distinction”.55 
Thirdly, Article 2.2 of the TBT Agreement requires WTO members to ensure that their technical 
domestic regulations do not have the effect of creating “unnecessary obstacles to trade”.56 Article 
2.2 clarifies this obligation by stating that “technical regulations shall not be more trade-restrictive 
than necessary to fulfil a legitimate objective, taking account of the risks non-fulfilment would 
create”.57 Article 2.2 acknowledges that the “protection of human health or safety, animal or plant 
life or safety” is a legitimate objective that members can seek to fulfil, provided that in doing so, the 
technical regulations are not more trade-restrictive than necessary. 
Scholars working in the field of international trade regulation and health have pointed to the 
considerable degree of deference shown by WTO panels and the Appellate Body towards the 
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legitimate policy objectives of members.58 For example, in the United States – Clove Cigarettes case, 
the WTO Panel found that United States legislation banning the production and sale of clove-
flavoured cigarettes59 was not more restrictive than necessary to fulfil the legitimate objective of 
reducing youth smoking, under Article 2.2 of the TBT.60 The Panel referred to the Partial guidelines 
for implementation of Articles 9 and 10 of the WHO FCTC, which recommend that “Parties should 
regulate, by prohibiting or restricting, ingredients that may be used to increase palatability in 
tobacco products”.61 The Panel noted that these guidelines “show a growing consensus within the 
international community to strengthen tobacco control policies through regulation of the content of 
tobacco products, including additives that increase the attractiveness and palatability of 
cigarettes”.62 
On the other hand, in the same case, the Appellate Body found that by exempting menthol 
cigarettes from the legislative ban that applied to all other flavoured cigarettes, the legislation gave 
less favourable treatment to clove cigarettes imported from Indonesia than it did to American-
produced menthol cigarettes, in breach of the national treatment principle in Article 2.1.63 The 
prohibition on discriminating between different imports, and between imports and domestic goods, 
contained in both Article 2.1 of the TBT and in the GATT, applies only to “like products”. As the 
Appellate Body pointed out, the concept of “like products” “serves to define the scope of products 
that should be compared to establish whether less favourable treatment is being accorded to 
imported products”.64 According to the Appellate Body, menthol and clove cigarettes were both like 
products, since both were in a competitive relationship for the purposes of satisfying smokers’ 
addition to nicotine, and both flavourings had the capacity to mask the harshness of tobacco 
smoke.65 
As pointed out above, a tobacco control law that has a detrimental impact on the competitive 
opportunities of imported tobacco products in the marketplace will not be inconsistent with Article 
2.1 provided that this detrimental impact stems exclusively from a legitimate regulatory 
distinction.66 The regulatory purpose of legislative provisions is therefore central to determining 
what constitutes less favourable treatment under Article 2.1.67 In United States – Clove Cigarettes, 
the Appellate Body decided that the distinction drawn under the United States legislation between 
menthol and other flavourings (including cloves) could not be sustained, since both menthol and 
cloves mask the harshness of tobacco and make initiation easier for young people – factors which 
undermined the legitimacy of the exemption for menthol under this legislation. 
The immediate lesson to draw from United States – Clove Cigarettes is that national authorities 
should take care, in framing their tobacco control laws, to ensure that product bans are applied 
equally to all imported and domestic tobacco products that are considered to be “alike”. The 
broader lesson is that, as with the impact of the TRIPS Agreement on national policies for providing 
universal access to essential medicines (see Chapter 15), countries will need to increase their 
familiarity with WTO obligations in order to frame and implement their national policies effectively. 
It may be helpful to coordinate the provision of expert assistance to governments of small and low-
income countries at the regional level, including through regional organizations.  WHO and the 
Secretariat of the WHO FCTC may also be able to provide assistance to national authorities that are 
considering or drafting tobacco control laws. At the national level, countries will need to coordinate 
the activities of their health, trade and finance ministries in order to ensure that they do not 
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undertake trade and investment obligations that conflict with their health goals, including their 
capacity to effectively regulate tobacco, alcohol and unhealthy food products. 
(d) Bilateral and regional investment agreements and domestic  
tobacco control laws 
This report does not provide a technical review of key obligations under WTO Agreements, nor of 
the obligations that may arise under bilateral or multilateral trade and investment agreements.68 
Trade and investment agreements cover a wide spectrum. They include investor-State contracts (for 
example, between a country and a transnational tobacco company), customs agreements, bilateral 
investment treaties, and regional trade and investment agreements, including the Transatlantic 
Trade and Investment Partnership (under negotiation at the time of writing),69 and the Trans-Pacific 
Partnership (concluded in 2015).70 While the GATT and TBT provisions described above prohibit 
discriminatory and trade-restrictive domestic regulations that place imports at a disadvantage, 
investment agreements protect the investments of foreign investors within the host country. In 
many cases, they also give the foreign investor standing to seek compensation if a dispute arises 
under the agreement.71 
Contracts entered into between a foreign tobacco company and a host State, as well as joint 
ventures between State-owned tobacco companies and foreign investors, may cause serious harm 
to tobacco control efforts when they contain freezing and stabilization clauses that provide the 
investor with an assurance that the regulatory environment will not change within the host State, or 
that the foreign investor may be compensated if it does.72 In circumstances where tax holidays are 
given to tobacco investors, this will reduce government revenues and undermine the capacity of the 
government to support worthwhile programmes in health and other sectors. Similarly, where the 
excise rate on tobacco products is frozen for the benefit of the tobacco investor, a country will 
deprive itself of the most powerful tool that can be applied to reduce tobacco consumption – that is, 
high rates of internal taxation applied to both imported and domestically produced tobacco 
products. Guidelines adopted by COP under Article 5.3 of the WHO FCTC recommend that Parties 
should not to give preferential tax treatment or other privileges to the tobacco industry, and should 
treat State-owned tobacco companies no differently to other members of the tobacco industry.73 
In addition to non-discrimination, international investment agreements typically require the host 
State to provide fair and equitable treatment to the investor, and to protect the investor against 
measures that effectively expropriate their investment. Recent challenges brought by tobacco 
companies under bilateral investment agreements illustrate how these agreements may be used as 
a weapon to resist implementation of the WHO FCTC and effective tobacco control laws. For 
example, in 2012, Philip Morris Asia brought a claim against Australia arguing that Australia’s 
tobacco plain packaging legislation represented an expropriation of its investment in Australia.74 In 
2015, this claim was unanimously dismissed.75 In 2010, Philip Morris companies began a claim for 
US$ 25 million compensation under its bilateral investment agreement with Uruguay.76 Uruguay’s 
legislation prevents the use of “brand families” as a marketing tool by restricting tobacco brands to 
one variant only, and requires health warnings to cover 80% of the front and back of the pack.77 
Although foreign investment may assist a country with its economic development, there is no health 
benefit in reducing the cost of tobacco products, less still in giving transnational tobacco companies 
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the right to seek compensation for the economic impacts of laws and policies that are designed to 
reduce tobacco consumption within that country. Scholars have pointed to a range of mechanisms 
that could be adopted by countries involved in the negotiation of trade and investment agreements 
in order to protect the policy space of governments seeking to implement the right to health. These 
include excluding tobacco products from all trade and investment agreements, or recognizing clear 
exceptions for measures that seek to protect human life and health.78 Other options include side 
letters acknowledging a shared understanding that certain measures shall not constitute a breach of 
the agreement. 
13.2 Pricing and taxation 
This report now turns to consider core obligations under the WHO FCTC whose implementation into 
domestic law will usually require legislation, executive orders and other forms of legal regulation. 
The WHO FCTC recognizes that tax and price measures are a powerful, cost-effective tool for 
reducing tobacco consumption, particularly among young people.79 Article 6 of the WHO FCTC calls 
on Parties to implement tax policies (and where appropriate, pricing policies) in order to reduce 
tobacco consumption, and to prohibit or restrict the availability of tax- and duty-free tobacco 
products.80 
Uniformly high tobacco prices achieved through high specific excise taxes, based on weight or 
amount of tobacco, help to prevent tobacco initiation, encourage quitting (rather than switching to 
cheaper brands), and to reduce the amount of tobacco consumed by those who do not quit.81 Excise 
taxes should be applied equally to the tobacco in all brands and forms of tobacco, whether imported 
or domestically produced. Low specific excise taxes in low-income countries are a substantial reason 
for the significant price differences between tobacco products in many low- and high-income 
countries.82 In addition, rapid economic growth and rising incomes have also contributed to an 
increase in the relative affordability of tobacco products in many low- and middle-income 
countries.83 Excise taxes should take account of inflation; for example, in Australia, the federal excise 
on tobacco is adjusted twice each year in line with average weekly earnings.84 An excise tax that 
comprises at least 70% of the retail price is a useful benchmark for countries where excise taxes are 
currently much lower; in addition to saving lives, and reducing the burden on national health 
systems, this benchmark will generate substantial tax revenues that governments may use to fund 
tobacco control and other health programmes.85 
The reduction in tobacco consumption that results from higher tobacco prices affects populations 
differently depending on their income levels. In high-income countries, evidence suggests that a 10% 
increase in the price of tobacco results in an average reduction in tobacco consumption of around 
4%.86 In low- and middle-income countries, the reduction in demand is significantly higher. WHO has 
published guidance to assist countries to develop effective and efficient tobacco taxation policies.87 
In low-income populations, tobacco consumption entrenches poverty and undermines health in 
other ways; for example, by diverting spending from necessities like food, education and health 
care.88 For example, in Indonesia, households with smokers spend an average 11.5% of household 
expenditure on tobacco, compared with 2.3% on health, 3.2% on education, and 11% on meat, fish, 
eggs and milk.89 There is evidence that low-income smokers, and youth smokers, are more price 
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sensitive and more likely to quit or to reduce their level of consumption when tobacco becomes 
more expensive. Reducing the relative affordability of tobacco products may therefore be an 
important way of reducing health inequalities between higher and lower income groups within a 
country.90 
Some countries have passed laws that dedicate a proportion of tobacco tax revenues to smoking 
cessation programmes, or to health and welfare programmes targeting low-income groups.91 By 
ensuring sustainable funding for health and social welfare programmes, governments may find that 
tobacco taxes receive a higher level of public support.92 To ensure that their impact is not eroded 
over time, governments should create a legislative mechanism to adjust excise taxes upwards to 
keep pace with inflation and real income growth. As discussed Section 13.1(d), entering into 
agreements with tobacco manufacturers or other entities to limit tax increases for imported or 
domestically produced tobacco products harms tobacco control efforts by undermining the most 
powerful tool in tobacco control: increasing the retail price of tobacco products. 
13.3 Labelling and packaging of tobacco products 
High rates of tobacco use are partly a result of lack of knowledge about the addictive nature and 
health risks of tobacco use. In China, for example, fewer than one out of every four adults are aware 
that tobacco use can cause stroke, heart disease and cancer.93 Prominent health warnings on 
tobacco packages are an important tool for communicating the specific risks of tobacco use which – 
in combination with other measures to reduce tobacco consumption – can encourage quitting.94 
Article 11 of the WHO FCTC requires Parties to implement laws to ensure that tobacco labelling is 
not false, misleading or deceptive. For example, for many decades tobacco companies have 
manufactured and advertised tobacco brands that are described as “light”, “mild”, and “low tar”, 
despite knowing that these products are no less harmful than regular products.95 Many smokers 
persist with the false belief that “light” cigarettes are less likely to cause them harm.96 Evidence also 
indicates that smokers of “light” cigarettes are less likely to quit.97 
Article 11 of the WHO FCTC requires Parties to implement effective measures to ensure that all 
tobacco products and packages carry health warnings describing the harmful effects of tobacco use. 
These warnings should cover 50% or more (and must cover 30%) of the principal display areas of 
each tobacco package. Guidelines for the implementation of Article 11 urge Parties to the WHO FCTC 
to use colour pictorial warnings to emphasize text-based warnings and to rotate health warnings 
periodically to ensure that their impact does not diminish over time.98 Furthermore, as experience in 
New Zealand illustrates, pictorial warnings should be culturally appropriate and should reflect the 
different concerns of smoker subgroups, as well as being well integrated into mass media 
campaigns.99  
The guidelines on Article 11 also recommend that Parties adopt “plain tobacco packaging” measures 
that restrict the use of trademarks, logos, brand colours and images, other than brand and product 
names in a standard colour and font.100 In 2011, Australia became the first country to pass plain 
tobacco packaging legislation embodying these characteristics,101 followed by the United Kingdom102 
and Ireland103 in 2015. In 2016, the Court of Justice of the European Communities upheld the right of 
Member States of the European Union to pass plain packaging laws that exceed the requirements 
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for the standardization of tobacco packaging contained in the European tobacco products 
directive.104 These requirements include mandatory health warnings, comprising text and colour 
photographs, covering 65% of the back and front of tobacco packages.105 Studies published since the 
introduction of Australia’s plain tobacco packaging legislation illustrate that these restrictions are 
not only associated with lower smoking appeal and more frequent thoughts about quitting,106 but 
also with more frequent requests for quitting assistance. For example, in Australia, one study 
reported a 78% relative increase in requests for quitting assistance four weeks after the new 
legislation took effect. This increase in requests for quitting assistance persisted over a significant 
period of time (43 weeks).107 Another study found that one year after implementation, there was no 
evidence of the catastrophic, unintended consequences predicted by the tobacco industry, including 
a rise in the use of unbranded, illicit or contraband tobacco.108 
13.4 Advertising, promotion and sponsorship 
Comprehensive bans on tobacco advertising can significantly reduce demand. Article 13 of the WHO 
FCTC requires Parties to implement a comprehensive ban on all forms of tobacco advertising, 
promotion and sponsorship, to the extent that this is possible under their national constitutions.109 
Article 13 emphasizes that this includes “a comprehensive ban on cross-border advertising, 
promotion and sponsorship” originating from the territory of each Party. 110 Parties must implement 
these requirements through appropriate legislative, executive or administrative measures within five 
years. Guidelines for the implementation of Article 13 emphasize that a comprehensive ban on 
advertising, promotion and sponsorship would extend not only to traditional forms of media, such as 
television, radio and print media, but to digital technologies (such as mobile phones and other 
devices connected to the Internet), and to advertising in cinemas prior to feature films.111 Such a ban 
would also extend to all forms of commercial communication and to all forms of contribution to 
individuals, activities and events that have the aim or likely effect of promoting tobacco products or 
tobacco use112 (Box 13.2). 
A comprehensive ban on tobacco advertising should include a ban on all retail advertising of tobacco 
products, including cigarette pack displays at point of sale, since these stimulate unplanned 
purchases, especially among smokers who are those trying to quit.113 The Guidelines for the 
implementation of Article 13 state that Parties to the WHO FCTC should only permit “the textual 
listing of products and their prices” at points of sale, “without any promotional elements”.114 They 
also state that a comprehensive ban, as required by Article 13, should include a ban on both 
incoming and outgoing forms of tobacco-related advertising, promotion and sponsorship that cross 
the borders of a Party to the Convention.115 One benefit of implementing a comprehensive ban on all 
tobacco advertising and promotion is that it reduces the influence of the tobacco industry over the 
media, and over entertainment, cultural and sporting organizations which would otherwise become 
proxies for the tobacco industry in resisting other tobacco control laws and policies.116 
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Box 13.2: Key features of a comprehensive ban on tobacco advertising, promotion and 
sponsorship under Article 13 of the WHO Framework Convention on Tobacco Control 
A comprehensive ban on tobacco advertising, promotion and sponsorship would apply to: 
• All kinds of tobacco products, as well as tobacco use generally; 
• Any tobacco brand names, trademarks, logos, and all other corporate promotion of tobacco 
manufacturers and tobacco businesses; 
• All forms of media advertising, regardless of the medium involved (including online 
interactive marketing), as well as retail sales promotions, direct marketing, billboard 
advertising, and public relations; 
• All forms of contribution and financial support to events, activities, individuals and 
organizations where the aim or likely effect is to promote tobacco use, tobacco products or 
tobacco businesses either directly or indirectly; 
• Cross-border advertising, that is, tobacco-related advertising, promotion and sponsorship 
that enters into, or which originates from, a country’s territory; 
• Any person or organization who is involved in producing, placing, organizing or 
disseminating tobacco advertising, promotion and sponsorship; 
• Entities responsible for tobacco advertising, promotion and sponsorship should be defined 
widely in order to cover the entire marketing chain. 
• In addition, the ban should extend to retail tobacco displays, vending machines, and to 
Internet sales of tobacco products. 
• Parties should consider plain tobacco packaging requirements that suppress the advertising 
of brand logos and design elements. 
• Promotion to the public of activities undertaken as part of “corporate social responsibility” 
programmes by tobacco companies should be prohibited. Financial contributions made by 
tobacco companies to community, welfare and arts organizations should also be prohibited. 
• Legislation should not include any list of prohibited activities which is understood to be 
exhaustive. 
• A comprehensive ban must be supported by public education programmes, and effective 
monitoring, enforcement, and penalties for breach. 
In some countries, the majority of spending on tobacco advertising and promotion takes the form of 
price discounts paid by tobacco manufacturers to create incentives for retailers to stock their 
brands, to lower the retail price of specific brands, and to stimulate competition based on price.117 
For example, in the United States, in 2013, US$ 7.6 billion (more than 85% of total tobacco 
advertising expenditures in that year) were spent on various kinds of incentive payments to 
wholesalers and retailers.118 Evidence suggests that these payments may cushion the impact of price 
rises on price-sensitive adolescents, resulting in higher rates of initiation to regular smoking.119 
Legislative responses to these forms of tobacco promotion and price manipulation include 
Page | 204  Advancing the right to health: the vital role of law 
 
mandatory reporting of all advertising and promotional payments by tobacco companies, bans on 
wholesale and retail price discounting, and minimum price laws that prohibit retailers from selling 
below a statutory minimum.120 In addition, WHO has recommended prohibiting tobacco 
manufacturers or retailers from claiming these payments as business tax deductions.121 
In many countries, smoking remains common in high-grossing movies and in popular television 
programmes.122 Smoking in films and interactive games, and the promotion of tobacco products 
through entertainment products has a powerful impact on young people.123 Guidelines for the 
implementation of Article 13 recommend that Parties prohibit the depiction of tobacco brand 
images in entertainment products and require entities involved in the production or distribution of 
those products to certify that no money, gifts, interest-free loans or other assistance have been 
given in exchange for this form of publicity.124 The guidelines recommend that Parties implement a 
classification or ratings system that takes account of tobacco use, and requires the display of anti-
tobacco advertisements at the beginning of any entertainment product that depicts tobacco 
products or tobacco use.125 In 2012, India implemented regulations that make television 
broadcasters and cinema and theatre owners responsible for broadcasting anti-tobacco messages to 
counteract the depiction of smoking and other forms of tobacco use in films and television 
programmes.126 These requirements are summarized in Box 13.3. 
Box 13.3: India’s law to counteract the depiction of tobacco use in films and television 
programmes127 
“Old” films and television programmes: 
• Since 2012, Indian regulations require 30-second anti-tobacco messages to be screened at 
the beginning and during the middle of all “old” films and television programmes that 
display tobacco products. An old film or television programme refers to a film that was 
certified or a television programme that was produced before the regulation took effect. 
• In the case of television programmes, a health warning must also be displayed at the bottom 
of the screen during the period that tobacco products are visible. 
• The anti-tobacco messages and health warnings must be in the same language used in the 
film or television programme (in the case of dubbed or subtitled programmes, the language 
of dubbing or subtitle). This language requirement applies to both new and old films and 
programmes. 
• Penalties for failure to comply with these requirements may include the suspension or 
cancellation of the licence of the broadcaster or cinema owner. 
“New” films and television programmes: 
• A 30-second anti-tobacco message must also be screened at the beginning and during the 
middle of all new films and television programme that display tobacco products or show 
them being used. 
• A health warning must also be displayed at the bottom of the screen during the period that 
tobacco products are visible in all new films and television programmes. 
• An audiovisual disclaimer warning of the harms caused by tobacco use (with a minimum 
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duration of 20 seconds) must be shown at the beginning and during the middle of all new 
films and television programmes that display tobacco products or their use. 
• New films that do not meet these requirements may not be certified for public exhibition. 
• Failure to comply with these requirements may result in cancellation or suspension of the 
licence of the broadcaster or cinema owner. 
13.5 Second-hand tobacco smoke 
Article 8 of the WHO FCTC requires Parties to implement legislative, executive and administrative 
measures that provide protection from exposure to tobacco smoke in “indoor workplaces, all public 
transport, indoor public places and, as appropriate, other public places”.128 Reducing exposure to 
second-hand tobacco smoke benefits health in many ways, such as by significantly reducing tobacco 
consumption129 and by reducing the likelihood that young people will progress to established 
smoking.130 For example, the Turkish Tobacco and Alcohol Market Regulatory Agency reported that 
tobacco sales fell by 16% in the year following the implementation of Turkey’s indoor smoking ban in 
2009.131 Smoke-free legislation is also associated with significant reductions in hospital admissions 
for myocardial infarction precipitated by exposure to tobacco smoke,132 and with significant 
reductions in both premature birth and paediatric hospital admissions for asthma.133 The obligation 
to provide protection from tobacco smoke is grounded in fundamental human rights and 
freedoms.134 Failure to provide protection from exposure to tobacco smoke not only undermines the 
right to health, but may violate a range of other human rights obligations that, in many countries, 
are enforceable by individuals through the courts.135 
The Guidelines for implementation of Article 8, adopted by the COP, confirm that there is no safe 
level or threshold value for exposure to tobacco smoke.136 National laws should therefore insist on a 
complete ban on smoking in order to create 100% smoke-free environments. The guidelines 
emphasize that “ventilation, air filtration and the use of designated smoking areas (whether with 
separate ventilation systems or not), have repeatedly been shown to be ineffective and there is 
conclusive evidence ... that engineering approaches do not protect against exposure to tobacco 
smoke.137 Effective protection from second-hand tobacco smoke requires legislation, since voluntary 
smoke-free policies based on accommodation of smokers’ needs have repeatedly been shown to be 
ineffective.138 
The Guidelines for the implementation of Article 8 provide advice on the definition of key terms in 
domestic legislation implementing this Article. For example, smoking bans operating in “indoor 
public places and, as appropriate, other public places” should apply to “all places accessible to the 
public… regardless of ownership or right of access”.139 This would include schools, hospitals and 
health care establishments, restaurants, bars, shops, train and bus stations, and airports. Since even 
small levels of exposure to tobacco smoke create a risk to health, lawmakers in some States and 
provinces have implemented smoking bans on public beaches, in and around playgrounds, sporting 
facilities and picnic areas, and in cars carrying children.140 
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Contrary to claims by the tobacco industry, evidence suggests that smoke-free laws do not reduce 
business profitability.141 Compliance with smoking bans can be encouraged by imposing monetary 
fines on both individuals and businesses, although enforcement efforts should focus on the latter.142 
Over time, smoke-free laws will increasingly be enforced by public convention, as cultural norms 
change and both smokers and non-smokers develop a preference for smoke-free environments. 
Governments may also consider extending smoke-free laws to smokeless forms of tobacco, and 
electronic cigarettes, in countries where either of these are commonly used. For example, the use of 
electronic cigarettes in smoke-free environments may undermine the denormalizing effects of 
smoke-free laws, reduce quitting incentives and expose bystanders to exhaled aerosol toxicants.143 
In August 2014, Maharashtra became the first state in India to ban the use of smokeless tobacco in a 
range of public places, with penalties for those caught chewing or spitting tobacco.144 In 2016, the 
state of California extended the smoke-free laws that apply to cigarettes to electronic cigarettes, and 
raised the minimum purchasing age for all forms of tobacco, including electronic cigarettes, to 21 
years.145 
13.6 Resisting industry interference in tobacco 
 control laws and policies 
Tobacco control laws and policies in many countries are vulnerable to the influence of tobacco 
companies and other business groups that benefit economically from high rates of tobacco use. 
Article 5.3 of the WHO FCTC requires Parties, in setting and implementing their public health policies 
with respect to tobacco control, to protect these policies from “commercial and other vested 
interests of the tobacco industry in accordance with national law”.146 Similarly, the Protocol to 
Eliminate Illicit Trade in Tobacco Products requires that national authorities responsible for tracking 
and tracing tobacco products should interact with the tobacco industry “only to the extent strictly 
necessary” to administer that system.147 
The Guidelines for implementation of Article 5.3 point to the “irreconcilable conflict between the 
tobacco industry’s interests and public health interests”.148 Accordingly, the guidelines urge Parties 
to limit their interactions with the tobacco industry and to ensure that any interactions that do occur 
are transparent. For example, the Russian Federation’s tobacco control law requires all 
correspondence between government agencies and the tobacco industry to be made publicly 
available on the Internet.149 Partnerships, memoranda of understanding and other non-binding or 
non-enforceable agreements with the tobacco industry should be rejected.150 Tobacco companies 
should not be involved in the drafting of tobacco control laws, nor should government accept 
voluntary codes of conduct drafted by the tobacco industry as a substitute for legally enforceable 
standards.151 Members of Parliament and government staff should resist any attempts by the 
tobacco industry to influence legislative and executive processes during the passage of tobacco 
control laws (this may extend to direct tampering with the wording of draft legislation during the 
legislative process).152 
The Guidelines for the implementation of Article 5.3 point out that “corporate social responsibility” 
activities undertaken by the tobacco industry should be recognized as marketing activities that are in 
conflict with the goals of tobacco control; accordingly, Parties should not endorse or support such 
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activities.153 Tobacco companies should not be involved in the design or implementation of any 
public education programmes related to tobacco control:154 this extends to industry support or 
involvement in youth non-smoking programmes. Parties should not give incentives (including tax 
incentives) to the tobacco industry to establish or run businesses, and State-owned tobacco 
enterprises should be treated no differently to other participants in the tobacco industry.155 
 
REFERENCESi 
1 Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. New England Journal of Medicine. 
2014;370:60–8; Tobacco. Fact sheet No. 339, June 2016. Geneva: World Health Organization; 2011 
(http://www.who.int/mediacentre/factsheets/fs339/en/index.html). 
2 Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H et al. A comparative risk assessment of burden 
of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a 
systematic analysis of the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60, 2238. 
3 Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014:53. 
4 Jha P. Avoidable deaths from smoking: a global perspective. Public Health Reviews. 2012;33:569–600, 581–3. 
5 Malone R. The tobacco industry. In: Wiist W, editor. The bottom line or public health: tactics corporations use 
to influence health and health policy, and what we can do to counter them. New York (NY): Oxford University 
Press; 2010:155–91, 160. 
6 Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and 
financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–53. 
7 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005). 
8 Conference of the Parties to the WHO Framework Convention on Tobacco Control [website]. Geneva: 
Convention Secretariat; 2016 (http://www.who.int/fctc/cop/en/). 
9 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 2.1. 
10 WHO report on the global tobacco epidemic, 2015. Geneva: World Health Organization; 2015:16–17. 
11 MPOWER: a policy package to reverse the tobacco epidemic. Geneva: World Health Organization; 2008 
(http://www.who.int/tobacco/mpower/en/). 
12 WHO report on the global tobacco epidemic, 2013. Geneva: World Health Organization; 2013:42. 
13 WHO report on the global tobacco epidemic, 2013. Geneva: World Health Organization; 2013:46–7. 
14 Kostova D, Andes L, Erguder T, Yurekli A, Keskinkiliç B, Polat S et al. Cigarette prices and smoking prevalence 
after a tobacco tax increase – Turkey, 2008 and 2012. Morbidity and Mortality Weekly Report. 2014;63:457–61 
(http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6321a2.htm). 
15 World Lung Foundation congratulates Russian government on new national tobacco control law [press 
release]. New York (NY): World Lung Foundation; 26 February 2013 
(http://www.worldlungfoundation.org/ht/display/ReleaseDetails/i/23180/pid/6858). 
16 Russian Federation. Federal Law No. 15-FZ of 23 February 2013 (Article 12) 
(http://www.tobaccocontrollaws.org/legislation/country/russia/laws). 
17 Russian Federation. Federal Law No. 15-FZ of 23 February 2013 (Article 16, Part 7) 
(http://www.tobaccocontrollaws.org/legislation/country/russia/laws). 
18 Russian Federation. Federal Law No. 15-FZ of 23 February 2013 (Article 16, Part 5) 
(http://www.tobaccocontrollaws.org/legislation/country/russia/laws). 
i All references were accessed on 1 May 2016. 
Page | 208  Advancing the right to health: the vital role of law 
 
                                                          
                                                          
19 Russian Federation. Federal Law No. 15-FZ of 23 February 2013 (Article 16, Part 3) 
(http://www.tobaccocontrollaws.org/legislation/country/russia/laws). 
20 Lunze K, Migliorini L. Tobacco control in the Russian Federation – a policy analysis. BMC Public Health. 
2013;13:64 (http://www.biomedcentral.com/1471–2458/13/64). 
21 Giovino G, Mirza S, Samset J, Gupta P, Jarvis M, Bhala N et al. Tobacco use in 3 billion individuals from 16 
countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380:668–
79. 
22 Tobacco industry interference with tobacco control. Geneva: World Health Organization; 2009. 
23 Bump JB, Reich MR, Adeyi O, Khetrapal S. Towards a political economy of tobacco control in low- and 
middle-income countries. Washington (DC): World Bank (Health, Nutrition and Population (HPN) Discussion 
Paper); August 2009:18–20, 37–42; Joossens L, Raw M. From cigarette smuggling to illicit tobacco trade. 
Tobacco Control. 2012;21:230–4. 
24 Bump JB, Reich MR. Political economy analysis for tobacco control in low- and middle-income countries. 
Health Policy and Planning. 2012;28:123–33, 127. 
25 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted on 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013. 
26 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 1 (definition of “illicit trade”), Article 3. 
27 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 45; United Nations Treaty Collection. Status of 
the Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 
(https://treaties.un.org/pages/ViewDetails.aspx?src=TREATY&mtdsg_no=IX-4-a&chapter=9&lang=en). 
28 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Preamble (http://www.who.int/fctc/protocol/en/); 
WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011:83. 
29 The global illicit trade in tobacco: a threat to national security. Washington (DC): United States Government, 
Department of State; 2015 (http://www.state.gov/documents/organization/250513.pdf ). 
30 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 6. 
31 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 6. 
32 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 8. 
33 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 8. 
34 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 11.2. 
35 Prevent All Cigarette Trafficking (PACT) Act P.L. 111–154 (United States) 
(http://www.gpo.gov/fdsys/pkg/PLAW-111publ154/content-detail.html). 
36 The General Agreement on Tariffs and Trade, signed 30 October 1947, 555 UNTS 194 (“GATT 1947”). 
37 Agreement on Technical Barriers to Trade (TBT Agreement), opened for signature 15 April 1994, Marrakesh 
Agreement Establishing the World Trade Organization, Annex 1A, The Legal Texts: The Results of the Uruguay 
Round of Multilateral Trade Negotiations, 1867 UNTS 3 (entered into force 1 January 1995) (“TBT 
Agreement”). 
38 Agreement on Trade-Related Aspects of Intellectual Property Rights, opened for signature 15 April 1994, 
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, The Legal Texts: The Results of 
the Uruguay Round of Multilateral Trade Negotiations, 1869 UNTS 299 (entered into force 1 January 1995) 
(“TRIPS Agreement”). 
39 Understanding the WTO: basics: principles of the trading system [website]. Geneva: World Trade 
Organization; 2016 (http://www.wto.org/english/thewto_e/whatis_e/tif_e/fact2_e.htm). 
 
Advancing the right to health: the vital role of law  Page | 209 
 
                                                                                                                                                                                    
40 Gleeson D, Friel S. Emerging threats to public health from regional trade agreements. Lancet. 
2013;381:1507–9; Trade, foreign policy, diplomacy and health [website]. Geneva: World Health Organization; 
2016 (http://www.who.int/trade/trade_and_health/en/); Voon T, Mitchell A, Liberman J, editors. Regulating 
tobacco, alcohol and unhealthy foods: the legal issues. London: Routledge; 2014; Thow AM, McGrady B. 
Protecting policy space for public health nutrition in an era of international investment agreements. Bulletin of 
the World Health Organization. 2014;92:139–45. 
41 Fooks G, Gilmore A. International trade law, plain packaging and tobacco industry political activity: the 
Trans-Pacific Partnership. Tobacco Control. 2014;23:e1. 
42 Confronting the tobacco epidemic in an era of trade and investment liberalization. Geneva: World Health 
Organization; 2012:102. 
43 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 5.3. 
44 Confronting the tobacco epidemic in an era of trade and investment liberalization. Geneva: World Health 
Organization; 2012:83–97. 
45 GATT 1994, Article II:1. 
46 GATT 1994, Article XI:1. 
47 Voon T, Mitchell A. International trade law. In: Voon T, Mitchell A, Liberman J, editors. Regulating tobacco, 
alcohol and unhealthy foods: the legal issues. London: Routledge; 2014:86–109, 101. 
48 Panel report: Thailand – restrictions on importation of and internal taxes on cigarettes. Report of the Panel 
adopted 7 November 1990 (WTO document DS10/R/-37S/200; 
http://www.wto.org/english/tratop_e/envir_e/edis03_e.htm); Vateesatokit P, Hughes B, Ritthphakdee B. 
Thailand – winning battles, but the war’s far from over. Tobacco Control. 2000;9:122–7. 
49 Understanding the WTO: basics: principles of the trading system [website]. Geneva: World Trade 
Organization; 2016 (http://www.wto.org/english/thewto_e/whatis_e/tif_e/fact2_e.htm). 
50 GATT 1994, Articles I, III. 
51 TBT Agreement, Article 2.1. 
52 TBT Agreement, Annex 1:1 (definition of “technical regulation”). 
53 GATT 1994, Article XX(b). 
54 TBT Agreement, Sixth recital. 
55 Appellate Body Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, 
WTO Doc WT /DS406/AB/R, 4 April 2012: paras 174, 182. 
56 TBT Agreement, Article 2.2. 
57 TBT Agreement, Article 2.2. 
58 Voon T, Mitchell A. International trade law. In: Voon T, Mitchell A, Liberman J, editors. Regulating tobacco, 
alcohol and unhealthy foods: the legal issues. London: Routledge; 2014:86–109, 89–90. 
59 Family Smoking Prevention and Tobacco Control Act of 2009 (United States) §907(a)(1)(A). 
60 Panel Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, WT Doc 
WT/DS406/R: paras 7.400–7.432. 
61 Partial guidelines for implementation of Articles 9 and 10 of the WHO Framework Convention on Tobacco 
Control. Geneva: World Health Organization; 2012: section 3.1.2.2(i) 
(http://www.who.int/fctc/guidelines/adopted/article_9and10/en/). 
62 Panel Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, WT Doc 
WT/DS406/R: para. 7.414. 
63 Appellate Body Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, 
WTO Doc WT /DS406/AB/R, 4 April 2012: paras 234–6. 
64 Appellate Body Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, 
WTO Doc WT /DS406/AB/R, 4 April 2012: para. 116. 
65 Appellate Body Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, 
WTO Doc WT /DS406/AB/R, 4 April 2012: paras 120, 131–2, 156–60. 
Page | 210  Advancing the right to health: the vital role of law 
 
                                                                                                                                                                                    
66 Appellate Body Report, United States – Measures Affecting the Production and Sale of Clove Cigarettes, 
WTO Doc WT /DS406/AB/R, 4 April 2012: para. 174. 
67 Voon T, Mitchell A. International trade law. In Voon T, Mitchell A, Liberman J, editors. Regulating tobacco, 
alcohol and unhealthy foods: the legal issues. London: Routledge; 2014:86–109, 91. 
68 Trade, foreign policy, diplomacy and health [website]. Geneva: World Health Organization; 2016 
(http://www.who.int/trade/trade_and_health/en/); Voon T, Mitchell A, Liberman J, editors. Regulating 
tobacco, alcohol and unhealthy foods: the legal issues. London: Routledge; 2014; Voon T, Mitchell A. The 
global tobacco epidemic and the law. Cheltenham: Edward Elgar; 2014; McGrady B. Trade and public health: 
the WTO, tobacco, alcohol, and diet. Cambridge: Cambridge University Press, 2011; Confronting the tobacco 
epidemic in an era of trade and investment liberalization. Geneva: World Health Organization; 2012. 
69 The Transatlantic Trade Investment Partnership [website]. Brussels: European Commission; 2016  
(http://ec.europa.eu/trade/policy/in-focus/ttip/). 
70 Trans-Pacific Partnership Full Text [website]. Office of the United States Trade Representative 
(https://ustr.gov/trade-agreements/free-trade-agreements/trans-pacific-partnership/tpp-full-text). 
71 McGrady B. International investment law. In: Voon T, Mitchell A, Liberman J, editors. Regulating tobacco, 
alcohol and unhealthy foods: the legal issues. London: Routledge; 2014:110–130. 
72 McGrady B. International investment law. In: Voon T, Mitchell A, Liberman J, editors. Regulating tobacco, 
alcohol and unhealthy foods: the legal issues. London: Routledge; 2014:110–30, 112–16. 
73 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: Recommendations 7.1–7.3, 8.1–8.3. 
74 Australian Government, Attorney General’s Department. Tobacco plain packaging – investor-state 
arbitration (http://www.ag.gov.au/tobaccoplainpackaging); Davison M, Emerton P. Rights, privileges, 
legitimate interests, and justifiability: Article 20 of TRIPS and plain packaging of tobacco. American University 
International Law Review. 2014;29:505–80. 
75 Philip Morris Asia Limited (Hong Kong) v. The Commonwealth of Australia, case no. 2012–12, Permanent 
Court of Arbitration (http://www.pcacases.com/web/view/5); Australian Government, Attorney-General’s 
Department. Tobacco plain packaging – investor-state arbitration 
(https://www.ag.gov.au/tobaccoplainpackaging). 
76 Philip Morris Brand Sàrl (Switzerland), Philip Morris Products S.A. (Switzerland) and Abal Hermanos S.A. 
(Uruguay) v. Oriental Republic of Uruguay (ICSID Case No. ARB/10/7) 
(https://icsid.worldbank.org/apps/ICSIDWEB/cases/pages/casedetail.aspx?CaseNo=ARB/10/7&tab=PRO). 
77 McGrady B. Implications of ongoing trade and investment disputes concerning tobacco: Philip Morris v 
Uruguay. In Voon T, Mitchell A, Liberman, Ayres G, editors. Public health and plain packaging of cigarettes: 
legal issues. Cheltenham: Edward Elgar; 2012:173–99. 
78 Voon T, Mitchell A. International trade law. In: Voon T, Mitchell A, Liberman J, editors. Regulating tobacco, 
alcohol and unhealthy foods: the legal issues. London: Routledge; 2014:86–109, 98–9; Sy D, Stumberg R. TPPA 
and tobacco control: threats to APEC countries. Tobacco Control. 2014, 23:466–70. 
79 WHO report on the global tobacco epidemic, 2015. Geneva: World Health Organization; 2015:26–45; IARC 
Handbooks of cancer prevention. Tobacco control. Volume 14: Effectiveness of tax and price policies for 
tobacco control. Lyon: International Agency for Research on Cancer, World Health Organization; 2011 
(http://www.iarc.fr/en/publications/pdfs-online/prev/handbook14/index.php); Jamison D, Summers L, Alleyne 
G, Arrow K, Berkley S, Binagwaho A et al. Global health 2035: a world converging within a generation. Lancet. 
2013;382:1898–1955, 1926–7. 
80 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 6. 
81 WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011:21–3, 90–3 
(http://www.who.int/tobacco/publications/tax_administration/en/index.html); Jha P, Peto R. Global effects of 
smoking, of quitting, and of taxing tobacco. New England Journal of Medicine. 2014;370:60–68; Chaloupka F, 
Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. Tobacco Control. 2012;21:172–80; Cavazos-
Rehg P, Krauss M, Spitznagel E, Chaloupka F, Luke D, Waterman B et al. Differential effects of cigarette price 
changes on adult smoking behaviours. Tobacco Control. 2014;23:113–18. 
 
Advancing the right to health: the vital role of law  Page | 211 
 
                                                                                                                                                                                    
82 Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. New England Journal of Medicine. 
2014;370:60–8, 64. 
83 WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011:87–9; 
Blecher E, van Walbeek C. An analysis of cigarette affordability. Paris: International Union Against Tuberculosis 
and Lung Disease; 2008. 
84 Excise Tariff Amendment (Tobacco) Bill 2014 (Australia), Explanatory Memorandum 
(http://www.aph.gov.au/Parliamentary_Business/Bills_Legislation/Bills_Search_Results/Result?bId=r5172). 
85 WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011:51–70; 
WHO report on the global tobacco epidemic, 2015. Geneva: World Health Organization; 2015:26–45. 
86 WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011:21–3 
(http://www.who.int/tobacco/publications/tax_administration/en/index.html); Curbing the epidemic: 
governments and the economics of tobacco control. Washington (DC): World Bank; 1999:41. 
87 WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011. 
88 Block S, Webb P. Up in smoke: tobacco use, expenditure on food, and child malnutrition in developing 
countries. Economic Development and Cultural Change. 2009;58:1–23. 
89 Barber S, Ahsan A, Adioetomo S, Setyonaluri D. Tobacco economics in Indonesia. Paris: International Union 
Against Lung Disease; 2008:9 (www.worldlungfoundation.org/ht/a/GetDocumentAction/i/6567). 
90 Nargis N, Ruthbah U, Hussain A, Fong G, Hug I, Ashiquzzaman S et al. The price sensitivity of tobacco 
consumption in Bangladesh: evidence from the International Tobacco Control (ICT) Wave 1 (2009) and Wave 2 
(2010) surveys. Tobacco Control. 2014;23:i39–i47; Choi S. Are lower income smokers more price sensitive? The 
evidence from Korean cigarette tax increases. Tobacco Control. published online first: 27 November 2014. 
doi:10.1136/tobaccocontrol-2014-051680; Townsend J, Roderick P, Cooper J. Cigarette smoking by 
socioeconomic group, sex, and age: effects of price, income, and health publicity. British Medical Journal. 
1994;309:923 (http://www.bmj.com/content/309/6959/923.long); van Hasselt M, Kruger J, Han B, Caraballo R, 
Penne M, Loomis B et al. The relation between tobacco taxes and youth and young adult smoking: what 
happened following the 2009 U.S. federal tax increase on cigarettes? Addictive Behaviors. 2015;45:104–9; 
Thomas S, Fayter D, Misso K, Ogilvie D, Petticrew M, Snowden A et al. Population tobacco control 
interventions and their effects on social inequalities in smoking: systematic review. Tobacco Control. 
2008;17:230–7. 
91 WHO report on the global tobacco epidemic, 2015. Geneva: World Health Organization; 2015:29–30. 
92 WHO technical manual on tobacco tax administration. Geneva: World Health Organization; 2011:90–93, 98–
102. 
93 Yang Y, Wang J, Wang C, Li Q, Yang G. Awareness of tobacco-related health hazards among adults in China. 
Biomedical and Environmental Sciences, 2010;23:437–44. 
94 Hammond D, Fong G, Borland R, Cummings K. Effectiveness of cigarette warning labels in informing smokers 
of the risks of smoking: findings from the international tobacco control (ITC) four-country survey. Tobacco 
Control. 2006;15(Suppl. III):19–25. 
95 The verdict is in: findings from United States v Philip Morris, light cigarettes. Saint Paul (MN): Tobacco 
Control Legal Consortium; 2006 (http://publichealthlawcenter.org/sites/default/files/resources/tclc-verdict-
light.pdf); National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured 
yields of tar and nicotine. Bethesda (MD): US Department of Health and Human Services; 2001; “Light” and 
“low tar” cigarettes: major scientific findings and public health statements. Washington (DC): Campaign for 
tobacco-free kids; 2010 (http://global.tobaccofreekids.org/files/pdfs/en/LL_findings_en.pdf). 
96 Brown A, McNeill A, Guignard R. Do smokers in Europe think all cigarettes are equally harmful? European 
Journal of Public Health. 2012;22(Suppl. 1):35–40; King B, Yong H-H, Borland R, Omar M, Ahmad A, 
Sirirassamee B et al. Malaysian and Thai smokers’ beliefs about the harmfulness or “light” and menthol 
cigarettes. Tobacco Control. 2010;19:444–50. 
97 Tindle H, Rigotti N, Davis R, Barbeau E, Kawachi I, Shiffman S. Cessation among smokers of “light” cigarettes: 
results from the 2000 National Health Interview Survey. American Journal of Public Health. 2006, 96:1498–
504. 
Page | 212  Advancing the right to health: the vital role of law 
 
                                                                                                                                                                                    
98 Guidelines for implementation of Article 11 of the WHO Framework Convention on Tobacco Control. 
Geneva: WHO Framework Convention on Tobacco Control; 2008: paras 8–22 
(http://www.who.int/fctc/guidelines/adopted/en/). 
99 Hoek J et al. Lessons from New Zealand’s introduction of pictorial health warnings on tobacco packaging. 
Bulleting of the World Health Organization. 2010;88:861–6. 
100 Guidelines for implementation of Article 11 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization; 2008: para. 46 (http://www.who.int/fctc/guidelines/adopted/en/); 
Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. Geneva: 
World Health Organization; 2008: para. 16 (http://www.who.int/fctc/guidelines/adopted/en/). 
101 Voon T, Mitchell A, Liberman, Ayres G, editors. Public health and plain packaging of cigarettes: legal issues. 
Cheltenham: Edward Elgar; 2012; Tobacco Plain Packaging Act (Australia) 
(https://www.comlaw.gov.au/Details/C2011A00148). 
102 The Standardised Packaging of Tobacco Products Regulations 2015 (UK) 
(http://www.bailii.org/uk/legis/num_reg/2015/uksi_2015829_en_1.html). 
103 Public Health (Standardised Packaging of Tobacco) Act 2015 (Ireland) 
(http://www.bailii.org/ie/legis/num_act/2015/0004.html). 
104 Philip Morris Brands SARL and others v Secretary of State for Health, Court of Justice of the European 
Communities [2016] EUECJ C-547/14 (4 May 2016). 
105 Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation 
of the laws, regulations and administrative provisions of the Member States concerning the manufacture, 
presentation and sale of tobacco and related products and repealing Directive 2001/37/EC Text with EEA 
relevance (http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014L0040). 
106 Wakefield M, Hayes L, Durkin S, Borland R. Introduction effects of the Australian plain packaging policy on 
adult smokers: a cross-sectional study. BMJ Open. 2013;3:e003175. 
107 Young J, Stacey I, Dobbins T, Dunlop S, Dessaix A, Currow D. The association between tobacco plain 
packaging and Quitline calls: a population-based, interrupted time series analysis. Medical Journal of Australia. 
2014;200:29–32. 
108 Scollo M, Zacher M, Durkin S, Wakefield M. Early evidence about the predicted, unintended consequences 
of standardised packaging of tobacco products in Australia: a cross-sectional study of the place of purchase, 
regular brands and use of illicit tobacco. BMJ Open. 2014;4:e005873. 
109 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 13. 
110 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 13.2. 
111 Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization; 2008: para. 11 (http://www.who.int/fctc/guidelines/adopted/en/). 
112 Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization; 2008: para. 3(c) (http://www.who.int/fctc/guidelines/adopted/en/). 
113 Clattenburg E, Elf J, Apelberg B. Unplanned cigarette purchases and tobacco point of sale advertising: a 
potential barrier to smoking cessation. Tobacco Control. 2013;22:376–81; Wakefield M, Germain D, Henriksen 
L. The effect of retail cigarette pack displays on impulse purchase. Addiction. 2007;103:322–8. 
114 Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization; 2008: para. 13 (http://www.who.int/fctc/guidelines/adopted/en/). 
115 Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization; 2008: para. 3(d) (http://www.who.int/fctc/guidelines/adopted/en/). 
116 WHO report on the global tobacco epidemic, 2013. Geneva: World Health Organization; 2013:27, 33. 
117 WHO report on the global tobacco epidemic, 2013. Geneva: World Health Organization; 2013:30–2. 
118 Federal Trade Commission cigarette report for 2013. Washington (DC): Federal Trade Commission; 2016 
(https://www.ftc.gov/reports/federal-trade-commission-cigarette-report-2013). 
 
Advancing the right to health: the vital role of law  Page | 213 
 
                                                                                                                                                                                    
119 Pierce J, Gilmer T, Lee L, Gilpin E, de Beyer J, Messer K. Tobacco industry price-subsidizing promotions may 
overcome the downward pressure of higher prices on initiation of regular smoking. Health Economics. 
2005;14:1061–71. 
120 Tobacco price promotion: policy responses to industry price manipulation. Boston (MA): Public Health and 
Tobacco Policy Center; 2011. 
121 WHO report on the global tobacco epidemic, 2013. Geneva: World Health Organization; 2013:36. 
122 Glantz S, Iaccopucci A, Titus K, Polansky J. Smoking in top-grossing US movies, 2011. Preventing Chronic 
Disease. 2012;9:120170 (http://www.cdc.gov/pcd/issues/2012/12_0170.htm). 
123 Choi K, Forster J, Erickson D, Lazovich D, Southwell B. The reciprocal relationships between changes in 
adolescent perceived prevalence of smoking in movies and progression of smoking status. Tobacco Control. 
2012;21:492–6; Sargent J, Tanski S, Stoolmiller M. Influence of motion picture rating on adolescent response to 
movie smoking. Pediatrics. 2012;130:228–36. 
124 Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: para. 31. 
125 Guidelines for implementation of Article 13 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: para. 31. 
126 Cigarettes and other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and 
Commerce, Production, Supply and Distribution) Amendment Rules, 2012 (Ministry of Health and Family 
Welfare Notification G.S.R. 708(E), 21 September 2012 (India). 
127 Cigarettes and other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and 
Commerce, Production, Supply and Distribution) Amendment Rules, 2012 (Ministry of Health and Family 
Welfare Notification G.S.R. 708(E), 21 September 2012 (India). 
128 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 8. 
129 Chapman S, Borland R, Scollo M, Brownson R, Dominello A, Woodward S. The impact of smoke-free 
workplaces on declining cigarette consumption in Australia and the United States. American Journal of Public 
Health. 1999;89:1018–23. 
130 Siegel M, Alberts A, Cheng D, Hamilton W, Biener L. Local restaurant smoking regulations and the 
adolescent smoking initiation process. Archives of Pediatrics & Adolescent Medicine. 2008;162:477–83. 
131 Cigarette consumption in Turkey drops by 16 percent. Today’s Zaman. 7 October 2010 
(http://www.todayszaman.com/news-223682-101-cigarette-consumption-in-turkey-drops-by-16-
percent.html). 
132 Sims M, Maxwell R, Bault L, Gilmore A. Short term impact of smoke-free legislation in England: 
retrospective analysis of hospital admissions for myocardial infarction. BMJ: 2010;340:c2161. 
133 Been J, Nurmatov U, Cox B, Nawrot T, van Schayck C, Sheikh A. Effect of smoke-free legislation on perinatal 
and child health: a systematic review and analysis. Lancet. 2014;383:1549–1560. 
134 Guidelines for implementation of Article 8 of the WHO Framework Convention on Tobacco Control. Geneva: 
World Health Organization: 2007: para. 4 (http://www.who.int/fctc/guidelines/adopted/en/). 
135 Exposure to secondhand tobacco smoke in the Americas: a human rights perspective. Washington (DC): Pan 
American Health Organization; 2006 (http://www.paho.org/english/ad/sde/ra/tobpublications.htm); Cabrera 
OA, Madrazo A. Human rights as a tool for tobacco control in Latin America. Salud pública de México. 
2010;5:S288–97. 
136 Guidelines for implementation of Article 8 of the WHO Framework Convention on Tobacco Control. Geneva: 
World Health Organization: 2007: para. 6 (http://www.who.int/fctc/guidelines/adopted/en/). 
137 Guidelines for implementation of Article 8 of the WHO Framework Convention on Tobacco Control. Geneva: 
World Health Organization: 2007: para. 6 (http://www.who.int/fctc/guidelines/adopted/en/). 
138 Guidelines for implementation of Article 8 of the WHO Framework Convention on Tobacco Control. Geneva: 
World Health Organization: 2007: para. 8; Yusuf O. Tobacco smoke pollution in the “non-smoking” sections of 
selected popular restaurants in Pretoria, South Africa. Tobacco Control. 2014;23:193–4. 
139 Guidelines for implementation of Article 8 of the WHO Framework Convention on Tobacco Control. Geneva: 
World Health Organization: 2008: para. 18 (http://www.who.int/fctc/guidelines/adopted/en/). 
Page | 214  Advancing the right to health: the vital role of law 
 
                                                                                                                                                                                    
140 For example, Smoke-Free Ontario Act, SO 1994, c 10 s. 9.2(1); Public Health (Tobacco) Act 2008 (NSW) s. 30 
(Australia). 
141 Scollo M, Lal A, Hyland A, Glantz S. Review of the quality of studies on the economic effects of smoke-free 
policies on the hospitality industry. Tobacco Control. 2003;12:13–20. 
142 Guidelines for implementation of Article 8 of the WHO Framework Convention on Tobacco Control. Geneva: 
WHO Framework Convention on Tobacco Control, 2007: para. 31. 
143 Electronic nicotine delivery systems: report by WHO (FCTC. FCTC/COP/6/10/ Rev. 1 (1 September 2014). 
Report to the Sixth session of the Conference of the Parties to the WHO FCTC, Moscow, Russian Federation, 
13–18 October 2014): para. 28 
(http://www.who.int/tobacco/communications/statements/eletronic_cigarettes/en/). 
144 Bagcchi S. Maharashtra state prepares to ban smokeless tobacco use in public places from August. British 
Medical Journal. 2014;349:g4849. 
145 California Senate Bill SB-5 Electronic cigarettes (2015–2016), signed into law 4 May 2016 
(http://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=201520162SB5); California Senate Bill SB-
7 Tobacco products: minimum legal age (2015–2016), signed into law 4 May 2016 
(http://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=201520162SB7); Morain SR, Winickoff JP, 
Mello MM. Have tobacco 21 laws come of age? New England Journal of Medicine. 2016;374:1601–4. 
146 WHO Framework Convention on Tobacco Control, adopted in resolution WHA56.1, opened for signature 
21 May 2003, 2302 UNTS 166 (entered into force 27 February 2005): Article 5.3. 
147 Protocol to Eliminate Illicit Trade in Tobacco Products, adopted 12 November 2012 in decision 
FCTC/COP/5/6, opened for signature 10 January 2013: Article 8(13). 
148 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: para. 13 (http://www.who.int/fctc/guidelines/adopted/en/). 
149 Russian Federation. Federal Law No. 15-FZ of February 23, 2013 (Article 8) 
(http://www.tobaccocontrollaws.org/legislation/country/russia/laws). 
150 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: Recommendation 3 
(http://www.who.int/fctc/guidelines/adopted/en/). 
151 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: Recommendation 3 
(http://www.who.int/fctc/guidelines/adopted/en/). 
152 Maulia E. Govt denies involvement in missing clause. Jakarta Post. 14 October 2009 
(http://www.thejakartapost.com/news/2009/10/14/govt-denies-involvement-missing-law-clause.html); 
Prakoso R. Indonesia activists push probe of dropped tobacco clause. Jakarta Post. 20 February 2012 
(http://www.thejakartaglobe.com/health/indonesia-activists-push-probe-of-dropped-tobacco-clause/499332); 
Indonesia: tobacco control advocates expose corruption after tobacco clause found missing from the National 
Health Bill [website]. Washington (DC): Campaign for Tobacco-Free Kids 
(http://global.tobaccofreekids.org/en/industry_watch/case_studies/indonesia_tobacco_control_advocates). 
153 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: Recommendation 6 
(http://www.who.int/fctc/guidelines/adopted/en/). 
154 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: Recommendation 3 
(http://www.who.int/fctc/guidelines/adopted/en/). 
155 Guidelines for implementation of Article 5.3 of the WHO Framework Convention on Tobacco Control. 
Geneva: World Health Organization: 2008: Recommendations 7–8 
(http://www.who.int/fctc/guidelines/adopted/en/). 
 
Advancing the right to health: the vital role of law  Page | 215 
 
                                                                                                                                                                                    
Chapter 14: Migration and retention  
of health care workers 
 
SUMMARY POINTS 
 
· The WHO Global Code of Practice on International Recruitment of Health Personnel sets out 
voluntary principles for ethical international recruitment of health care workers, and is intended 
to improve the legal and institutional framework for recruitment practices at the country level. 
· The Code encourages Member States to scale up the training of health personnel, to consider 
measures to address the geographical misdistribution of health workers in underserved areas, and 
to monitor the national health labour market. 
· Member States should consider establishing or designating a national authority responsible 
for the exchange of information regarding health personnel migration and the implementation of 
the Code. 
· There is a range of strategies that may assist source countries to retain and build their health 
workforce, while also ensuring a better distribution of health workers between urban, rural and 
remote areas. These include compulsory service requirements, bonding schemes, improvements in 
human resource management, a safe working environment, greater investment in facilities and 
equipment, improved pay and conditions, and career development opportunities. 
 
Introduction 
An adequate and effective health workforce is one of the foundations of a successful health system. 
The health workforce includes medical practitioners (including specialist physicians), nurses, 
midwives, allied health care professionals, health administrators as well as other public health 
personnel. A country’s health workforce can be expensive to train and shortages can be difficult to 
fill quickly, due to the lead-time in recruiting and training new staff. Some countries have no medical 
schools at all.1 
Over the past 25 years, international trade in skilled services has increased dramatically. While some 
countries face challenges due to the migration of domestically trained health care workers,2 other 
countries have experienced a rapidly growing domestic market for health care services due to 
“medical tourism”. The 2006 World Health Report estimated that 57 countries, particularly in sub-
Saharan Africa, faced critical shortages of health personnel totalling 2.4 million doctors, nurses and 
midwives.3 Overall, WHO estimates that there is a global shortage of about 4.3 million health care 
workers, a shortfall of about 15%.4 In France and Germany, for example, the density of physicians 
per 10 000 population was 32 and 39, respectively, over the period 2007–2013, whereas in a number 
of African countries it was less than 1 per 10 000 population.5 Over this period, the average density 
of physicians, and of nursing and midwifery personnel for the WHO European Region was 32 and 80 
per 10 000 population, respectively, but only 2.7 and 12.4 per 10 000 population for the African 
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Region.6 These shortages are aggravated by the migration of health care workers away from the 
countries that most need them. 
Health professionals from developing countries emigrate for a variety of reasons. They may be 
attracted to high-income countries by the prospect of higher income, better equipment and working 
conditions, better job security and opportunities for career development, or they may be 
discouraged by ineffective management or safety and security concerns in their home countries.7 
Migration of health workers within countries, particularly from rural to urban areas and a lack of 
employment opportunities for health professionals within their own country pose additional 
problems. 
14.1 International strategies 
In May 2010, the World Health Assembly adopted the WHO Global Code of Practice on International 
Recruitment of Health Personnel, which outlines voluntary principles for ethical international 
recruitment, and is intended to improve the legal and institutional framework for recruitment 
practices at the country level (Box 14.1).8 
The Code urges all countries, in their international recruitment practices, to take into consideration 
the needs of source countries for a sustainable health workforce. It recognizes the benefits that 
opportunities to study and work abroad can provide, both to source and destination countries, and 
to health care workers themselves. However, it urges countries to discourage the recruitment of 
health personnel in countries facing critical shortages. While recognizing the benefits of circular 
migration, the Code encourages WHO Member States to develop a sustainable workforce that will 
reduce long-term reliance on migrant health workers. The Code also encourages Member States to 
scale up the training of health personnel, to consider measures to address the geographical 
maldistribution of health workers in underserved areas, and to monitor the national health labour 
market. All States should, as appropriate, designate a national authority responsible for the 
exchange of information regarding health personnel migration and the implementation of the 
Code.9 
Regional and bilateral agreements provide additional tools for implementing the principles of the 
Code and improving health workforce labour market practices. Bilateral agreements can recognize 
the need for both source and destination countries to monitor the extent of migration and its impact 
on the source country, and to ensure adequate training and strategies for financial support to the 
health system in the source country. Key issues that bilateral agreements can address include: 
recruitment standards, employment standards, recognition of the freedom to migrate and to engage 
in professional development, monitoring and implementation, and dispute resolution. 
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Box 14.1: Key Messages from the WHO Global Code of Practice on the International Recruitment 
of Health Personnel10 
3.2 Addressing present and expected shortages in the health workforce is crucial to protecting global 
health. International migration of health personnel can make a sound contribution to the 
development and strengthening of health systems, if recruitment is properly managed. ... 
3.4 Member States should take into account the right to the highest attainable standard of health of 
the populations of source countries, individual rights of health personnel to leave any country in 
accordance with applicable laws, in order to mitigate the negative effects and maximize the positive 
effects of migration on the health systems of the source countries. ... 
3.6 Member States should strive, to the extent possible, to create a sustainable health workforce 
and work towards establishing effective health workforce planning, education and training, and 
retention strategies that will reduce their need to recruit migrant health personnel. ... 
3.8 Member States should facilitate circular migration of health personnel, so that skills and 
knowledge can be achieved to the benefit of both source and destination countries. 
4.6 Member States and other stakeholders should take measures to ensure that migrant health 
personnel enjoy opportunities and incentives to strengthen their professional education, 
qualifications and career progression, on the basis of equal treatment with the domestically trained 
health workforce subject to applicable laws. ... 
5.1 ... Destination countries are encouraged to collaborate with source countries to sustain and 
promote health, human resource development and training as appropriate. Member States should 
discourage active recruitment of health personnel from developing countries facing critical 
shortages of health workers. 
5.2 Member States should use this Code as a guide when entering into bilateral, and/or regional 
and/or multilateral arrangements, to promote international cooperation and coordination on 
international recruitment of health personnel. ... 
5.4 As the health workforce is central to sustainable health systems, Member States should take 
effective measures to educate, retain and sustain a health workforce that is appropriate for the 
specific conditions of each country, including areas of greatest need, and is built upon an evidence-
based health workforce plan. All Member States should strive to meet their health personnel needs 
with their own human resources for health, as far as possible. 
5.5. Member States should consider strengthening educational institutions to scale up the training of 
health personnel and developing innovative curricula to address current health needs. … 
5.7 Member States should consider adopting measures to address the geographical maldistribution 
of health workers and to support their retention in underserved areas, such as through the 
application of education measures, financial incentives, regulatory measures, social and professional 
support. 
7.3. For purposes of international communication, each Member State should, as appropriate, 
designate a national authority responsible for the exchange of information regarding health 
personnel migration and the implementation of the Code. 
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At the national level, both source and destination countries can develop laws and policies to reduce 
the loss of health personnel from developing countries and also to promote a more equitable 
distribution of human resources for health across rural areas – where 50% of the world lives, but 
only 24% of health professionals work.11 
In the United Kingdom, for example, the Code of Practice for the International Recruitment of 
Healthcare Professionals regulates recruitment practices by the National Health Service.12 
Recruitment is only permitted in countries where there is an explicit government-to-government 
agreement that permits recruitment activities (Box 14.2). There is no active recruitment of health 
care professionals from those developing countries that are included on the Department of Health 
website. Any hiring of public sector health workers must occur through an approved recruitment 
agency that complies with the Code.13 
Box 14.2: United Kingdom: Code of Practice for the International Recruitment of Healthcare 
Professionals 
Guiding principles 
3. Developing countries will not be targeted for recruitment, unless there is an explicit government-
to-government agreement with the UK to support recruitment activities. 
6. International healthcare professionals legally recruited from overseas to work in the UK are 
protected by relevant UK employment law in the same way as all other employees. 
Best practice benchmarks for international recruitment 
1. There is no active recruitment of healthcare professionals from those developing countries that 
are included on the Department of Health website. 
• No active recruitment will be undertaken in developing countries by UK commercial 
recruitment agencies, or by any overseas agency sub-contracted to that agency, or any 
healthcare organisation unless there exists a government-to-government agreement that 
healthcare professionals from that country may be targeted for employment. 
… 
• Healthcare organizations may consider unsolicited applications direct from an individual in a 
developing country if that individual is making an application on their own behalf and not 
using a third party, such as a recruitment agency. 
2. All international recruitment by healthcare employers will follow good recruitment practice and 
demonstrate a sound ethical approach.  
… 
• Any international recruitment will be sensitive to local healthcare needs so that 
international recruitment from any country should not destabilize local health. 
3. International healthcare professionals will not be charged fees in relation to gaining employment 
in the UK. 
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14.2 Retention strategies for source countries 
Countries that tend to be source countries for the migration of health care workers frequently face 
both critical shortages, and large disparities in access to health care workers between remote, rural, 
and (more developed) urban areas. Countries may consider a range of policies to address these 
problems including compulsory service requirements, bonding schemes, human resource 
management, improved pay and conditions, greater investment in facilities and equipment, and 
greater career development opportunities. 
Compulsory service schemes may require medical practitioners to remain within the country, or to 
locate to rural or remote areas during their normal period of clinical residency, or for a specified 
period following completion.14 In Indonesia, for example, doctors, dentists and midwives were 
previously required to work as contract staff during a period of compulsory service which ranged 
from six months to three years, depending on the remoteness of the location.15 In 2007, this period 
of service became voluntary, but the contract scheme has remained popular among new graduates 
due to increased financial incentives, and the short length of the contract period.16 In 2009, the 
Ministry of Health introduced an additional Special Assignment Programme in order to address 
specific shortages in “strategic health workers” including nurses, nutritionists and public health 
workers, in specific underserved locations.17 
For more than four decades, Thailand has adopted a policy of compulsory rural service for early-
career health workers graduating from government-funded professional schools.18 Doctors and 
nurses sign a rural service contract at the commencement of their training in a public medical or 
nursing school. Although there are penalties for breaking this commitment (up to US$ 10 000 for 
physicians), some nevertheless break these contracts in order to take up more highly-paid positions 
in the private sector.19 Following the introduction of Thailand’s universal coverage scheme (originally 
known as the “30 baht” policy), demand for medical services in rural areas increased substantially. In 
response, the Thai Ministry of Public Health established new medical schools in rural areas and 
offered higher salaries to government-employed doctors in rural areas.20 The government has also 
established special admission tracks for entry to medical school that target high-school graduates in 
particular provinces. Following graduation, these health workers are required to undertake 
mandatory service (for a period of three years, or 12 years, depending on the scheme) in provinces 
that are experiencing health worker shortages.21 In addition, those who want to seek specialty 
training are required to complete one year of rural service, and those who work in a rural setting for 
at least three years are eligible for a full scholarship for specialty training.22 In an effort to retain an 
adequate number of experienced physicians in rural areas, the government offers board certification 
(with an accompanying pay raise) for those who work in rural areas for over five years.23 
Bonding schemes require health professionals who received State-funded scholarships during their 
period of training to fulfil public service obligations after graduation. In Australia, for example, 
individuals who receive government support for their medical education must perform a contracted 
number of years of public service, often in rural hospitals, before they can receive a billing number 
that allows them to be paid under the national health care system.24 Buy-outs are not allowed, and 
medical practitioners who fail to complete their contract are required to wait twice the contract 
period before they are given a billing number (Box 14.3). To reduce the possibility that health 
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workers will seek to avoid their service obligations by migrating, the WHO Global Code of Practice 
encourages recruiters and employers to respect the legal obligations of health personnel that apply 
within their countries of origin.25 
Box 14.3: Bonding schemes for retention of health care workers: an example from Australia 
Health Insurance Act 1973 26 
Section 19ABA. Medicare benefits not payable in respect of services rendered by doctors who 
breach certain contracts with the Commonwealth 
(1) Despite section 19AA, a medicare benefit is not payable in respect of a professional service 
rendered by, or on behalf of, a medical practitioner who has breached a contract with the 
Commonwealth under which the practitioner agreed to work in a rural or remote area. 
(2) The period during which medicare benefits are not payable under subsection (1) is a period equal 
to twice the length of the period that the practitioner agreed, under the contract, to work in the 
rural or remote area or such shorter period as is determined in, or in accordance with, the contract. 
(3) Subsections (1) and (2) apply whether or not the medical practitioner referred to in those 
subsections was a medical practitioner at the time of entering the contract or at the time of the 
breach. 
Strategies that rely on compulsory service and bonding schemes may be effective in dealing with 
urgent gaps and shortages, but may not address the underlying reasons why experienced health 
professionals are reluctant to settle in rural or remote areas. Policies for work retention are best 
coupled with human resources management strategies designed to make service in underserved 
areas more attractive. Important elements in an effective human resource management strategy 
include: 
• detailed job descriptions for health workers at all levels, consistent with their training; 
• defined career trajectories at all levels, with a clear explanation of what is required for 
advancement; 
• routine performance reviews; 
• on-time payment; 
• a strategy to keep health professionals informed of policy changes within the health system; 
• a system that is responsive to complaints by health care workers and gives reasons for 
decisions; 
• regular contact from supervisors and the central health system, particularly in rural areas. 27 
To retain health workers, countries may also consider moving towards a performance-based reward 
system that rewards health workers for good performance in improving patient outcomes, or in 
meeting health needs at the community level. Performance-pay systems should be carefully tailored 
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to ensure that improvements are evidence-based, rather than based on selective reporting or choice 
of patients.28 Workplace systems that take account of individual workloads in planning the 
distribution of health workers between facilities, which offer flexible working hours, and which 
encourage workers to develop their own solutions to local problems, can also contribute to a 
positive working environment where health workers feel supported and motivated (Box 14.4).29 
Strategies to reduce the time that health professionals spend on activities that do not require their 
professional expertise may also increase efficiency and motivation.30 
Box 14.4: Human resource management strategies: an example from Kenya and Guinea 
Decentralizing task management31 
In 1999, Kenya and Guinea trialled a COPE (Client-Oriented, Provider-Efficient) model of human 
resource management within eight intervention sites in the two countries. The programme was 
supported by simple tools and was based on a philosophy of participation and teamwork, 
transferring decision-making power to the local, on-site team, maintaining a focus on clients’ rights 
and needs, cost-consciousness and efficiency. An evaluation of the programme found that both skills 
and performance were enhanced through the programme, attendance at clinics increased, as well as 
immunization rates and quality of care. The evaluation found that local staff were able to resolve a 
range of problems without outside assistance, including small renovations, improving staff working 
conditions, and service-delivery issues – such as long waiting times, and poor record-keeping and 
referral systems. These improvements were validated by exit interviews with clients. Core features 
of the COPE model include the autonomy and independence of the local team, shared responsibility 
for actions, and a focus on improving systems and developing staff capacity: these helped to create 
an enabling environment in which local staff felt empowered to act and to assume responsibility for 
problems and their solutions.32 
A safe working environment, including adequate facilities and equipment, are essential to health 
worker retention (Box 14.5). Minimum safe working conditions include clean water, a safe electricity 
supply, and adequate office space, equipment and supplies.33 Physical violence may drive workers to 
leave their positions, particularly female nurses in rural areas.34 National law must ensure that 
employers respond swiftly to reports of workplace violence and that employees who complain are 
protected from retribution or discrimination. Health workers require protective equipment, 
including gloves and containers for the safe disposal for needles and blood products.35 Health 
workers should also be immunized and have access to post-exposure prophylaxis for HIV infection in 
case of a needle-stick injury.36 
Sufficient pay is another factor that is essential to improving retention in the public health sector 
(Box 14.5).37 Low wages are often a motivation for leaving the public health care sector, particularly 
in developing nations.38 However, raising salaries – or seeking to compete with private sector 
salaries – is not the only way of increasing remuneration. Incentive programmes may include vehicle 
and education subsidies, hardship allowances, housing, travel allowances, paid vacation, preferential 
placement for advanced training opportunities and even access to good quality Internet services 
(Box 14.5).39  
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Box 14.5: Haiti: Partners in Health clinics40 
Investing in safe working conditions 
The loss of staff from public sector health clinics to the private sector has long been a problem in 
Haiti. However, Partners in Health (PIH) has turned its rural clinics into the most sought-after 
residency sites in the country despite offering lower pay than private clinics. Programme directors 
attribute the high retention levels in these clinics to the quality of the clinic facilities, which are 
stocked with essential medicines and technology so that health workers are not frustrated by their 
inability to provide care. Although PIH is an externally funded operation, its success in increasing 
retention of local workers is instructive. 
Increased pay and incentives 
Even with wages lower than the private sector (though higher than government positions), PIH 
recruits top candidates to its rural locations because it offers them transport back to cities to visit 
their families, and provides lodging and food. Often-cited is the satellite Internet service that PIH 
provides, which enables doctors to communicate with their families and professional colleagues and 
gives them access to extensive medical reference material and patient management systems. PIH 
also offers opportunities for Haitian medical professionals to collaborate with researchers 
worldwide, publish in academic journals and speak at conferences. 
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Chapter 15: Access to essential medicines, TRIPS 
and the patent system 
 
SUMMARY POINTS 
 
· All countries should develop a national medicines policy that includes a national list of 
essential medicines that takes account of national needs. In some countries, the national 
constitution commits governments to providing equitable access to essential medicines and health 
care services. 
· A national procurement strategy may assist governments to formalize a range of measures to 
purchase quality medicines at cheaper prices. Addressing corruption, eliminating tariffs on 
imported drugs, controlling mark-ups on drugs at wholesale and retail levels, requiring or creating 
incentives for the supply of generic versions of drugs by pharmacists and medical practitioners, 
and banning or limiting direct-to-consumer advertising of medicines, are some of the strategies 
that may reduce prices. 
· Most essential medicines are not under patent, and generic versions can be produced or 
imported without infringing patent rights. 
· Affordable access to essential medicines that are under patent depends partly on the terms of 
national patent laws, and on the actions of the patent holder. The Agreement on Trade-Related 
Aspects of International Property Rights (TRIPS) includes a number of flexibilities that can be used 
to reduce the prices of essential medicines and to better meet the goal of universal access. TRIPS 
does not prevent national governments from issuing compulsory licences in order to meet 
national health objectives, from choosing an exhaustion regime that best suits national 
circumstances (allowing parallel importing for example), or from defining patentability criteria in 
national patent legislation.1 
· A patent holder may enter into a voluntary licence with third parties, such as generic 
producers, to produce, market and distribute a particular drug within a specified territory. 
Royalty-free, non-exclusive licences that include a large number of countries within the licensed 
territory, permit sale to both the public and private sector, and permit licensees to source active 
pharmaceutical ingredients from anywhere in the world are more likely to encourage robust 
competition and the economies of scale that are needed to substantially reduce prices. Other 
strategies that support access to essential medicines include tiered pricing, donation of drugs, 
non-filing of patents in least developed countries, and non-enforcement of patents. 
Introduction 
Ensuring universal access to free or affordable essential medicines is one of the “core obligations” 
for fulfilling the right to health.2 WHO has encouraged countries to amend their national legislation 
or constitutions to provide for this specific right3 (Box 15.1). For example, the Universally Accessible 
Cheaper and Quality Medicines Act of 2008, enacted by the Philippines, contains the following 
declaration of policy: 
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It is the policy of the State to protect public health and, when the public interest or circumstances of 
extreme urgency so require, it shall adopt appropriate measures to promote and ensure access to 
affordable quality drugs and medicines for all. 4 
The Act also states that any doubts about the interpretation of provisions of the Act shall be 
resolved by adopting a construction in favour of the protection of public health.5 
Box 15.1: Constitutional protections for access to medicines: examples from Panama and the 
Philippines 
Political Constitution of the Republic of Panama6 
Article 110. In matters of health, the State is primarily obligated to develop the following activities, 
integrating the functions of prevention, treatment, and rehabilitation: 
… 
5. Establish, in accordance with the requirements of each region, centres which provide 
comprehensive health care services and supply medicines to the population. These health services 
and medicines shall be given free to those who lack economic means to purchase them. 
Constitution of the Republic of the Philippines7 
Article 13. 
Section 11. The State shall adopt an integrated and comprehensive approach to health development 
which shall endeavour to make essential goods, health and other social services available to all the 
people at affordable cost. There shall be priority for the needs of the underprivileged, sick, elderly, 
disabled, women, and children. The State shall endeavour to provide free medical care to paupers. 
Section 12. The State shall establish and maintain an effective food and drug regulatory system and 
undertake appropriate health manpower development and research, responsive to the country's 
health needs and problems. 
In some countries, the treaty obligations assumed by countries are enforceable through the 
domestic courts, providing members of the population with a legal pathway for seeking greater 
access to essential medicines at affordable prices.8 For example, Argentina’s Constitution refers to a 
number of human rights treaties which supersede domestic law (Box 15.2). In 2000, the Argentinian 
Supreme Court ruled that the right to life enshrined in the International Covenant on Economic, 
Social and Cultural Rights9 was enforceable under Argentinian law in that country’s domestic courts. 
The ruling provided, in part, that the government had a positive duty – going beyond what was 
specifically required by Argentinian legislation – to provide medicine to a disabled child.10 
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Box 15.2: Using international treaties to promote access to medicines: human rights treaties that 
supersede domestic law in the Constitution of Argentina 
Section 75  
… 
22. The American Declaration of the Rights and Duties of Man; the Universal Declaration of Human 
Rights; the American Convention on Human Rights; the International Covenant on Economic, Social 
and Cultural Rights; the International Covenant on Civil and Political Rights and its empowering 
Protocol; the Convention on the Prevention and Punishment of Genocide; the International 
Convention on the Elimination of all Forms of Racial Discrimination; the Convention on the 
Elimination of all Forms of Discrimination against Woman; the Convention against Torture and other 
Cruel, Inhuman or Degrading Treatments or Punishments; the Convention on the Rights of the Child; 
in the full force of their provisions, they have constitutional hierarchy [above national law], ... [and] 
are to be understood as complementing the rights and guarantees recognized herein. 
15.1 Establishing a national drugs policy 
In order to ensure access to essential medicines, countries need to establish a national drugs policy. 
WHO has released comprehensive guidance on creating these policies, which should address access 
to, and the quality and rational use of, medicines.11 The WHO Model List of Essential Medicines can 
help to guide drug selection, although the development of a national list should take account of 
national priorities and disease challenges.12 A national drug policy, including a list of essential 
medicines and standard treatment guidelines, can increase the use of generics, improve prescribing 
practices and protect against drug resistance. 
For example, during the 1990s, South Africa developed a national drug policy in collaboration with 
WHO. The Minister for Health appointed a Drug Policy Committee to develop a pricing plan for drugs 
used in both the public and private sectors, to develop a plan for the evaluation of drugs for 
effectiveness, and to develop an essential drugs list for use in the public sector. The committee also 
considered strategies for increasing the use of generic drugs, and for procurement and distribution, 
particularly in rural areas.13 The policy developed as a result of this process secures the right to 
universal access to essential medicines by committing the government to:14 
• ensure the availability and accessibility of essential medicines to all citizens; 
• ensure the safety, efficacy and quality of drugs; 
• ensure good prescribing and dispensing practices; 
• promote the rational use of drugs by prescribers, dispensers and patients through provision 
of the necessary training, education and information; and 
• promote the concept of individual responsibility for health, preventive care and informed 
decision-making. 
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The South African government has since established the South African Drug Action Programme 
within the Department of Health to implement the new policy and to support provincial strategies. 
15.2 Pricing and procurement 
A national procurement policy is an important tool for assisting governments to purchase quality 
drugs at the lowest possible prices. An effective procurement strategy must accurately estimate the 
drug needs of the country and select the most appropriate purchasing strategy based on resources 
and time. There are four general methods for procuring pharmaceuticals: open tenders, restricted 
tenders, competitive negotiations and direct procurement.15 The procurement method chosen by a 
government should seek to achieve the following objectives: (1) to procure the most cost-effective 
drugs in the right quantities; (2) to select reliable suppliers of high-quality products; (3) to ensure 
timely delivery of essential medicines; and (4) to achieve the lowest possible total cost.16 Countries 
may choose to incorporate these objectives into national legislation or administrative guidelines, as 
Sri Lanka has done (Box 15.3). 
Box 15.3: Sri Lanka’s National Procurement Strategy: guidelines for procurement of 
pharmaceuticals and medical devices17 
Section 1.1. All pharmaceuticals procured must fulfil quality, safety and efficacy criteria. All medical 
devices procured should satisfy quality, safety, performance, effectiveness and efficacy criteria. 
Section 1.2. The strategic objectives of procurement of pharmaceuticals & medical devices should 
be: 
• procure the most cost-effective pharmaceuticals and medical devices in the right quantities; 
• ensure supplier reliability with respect to service and quality; 
• arrange timely delivery to avoid shortages and stock outs; and 
• achieve the lowest possible evaluated cost. 
Section 6. Pharmaceuticals and medical devices may be procured by International Competitive 
Bidding (ICB), National Competitive Bidding (NCB), Limited/restricted International Competitive 
Bidding (LIB), in accordance with the applicable provisions stipulated in [procurement guidelines], 
subject to any modifications contained herein. 
Section 7.2. To ensure that the [procuring entity] obtains competitive prices the [procuring entity] 
should have reference to historical prices and may also refer to the Annual International Drug Price 
Indicator Guide published by the Management Sciences for Health. [The procuring entity] may also 
consult with neighbouring countries on prices offered to them and inquire into the possibility of 
pooled procurement schemes. 
Pharmaceutical drugs are estimated to account for 25% of global health spending. However, 10–25% 
of public spending on procurement is thought to be lost to corruption.18 WHO has published 
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guidance to assist public authorities to avoid corruption.19 Important steps include registering 
medicines on the national list, licensing importers of pharmaceuticals and medical equipment, 
licensing pharmacists and dispensers of drugs, inspecting facilities, controlling the advertising and 
promotion of medicines, introducing oversight mechanisms for clinical trials, and developing a 
comprehensive plan for selecting and procuring essential medicines.20 In Kenya, neutral observers 
are invited to be present at committee meetings where large tenders are considered (Box 15.4). 
Other legal strategies include giving legislative protection to whistle-blowers, requiring members of 
the national drug registration committee to file a conflict of interest declaration, and prosecuting 
acts of corruption in a timely manner.21 
Box 15.4: Applying good governance principles to procurement strategies in Kenya 
Public Procurement and Disposal Regulations, 200622 
12. Procedure for tender committee meetings. 
… 
(8) To enhance transparency of the procurement process the procuring entity shall invite in addition 
to the representative of various departments, at least two observers to attend its meetings in cases 
where the value of the contract is estimated to be above fifty million shillings. 
(9) At least one of the observers invited under paragraph (8) shall come from a duly recognized 
private sector organization or discipline relevant to the procurement under consideration. 
In addition to minimizing corruption, a national drugs policy can reduce the systemic costs that 
create barriers to access to essential medicines. This can occur by eliminating tariffs on the import of 
drugs that are not produced domestically and by controlling the mark-ups that can be applied to 
drugs that are resold in the private and public sectors.23 In South Africa, mark-ups on the prices of 
drugs at the wholesale and retail levels have been replaced with a fixed fee (Box 15.5). Programmes 
that create incentives for pharmacists and medical practitioners to dispense or prescribe generic 
versions of drugs, where available, can also reduce the price paid by patients and improve access.24 
Argentina, the Plurinational State of Bolivia, Peru and Uruguay all require physicians to use generic 
names when writing prescriptions: this allows pharmacists to fill orders with cheaper alternatives to 
brand name drugs when they are available.25 
Box 15.5: Monitoring pharmaceutical pricing: South Africa’s National Drug Policy26 
Section 4.1. Rationalization of the pricing structure 
• A Pricing Committee with clearly defined functions to monitor and regulate drug prices will 
be established within the Ministry of Health. Committee members will include health 
economists, pharmacoeconomists, and representatives from the Department of Finance, the 
Department of Trade and Industry, the Procurement Unit of the Department of Health, the 
Department of State Expenditure, and consumer representatives. 
• There will be total transparency in the pricing structure of pharmaceutical manufacturers, 
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wholesalers, providers of services, such as dispensers of drugs, as well as private clinics and 
hospitals. 
• A non-discriminatory pricing system will be introduced and, if necessary, enforced. 
• The wholesale and retail percentage mark-up system will be replaced with a pricing system 
based on a fixed professional fee. … 
• A database will be developed to monitor the cost of drugs in the country in comparison with 
prices in developing and developed countries. 
• Price increases will be regulated. 
• Where the State deems that the retail prices of certain pharmaceuticals are unacceptable 
and that these pharmaceuticals are essential to the well-being of any sector of the 
population, the State will make them available to the private sector at acquisition cost plus 
the transaction costs involved. 
In addition, laws that ban or limit the advertising of pharmaceuticals direct to consumers can reduce 
patient demand for unnecessarily expensive drugs.27 Direct-to-consumer advertising stimulates the 
prescribing of advertised medicines, and is rare outside the United States, where commercial free 
speech by pharmaceutical manufacturers is protected by the Constitution.28 Finally, where a 
branded medicine has previously received regulatory approval, governments may encourage the 
supply of generic or bioequivalent versions of the same drug by offering a faster, preferential 
process for regulatory approval, together with discounted registration fees.29 
15.3 Access to medicines, patents and TRIPS 
The national drugs policy adopted by each country needs to be consistent with international law 
governing intellectual property rights. Medicines, as well as the processes required to produce them, 
are patentable under the Agreement on Trade-Related Aspects of Intellectual Property Rights 
(TRIPS).30 TRIPS is one of the family of agreements that Members of the World Trade Organization 
(WTO) are required to implement. In order to implement TRIPS, all Members of the WTO are 
required to enforce national legislation that recognizes and enforces pharmaceutical patents.31 This 
section reviews some features of national patent laws that may influence access to medicines, and 
the prices at which medicines are available for purchase, within the context of countries’ TRIPS 
obligations. 
(a) The purpose of patents 
A patent is an exclusive right that enables the patent holder to exclude competing suppliers during 
the term of the patent. In return, the patent holder publicly discloses their invention: this facilitates 
free use of this information when the patent expires.32 Like any other property right, a patent may 
be sold, licensed or transferred. Patent laws are intended to encourage investors to make the huge 
investments that are required to discover, develop and deliver a new drug to market. In theory, 
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patent protection helps to ensure the continued development and availability of medicines in future, 
provided that markets can generate a return to the patent holder for their costs of research and 
development. When patent regimes work well, they promote technological innovation, by ensuring 
a return on investment for the patent holder, while also ensuring the transfer and dissemination of 
technology and the continued availability of generic medicines after the patent has expired.33 
However, since patents eliminate competition, they can also lead to high prices for medicines during 
the term of the patent. 
High prices, as well as the scale of need for particular drugs, may combine to defeat the goal of 
providing universal access to a national list of essential medicines, especially in low-income 
countries. Furthermore, the incentive to invest in research and development in order to bring new 
medicines to market may not be present when the market value of the innovation is small. In the 
case of “neglected diseases” that disproportionately affect poor populations and low-income 
countries, patents have failed to achieve their objective as instruments of innovation since both 
governments and patients lack the purchasing power to create a market that justifies the necessary 
investment in the first place.34 A variety of other policy instruments will be required to overcome 
market failure and to encourage research and development of neglected diseases.35 
(b) The TRIPS Agreement and intellectual property rights 
The TRIPS Agreement came into force on 1 January 1995. WTO Members were given different dates 
by which to amend their domestic laws and practices in order to protect patent rights on 
pharmaceuticals, according to their status as developing countries and whether or not they had any 
previously existing laws recognizing patents in this area.36 Under Article 66.1, least developed 
countries were originally given until 2006 to recognize and enforce patents on pharmaceuticals, 
although this date has since been extended to 1 January 2033.37 On two occasions, the Council for 
TRIPS has granted a broader extension of time to least developed countries to implement the 
substantive provisions of TRIPS (other than the non-discrimination provisions), most recently to 1 
July 2021.38 
Article 27 of the TRIPS Agreement states that patents shall be available for both products and 
processes, in all fields of technology, provided they are new, involve an inventive step and are 
capable of industrial application.39 The period of patent protection is 20 years.40 In the case of 
products, Article 28 states that the rights of a patent holder include the right to prevent third parties 
from “making, using, offering for sale, selling, or importing” the product without the patent holder’s 
consent.41 
Since the majority of medicines that WHO considers to be essential medicines are not under 
patent,42 it follows that the obligation of WTO Members to implement patent laws covering 
pharmaceuticals should not constitute a barrier to access for most drugs included in a national list of 
essential medicines. The extent to which patent protection for a particular medicine affects price 
and availability will depend upon the terms of patent laws and the patent status of that drug in each 
country, together with the existence of any voluntary or compulsory licences that have been issued. 
In cases where the period of patent protection has expired, generic versions of the drug may be 
produced and imported without infringing any patent rights. During the period of patent protection, 
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national authorities, as well as private suppliers, will need to negotiate with the patent holder on 
commercial terms for the price at which the medicine can be imported into that country, or 
alternatively, negotiate for a licence to manufacture the medicine within the country – assuming 
that there are no other generic medicines that are equally effective. 
Article 63 of the TRIPS Agreement requires WTO Members to notify the Council for TRIPS about the 
national laws, regulations, and judicial and administrative decisions that affect the scope of 
protection for patents and other intellectual property rights, and to respond to requests from other 
WTO Members about the scope of their laws.43 Disputes between WTO Members about a Member’s 
compliance with its obligations under TRIPS are considered by a panel of experts who are appointed 
to hear each complaint. The panel’s decision may be appealed to the WTO Appellate Body. The 
TRIPS Agreement provides for the imposition of trade sanctions by a Member on behalf of the 
patent holder in cases where another Member has failed to implement the report of the panel or 
Appellate Body and to act in accordance with that Member’s obligations under TRIPS.44 
Despite their obligation to implement laws granting and enforcing patents on pharmaceutical 
products, WTO Members retain considerable scope to adjust their patent laws in order to achieve 
public health objectives. For example, national laws may authorize the judiciary, the executive, or an 
administrative body to issue a compulsory licence to manufacture or import a patented drug without 
the permission of the patent holder in circumstances where licensing negotiations with the patent 
holder have failed or in cases of emergency or government use, in order to achieve the 
government’s policy of providing universal access to medicines, diagnostics, vaccines or medical 
devices.45 The Declaration on the TRIPS Agreement and Public Health, adopted by Trade Ministers at 
the Doha Ministerial Meeting in November 2001, states that “Each Member has the right to grant 
compulsory licences and the freedom to determine the grounds upon which such licences are 
granted”.46 Although the TRIPS Agreement does not refer specifically to compulsory licences, the 
wording of Article 31 recognizes that national patent laws may authorize public, non-commercial 
uses of patents by or on behalf of government, where the conditions set out in Article 31 are 
satisfied (Box 15.6).47 
Box 15.6: Flexibilities recognized in Articles 8 and 31 of the Agreement on Trade-Related Aspects 
of International Property Rights (TRIPS) 
Article 8 
1. Members may, in formulating or amending their laws and regulations, adopt measures necessary 
to protect public health and nutrition, and to promote the public interest in sectors of vital 
importance to their socio-economic and technological development, provided that such measures 
are consistent with the provisions of this Agreement.  
Article 31 
Other Use without Authorization of the Right Holder 
Where the law of a Member allows for other use of the subject matter of a patent without the 
authorization of the right holder, including use by the government or third parties authorized by the 
government, the following provisions shall be respected: 
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(b) such use may only be permitted if, prior to such use, the proposed user has made efforts 
to obtain authorization from the right holder on reasonable commercial terms and 
conditions and that such efforts have not been successful within a reasonable period of 
time. This requirement may be waived by a Member in the case of a national emergency or 
other circumstances of extreme urgency or in cases of public non-commercial use. In 
situations of national emergency or other circumstances of extreme urgency, the right 
holder shall, nevertheless, be notified as soon as reasonably practicable. … 
(f) any such use shall be authorized predominantly for the supply of the domestic market of 
the Member authorizing such use; 
(h) the right holder shall be paid adequate remuneration in the circumstances of each case, 
taking into account the economic value of the authorization… 
In addition to licences issued on public interest grounds, the practice of WTO Members illustrates 
that national laws may authorize compulsory licences on a number of additional grounds.48 For 
example, Zimbabwe’s Patent Act provides that during periods of emergency (which legislators have 
authority to define), national laws may authorize the use of a patent without the permission of the 
patent holder, due to the scale of the health threat caused by a natural disaster, epidemic or security 
threat, as well as the physical interruption of supplies at affordable prices (Box 15.7). Other grounds 
for the issuing of a compulsory licence may arise where anti-competitive practices and pricing 
policies of patent holders have inflated drug prices to the point where they are no longer affordable, 
or where the patent holder has failed to exploit a patent or to license it within the jurisdiction.49 
Box 15.7: Public, non-commercial (government) use of patents: Patent Act of Zimbabwe 50  
Section 34. Use of patented inventions for service of the State 
(1) Notwithstanding anything in this Act, any department of the State or any person authorized in 
writing by the Minister may make, use or exercise any invention disclosed in any specification lodged 
at the Patent Office for the service of the State in accordance with this section. 
Section 35. Special provisions as to State use during emergency 
(1) During any period of emergency the powers exercisable in relation to an invention by a 
department of the State or a person authorized by the Minister under section thirty-four shall 
include power to make, use, exercise and vend the invention for any purpose which appears to the 
Minister necessary or expedient— 
... 
(b) for the maintenance of supplies and services essential to the life of the community; or 
(c) for securing a sufficiency of supplies and services essential to the well-being of the 
community. 
At the WTO Ministerial Conference in Doha, Qatar, in 2001, WTO Ministers affirmed that TRIPS 
should be implemented in a way that supports the right of WTO Members “to protect public health 
and…to promote access to medicines for all”.51 The Declaration pointed to a number of provisions in 
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TRIPS that may assist Members to adjust their domestic laws to provide adequate protection to drug 
manufacturers and other patent holders within the territory of each Member, while acting to ensure 
that essential medicines remain affordable for all: 
• As stated above, each Member retains the right, in accordance with their national laws, to 
grant compulsory licences (which authorize the use of the patent without the permission of 
the patent holder) and to determine the conditions to be satisfied before the compulsory 
licence is granted. 
• In addition, each Member retains the right to determine what constitutes “a national 
emergency or other circumstances of extreme urgency” within the terms of Article 31. In 
either case, Article 31 authorizes the Member to waive the requirement to first seek a 
licence from the patent holder on reasonable commercial terms before issuing a compulsory 
licence to use the patent without the consent of the patent holder. 
• Each Member also retains the right to define the circumstances in which, under their 
national laws, the patent holder’s rights in a drug are exhausted. 
The operation of these and other TRIPS flexibilities is discussed below. 
(c) Awareness of TRIPS flexibilities 
It is important for national health authorities to be aware of the flexibilities in the TRIPS Agreement 
when considering strategies to improve access to essential medicines, and to carefully consider their 
benefits before entering bilateral or regional trade agreements that limit any of these flexibilities.52 
By agreeing to enforce intellectual property rights that are more extensive than those recognized 
under  the TRIPS Agreement, the cost of providing universal access to a national list of essential 
medicines may rise substantially. WHO, the WTO and the World Intellectual Property Organization, 
as well as the Commission on Intellectual Property Rights, Innovation and Public Health (established 
by the World Health Assembly in 2003), have published detailed guidance to assist national 
authorities to improve access to essential medicines.53 The United Nations Development 
Programme54 and the World Bank55 have also published reports to assist countries to use the 
flexibilities in TRIPS effectively, having due regard to their obligations to respect patents and other 
intellectual property rights. 
Article 31 requirements 
Article 31 of the TRIPS Agreement states that in circumstances where the national law of a WTO 
Member permits a compulsory licence to be issued, the Member must first seek permission to use 
the patent from the patent holder on reasonable commercial terms. However, prior attempts to 
obtain access to the patented drug on commercial terms are not required in the case of a national 
emergency (which each Member is free to define), in other circumstances of extreme urgency, or in 
cases of public, non-commercial use – such as when a government is seeking to ensure universal 
access to essential drugs, or is using the patent for other government purposes (Box 15.6, above). 
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The operation of Article 31 is illustrated by the case of Thailand, which issued government use 
licences for seven medicines for the treatment of HIV and cancer, over the period 2006–2008.56 
Thailand’s National Health Security Act of 2002 established a universal health care scheme that 
included a right of access to medicines on Thailand’s National List of Essential Medicines.57 In 
October 2003, the government declared its intention to provide universal access to triple 
antiretroviral therapy for people with HIV. However, the cost of providing this treatment rose 
rapidly, reaching nearly US$ 51 million (2.1 billion baht) in 2003. 
In 2007, the Minister of Public Health, Dr Mongkol Na Songkhla, appointed two committees to 
support the implementation of government use licences. The first, the Committee on Price 
Negotiation of Patented Essential Medicines, sought to engage pharmaceutical companies in 
negotiations for price reductions. However, with the exception of imatinib, a cancer drug produced 
by Novartis, the discounts offered did not meet the Health Minister’s benchmark that the 
discounted price should be within 5% of the price of generic versions of the medicine.58 In the case 
of lopinavir/ritonavir, a fixed-dose combination used to treat HIV infection, the cost per patient for 
middle-income countries, including Thailand, was US$ 2967 per year, although this was reduced in 
August 2006 to US$ 2200 per patient per year.59 The government issued a compulsory licence. By 
early 2008, the number of patients using lopinavir/ritonavir had tripled.60 
Thailand’s Minister of Public Health expressed the motivation for issuing compulsory licences for 
essential drugs, under Thailand’s Patent Act, as follows: 
When a government such as ours declares a ‘compulsory licence’ to allow for public non-
commercial use of patented products by the government for the greater public good, we are 
doing so to increase access to these essential, often life-saving, medications for the poor and 
marginalized members of our communities who were not consumers of these expensive, 
patented drugs. The more well-off members of our society continue to consult their own 
private physicians and continue to pay – out of their own pockets – the price of patented 
medications.61 
In order to establish a clear legal basis for exercising the flexibilities that are permitted under the 
TRIPS Agreement, WTO Member States should enact legislation that sets out the circumstances in 
which the government reserves the right to issue a compulsory license. Apart from the exceptions 
mentioned in Article 31(b), such legislation should provide for a reasonable, yet time-limited period 
for negotiating with the patent holder before the designated national authority issues the licence 
(see Box 15.8). The legislation can reduce the administrative difficulty of issuing a compulsory 
licence by specifying which Minister or administrative body should perform this function, the 
approval process required, and by prohibiting patent holders from unreasonably stalling the process 
through litigation.62 
Box 15.8: Legislation authorizing the issuing of a compulsory licence: Industrial Property Law63 of 
Brazil 
Article 68. The patent owner shall be subject to having the patent licensed on a compulsory basis if 
he exercises his rights derived therefrom in an abusive manner, or if he uses it to abuse economic 
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power according to the law in force, under the terms of an administrative or judicial decision. 
Article 73. An application for a compulsory licence shall set forth the conditions offered to the patent 
owner. 
(1) After an application for a licence has been submitted, the patent owner shall be invited to 
submit his comments within a period of 60 (sixty) days, at the end of which, in the absence of a 
submission from the patent owner, the proposal shall be deemed accepted under the conditions 
offered. 
… 
(6) In the arbitration of the remunerations, the circumstances of each case shall be taken into 
consideration and shall include the economic value of the granted licence. 
(7) Once the case has been examined, the National Institute of Industrial Property shall decide on 
the grant and on the conditions of the compulsory licence within a period of 60 (sixty) days. 
(8) Appeals from decisions to grant a compulsory licence shall not have a suspensive effect. 
In circumstances where a Member issues a compulsory licence without the authorization of the 
patent holder, Article 31 of the TRIPS Agreement requires the patent to be used “predominantly” in 
order to meet the domestic needs of the WTO Member that has authorized the licence, and 
“adequate compensation” (which TRIPS does not define) shall be paid to the patent holder.64 
However, in 2005, WTO Members approved an amendment to the TRIPS Agreement, which permits 
these requirements to be waived where certain conditions are met.65 
WTO General Council Decision of 6 December 2005 
The amendment approved in 2005 sets out a special procedure for the benefit of WTO Members 
whose domestic manufacturing sector lacks the capacity to manufacture the quantities of medicine 
that are needed. The procedure works by allowing a Member that does have adequate 
manufacturing capacity to issue a compulsory licence for the manufacture and export of a generic 
version of the patented medicine to a Member that lacks domestic manufacturing capacity. Box 15.9 
summarizes some of the key conditions that apply.66 
Box 15.9: Key conditions that apply to compulsory licences issued under the WTO General Council 
Decision of 6 December 2005 
• The importing Member must notify the Council for TRIPS of the names and quantities of 
medicines that it needs, and indicate that a compulsory licence has or will be granted for 
those medicines that are under patent within its territory. 
• The compulsory licence issued by the exporting Member shall contain conditions restricting 
the manufacture of the patented medicine to the amounts that are necessary to meet the 
needs of the importing Member. The medicines themselves must be clearly identified as 
being manufactured under the scheme so that they cannot be improperly diverted to third 
markets. All the medicines produced in this way must be exported to the importing Member. 
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• The exporting Member must post the amounts being exported and the distinguishing 
features of the shipment on a website, and notify the Council for TRIPS about the 
compulsory licence and the conditions that apply to it. 
• Eligible importing Members are required to take reasonable steps to ensure that medicines 
imported under the scheme are not re-exported. 
In order to use this procedure, the importing Member must either be a least developed country or 
must have notified the TRIPS Council of its intention to use the procedure.67 Countries exporting 
pharmaceutical products under the procedure to an eligible importing country must also notify the 
TRIPS Council when they do so.68 Unless they have opted out of doing so, all WTO Members are 
eligible to use the procedure, whether as countries that issue a compulsory licence and manufacture 
medicines for export to the importing country, or as an importing country that lacks domestic 
manufacturing capacity of its own and seeks to import essential medicines to meet its health needs. 
WTO Members with established pharmaceutical industries have an important role to play in making 
the procedure set out in the TRIPS amendment work effectively. Patent laws in exporting countries 
can help to achieve this by not imposing additional conditions on licensees and importing countries 
above those that are already imposed by the TRIPS amendment itself. For example, the TRIPS 
Agreement does not require either the importing or exporting Member to engage in commercial 
negotiations with the patent holder in circumstances where the importing Member is facing a 
national emergency or using the patent for a public, non-commercial purpose; for example, in order 
realize a government commitment to providing universal access to essential medicines.69 Given that 
the importing Member may only be capable of paying a modest price for medicines manufactured 
under the compulsory licence, exporting countries may also consider offering tax incentives to 
encourage pharmaceutical manufacturers within their territory to participate in the scheme.70 
Exhaustion of patent rights 
National patent laws dealing with the exhaustion of patent rights may also influence the price and 
availability of essential medicines within that country. Exhaustion governs the “extent to which a 
[patent] holder can prevent the resale and importation of genuine goods”, once they have been 
placed on the market with its consent in either the same or another country.71 For example, national 
patent laws may be framed so that once a patent holder has exported a drug into a national market, 
or licensed its manufacture within that country and received compensation for doing so, the patent 
holder’s intellectual property rights in that drug are taken to be exhausted (so-called international 
exhaustion). Patents legislation that permits the resale or import of medicines that have been 
legitimately placed on the market by or with the consent of the patent holder in another country 
stimulates competition and helps to keep prices low. Medicines imported into a country in these 
circumstances may be unauthorized, but will not be infringing any patent rights, since the patent 
holder has authorized their first sale.72 
The practice of importing genuine products that have been placed on the market by the patent 
holder (or authorized licensee) in another country, without the permission of the patent holder, is 
known as “parallel importing”. By engaging in parallel importing, the importing country seeks to 
avoid the need to purchase the drugs at a higher price within their own domestic market, or to 
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negotiate with the patent holder for a licence on commercial terms. The importation of genuine 
pharmaceuticals from another country without the permission of the patent holder does not breach 
the TRIPS Agreement, since TRIPS leaves WTO Members free to establish their own laws for the 
exhaustion of intellectual property rights.73 
The principle of exhaustion can be implemented at the national, regional or global levels. For 
example, if the principle of international exhaustion applies within the domestic law of an importing 
country, the patent holder’s rights will be exhausted after the first sale anywhere in the world. An 
importing country will therefore be able to import medicines lawfully placed on the market 
anywhere in the world without infringing the patent holder’s rights.74 By contrast, if a principle of 
domestic exhaustion, or, alternatively, regional exhaustion, is applied, the patent holder would only 
lose the right to object to the resale of medicines within that country, or within the region, 
respectively. 
The practice of parallel importing may constitute an infringement of the patent within countries that 
have adopted a principle of national exhaustion. By contrast, countries that implement a principle of 
regional or international exhaustion within their national patent laws may be able to resist the 
efforts of the patent holder to segregate markets and to insulate them from the cheaper prices that 
may be achieved through parallel importation from countries outside the region, or from any other 
country, respectively. Even in circumstances where national patent legislation adopts the principle of 
international exhaustion, there may be other obstacles to the practice of parallel importation. For 
example, if the export of medicines by an international distributor would breach a term of the 
distributor’s licence, the result may be that within the domestic law of the importing country, 
parallel importation is regarded as a violation of the rights of the patent holder.75 
As Box 15.10 illustrates, Kenya revised its intellectual property laws in 2001 to authorize the parallel 
importation of pharmaceuticals that were legitimately on the market in the exporting country. As 
confirmed by clause 37 of Kenya’s Industrial Property Regulations (2002), this would not authorize 
the import and sale of pirated or stolen medicines that could not lawfully be sold in the country of 
export.76 On the other hand, it confirms the principle of international exhaustion by permitting 
Kenya to import medicines from any country in which those medicines are lawfully available for sale. 
Box 15.10: Legislation authorizing parallel imports: an example from Kenya 
Industrial Property Act77  
Section 53. (1) The applicant or the owner of the invention shall have the following rights: 
(a) to be granted the patent, where the relevant requirements under this Act are fulfilled; 
(b) after the grant of the patent and within the limits defined in section 58 to preclude any person 
from exploiting the patented invention in the manner referred to in section 53; and 
(c) to conclude licence contracts as provided for in Part X of this Act, and subject to the obligations 
referred to in subsection (2). … 
Section 58. (2) The rights under the patent shall not extend to acts in respect of articles which have 
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been put on the market in Kenya or in any other country or imported into Kenya.  
… 
(5) The rights under the patent shall be limited by the provisions on compulsory licences for reasons 
of public interest or based on interdependence of patents and by the provisions on State 
exploitation of patented inventions. 
(6) The rights of the patent shall not extend [to] variants or mutants of living forms or replicable 
living matter that is distinctively different from the original for which patents were obtained where 
such mutants or variants are deserving of separate patents. 
Industrial Property Regulations78 
Section 37. The limitation on the rights under a patent in section 58(2) of the Act extends to acts in 
respect of articles that are imported from a country where the articles were legitimately put on the 
market. 
Restrictions on incremental patents 
The TRIPS Agreement requires WTO Members to grant patents for all products and processes 
“provided that they are new, involve an inventive step and are capable of industrial application”.79 
Patent holders may seek patents for minor improvements or adjustments to a drug, such as another 
crystalline form, an alteration of the form of delivery, a dosage form, or for new uses of an existing 
drug (second medical indications). While some incremental innovations can bring important benefits 
to patients, some of these patents may simply serve to delay the entry of cheaper, generic versions 
into the marketplace. While incremental patenting (also called life-cycle management or 
“evergreening” – depending on the point of view) may increase the return on investment for the 
patent holder, it may also keep prices high. National governments seeking to ensure access to 
essential medicines at the lowest prices may consider amending their patent laws or the guidelines 
for patent examiners in order to restrict the award of patents to products that can truly be said to 
involve an inventive step and to be “novel”, resisting pressure to permit patents for small 
alterations, or new therapeutic uses of existing chemical compounds (Box 15.11). 
Box 15.11: Prohibiting patentability of minor adjustments to a pharmaceutical product in the 
Andean Community 
Andean Community Decision: Common Intellectual Property Regime80 
Article 21. Products or processes already patented and included in the state of the art within the 
meaning of Article 16 of this Decision may not be the subject of new patents on the sole ground of 
having been put to a use different from that originally contemplated by the initial patent. 
India’s Patents Act provides an example of national legislation intended to restrict the practice of 
incremental patents.81 India amended its national patent laws in 2005 to bring them into compliance 
with TRIPS. In Novartis AG v Union of India,82 the Supreme Court of India explained the statutory 
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requirements that must be satisfied. The Patents Act provides for patents to be granted for 
“inventions”. An invention must be: 
• new; 
• capable of industrial application; and 
• must involve an inventive step that: (i) involves a technical advance over previous 
knowledge or has economic significance; and (ii) makes the invention not obvious to a 
person skilled in the art.83 
However, under Indian law, not all innovations will fulfil the requirements for patentability. For 
example, the Act provides that “the mere discovery of a new form of a known substance which does 
not result in the enhancement of the known efficacy of that substance” is not an invention within 
the meaning of the Act.84 The Act also states that “salts, esters, ethers, polymorphs, metabolites, 
pure form, particle size, isomers, mixtures of isomers, complexes, combinations and other 
derivatives of known substance shall be considered to be the same substance, unless they differ 
significantly in properties with regard to efficacy”.85 
Novartis AG had applied for a patent for imatinib mesylate salt in beta crystalline form (brand name: 
Glivec), a drug used in treatment of leukaemia and a number of other forms of cancer. In the 
Novartis case,86 the Supreme Court of India explained that the bar for patentability is set higher for 
pharmaceuticals and chemical substances, since in addition to being an “invention”, the medicine 
must pass the hurdle set out in section 3(d), which excludes from patent different chemical forms of 
the same substance. The court accepted that “all the pharmacological effects of imatinib mesylate in 
beta crystalline form are equally possessed by imatinib in free base form”.87 Although Indian 
legislation does not exclude patent protection for incremental inventions of pharmacological 
substances that “lead to an enhancement of therapeutic efficacy”, there was no evidence before the 
court that the beta crystalline form of imatinib mesylate met this requirement.88 
Regulatory review exception 
Article 30 of the TRIPS Agreement permits Members to pass legislation creating limited exceptions 
to patent rights, provided that they do not “unreasonably conflict with a normal exploitation of the 
patent”.89 This exception is generally recognized to permit national legislation authorizing 
researchers to conduct research on (and in some cases, research carried out using) the patented 
invention.90 For example, the Common Intellectual Property Regime of the Andean Community 
provides that the rights of the patent holder do not extend to “acts carried out exclusively for the 
purposes of teaching or scientific or academic research” (Box 15.12). 
Box 15.12: Exemptions from patent infringement liability: examples from the Andean Community 
and Kenya 
Andean Community Decision: common intellectual property regime91 
Article 53. A patent owner may not exercise the right referred to in the previous article with respect 
to the following acts: 
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(a) acts carried out in a private circle and for non-commercial purposes; 
(b) acts carried out exclusively to experiment with the subject matter of the patented invention; 
(c) acts carried out exclusively for the purposes of teaching or scientific or academic research; 
… 
(e) where the patent protects biological material that is capable of being reproduced, except for 
plants, using that material as a basis for obtaining a viable new material, except where the patented 
material must be used repeatedly to obtain the new material. 
Kenya: Industrial Property Act92 
Section 58(1). The rights under the patent shall extend only to acts done for industrial or commercial 
purposes and in particular not to acts done for scientific research. 
Another common exception permits an applicant seeking marketing approval for a generic version of 
a drug (and any other parties producing the active ingredient within the medicine) to use the patent 
for the purposes of producing the drug and meeting regulatory requirements. For example, Canada’s 
Patent Act93 stipulates that: 
It is not an infringement of a patent for any person to make, construct, use or sell the patented 
invention solely for uses reasonably related to the development and submission of information 
required under any law of Canada, a province or a country other than Canada that regulates the 
manufacture, construction, use or sale of any product. 
In 2000, a WTO Panel confirmed that the regulatory review exception, as set out in Canada’s 
legislation, is authorized by Article 30 of TRIPS.94 This interpretation facilitates the more rapid 
introduction of cheaper, generic versions of a medicine into a national market after the brand name 
patent has expired. However, while the patent provisions of TRIPS may not prevent an applicant 
from seeking marketing approval for a generic version of a drug during the patent period, the 
capacity to obtain early approval for generics may also be affected by legal requirements protecting 
the exclusivity of test data, as explained below. 
Protection of test data 
Irrespective of whether a drug patent has expired, the capacity of generic drug manufacturers to 
manufacture a particular drug may also be affected by national laws regulating the protection of test 
data. The process of developing a pharmaceutical drug will involve the generation of a significant 
amount of test data relating to the efficacy and pharmacological effects of the drug. These data will 
be generated through clinical trials and other tests, and are a product of the efforts of the 
originating company.  
Not all countries will have the capacity to independently evaluate the safety, quality and efficacy of 
pharmaceutical products submitted for marketing approval within a national market. Some 
countries may simply rely on the fact that marketing approval has been granted by the United States 
Food and Drug Administration, or by authorities in other countries. However, in cases where a 
country requires the submission of test data as a condition to granting marketing approval, the TRIPS 
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Agreement requires WTO Members to protect such data against disclosure, except where steps have 
been taken to “ensure that the data are protected against unfair commercial use”.95 The 
requirement to protect test data only arises in circumstances where: data have not previously been 
published and have been generated through considerable effort, where the country reviewing a 
pharmaceutical product requires the submission of test data as a condition of giving marketing 
approval, and where the product itself utilizes “new chemical entities”.96 
The TRIPS Agreement does not define what constitutes “unfair commercial use”, nor is there 
authoritative WTO jurisprudence that settles this issue.97 Intellectual property laws in many 
developed countries recognize a fixed period of data exclusivity that disentitles regulatory 
authorities from relying on test data for periods of between five and 10 years from the date on 
which the originator product obtained marketing approval. Since the protection of test data is a 
distinct category of intellectual property, data exclusivity may be protected under national law 
regardless of whether a valid patent exists in respect of the same product in the same national 
market.98 
Where national laws grant data exclusivity protection to the holder of a pharmaceutical patent, 
regulatory authorities will not be entitled to rely on those data when considering subsequent 
applications for marketing approval for generic substitutes of the brand name drug.99 As a result, an 
applicant seeking marketing approval for a generic may be obliged to “duplicate tests (often 
involving suffering of animals) in order to reach results that are already known”.100 Data exclusivity 
may also interfere with the issuing of a compulsory licence, “as the entry of the generic product 
would be delayed for the duration of the exclusivity period or for the time it takes to undertake a 
new compilation of test data”.101 
Policy-makers in developing countries have considerable flexibility to define what constitutes “unfair 
commercial use”, and to ensure that any period of data exclusivity granted in legislation is 
appropriately balanced with the goal of ensuring a competitive market for the supply of essential 
medicines. For example, national laws may grant national authorities and courts the right to declare 
that the use by a generic manufacturer of a patent holder’s test data does not constitute “unfair 
commercial use” in circumstances where the government is issuing a compulsory licence to ensure 
wider access to essential medicines at affordable prices under a national drugs policy. To the extent 
that national courts and authorities give a wide interpretation to the exceptions recognized in data 
exclusivity provisions, they will facilitate faster access to essential medicines as soon as the 
patent expires, and support the efforts of national governments to realize this aspect of the right to 
health.102 
(d) Voluntary licence agreements for essential medicines 
Pharmaceutical companies that hold patents or other intellectual property rights over essential 
medicines can decide when and how to exercise their exclusive rights and as a result may choose to 
enter into voluntary licences with third parties, such as generic producers, to produce, market and 
distribute a particular drug within a specified territory. Where the licence is non-exclusive and 
foresees moderate royalties or is royalty-free, the licence may encourage competition between 
generic producers to supply the market within the authorized territory, thereby reducing the market 
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price.103 Voluntary licences have been widely used by companies producing HIV medicines,104 and 
could have a significant impact on the global epidemic of hepatitis C.105 To avoid legal disputes, it is 
important for the voluntary licence to clearly set out the actions that licensees are permitted to take, 
and the territories to which the licence extends. 
Voluntary licences are part of a broader set of strategies that pharmaceutical companies can use, as 
part of their corporate social responsibility or humanitarian programmes, to increase access to 
essential medicines at affordable prices. Other strategies include tiered pricing, donation of drugs, 
non-filing of patents in least developed countries, and non-enforcement of patents.106 The originator 
company or rights owner may formalize their decision not to enforce patent rights by making a non-
assert declaration, or by entering into a non-assertion covenant or immunity-from-suit agreement 
that sets out the conditions under which the rights owner will not enforce their patent rights. 
The Medicines Patent Pool (MPP),107 established by the International Drug Purchase Facility 
(UNITAID) in 2006,108 negotiates licence agreements with patent owners and enters into sub-
licensing agreements with generic companies to produce licensed drugs and drug combinations for 
low- and middle-income countries. For example, in 2015, AbbVie entered into an agreement with 
MPP to grant non-exclusive, royalty-free sub-licences for the manufacture and sale of lopinavir 
and/or ritonavir (LPV/r), two second-line HIV drugs, for prevention and treatment of HIV within (all) 
African countries.109 This licence agreement requires sub-licensees to demonstrate their capacity to 
manufacture these compounds in a manner consistent with WHO prequalification standards,110 to 
agree not to divert them outside African countries where this would infringe an existing AbbVie 
patent, and to cooperate in pharmacovigilence reporting responsibilities. In 2015 the MPP was 
expanded to include drugs for tuberculosis and hepatitis. The first licence issued for declatasvir, a 
hepatitis C drug, covers 112 countries.111 
There are a number of variables within licensing agreements that may help to increase competition 
and to reduce the market price for essential medicines. For example, royalty-free, non-exclusive 
licences – which include a large number of countries within the licensed territory, permit sale to 
both the public and private sector, and permit licensees to source active pharmaceutical ingredients 
from anywhere in the world – are more likely to encourage robust competition and the economies 
of scale that are needed to substantially reduce prices. Other variables that support access include 
the publication of licence agreements, permitting licensees to supply countries that issue 
compulsory licenses in accordance with TRIPS flexibilities, and not restricting the rights of licensees 
to challenge the licensor’s patent or to market the drug in countries where it is not under patent.112 
Where the originator company permits the licensee to rely on its pharmaceutical data, this may 
speed up the process of obtaining marketing approval for the drug in countries where data 
exclusivity provisions apply. Originator companies may also contribute to local capacity in the 
manufacture and distribution of essential medicines by including technology transfer components 
within the licence.113 For example, the originator company may offer support to the licensee in 
meeting quality standards for manufacturing, packaging and storage, as well as registration 
requirements applicable within the authorized countries. Conversely, generic companies may also 
contribute expertise to the partnership with the originator company through their knowledge of 
registration processes and supply chain management within the authorized countries.114 
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Chapter 16: Legal responses to poor nutrition: 
undernutrition, overweight and obesity 
 
SUMMARY POINTS 
 
· The human right to food, as recognized in the International Covenant on Economic, Social and 
Cultural Rights encompasses a right to be free from hunger, and to have an adequate supply of 
safe and nutritious food. 
· Many low- and middle-income countries are moving towards a “Western diet” that is higher in 
fats, sugars, refined carbohydrates, meat and animal products, but poorer in vegetables, legumes 
and coarse grains. Obesity and diet-related risk factors are contributing to the rapid rise of 
diabetes and other noncommunicable diseases, including in countries that continue to face a 
substantial burden from infectious diseases and undernutrition. 
· Legal and regulatory policies for reducing diet-related disease cover three main policy 
domains: the food environment (including the retail food environment), the food production 
system (including regulation of the food supply chain and the nutritional content of food), and 
consumer behaviour. 
· Improvements in agricultural and fiscal policies can benefit health; for example, by abolishing 
subsidies on sugar and other sweeteners, or by focusing investment away from the manufacture 
and export of oils that are high in saturated fats. 
· Food companies use a wide variety of sophisticated advertising and promotional techniques to 
manipulate and shape children’s food preferences. A number of countries have implemented legal 
controls on food advertising and promotion in order to protect children from excessive exposure 
to advertising and promotion of energy-dense but nutrient-poor foods, including through the 
media. 
· WHO has recommended that settings where children gather (including schools, pre-schools, 
and playgrounds) should be free from “all forms of marketing of foods high in saturated fats, 
trans-fatty acids, free sugars, or salt”. Governments can improve the school food environment by 
directly restricting the advertising and promotion of unhealthy foods in schools, and ensuring that 
all food sold or made available on school grounds during the school day is safe to eat and meets 
minimum nutritional criteria. 
· Food labelling, including nutritional information panels, front-of-pack interpretive labelling 
schemes, warning labels and suitably regulated health claims, may assist consumers to choose 
more nutritious foods. Countries may also consider extending interpretive nutrition labelling to 
restaurants and food stalls. 
· Imposing non-trivial taxes on sugar-sweetened beverages and on foods that are high in salt, 
saturated fat, and/or added sugar is a potential strategy for raising the prices of these products in 
order to reduce consumption. Quite apart from their observed impact on consumption, food and 
beverage taxes may encourage product reformulation by manufacturers, resulting in healthier 
products that can compete more effectively on price. 
· Food and beverage taxes may also provide an additional revenue stream for governments to 
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invest in health. 
· Governments may consider sales bans or mandatory food standards where there is a clear 
case for eliminating harmful substances from the food supply (e.g. trans-fat). Mandatory 
standards may also be considered appropriate where voluntary or co-regulatory processes for 
food reformulation are moving too slowly or have proved ineffective in meeting national 
nutritional goals and targets; for example, in reducing population salt intake. 
· Governments may also adopt regulations or mandatory standards in order to implement food 
fortification programmes to improve micronutrient deficiencies. Examples include universal 
iodization of salt, and mandatory fortification of wheat flour with iron, folic acid, and/or zinc. 
· There are many ways that law can support a healthy food and physical activity environment, 
including through the use of zoning and planning controls, and incentives for the establishment of 
stores and stalls selling healthy and fresh food. 
· Undernutrition remains a major problem in many countries, particularly developing countries. 
Legal recognition of the right to adequate food and nutritional security provides the basis for 
holding governments accountable for policies to address hunger and micronutrient deficiencies. In 
some countries, this right may be enforced through national courts. 
· As illustrated by Brazil’s Bolsa Família, a cash transfer paid to the female head of household 
may be an effective strategy for increasing food security, and providing a flexible safety net for 
other needs. 
Introduction 
The right to food is a human right recognized in the International Covenant on Economic, Social and 
Cultural Rights (ICESCR),1 the Convention on the Rights of the Child,2 and a number of other human 
rights instruments. The right to food in the ICESCR encompasses the right to be free from hunger, as 
well as the right of everyone to access adequate, safe and nutritious food.3 Discharging these 
obligations is one of the core obligations owed by States under the right to health.4 
Diets in low- and middle-income countries are changing rapidly. Countries that have traditionally 
faced problems with undernutrition and infectious diseases are now also facing a rapid upsurge in 
obesity and dietary risk factors, leading to diabetes and other noncommunicable diseases.5 In 2010, 
dietary risk factors, combined with lack of physical activity, were responsible for 10% of the global 
burden of disease, and 12.5 million deaths.6 There are many factors that are thought to be 
contributing to changing dietary patterns and to the burden of diet-related disease.7 These include: 
• rising incomes due to economic development (leading to diets richer in sugar and fats, and 
access to labour-saving technology, including motor vehicles); 
• urbanization (resulting in greater access to a wider range of processed foods, greater 
exposure to food advertising, and reduced levels of physical activity); 
• trade liberalization policies (leading to expanded international trade in food products 
including, for example, imports of low-quality, fatty meat products);8 
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• developments in food technology (leading to the cheap production of vegetable oils and 
caloric sweeteners); 
• foreign direct investment in national food systems (supermarkets replacing local markets); 
and 
• the advertising of processed, ready-made foods that are high in salt, sugar and saturated 
fat.9 
These developments have hastened the convergence towards a “Western diet” that is higher in fats, 
sugars, refined carbohydrates, meat and animal products, but poorer in vegetables, legumes and 
coarse grains. 
In 2013, the World Health Assembly adopted a set of voluntary global noncommunicable disease 
(NCD) targets, to be met by 2025, as part of the global monitoring framework on the prevention and 
control of NCDs.10 These targets include a 0% increase in obesity and diabetes, a 30% relative 
reduction in population salt intake, and either a 25% relative reduction in the prevalence of raised 
blood pressure or containing the prevalence of raised blood pressure, according to national 
circumstances (see Section 12.1(a)).11 Reducing salt intake, replacing trans-fats with unsaturated fats 
in food, and public education campaigns on diet and physical activity have also been identified as 
very cost-effective priorities for governments.12 
Some scholars have emphasized the contribution that large food companies can make to reducing 
diet-related disease through public–private partnerships and voluntary actions; for example, by 
reformulating products and shifting advertising expenditure towards healthier products.13 Others, 
however, have pointed to the food industry’s role in undermining and weakening public health 
policies and programmes, and to the absence of evidence that voluntary actions are effective in 
achieving significant reductions in obesity or in diet-related risk factors.14 Some have pointed to 
similarities between the behaviour of tobacco companies and that of food and beverage companies, 
arguing that the latter are vectors for the spread of dietary risk factors for NCDs.15 Many scholars 
would agree that there is a need for greater accountability by the food industry for its policies and 
practices, and that law is an important tool for responding to diet-related disease.16 
16.1 Food policy domains 
Legal and regulatory policies for reducing diet-related disease can be categorized in a variety of 
ways.17 Governments can adopt laws that seek to improve nutrition and to reduce obesity by 
creating healthier food environments that offer easier access to healthy foods at affordable prices. 
Secondly, they can impose standards to specify or improve the nutritional content of food itself, and 
to regulate the food supply chain and the systems responsible for production and distribution of 
food. Thirdly, governments can pass laws that seek to assist consumers to make healthier choices. 
This categorization draws attention to three overlapping policy domains: 
• the food environment, including the food retail environment; 
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• the food production system, including the food supply chain and food content regulation; 
and 
• consumer behaviour. 
These domains by no means exhaust the range of legislative actions that governments may take in 
support of obesity prevention and better nutrition. For example, governments have used legislation 
to establish health promotion agencies, prevention councils and other processes to better 
coordinate government efforts to improve food and physical activity environments. Spain’s law on 
food safety and nutrition commits the government to establishing an intersectoral strategy on 
nutrition, physical activity and prevention of obesity, to be reviewed every five years, and also 
prohibits discrimination on grounds of overweight or obesity.18 
Laws that shape the broader environment in order to encourage healthier lifestyles and access to 
healthy and affordable food cover a broad area. They include nutrition support programmes for low-
income and disadvantaged groups, laws imposing nutritional requirements on foods sold or made 
available in schools, zoning and licensing controls affecting retail food businesses, and efforts to 
create walk-able, more physically active neighbourhoods through investment in infrastructure. Laws 
that target the food production system include laws removing agricultural subsidies for the 
production of cheap fats and sweeteners (including sugar and high-fructose corn syrup),19 and laws 
restricting or banning the sale of foods containing harmful ingredients (e.g. trans-fats).20 For 
example, in its 2014 budget, Malaysia abolished its subsidy on sugar, removing a costly source of 
government expenditure that also contributes to over-consumption of sugar-sweetened products.21 
Laws encouraging healthier choices by consumers include labelling laws that require food 
manufacturers to list the ingredients of food products and their nutritional value on food packages, 
tax rebates for the purchase of exercise or fitness equipment, controls on the kind of health claims 
that can be made in relation to food, and laws restricting the advertising of certain foods, 
particularly to children. 
The WHO Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020 
recognizes that a range of policy changes will be required, across a number of government sectors, 
in order to make progress.22 Laws and regulations do not exist in isolation, but should be included, 
where appropriate, as part of broader strategies to promote the benefits of a healthy diet, to reduce 
poverty, to increase food security, and to ensure an environmentally sustainable diet. The following 
sections give examples of legal and regulatory actions that governments might consider, 
acknowledging that the context and exact form of these interventions may vary substantially 
between countries. 
16.2 Economic instruments 
The WHO Global Strategy on Diet, Physical Activity, and Health recognizes that fiscal policies, 
including taxes and subsidies, can play a role in fighting obesity and poor nutrition.23 Imposing non-
trivial taxes on sugar-sweetened beverages, and on foods that are high in saturated fat, added salt 
and/or added sugar, is a potential strategy for raising the prices of these products in order to reduce 
consumption.24 Quite apart from their observed impact on consumption, tax increases may also 
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encourage food reformulation by manufacturers, resulting in healthier products that can compete 
more effectively on price. Since taxes are unlikely to cause consumers to avoid the taxed foods 
entirely, taxes may also generate additional revenues for government, and possibly fund social 
welfare programmes giving low-income groups better access to healthier foods. 
Food and beverage taxes need to be designed carefully. Assuming that the tax is entirely passed on 
to the consumer, the overall health effects of the tax will depend, firstly, on how the price increases 
that result from the tax alter levels of consumption of the affected foods. To achieve a beneficial 
health effect, governments need to adopt a tax rate that is high enough to change consumption 
patterns, and to target the tax effectively so that it applies to the appropriate category of unhealthy 
foods, or alternatively, to over-consumed ingredients or nutrients. Given the persistence of demand 
for certain foods despite a higher price (inelasticity of demand), one review suggests that food taxes 
need to be substantial (at least 20%) in order to have a significant health impact.25 
The health impact of a tax will also be affected by the substitution effects of the tax (for example, 
whether there are cheaper and healthier products that can be substituted for the taxed product), 
and by income effects (for example, whether price increases for more highly taxed products mean 
that consumers have less income to purchase healthy food).26 Since those with lower incomes are 
likely to be most sensitive to price increases that result from the tax,27 governments should carefully 
consider the nutritional consequences of food substitution resulting from the tax,28 especially in 
settings where over- and under-nutrition coexist.29 In October 2011, Denmark introduced a tax on 
foods containing more than 2.3% saturated fat, although it was repealed a year later due to 
concerns about administration costs, its impact on employment, and concerns that consumers were 
avoiding the tax altogether by making shopping trips to Germany and Sweden.30 In 2013, Tonga – 
which has an obesity rate of nearly 60%31 – introduced an excise tax of 50 cents per litre for sugar-
sweetened beverages, and T$ 1 per kilogram for a range of animal fats, in order to discourage 
consumption of fatty meat, including mutton flaps and turkey tails.32 
Sugar-sweetened beverages (SSBs) have been suggested as an appropriate candidate for taxation, 
since they have no nutritional benefits, are a major source of calories in many countries and are 
associated with weight gain and diabetes,33 and since people do not compensate for the calories 
they consume from sweetened beverages by reducing their intake of other foods.34 One study 
estimates that 184 000 deaths per year are attributable to consumption of SSBs, due to diabetes, 
cardiovascular disease and cancer.35 In January 2014, Mexico introduced a tax of one peso per litre 
(about 10%) on SSBs.36 During that year, the rate of reduction in consumption of SSBs increased, 
reaching 12% on average, and 17% among the lowest socioeconomic group.37 
Evidence suggests that demand for SSBs is highly elastic. For example, the pooled price elasticity 
from one meta-analysis of nine studies suggested that a 10% increase in the price of SSBs could 
result in a reduction in consumption of around 13%.38 The authors of this study also conclude that 
taxes on SSBs may result in modest reductions in obesity within the population.39 Scholars have 
pointed out that a tax on the added sugar content on SSBs, regularly indexed, would prevent 
substitution in favour of other products with high sugar that were not taxed, and also provide an 
incentive for manufacturers to reduce the added sugar in SSBs.40 By reducing sugar intake, a tax on 
SSBs may also improve dental health, particularly in children.41 
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In addition to taxing over-consumed foods or nutrients, governments may consider subsidizing less 
energy-dense foods, such as fresh fruit and vegetables, especially among low-income groups.42 
Governments can support the price and availability of healthier foods in a variety of ways, including 
through production subsidies, quotas, payments to reduce the retail price of fruit and vegetables, or 
by providing cash vouchers directly to eligible low-income and disadvantaged recipients.43 Indonesia 
transitioned from a fiscally unsustainable universal rice subsidy to targeting low-income individuals 
with ration cards in 1997, reaching 85% of eligible persons within a year.44 Governments may 
consider production subsidies where market prices are too low to encourage sufficient production, 
or in order to encourage the fortification of foods with essential micronutrients. These may take a 
variety of forms, including tax exemptions, import preferences, assistance with start-up, and 
training.45 Governments can also reduce tariffs on healthy foods, which may be administratively 
simpler and align with trade liberalization priorities.46 
To achieve their intended effect, food subsidies should be targeted appropriately, avoiding foods 
with minor health benefits and foods that exacerbate existing dietary imbalances such as the over-
consumption of saturated fats and caloric sweeteners. Food subsidies are unlikely to be sustainable 
if spread across too many food products, and their impact on the target (poor) population group 
should be carefully monitored.47 
16.3 Food advertising controls 
Laws that restrict the advertising and promotion of foods that are high in saturated fat, salt or added 
sugar – particularly to children – may be an effective way of moderating demand for foods that are 
over-consumed, and which contribute little to a healthy diet.48 One model predicts that eliminating 
food marketing targeting children in the United States might have prevented obesity in up to one 
third of obese children.49 In the United Kingdom, restrictions on food advertising to children were 
implemented in 2005 as part of a co-regulatory approach to advertising regulation (see Box 2.1). 
Between 2005 and 2009, this resulted in a 37% decline in advertisements aimed at children for 
products high in fat, salt, or sugar (see Box 16.1).50 
Box 16.1: Restricting food advertisements that target children: the Code of Broadcast Advertising, 
United Kingdom 
In the United Kingdom, broadcast advertising is regulated by the UK Code of Broadcast Advertising 
(BCAP Code),51 which was written and is reviewed by an industry body, the Broadcast Committee of 
Advertising Practice (BCAP) under delegation from Ofcom, the government telecommunications 
regulator. The BCAP Code, revised in 2010, includes a ban on the advertising of high fat, high salt or 
high sugar foods to children: 
Section 32.5. These products may not be advertised in or adjacent to programmes commissioned 
for, principally directed at, or likely to appeal particularly to audiences below the age of 16: 
Section 32.5.1 food or drink products that are assessed as high in fat, salt or sugar (HFSS) in 
accordance with the nutrient profiling scheme published by the Food Standards Agency (FSA) on 6 
December 2005. 
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In Quebec, commercial advertising directed at persons under 13 years of age has been banned since 
1980.52 The ban covers all advertising – including food advertising – and applies to both electronic 
and print media.53 The legislation specifies criteria to be used in determining whether an 
advertisement is directed at persons under 13 years, including the nature and intended purpose of 
the goods advertised, the manner of presentation, and the time and place the advertisement is 
shown.54 According to one study, the ban resulted in a reduction of US$ 88 million spent on fast food 
during 2010, and a reduction of 13.4–18.4 billion fast food calories consumed by French-speaking 
households.55 
For broadcast media, scholars have pointed out that if the purpose of regulation is to reduce 
children’s overall exposure to unhealthy food advertising, this is more likely to be achieved by using 
the time of day as the basis for defining the obligations of advertisers. Since large numbers of 
children watch television programs that are primarily intended for older audiences, restrictions that 
apply to children’s programming alone may have limited impact.56 
Food companies use a wide variety of sophisticated advertising and promotional techniques to 
manipulate children’s food preferences and to attract them to unhealthy foods, including through 
television, websites, and mobile electronic communications, product placement, sponsorship, point-
of-purchase displays, competitions and prizes, and by including toys and other incentive items in 
restaurant meals.57 In some countries, unhealthy food is systematically promoted and sold in 
schools.58 
In the Republic of Korea, the Special Act on Safety Control of Children’s Dietary Life, introduced in 
2009, prohibits the advertising of free, non-food items such as toys, in the course of an 
advertisement for “children’s preferred foods” (as defined in the enforcement decree).59 These 
preferred foods cover a range of processed and prepared foods including confectionary, bakery 
foods, chocolates, ice-cream, noodles, hamburgers, pizza and deep-fried foods.60 The Special Act, as 
amended, also empowers the Minister for Food and Drug Safety to limit the advertising time or to 
prohibit the advertising of high-calorie, nutrient-poor foods.61 
In Chile, a Presidential decree issued in 2015 (which implements a national law passed in 201262) 
prohibits food advertising directed at children aged less than 14 years where the food exceeds 
specified limits for energy, sodium, sugar or saturated fat.63 The decree defines advertising directed 
at children with reference to the use of characters and figures, cartoons, toys, games, music and 
animals attracting the interest of children, as well as children’s language and expressions and the 
depiction of children’s daily life. The ban applies to broadcast programmes and websites where 
more than 20% of the audience is under 14 years of age, and extends to advertising before, during or 
after the broadcast of programmes or web content. It also extends to interactive games. In addition 
to the ban on advertising of foods that fail to meet the nutritional limits, the decree prohibits the 
use of accompanying promotional strategies directed at children under 14 years, including free 
offers, toys and stickers. These advertising controls also apply within pre-schools, primary and 
secondary schools.64 
WHO has produced recommendations on the marketing of food and non-alcoholic beverages to 
children,65 and a framework to assist countries to implement these recommendations.66 The 
recommendations state that settings where children gather should be free from “all forms of 
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marketing of foods high in saturated fats, trans-fatty acids, free sugars, or salt”.67 These settings 
include schools, pre-schools, playgrounds, family and child clinics and paediatric services, and during 
sporting and cultural events. Since both in-flowing and out-flowing cross-border marketing can 
undermine national controls on food marketing to children, WHO has recommended that Member 
States reach agreement on minimum standards for marketing having cross-border effects, in order 
to “achieve the highest possible impact of any national policy”.68 
16.4 Nutrition labelling laws 
Food labelling laws can support healthier food choices by informing consumers of the ingredients of 
food products, by presenting basic nutritional information about the food in a readable format, and 
by ensuring the accuracy of nutrient claims about the food.69 Labelling requirements should be 
uniform and sufficiently detailed to prevent confusion among consumers.70 For example, the 
European Union’s food labelling law, revised in 2011, requires a mandatory nutrition declaration on 
most packaged foods that are sold commercially, with certain exemptions.71 The regulation sets out 
the nutrition information that must appear in the nutrition panel, including the energy value of the 
food, and the amounts of fat, saturated fat, carbohydrate, sugars, protein and salt it contains.72 Very 
similar requirements are imposed by the Food Standards Code, which applies within Australia and 
New Zealand (Box 16.2).73 
It is preferable for regulations to require manufacturers to list the nutrients in a standardized unit or 
quantity of the food (for example, grams of fat per 100g), rather than allow the manufacturer to list 
the amounts of nutrients in a serving size of their own choice. Standardized quantities enable 
consumers to make comparisons between foods based on nutrient amounts, and to choose products 
containing lower levels of over-consumed nutrients. The European Union law confirms that the 
mandatory nutrition declaration should refer to 100g or 100ml amounts, while allowing additional, 
portion-based declarations as appropriate.74 
Box 16.2: Labelling requirements for packaged food: the Australia New Zealand Food Standards 
Code75 
Standard 1.2.8 – Nutrition Information Requirements 
Section 1.2.8-6 What must be on a nutrition information panel 
(1) A nutrition information panel must include the following information: 
(a) the number of servings in the package, expressed as either 
(i) the number of servings of the food; or 
(ii) if the weight of the volume of the food as packaged is variable – the number of servings 
of the food per kilogram, or other unit as appropriate; 
(b) the average quantity of the food in a serving expressed in: 
(i) for a solid or semi-solid food – grams; or 
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(ii) for a beverage or other liquid food – millilitres; 
(c) the unit quantity of the food 
(d) for a serving of the food and a unit quantity of the food: 
(i) the average energy content expressed in kilojoules or both in kilojoules and in calories 
or kilocalories; and 
(ii) the average quantity of: 
 (A) protein, carbohydrate, sugars, fat, and 
(B) subject to subsection (4), saturated fatty acids, expressed in grams; and 
(iii) the average quantity of sodium, expressed in milligrams or both milligrams and 
millimoles; and 
(iv) the name and the average quantity of any other nutrient or biologically active 
substance in respect of which a nutrition claim is made, expressed in grams, milligrams, 
micrograms and other units as appropriate… 
(2) A nutrition information panel must be set out in the format in section S12-2, unless this Code 
provides otherwise. 
(a) Front-of-pack nutrition labelling 
Nutrition labels on the front of a food package are a highly visible way of informing consumers of the 
nutritional characteristics of food products, and assisting them to make healthy choices rapidly. For 
example, European Union law recognizes the potential benefits of repeating the most important 
elements of the nutrition declaration “in the principal field of vision” (the front of the pack).76 The 
“traffic light” food labelling system, originally developed by the Food Standards Agency in the United 
Kingdom, uses colour-coded labels to indicate whether foods have low, medium or high levels of 
sodium, saturated fat and added sugars.77 Food labelling systems like the “traffic light” system are 
known as “interpretive” systems, since they interpret the nutritional characteristics of the food. This 
allows consumers to compare different foods and to make healthier choices, while also creating 
incentives for food and snack manufacturers to reduce unnecessary levels of salt, saturated fat and 
added sugars in their products.78 In 2011, the Republic of Korea became the first Asian country to 
introduce voluntary traffic light labelling for “children’s preferred foods”.79 
Apart from traffic lights, other interpretive front-of-pack nutrition labelling systems that may assist 
consumers to choose healthier foods include “star rating” systems that award stars to food, based 
on an overall assessment of its nutritional content.80 In the United States, the Institute of Medicine 
has advocated a system that awards zero to three nutritional points to food, based on the level of 
saturated and trans-fat, sodium and added sugars. However, nutritional points are only awarded 
where the food does not exceed a threshold limit for these nutrients.81 
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(b) Nutrition warning labels 
In Finland, salt labelling legislation was introduced in 1993 to support national efforts to reduce 
population salt intake. High salt and low salt limits were set for a basic range of foods that are major 
sources of dietary salt in Finland. Relevant foods that exceed the upper limit, based on the 
percentage of salt in the fresh weight of the product, must carry a “high salt content” label.82 
Manufacturers are also permitted to label foods as “reduced salt” if the salt percentage falls below 
the low salt limit. For example, breads with salt levels exceeding 1.3% must be labelled as high salt, 
but may be labelled as low salt if they do not exceed 0.7%. The “high salt” labelling requirement 
encouraged manufacturers to reformulate their products; as a result, a variety of high salt products 
disappeared from the market.83 
In some countries, lawmakers have debated the introduction of mandatory health warnings on 
sugary drinks, and other products that are nutritionally poor or which contribute nothing to a 
healthy diet.84 In Chile, a Presidential decree requires packaged food products that exceed limits set 
per 100 g/100 ml for energy, sodium, sugar or saturated fat, respectively, to be prominently labelled 
as “high in” each of the relevant nutrients. The decree contains detailed requirements for the size 
and placement of these warnings. The cut-off points that trigger the warnings are to be 
implemented incrementally with annual reductions over a three-year period.85 
(c) Preventing misleading and deceptive health claims 
In order to prevent misleading and deceptive health claims, national governments may consider 
introducing laws that only permit manufacturers and advertisers to make health claims about foods 
that satisfy minimum criteria for good nutrition. This would prevent food manufacturers from 
advertising that a product that was high in added sugars, saturated fats or salt was healthy merely 
because it contained added vitamins. Indonesia has introduced legislation that permits nutrition 
claims, health claims and glycaemic index claims to be made about processed foods, but restricts 
these claims to foods that do not exceed limits for total fat, saturated fat, cholesterol and sodium.86 
The International Code of Marketing of Breast-milk Substitutes also contains provisions designed to 
prevent misleading and deceptive practices by manufacturers and distributors of infant formula and 
breast-milk substitutes. The Code states that infant formula should contain a clear statement of the 
superiority of breastfeeding, and a statement that the product should only be used following advice 
from a health worker. The container and labels should not contain pictures of infants, or include 
pictures or text that “may idealize the use of infant formula”.87 
(d) Menu labelling 
In countries where chain restaurants are common, and where an increasing proportion of meals are 
eaten outside the home, nutrition labelling laws can be extended beyond pre-packaged foods to the 
standard menu items sold in chain restaurants.88 In the United States, federal law requires calorie 
counts to be shown beside standard food items that appear on the menu for at least 60 days per 
year in retail food chains with 20 or more locations.89 Consumers routinely underestimate the 
number of calories in food items, particularly as portion sizes increase.90 Restaurant labelling laws 
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requiring disclosure of calories, and potentially other nutrients, including saturated fat, trans-fat and 
salt, could serve dual purposes, assisting consumers to make healthier choices, while increasing the 
incentives for food manufacturers to improve the nutritional quality of products on the menu.91 
Other options for identifying healthier foods include Singapore’s “Healthier Choice” logo, 
administered by the Health Promotion Board, which enables manufacturers to obtain a renewable 
two-year licence to use the logo on their products if they meet nutritional guidelines set for over 60 
food categories.92 Singapore’s approach has enabled the Board to update the nutritional criteria 
over time, and to permit different health claims to be made in conjunction with the logo, such as 
“lower in sodium”, and “lower in saturated fat”.93 The Board has adapted the healthier choice 
symbol to healthier snacks, healthier ingredients and healthier hawker food. Under the Board’s 
healthier dining programme, grants are also available to restaurants to expand their healthier menu 
options.94 
16.5 The school environment 
Governments and school authorities can use a variety of legal tools to ensure that healthier foods 
are sold or made available on school premises. For example, governments that subsidize school 
meals can impose conditions on their provision of financial support, requiring schools and 
educational authorities to ensure that school food complies with criteria on safety and good 
nutrition. The use of conditional grants is a powerful strategy in countries where there is fiscal 
inequality between national and regional governments, and where regional governments are 
responsible for the provision of services but rely on grants from national governments to 
supplement their budgets. School authorities – including government, private sector and not-for-
profit entities – can also use their contracting powers to ensure that food businesses that are 
permitted to sell foods and beverages on school premises, or to supply snacks and meals to schools, 
meet nutritional standards. Governments can also mandate that education on nutrition is included 
in the school curriculum in order to lay a foundation for health literacy in later life. 
In many countries, school lunch programmes provide an important opportunity for children to 
receive sufficient nutrients, particularly children from poor and disadvantaged backgrounds. For 
example, in the United States, the Department of Agriculture oversees a national school meal 
programme that provides low-cost or free breakfasts, lunches and afterschool snacks to children 
from low-income families.95 Federal food assistance programmes for schools, and for low-income 
families, are periodically re-authorized by Congress.96 Under the Healthy, Hunger-free Kids Act of 
2010, schools that provide meals that comply with updated nutritional guidelines became eligible to 
receive additional reimbursement.97 The Act also required that all other food sold on the school 
campus, outside the school meal programmes, must comply with national dietary guidelines.98 
Legislatures in some states have also imposed minimum nutritional criteria for all food sold in 
schools. For example, in 2005, the State of Kentucky restricted the sale of fast foods in school 
cafeterias to once per week, and introduced minimum nutritional standards for all foods and 
beverages available on public school campuses during the school day (Box 16.3). In the same year, 
France banned all vending machines selling snacks and drinks in schools.99 
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Box 16.3: Laws regulating the sale of snacks and drinks in schools: examples from the State of 
Kentucky, United States  
Conduct of Schools – Special Programs100 
Section 158.850 Limitation on sale of retail fast foods in school cafeteria. 
[E]ach school shall limit access to no more than one (1) day each week to retail fast foods in the 
cafeteria, whether sold by contract, commercial vendor, or otherwise. 
Administrative Regulations101 
Minimum nutritional standards for foods and beverages available on public school campuses during 
the school day; required nutrition... 
Section 1. Beverages... a beverage offered for sale through a vending machine, school store, 
canteen, or fundraiser on school property shall: 
(1) Be a: 
(a) Fluid unflavored or flavored milk that is no more than one (1) per cent milk fat; 
(b) Plain or flavored, non-caloric, noncarbonated water; 
(c) 100% fruit or vegetable juice or any combination of both totaling 100%; or 
(d) Any other beverage that contains no more than ten (10) grams of sugar per serving, except this 
limit shall not apply to 100% fruit or vegetable juice or any combination of both equaling 100%; and 
(2) (a) ... not exceed a volume size of seventeen (17) ounces, except for plain or flavored, non-
caloric, noncarbonated water 
Section 2. Food ... a food item offered for sale through a vending machine, school store, canteen, or 
fundraiser on school property shall meet the requirements established in this section. 
(1) Calories from fat shall not exceed thirty (30) per cent, excluding reduced fat (two (2) per cent 
milk-fat or less), cheese, nuts, seeds, and nut butters. 
(2) Calories from saturated fat shall not exceed ten (10) per cent. 
(3) Calories from sugar shall not exceed thirty-two (32) per cent by weight…. 
(b) The grams of sugar shall not exceed fourteen (14) grams. 
(c) The limit established in this section shall not apply to fresh, frozen, canned, or dried fruits and 
vegetables. 
(4) (a) Chips, cereals, crackers, baked goods, and other snack items shall not contain more than 300 
milligrams of sodium per serving. 
(b) Pastas, meats, and soups shall not contain more than 450 milligrams of sodium per serving. 
(c) pizza, sandwiches, and main dishes shall not contain more than 600 milligrams of sodium per 
serving. 
(5) The portion or pack size for chips, crackers, popcorn, cereal, trail mix, nuts, seeds, or jerky shall 
not exceed two (2) ounces. 
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(6) The portion or pack size for cookies shall not exceed one (1) ounce. 
(7) The portion or pack size for cereal bars, granola bars, pastries, muffins, doughnuts, bagels, or 
other bakery-type items shall not exceed two (2) ounces. 
(8) The portion or pack size for non-frozen yogurt shall not exceed eight (8) ounces. 
(9) The portion or pack size for frozen dessert items... shall not exceed four (4) ounces. 
In Costa Rica, the Ministries of Health and Education proposed regulations, issued in 2012, which 
restrict the use of added sugars, oil, butter, margarine, cream, mayonnaise and cream cheese in 
food prepared in school cafeterias. Deep-frying of foods, and foods containing trans-fatty acids, are 
prohibited.102 The same decree also prohibits the sale or distribution of pre-packaged foods and 
drinks that exceed limits for fat, saturated fat, sodium, sugar and energy. The sale of energy drinks, 
and carbonated drinks (including “light” and “diet” drinks) is not permitted. All foods sold must have 
labels that indicate their nutritional content.103 These regulations, which are mandatory for all public 
schools, and recommended for private schools, were implemented incrementally over a period of 
three years, in order to permit manufacturers to reformulate their products.104 
School authorities should carefully consider the potential risks of accepting payments from food and 
beverage manufacturers in return for the exclusive right to market brand-name foods within 
schools.105 Pre-packaged food may be high in sugar, salt and saturated fat, and advertising in schools 
affects student choices not only in the cafeteria but also outside school hours, often resulting in 
increased consumption of sugar and fats.106 As noted previously, WHO has recommended that 
schools, pre-schools, playgrounds and other settings where children gather should be free from “all 
forms of marketing of foods high in saturated fats, trans-fatty acids, free sugars, or salt”.107 
In the Republic of Korea, the Special Act on Safety Control of Children’s Dietary Life introduced a 
number of innovative controls to improve children’s nutrition and to prevent obesity. For example, 
the Act authorized the head of each self-governing city or local government to designate areas 
within 200 metres of schools as “green food zones”.108 Local governments are authorized to appoint 
managers to assist local food stores within the green zone to improve the nutritional quality of the 
foods they make available for sale to children.109 Local food businesses that comply with minimum 
nutrition standards that apply to a range of children’s preferred foods may apply for designation as 
exemplary stores.110 Children’s preferred foods that do not comply with these criteria may not be 
sold in schools or in the designated stores.111 The creation of green food zones around schools is one 
example of how the regulation of the built environment may support improvements in nutrition (see 
Section 16.7, below).112 The Special Act also authorized the head of self-governing local districts to 
establish centres to support the safety and nutritional quality of meals provided by children’s meal 
services to nurseries, kindergartens and schools.113 
 
Advancing the right to health: the vital role of law  Page | 263 
 
16.6 Mandatory food standards, and restrictions on 
 sale 
In some countries, governments have used sales bans and other legal restrictions to support national 
nutritional objectives. For example, between 1987 and 1992, Mauritius imposed restrictions on the 
amount of palm oil in the cooking oil (“ration oil”) commonly used in that country, replacing it with 
soya bean oil. This substitution led to a reduction in the saturated fat content of ration oil, resulting 
in an average 15% reduction in cholesterol among adults over this five-year period.114 Similarly, 
Ghana has implemented a food standard which prevents the import or sale of fatty cuts of meat that 
exceed the prescribed percentage of fat: poultry (15%), beef (25%), mutton (30%), and pork (25%).115 
This section considers mandatory food standards in three areas. Firstly, sales bans and mandatory 
standards that apply to food manufacturers and retailers may be an appropriate strategy where 
there is a clear case for eliminating a harmful substance from the food supply.116 Conversely, 
governments may use mandatory fortification laws to require nutrients to be added to food, in an 
attempt to reduce micronutrient deficiencies in the population. Thirdly, governments may introduce 
regulatory measures to reduce consumption of over-consumed nutrients in the population, in 
circumstances where the regulatory goal is moderation, rather than elimination. For example, 
governments may consider mandatory standards where voluntary or co-regulatory processes for 
food reformulation have proved ineffective in meeting national nutritional goals; for example, in 
reducing average consumption of salt.117 
(a) Eliminating harmful substances from the food supply: trans-fats 
In some cases, substances contained in or added to food may cause such harm that governments 
may seek to eliminate them from the food supply, as distinct from warning consumers of their 
presence through mandatory labelling requirements. WHO has identified the elimination and 
replacement of trans-fats with unsaturated fats as a cost-effective priority for reducing 
cardiovascular diseases, diabetes, and other conditions associated with trans-fat intake.118 Bans on 
the use of industrially produced, partially hydrogenated vegetable oils in food are the most effective 
way to achieve this, since they are likely to lead to product reformulation.119 Such bans should be 
applied to trans-fats in all foods, rather than simply restaurant foods, as occurs in some 
jurisdictions.120 
In 2015, the United States Food and Drug Administration (FDA) issued a final determination that 
partially hydrogenated oils, the principal source of trans-fat, are not “generally recognized as safe” 
(GRAS) under the Federal Food, Drug, and Cosmetics Act.121 The classification of a food ingredient as 
GRAS under the Act excludes it from the definition of a “food additive”122 and enables a food 
manufacturer to avoid the pre-market approval processes that would otherwise require them to 
petition the FDA and to demonstrate with reasonable certainty that the additive is not harmful 
under the conditions of intended use.123 Federal regulations authorize the FDA to contest the pre-
existing GRAS status of a food ingredient through a public process that involves making a preliminary 
determination, making the supporting evidence publicly available and considering public 
comments.124 Thereafter, if the Commissioner concludes that there is a lack of convincing evidence 
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that the ingredient is GRAS, the Commissioner may ban the use of the additive, or alternatively issue 
regulations setting out the levels for the safe use of the additive in food.125 The process of reviewing 
the GRAS status of a substance in food therefore provides a mechanism for removing it from the 
food supply, as the FDA is unlikely to grant approval for its use as a food additive. 
In Canada, the province of British Columbia used its statutory power to regulate “health 
impediments” in order to issue regulations that require restaurants to ensure that the trans-fat 
content of partially hydrogenated oil or margarine used in restaurant food is less than 2%, and in any 
other case, is less than 5% of the total fat content of the food (Box 16.4). 
Box 16.4: Regulating trans-fat in British Columbia 
Public Health Impediments Regulation 2009126 
Section 3 (1) In this section: 
"food" means food 
(a) located on the premises of, or prepared, served or offered for sale in, a food service 
establishment, other than food that is 
(i) required under the Food and Drugs Act (Canada) to be labelled with a nutrition facts 
table, or 
(ii) not intended for public consumption, or 
(b) used on the premises of a food service establishment as an ingredient in the preparation of 
a food or beverage served or offered for sale in the food service establishment; 
(2) Food is deemed to contain trans fat if: 
(a) under the heading "Fat" on the nutrition facts table with which the food is labelled, it is 
indicated that the food contains more than 0 grams of trans fat, or 
(b) an ingredient of the food is partially hydrogenated 
(i) vegetable shortening, 
(ii) margarine, or 
(iii) vegetable oil. 
(3) Subject to subsection (4), an operator of a food service establishment must ensure that the trans-
fat content of food is, 
(a) in the case of a partially hydrogenated vegetable oil or soft, spreadable partially 
hydrogenated margarine, 2% or less of the total fat content of the oil or margarine, and 
(b) in any other case, 5% or less of the total fat content of the food. 
(4) The limit set out in subsection (3) (b) does not apply in respect of a food in which the trans-fat 
comes from dairy products or ruminant meat only. 
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(b) Mandatory food fortification 
Governments may also adopt regulations or mandatory standards in order to implement food 
fortification programmes to improve micronutrient deficiencies. Examples include laws or standards 
requiring the universal iodization of salt, and the fortification of flour with iron, folic acid, and/or 
zinc.127 For example, Nigeria dramatically reduced iodine deficiency disorders through an effective, 
multisectoral approach.128 In Nigeria, most salt for domestic consumption is imported through four 
major ports, creating a favourable environment for regulation. In 1992, the Standards Organization 
of Nigeria (SON) mandated that all food-grade salt must be iodized with potassium iodate. In 2002, a 
multisectoral taskforce was formed to improve and sustain universal salt iodization in Nigeria. It 
included salt producers, the federal Ministries of Health and Education, SON (which carries out 
inspections at ports, and at salt companies), and the National Agency for Food and Drug 
Administration and Control (NAFDAC), which is responsible for enforcement of SON standards at 
retail level. Household surveillance also occurs through primary schools, with children bringing salt 
samples to school for testing. In 2004, NAFDAC was reported to have destroyed more than 10 000 
20 kg bags of non-iodized salt since it joined the taskforce.129 Through product registration, 
education, and comprehensive inspection and surveillance at factory, distributor, retailer and 
household level, the taskforce has achieved impressive levels of compliance with universal salt 
iodization standards,130 providing a benchmark for salt iodization programmes elsewhere. 
(c) Regulatory measures to reduce over-consumed nutrients 
Regulatory efforts to moderate the consumption of over-consumed nutrients, including salt, sugar 
and saturated fat, can take many different forms. These include food laws that require the 
elimination or reduction of particular nutrients as a precondition to using specific descriptors in 
relation to that food. For example, European Union law defines “fruit juice”, as well as the 
ingredients and substances that may be added to it, and provides that fruit juices may not contain 
added sugar.131 Alternatively, governments may adopt voluntary or statutory targets for reductions 
in salt, saturated fat and/or sugar levels in food and require food manufacturers to meet them over 
a defined period of time (usually several years). 
Salt reduction measures 
In 2010, global average salt consumption was estimated to be around 9.9 g/day (3.95 g/day sodium), 
nearly twice the WHO recommended limit of 5 g/day.132 Excess salt consumption has been estimated 
to cause over 3.1 million deaths each year.133 For this reason, reducing average salt intake has been 
identified by WHO as a cost-effective priority for reducing diet-related disease.134 A number of 
countries have implemented legislation, including mandatory, maximum salt levels either for 
particular products (e.g. bread), or for a wider range of food categories that contribute large 
amounts of salt to the diet.135 In 2013, South Africa introduced regulations that impose maximum 
salt levels for 13 food categories, including bread, breakfast cereals and porridges, butter and fat 
spreads, processed meat, dry soup and stock powders, ready-to-eat savoury snacks and potato 
crisps.136 
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Argentina’s salt reduction law sets maximum sodium limits for a wide range of meat products, flour 
and bakery products (including crackers and cookies), and soups, dressings and canned foods.137 The 
law authorizes the Ministry of Health to set maximum salt values for additional food categories. In 
addition, it authorizes the Ministry to require restaurant menus and products containing sodium to 
include warning messages about the risks of excess sodium consumption, to require restaurants to 
offer menu options without added salt, and to set new norms and defaults for low-sodium salt and 
for the availability of salt shakers and salt packets in restaurants.138 In 2013, Uruguay banned salt 
shakers in public and private high schools throughout the country,139 while the capital city, 
Montevideo, passed a municipal law that requires bars and restaurants to withdraw condiments that 
exceed sodium limits, and to make salt shakers available only upon request.140 
Mandatory salt reduction standards may be a useful option for governments to consider, particularly 
in countries where many people with hypertension are never diagnosed nor treated, where stroke 
victims are often left disabled and impoverished, and where nutritional literacy is low.141 
Governments may also consider mandatory standards in countries where industry-led salt reduction 
programmes have failed to reach agreement on an adequately ambitious set of salt reduction 
targets, or where a significant number of major food companies fail to reformulate their products in 
order to achieve them (see Section 2.3).142 For example, governments may specify national goals for 
reductions in salt intake and require industry to revise targets for a sufficiently broad range of food 
categories to enable the goal to be achieved within a defined time frame. Governments may also 
make participation in food reformulation programmes mandatory for larger food companies, require 
companies to submit annual reports of their progress, and require independent audits of progress. 
16.7 Regulating the built environment 
Regulation of the physical and built environment provides opportunities to improve nutrition and 
reduce overweight and obesity, by: improving access to healthier foods, facilitating greater daily 
physical activity, and removing other disincentives to a healthy lifestyle.143 Zoning and development 
regulations control the kinds of land use that are permissible in a local area, including local design 
features, the infrastructure that must accompany new residential and commercial developments, as 
well as transport options and the kinds of activities that are available.144 These laws are not directed 
at individuals, but can influence patterns of behaviour within the population over a longer timescale, 
both by changing the conditions for approval to carry out new developments, and by gradually 
altering the character of existing neighbourhoods. 
The development processes that govern approvals for new developments and urban renewal 
projects provide opportunities to introduce new land-use patterns, and to significantly reduce or 
reverse those features of a neighbourhood that work against an active lifestyle and a healthy diet. 
For example, this can occur through the requirement for public or private developers to improve 
public infrastructure: creating new street layouts, widening and improving sidewalks, creating 
dedicated bike lanes, parkland, children’s playground areas and community space to promote social 
interaction and opportunities for physical activity. Although improvements in neighbourhood 
infrastructure can create an “enabling environment” for more physically active lifestyles, their 
impact will not be automatic. In addition, local governments and other responsible authorities will 
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need to meet community expectations about the safety and amenity of the local environment. 
Issues to consider include measures to calm traffic and to protect pedestrians from exhaust fumes 
and risks of motor vehicle injuries, adequate lighting and visibility to reduce security concerns, 
removal of rubbish and other hazards (e.g. discarded needles), protection from toxic exposures, 
control of pets, feral animals and animal droppings, and the maintenance of a clean and attractive 
environment.145 
Zoning regulations can also alter the character of existing neighbourhoods in ways that support 
healthier lifestyles.146 In many cities, local government zoning controls have segregated businesses 
from residential areas, schools and restaurants, encouraging automobile use while neglecting public 
transport options.147 Zoning laws that encourage higher density, mixed use development along 
transport corridors have the capacity, over time, to bring private residences, centres of employment, 
small businesses, shops and places of recreation into closer proximity. Active transport options (e.g. 
walkways, cycle lanes), together with efficient and well-run public transport systems, can encourage 
incidental physical activity while reducing greenhouse gas emissions. 
Zoning and development regulations, and economic policies, can also alter the character of the local 
food environment.148 Evidence suggests that the distribution and concentration of fast food 
restaurants selling foods of low nutritional value, and the absence of supermarkets selling fresh 
fruits and vegetables, can affect the quality of diets among residents in the local area, creating risks 
for weight gain and metabolic disease.149 New York City created zoning and tax incentives to 
encourage grocery stores to carry an appropriate selection of fresh produce (see Box 16.5). 
Economic incentives for large supermarket and grocery chains to open stores in underserved and 
disadvantaged neighbourhoods may also increase access to fresh and healthy food, since the scale 
and supply chain management of these stores may enable them to carry healthy foods at lower 
prices than smaller stores.150 New York City also created a new class of permit for “green carts” that 
were specifically authorized to sell (only) fresh fruit and vegetables on city streets. It provided micro-
loans and technical assistance to assist new operators to become established.151 
Box 16.5: Creating incentives for local grocery stores to carry fresh produce, dairy products and 
meats 
In New York City, the Food Retail Expansion to Support Health project (FRESH) provides zoning and 
tax incentives to retailers who qualify as FRESH food stores (i.e. those devoting certain amounts of 
floor space to the sale of fresh produce, dairy, canned and frozen foods, and fresh and prepared 
meats, fish and poultry).152 Qualifying stores are eligible for additional floor space in mixed 
residential and commercial buildings, a reduction in required parking for patrons, increased access 
to real estate in districts designated for light manufacturing, real estate tax reductions, sales tax 
exemptions and mortgage recording tax deferrals.153 
Amendments to zoning laws and retail permit laws can also remove barriers to farmers’ markets 
selling fresh produce in appropriate locations, such as near schools, close to public transport and in 
underserved areas.154 The City of Detroit in the United States requires a minimum distance of 500 
feet (approximately 150 metres) separating schools and specified kinds of fast food and take-away 
restaurants.155 As noted in Section 16.5, legislation in the Republic of Korea has created “green food 
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zones” around schools, and provides certification for “exemplary” businesses selling children’s 
preferred foods within the zone that meet minimum nutritional criteria.156 Scholars and public health 
institutions have pointed to the clustering of fast food restaurants around schools and advocated 
using zoning controls to reduce their density, or to prevent their location close to schools.157 
16.8 Addressing hunger and food insecurity 
Despite rising rates of overweight and obesity, undernutrition remains a problem in many parts of 
the world. The Food and Agriculture Organization of the United Nations has estimated that, in 2014–
2016, 795 million people (one in nine of the global population) were undernourished.158 The vast 
majority of these people – 780 million – lived in developing regions. Despite significant reductions in 
morality among children under five years, malnutrition remains a significant hurdle to efforts to 
improve the health of women and children, particularly in sub-Saharan Africa and south Asia.159 In 
2010, child and maternal undernutrition, including suboptimal breastfeeding, childhood 
underweight and child micronutrient deficiencies, were responsible for over 1.4 million deaths, and 
around 7% of the global burden of disease.160 In 2012, WHO Member States made the commitment 
to achieve a range of global targets for maternal, infant and young child nutrition, to be met by 
2025. These include a 30% reduction in low birth weight, a 40% reduction in the global number of 
children who are stunted, and a goal of reducing childhood wasting to less than 5%.161 
An important element in the success of Brazil’s efforts to reduce hunger and improve infant nutrition 
was the legal recognition, in the Organic Law of Food Security and Nutrition, that Brazilian citizens 
have a right to adequate food and nutritional security (Box 16.6).162 The legislative commitment of 
the Government of Brazil to fulfil this right, in collaboration with civil society, provided the basis for a 
diverse set of policies addressing access to food, supporting income-generating activities (including 
smallholder agriculture), and improving primary health care. As a result of these policies, Brazil has 
achieved impressive reductions in underweight, wasting and stunting (see further, section 6.3(c)).163 
Box 16.6: Legal recognition of the right to adequate food and nutritional security in Brazil 
Organic Law of Food Security and Nutrition164 
Article 1 This Law establishes the definitions, principles, guidelines, objectives and composition of 
the National System for Food Security and Nutrition (SISAN), through which the government, with 
the participation of civil society, will formulate and implement policies, plans, programmes and 
actions aimed at ensuring the human right to adequate food. 
Article 2 Recognizing that adequate food is a fundamental right of human beings, inherent to human 
dignity and essential to the realization of the rights enshrined in the Constitution, the government 
should adopt policies and actions as necessary to promote and ensure the food safety and nutrition 
of the population. 
Article 7 Achieving the human right to adequate food and ensuring the food and nutritional security 
of the population will be accomplished through SISAN, comprised of a set of entities including 
federal, state, federal district and municipal institutions, private or non-profit, which are interested 
in food security and nutrition and which show an interest in joining the system, with respect to the 
applicable legislation. 
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In some countries, the right to food is justiciable, whether through constitutional recognition of the 
right to food or related human rights, or through framework legislation for food security.165 In the 
course of public interest litigation which began in 2001, the Supreme Court of India recognized that 
the right to life enshrined in Article 21 of the National Constitution includes a right to “live with 
human dignity”, which encompasses the right to food.166 Further support for this right appears in 
two Directive Principles of State Policy, which recognize the right to an adequate standard of living 
(Article 39(a)), as well as the primary obligation of the State to “raise the level of nutrition and the 
standard of living of its people” (Article 47). In a series of orders based on Article 21, the Supreme 
Court has ordered national and state governments to implement various programmes to ensure 
food access, including midday meal programmes in primary schools, converting the benefits offered 
under these schemes to legal entitlements, and expanding coverage. In 2003, the Supreme Court 
ruled that six priority groups were entitled to food assistance, including aged, infirm, disabled and 
destitute men and women, pregnant and lactating women and widows, single women and persons 
aged over 60 years with no means of support.167 In 2002, the Supreme Court appointed two 
Commissioners to act on the Court’s behalf, monitoring compliance with court orders, investigating 
violations and seeking further court interventions if required.168 
Government programmes to improve food security for women and children are an important 
strategy for fulfilling the right to adequate food and nutrition. The entitlements and conditions for 
participation in these programmes must be carefully defined. As illustrated by Box 16.7, the impact 
of food aid programmes on nutrition at the household level may vary by gender and should be 
carefully monitored. Cash transfer programmes, such as Brazil’s Bolsa Família (Family Grant), are an 
alternative to direct food aid, and have been shown to be successful in reducing undernutrition and 
improving maternal and child health. By giving each female head of household a monthly cash 
stipend based upon the number of children in the household, the programme has increased food 
security and provided a flexible safety net that can be spent on a variety of needs, including food, 
clothing, safe accommodation and health care. 
Box 16.7: Food programmes for maternal and child health: food distribution and food-for-work in 
Ethiopia 
The Government of Ethiopia implemented a comprehensive food aid programme, basing assistance 
on food-for-work (for able-bodied persons), or free distribution for those unable to work.169 Analysis 
of this programme revealed different impacts based on gender. Food-for-work assistance resulted in 
an improvement in the nutritional status of boys, relative to girls, while food assistance delivered for 
free (no work required) improved the nutrition of girls.170 Ethiopia’s experience of linking food 
distribution to work demonstrates the importance of monitoring the outcomes of nutrition 
assistance programmes to ensure both efficacy and equity. Food-for-work programmes should also 
be carefully scrutinized, not only in terms of the distribution method (free assistance or food-for-
work), but also who is targeted for each kind of programme. For example, the hard physical labour 
required for food-for-work programmes may cause deterioration in the nutritional status of workers, 
while also reducing the time available for household administration, and for other income-
generating activities. 
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 Chapter 17: Maternal, reproductive and child health 
 
SUMMARY POINTS 
 
· The right to health requires countries to invest in maternal, reproductive and child health. 
Progress in maternal and child health depends on improvements in a range of areas both within 
and beyond the health sector. 
· Discrimination is a formidable barrier to improvements in maternal and child health. 
Discrimination encompasses not only direct, physical exclusion, but unequal access, the stigma 
that results in self-exclusion, lack of courtesy and mistreatment by service providers, and loss of 
control over fertility, including through lack of access to contraception. 
· Parties to the International Covenant on Economic, Social and Cultural Rights have an 
immediate obligation to respect the right to health by preventing discrimination in access to 
curative, palliative and preventive services, and to ensure legal protection from discrimination on 
the basis of “race, colour, language, religion, political or other opinion, national or social origin, 
property, birth or other status”. 
· Violence against women is a serious form of discrimination that violates the right to health 
and is prohibited by the Convention on the Elimination of All Forms of Discrimination Against 
Women. Violence against women includes domestic violence within the family, rape and sexual 
assault, coercion and deprivation of liberty, sexual harassment, trafficking and forced prostitution, 
forced marriage, acid attacks, so-called “honour killings”, and female genital mutilation. 
· Legal responses to violence should address both the causes and consequences of violence, and 
include primary, secondary and tertiary prevention. Countries must take steps to improve their 
capacity to deliver justice to victims of violence, by investigating cases and enforcing remedies and 
penalties. 
· Legislation can support access to prenatal and maternal health services by recognizing 
women’s entitlement to these services, and by committing governments to developing strategies 
to fund them and to address barriers to care. 
· Systemic failures may negate the right of women and children to adequate health services. 
These include the inequitable geographical distribution of emergency obstetric care facilities, and 
unacceptably high levels of unmet need for emergency obstetric care and of obstetric deaths in 
facilities. 
· Countries have an obligation to monitor the performance of private health care organizations, 
including private insurers, to ensure that services that are essential to women’s health are not 
excluded. These include prenatal assessment, attended birth, postnatal care and family planning. 
· The Comprehensive Implementation Plan on Maternal, Infant, and Young Child Nutrition, 
adopted by the World Health Assembly in 2012, includes a range of global targets for mothers and 
children. Progress towards these targets requires both nutrition-specific interventions, such as 
support for breastfeeding, and nutrition-sensitive interventions across a range of sectors. 
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· The WHO International Code of Marketing of Breast-milk Substitutes supports infant nutrition 
by reducing commercial marketing practices that undermine breastfeeding. Governments should 
consider implementing the Code through national legislation, and by monitoring the marketing 
practices of companies that manufacture and sell infant formula. 
· A legal entitlement to paid maternity leave is an important component of a comprehensive 
strategy for maternal and infant health. The Maternity Protection Convention of the International 
Labour Organization incorporates standards that may assist governments in specifying national 
legal entitlements to maternity leave. 
· Legislators should ensure that family planning programmes are adequately funded and that 
women have full access to whatever fertility methods they choose. 
· Universal primary and secondary education is an important strategy for improving maternal 
and child health. In the poorest communities, where children work to ensure the economic 
survival of their families, school attendance cannot be separated from family-focused poverty 
reduction efforts. 
Investing in the health of women and children is a vital part of the right to health, encompassing 
reproductive and maternal health (prenatal and postnatal), and child health care.1 Article 12.2(a) of 
the International Covenant on Economic, Social and Cultural Rights (ICESCR) requires States to take 
the necessary actions “for the reduction of the stillbirth-rate and of infant mortality and for the 
healthy development of the child”.2 Improving maternal, reproductive and child health not only 
helps to secure the right to health, but reduces poverty and stimulates economic growth.3 Over the 
period 1990–2015, the mortality rate for children under five years declined by more than 50%, yet in 
2015, 5.9 million children under five years still died from preventable causes.4 In 2015 there were an 
estimated 303 000 maternal deaths.5 Around three quarters of maternal deaths have obstetric 
causes, including haemorrhage, hypertensive disorders and sepsis.6 
Progress in maternal and child health depends on a country’s capacity to achieve improvements in a 
range of areas both within and beyond the health sector. Health sector improvements include 
immunization, family planning, skilled birth attendance and the provision of antenatal and postnatal 
care. Improvements outside the health sector include reductions in the total fertility rate, economic 
development, good governance (control of corruption), the participation of women in politics and in 
the workforce, strong leadership, poverty reduction, female education and good environmental 
management.7 This chapter considers a select number of mostly health sector policies that may be 
strengthened through law and regulation. 
 
17.1 Preventing discrimination 
Women and children are entitled to the highest attainable standard of health: this necessarily 
includes access to adequate health care services and to a fair and adequate allocation of resources 
for maternal and child health (Box 17.1). Women and children may face discrimination in access to 
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health care due to the stigma associated with particular diseases and conditions, including HIV and 
AIDS,8 diabetes,9 and prolapse of the uterus.10 Women face mistreatment from service providers, 
reducing their ability to access care or their willingness to engage with the health system.11 Women 
may also face discrimination or harassment that interferes with their right to breastfeed infants. 
Discrimination and inequality can impair women’s ability to move freely, to own property and to 
control their fertility – each of which can threaten a woman’s ability to access health care or to 
protect her health and the health of her children. Discrimination against indigenous persons can also 
have a disproportionate impact on women and children.12 
Box 17.1: The duty to secure maternal and child health 
The Millennium Development Goals called for a reduction in the mortality rate of children under five 
years of age by two thirds between 1990 and 2015 (Goal 4), and a reduction in the maternal 
mortality ratio by three quarters over the same period (Goal 5). Between 1990 and 2015, under-five 
mortality rates dropped by 53%,13 and maternal mortality rates declined by 43%.14 In 2015, the 
global maternal mortality ratio was 216 maternal deaths per 100 000 live births, although a woman’s 
chance of dying in childbirth remains 20 times higher in developing regions than in developed 
regions.15 Despite this, significant gains have been made in some countries. For example, Sri Lanka 
reduced its rate of maternal mortality by 87% over a 40-year period by ensuring that 99% of 
pregnant women receive four prenatal visits and thereafter give birth in a health facility.16 
International law recognizes the vulnerability of women and children and their right to the highest 
attainable standard of health. The Universal Declaration of Human Rights recognizes that 
“motherhood and childhood are entitled to special care and assistance”.17 The Convention on the 
Elimination of All Forms of Discrimination against Women specifically protects the status of 
motherhood and the special health needs of women, and requires Parties to provide access to 
medical care and to other resources necessary for a safe pregnancy.18 The Convention on the Rights 
of the Child recognizes that children are vulnerable in their health and that Parties must take steps 
to ensure that all children achieve the highest attainable standard of health. This includes taking 
steps to reduce infant and child mortality, to provide access to health care consistent with the needs 
of children, to combat disease and malnutrition, to provide maternal health care, and to ensure 
adequate health education for children and their families.19 
As explained in Section 1.1(a), Parties to the ICESCR have an immediate obligation to respect the 
right to health by preventing discrimination in access to curative, palliative and preventive services.20 
Under the ICESCR itself, countries have an obligation to undertake to guarantee the rights 
recognized in the Covenant without discrimination on the grounds of “race, colour, language, 
religion, political or other opinion, national or social origin, property, birth or other status”.21 A legal 
entitlement to protection from discrimination has been included in the constitutions and domestic 
laws of many countries: this entitlement provides an important foundation for national efforts to 
improve the health of women and children (Box 17.2). 
Box 17.2: Legal protection from stigma and discrimination in national constitutions 
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Basic Law for the Federal Republic of Germany22 
Article 3. Equality before the law 
(2) Men and women shall have equal rights. The State shall promote the actual implementation of 
equal rights for women and men and take steps to eliminate disadvantages that now exist. 
(3) No person shall be favoured or disfavoured because of sex, parentage, race, language, homeland 
and origin, faith, or religious or political opinions. 
Constitution of Uganda23 
Article 21. Equality and freedom from discrimination. 
(1) All persons are equal before and under the law in all spheres of political, economic, social and 
cultural life and in every other respect and shall enjoy equal protection of the law. 
(2) Without prejudice to clause (1) of this article, a person shall not be discriminated against on the 
ground of sex, race, colour, ethnic origin, tribe, birth, creed or religion, social or economic standing, 
political opinion or disability. 
Constitution of Portugal24 
Article 13. Principle of equality 
1. Every citizen shall possess the same social dignity and shall be equal before the law. 
2. No one shall be privileged, favoured, prejudiced, deprived of any right or exempted from any duty 
on the basis of ancestry, sex, race, language, place of origin, religion, political or ideological beliefs, 
education, economic situation, social circumstances or sexual orientation. 
In addition to discrimination, reproductive and maternal health is protected by the constitution in 
some countries, and may also be enforceable through the courts. For example, the Constitution of 
Uganda commits the State to “provide the facilities and opportunities necessary to enhance the 
welfare of women to enable them to realize their full potential and advancement”. It stipulates that 
the State “shall protect women and their rights, taking into account their unique status and natural 
maternal functions in society”.25 In addition to motivating action by governments, constitutional 
recognition of the State’s duty to address inequalities in health – and to invest the resources 
required to meet its health obligations – can mobilize civil society to seek greater access to health 
care and quality of care on behalf of women, children and vulnerable groups. 
 
17.2 Freedom from violence 
Freedom from violence is a fundamental precondition to enjoyment of the right to health. Violence 
against women is itself a form of discrimination and is prohibited by the Convention on the 
Elimination of All Forms of Discrimination Against Women (CEDAW).26 CEDAW protects women from 
violence that is “directed against a woman because she is a women or that affects women 
disproportionately”.27 It applies to actions taken by the State, by private persons and non-State 
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actors.28 It includes violence within the family, rape and sexual assault, coercion and deprivation of 
liberty, sexual harassment in the workplace, trafficking and forced prostitution, and other practices 
involving coercion and violence, such as forced marriage, dowry-related violence, acid attacks, 
“honour killings” and female genital mutilation.29 
Violence against women is extremely common and may occur in both public and private life. 
Globally, 30% of women have experienced physical or sexual violence carried out by an intimate 
partner; in some regions the rate is as high as 37%.30 The global rate of sexual violence against 
women by persons other than their intimate partner is 7%.31 While as many as 38% of murdered 
women are killed by their intimate partners, only 6% of men who are murdered are killed by an 
intimate partner.32 
Many women are victims of violence during pregnancy. In 11 of the 19 countries surveyed by WHO, 
over 5% of women who had carried a child had experienced violence during pregnancy (in rural 
areas, the prevalence was much higher).33 In addition to the long-term consequences of violence 
upon the physical and mental health of women, violence directly affects the health of children and 
may affect the health and survival of the fetus. Women who have been physically or sexually abused 
by an intimate partner are 16% more likely to have a low birth weight baby, and more than twice as 
likely to have an induced abortion, than those who have not suffered such abuse.34 
Women who are victims of violence experience negative health effects across the life-course.35 
A woman who has ever suffered abuse, regardless of how recent, is more likely to have suicidal 
thoughts and demonstrate symptoms of emotional distress than her peers.36 In some WHO regions, 
women who have suffered intimate partner violence are 1.5 times more likely to acquire HIV or 
syphilis.37 Women who have suffered either violence from an intimate partner or sexual violence 
from someone other than their partner are more likely to experience depression and to have alcohol 
abuse disorders.38 
Laws that promote the safety and equality of women must be consistent with human rights 
standards, while responding to the specific challenges faced in each country. Although they may 
include criminal penalties for domestic violence, “honour killings”, and other forms of gender-based 
abuse, these laws alone will not be sufficient.  The public health approach to protecting women’s 
health is therefore interdisciplinary in nature. It includes information campaigns, monitoring of 
trends in violent behaviour, training programmes for service provides, and a functioning criminal 
justice system with adequate resources to deliver justice to victims of violence by investigating 
complaints, and enforcing remedies and penalties. Box 17.3 provides a case study of how the 
Government of India, legislature and Supreme Court have responded to both the causes and 
consequences of acid attacks upon women. 
Box 17.3: India’s response to acid attacks against women39 
India’s national Ministry of Home Affairs responded to the growing number of acid attacks on 
women by drafting model rules that classify corrosive acids such as hydrochloric acid and sulphuric 
acid as poisons under India’s Poisons Act. Under the rules, the strength of acids available for retail 
sale would be reduced, retailers of acids would require a licence, acid sales would be restricted to 
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adults, and purchasers would need to produce a photo identity card prior to sale.40 In order to 
hasten the implementation of the draft model rules by the states, the Supreme Court of India issued 
interim orders in 2013 that prohibit acid sales unless retailers declare all stocks of acid with a 
subdivisional magistrate and thereafter maintain a register which records the details of all persons 
to whom acid was sold. Undeclared stocks of acid may be confiscated, and penalties apply for failure 
to comply with the directions.41 
India’s Penal Code has also been amended to include specific offences for acid attacks, including a 
minimum term of 10 years (and up to life) imprisonment for voluntarily causing grievous hurt by 
throwing or administering acid.42 Additional offences have been introduced for failure to record 
information relevant to the commission of an acid attack, or for failing to ensure full and free 
hospital treatment for all victims of acid attacks.43 A fine is also payable to the victim to meet (her) 
medical expenses. 
In India, the provision of health care is a state responsibility. Although a number of Indian states 
have created compensation schemes for victims of acid attacks, the Supreme Court pointed to 
significant variations in the amount of compensation between states and concluded that the amount 
of compensation payable was inadequate. In order to fund the series of surgeries that are often 
required by victims of acid attacks, the Supreme Court ordered that all states and territories shall 
pay compensation of at least 3 lakh rupees (300 000 rupees) to each victim, with one third payable 
within 15 days and the balance within two months.44 India’s Criminal Procedure Code was 
subsequently amended to require each state government, in coordination with the central 
government, to prepare a scheme providing compensation to those who have suffered injury as a 
result of acid attacks. This compensation is in addition to the fine payable by the perpetrator to the 
victim.45 
WHO has released a comprehensive strategy that takes a life-course approach to preventing 
domestic violence. This strategy encompasses primary, secondary and tertiary prevention 
strategies.46 Primary prevention strategies seek to prevent violence from occurring. They include 
programmes to promote equality between men and women, and legislation granting men and 
women equal rights in access to health care, property ownership, education, political participation, 
employment, and entering and leaving marriages (Box 17.4). 
Box 17.4: Responding to violence against women in Kyrgyzstan 
Following the dissolution of the Soviet Union, women and children in Kyrgyzstan lost many of the 
formal legal rights they had previously enjoyed. Enrolment of girls in school decreased, and 
polygamy and bride theft, among other discriminatory practices, increased.47 Although men and 
women are equal under the Constitution, in practice men were usually registered as the sole owners 
of house plots held by the owners of the residence, since “custom and tradition assume [men] are 
the heads of household and usually control the household’s productive assets”.48 Similarly, although 
formal succession law does not discriminate, customary law favours men; for example, divorced 
women have great difficulty in obtaining their share of household land or its value.49 In response, the 
United Nations Entity for Gender Equality and the Empowerment of Women (UN Women) has 
focused on providing training to government staff (especially local government officials) and civil 
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society groups to improve understanding of CEDAW, and of women’s rights, including their land 
rights.50 Over the period 2004–2009, nearly 3000 women attended legal training workshops, and 
1200 gained access to land previously denied to them.51 
Secondary prevention strategies seek to respond swiftly and appropriately to cases of violence. They 
include training programmes to enable police to investigate and respond effectively to allegations of 
rape and family violence, criminal justice reforms to enable courts to investigate complaints and to 
make restraining orders, and resources to provide safe havens for victims. South Africa’s Domestic 
Violence Act has been praised for its extensive protections against intimate partner violence, which 
include a duty upon police to assist victims to find shelter and medical treatment.52 While critically 
important, these provisions are not self-executing, and their implementation must be matched by 
adequate resourcing of courts and the police to enable women to overcome the obstacles to seeking 
relief from violence.53 
As the Constitutional Court of South Africa has stated, a common feature of domestic violence is that 
it is hidden, repetitive and frequently goes unpunished.54 Civil protection orders authorize courts to 
remove a person who is the subject of a complaint of domestic violence from a joint place of 
residence, and to require the accused not to further threaten or approach the applicant. For 
example, in Costa Rica, when a woman or members of her family file a complaint, the judge will 
investigate the evidence, and in order to protect the woman from retaliation or further abuse, will 
require the accused to leave the joint matrimonial home.55 In addition, the judge will require the 
accused to make available an adequate sum of money to ensure that those who are economically 
dependent on the accused are not deprived of support. Central American countries have introduced 
a range of additional protections for victims of sexual abuse, including legal protection for relatives, 
orders to protect the confidentiality of the victim’s identity, the assignment of bodyguards, 
relocation, change of identity, provision of living expenses, and the use of video links to enable 
victims and witnesses to testify.56 
The Government of Pakistan has enacted ground-breaking legislation to protect the health and 
welfare of women by introducing a criminal offence of sexual harassment into the Penal Code. This 
offence applies to conduct at home, in workplaces, and in streets, markets and other public places. A 
separate Act requires government bodies, corporations and civil society organizations to implement 
a Code of Conduct for Protection against Harassment of Women in the Workplace into their 
management policies (Box 17.5).57 The Act requires organizations to establish a three-person 
enquiry committee within each organization to hear complaints of harassment. Where a complaint is 
upheld, the enquiry committee is authorized to recommend penalties to a supervising government 
authority: these penalties range from censure and delays in promotion or pay increments to 
demotions, dismissals and fines. Alternatively, women can complain to a federal or provincial 
ombudsman, who can impose the same penalties. By reducing sexual harassment and intimidation, 
these initiatives seek to remove the obstacles that prevent women from pursuing an education, 
accessing health care services, entering the job market and working their way out of poverty. 
¨ 
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Box 17.5: Protecting women from sexual harassment in Pakistan 
Amendments to the Penal Code  
Section 509A. Sexual harassment. Whoever makes sexual advances, or demands sexual favours or 
uses written or verbal or physical conduct of a sexual nature which intends to annoy, insult, 
intimidate or threaten the other person or commits such acts at the premises of [a] workplace, or 
makes submission to such conduct either explicitly or implicitly a term or condition of an individual’s 
employment, or makes submission to or rejection of such conduct by an individual a basis for [an] 
employment decision affecting such individual, or retaliates because of rejection of such behaviour, 
or conducts such behaviour with the intention of unreasonably interfering with an individual’s work 
performance or creating an intimidating, hostile, or offensive working environment, shall be 
punished with imprisonment which may extend to three years or [a] fine up to five hundred 
thousand rupees or with both. 
Protection Against Harassment of Women at the Workplace Act 2010  
Section 2(h) “Harassment” means any unwelcome sexual advance, request for sexual favours or 
other verbal or written communication or physical conduct of a sexual nature or sexually demeaning 
attitudes, causing interference with work performance or creating an intimidating, hostile or 
offensive work environment, or the attempt to punish the complainant for refusal to comply to such 
a request or is made a condition for employment. 
Tertiary prevention is critical to preventing women from falling back into abusive relationships and 
environments, although unfortunately it is less commonly included in public health laws and policies. 
Tertiary prevention strategies include options for women to access long-term care, and 
rehabilitation to assist women to return to normal life after suffering abuse.58 Legislation can 
commit governments to a comprehensive strategy for violence prevention; for example, by 
recognizing a duty on government to ensure the provision of adequate services (not necessarily 
provided directly by government agencies themselves) to victims of violence and sexual abuse. 
17.3 Prenatal and maternal health care services 
The provision of reproductive, prenatal and postnatal health care services is a critical part of the 
right to health, comparable with the core obligations that are subject to immediate effect, rather 
than progressive realization under Article 12 of the ICESCR (see Section 1.1). Universal access to 
prenatal care, including folic acid supplements, HIV testing, malaria prevention, assessment for 
diabetes, and other prenatal assessments, is a cost-effective way to reduce mortality and morbidity, 
both during pregnancy and birth, for both the mother and the child.59 Legislation can support access 
to prenatal and maternal health services by recognizing women’s entitlement to these services and 
by committing governments to developing strategies to fund them. Since many clinics rely on user 
fees to pay salaries and purchase supplies, government policies to provide free health care services 
must be accompanied by financial arrangements to ensure that they can be delivered sustainably, 
whether from government or other sources.60 Vital statistics legislation should require all births to 
be registered, with reporting and investigation of perinatal and neonatal deaths.61 
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In 1994, the government of Ecuador introduced and subsequently updated a law for the provision of 
free maternity and child care in order to improve the reproductive health of low-income women 
(Box 17.6).62 This law included a number of unique features. It was administered by local 
management committees, which comprised not only the mayor and director of each health district, 
but representatives of community, women’s and indigenous organizations. Funds to pay for the 
provision of services were received both from the central government (partly generated by 
consumption taxes), as well as from local governments. In addition to administering the local health 
solidarity fund derived from these sources, the role of the local committees included carrying out 
local health needs assessments, identifying local health priorities, and identifying additional funding 
sources. Community participation was also strengthened by local users’ committees, which 
promoted participation, evaluated the quality of the health services provided, and coordinated with 
health facilities in order to improve quality. 
Box 17.6: Eliminating user fees for prenatal and obstetric care: an example from Ecuador 
Free Maternity and Child Care Law63 
1. Every woman has the right to free quality health care during pregnancy, including childbirth and 
postpartum, and access to sexual and reproductive health programmes. Likewise, free health care is 
to be given to newborn infants and children under five years of age as a public health responsibility 
of the State. 
2. This Act has as one of its purposes the financing of the costs of medicines, materials, 
micronutrients, supplies, basic laboratory tests and complementary tests for the care of pregnant 
women, newborn infants, and children under five years of age in the following areas: 
(a) Maternity: ensure that women have access to necessary and timely antenatal care services 
regardless of the level of complexity; basic treatment for sexually transmitted diseases... care for 
childbirth, both normal and high-risk, including caesarean delivery and vaginal delivery; emergency 
obstetric care, including treatment for domestic violence, toxaemia, and haemorrhage; and 
pregnancy-related sepsis, both at delivery and postpartum, including the provision of blood or blood 
products. 
(b) Infants and children under 5 years of age: ensure necessary and appropriate care regardless of 
complexity to newborn infants, including healthy infants, premature infants, infants with low birth 
weight and/or disorders (perinatal asphyxia, jaundice, fetal distress and sepsis), and to children 
under 5 years of age who have diseases included in the Comprehensive Care Strategy for the 
Management of Childhood Illness, and all complications according to current regulations of the 
Ministry of Public Health. 
The physical accessibility of maternal health care services is a determinant of use and of maternal 
mortality.64 The case of Alyne da Silva Pimentel v Brazil65 illustrates this important issue. The 
Committee on the Elimination of Discrimination Against Women, which oversees the 
implementation of CEDAW66 by States Parties, found that the failure to provide a Brazilian national 
of African descent with timely access to emergency obstetric care violated her right to life and her 
right to health under the Convention. The Committee found that these rights are “obligations of 
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immediate effect” which are immediately enforceable under CEDAW, and which require urgent 
government action.67 In this case the deceased died as a result of preventable delays in conveying 
her to hospital, in carrying out diagnostic tests, and in performing surgery to remove the placenta 
after she gave birth to a stillborn fetus at six months. The underlying problem that the Committee 
identified was the inequitable geographical distribution of emergency obstetric care facilities, 
unacceptably high levels of unmet need for emergency obstetric care, and of obstetric deaths in 
facilities.68 The Committee emphasized that the State’s obligations under CEDAW extend to 
monitoring the performance of private health care institutions, and that the State cannot outsource 
its obligation to ensure compliance with human rights obligations to private health services.69 
One practical strategy for improving maternal outcomes for women living in isolated locations is 
through the construction of maternal waiting homes. This allows women living in remote and rural 
areas to plan for the birth of their children and to travel to a clinic before labour commences. 
Obstetric care has repeatedly been demonstrated to increase health outcomes related to birth.70 
Maternal waiting homes enable women to benefit from government strategies to ensure that all 
births are monitored by a skilled birth attendant, without the need to pay for lodging days before 
she expects to deliver (Box 17.7). 
Box 17.7: Improving maternal and child health: maternal waiting homes in rural Zambia 
Maternal death is unacceptably high among women in developing countries, particularly in rural 
areas. In sub-Saharan Africa in 2015, there were approximately 546 maternal deaths per 100 000 live 
births, and women face a lifetime risk of maternal death of 1 in 36, more than four times higher than 
the global average, and 100 times higher than the risk of maternal death in developed countries.71 
To improve maternal outcomes, women with high-risk pregnancies in Zambia are encouraged to 
travel to maternal waiting homes during their 36th week of pregnancy. This enables the health of 
the woman to be monitored, and their delivery to be attended by a skilled professional, with access 
to the necessary surgical procedures if complications arise. A review of the maternal waiting homes 
in Zambia found that the provision of free lodging and free meals were important components of the 
strategy. A review of maternal waiting homes in other countries found that those that did not 
provide meals were less well attended then those in Zambia.72 Maternal waiting homes are part of a 
continuum of services supporting maternal and child health that will vary according to country 
circumstances. The law should support women’s access to these services on a non-discriminatory 
basis, with priority based on economic need. 
Women’s ability to control their fertility through family planning substantially reduces the number of 
maternal deaths and improves the health of infants.73 WHO has estimated that 225 million women 
globally have an unmet need for contraception; in Africa, this extends to more than 23% of women 
of reproductive age. The WHO publication, Family planning: a global handbook for providers,74 gives 
evidence-based guidance on 20 family planning methods, and discusses other components of 
effective family planning programmes, including treatment for sexually transmitted infections, 
counselling and strategies for dealing with violence against women. Legislators should ensure that 
family planning programmes are adequately funded and that women have full access to whatever 
fertility methods they choose. 
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For countries without national health care schemes, ensuring that pregnant women and mothers 
can access health care services is crucial. In private markets, health insurance providers may reduce 
costs by excluding coverage for services that are critical to women’s health, including prenatal 
assessment, attended birth, postnatal care, family planning, and preventive health services such as 
mammograms. Women may be unaware that these services are excluded, or may be unable to 
purchase higher levels of insurance cover due to cost. One legislative option, where appropriate, is 
to mandate that relevant insurance products offered in the private market must include an essential 
package of maternal and child health services (Box 17.8). Minimum entitlements expand access and 
demand by reducing barriers to the health care services women need to improve their own health 
and the health of infants. They also provide economic stability, protecting women and families from 
catastrophic expenses in times of emergency. 
Box 17.8: Mandatory insurance coverage of women’s health in the United States (State of 
Colorado) 
All individual health care or indemnity contracts issued ... shall insure against the expense of normal 
pregnancy and childbirth or provide coverage for maternity care and provide coverage for 
contraception in the same manner as any other sickness, injury, disease or condition is otherwise 
covered under the policy or contract.75 
17.4 Maternal and child nutrition 
Improving nutrition during pregnancy is critical not only to reduce the incidence of low birth weight, 
but to improve long-term childhood development.76 Even temporary interruptions to a family’s food 
supply can have lasting effects on a child’s growth and development.77 The Comprehensive 
Implementation Plan on Maternal, Infant, and Young Child Nutrition, adopted by the World Health 
Assembly in 2012, includes a range of global targets for mothers and children (Box 17.9).78 
Legislation and governance arrangements play an important role in progress towards these targets. 
As recognized by the Scaling Up Nutrition (SUN) movement,79 progress in child and maternal 
nutrition requires both nutrition-specific interventions, such as support for exclusive breastfeeding 
and micronutrient supplementation, and a range of multisectoral, nutrition-sensitive interventions. 
These include education, access to health care, clean water and sanitation and support for resilience. 
Multisectoral collaboration is an important strategy for countries involved in scaling up nutrition, 
helping to ensure that important interventions outside the health sector that have an impact on 
maternal and child nutrition are included in national plans and strategies.80 
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Box 17.9: Global targets for maternal, infant and young child nutrition 
In 2012, the World Health Assembly adopted the following voluntary targets: 
• Global target 1: by 2025, a 40% reduction in the global number of children under five years 
who are stunted; 
• Global target 2: by 2025, a 50% reduction in anaemia in women of reproductive age; 
• Global target 3: by 2025, a 30% reduction of low birth weight; 
• Global target 4: by 2025, no increase in child overweight; 
• Global target 5: by 2025, increase the rate of exclusive breastfeeding in the first six months 
up to at least 50%; 
• Global target 6: by 2025, reduce and maintain childhood wasting to less than 5%. 
WHO has estimated that optimal breastfeeding of infants aged 0–23 months could avoid up to 
800 000 deaths each year in children under five years.81 The International Code of Marketing of 
Breast-milk Substitutes,82 adopted by the World Health Assembly in 1981, supports infant nutrition 
by reducing commercial marketing practices that undermine breastfeeding. The Code prohibits the 
advertising of infant formula and other breast-milk substitutes to the general public, to pregnant 
women and mothers, and to health workers who are concerned with infant and maternal nutrition. 
It also prohibits the giving of samples and other incentives for purchase.83 Governments are urged to 
implement the Code through national legislation, regulations or other suitable measures.84 In 2016, 
WHO reported that 136 countries had included some aspects of the Code in national legislation; 39 
countries had comprehensive legislation.85 Although important, legislation is not likely to be 
sufficient by itself: governments should monitor the marketing practices of companies promoting 
infant formula, and civil society may also have an important role in exposing companies that ignore 
the Code or engage in inappropriate marketing practices.86 
17.5 Maternity leave 
Laws and policies requiring employers to provide women with paid maternity leave are another 
important component of a comprehensive strategy for maternal and infant health.87 An extended 
period of maternity leave significantly reduces infant mortality, low birth weight and post-neonatal 
mortality, even after accounting for other government infant health programmes.88 The Maternity 
Protection Convention (2000) of the International Labour Organization (ILO) includes a number of 
provisions that may assist governments in meeting minimum requirements for the protection of 
maternity leave (Box 17.10).89 ILO Conventions are adopted by a two thirds majority of the ILO 
Conference – which provides representation for governments, labour and employment 
organizations – and are legally binding on countries that have ratified them.90  
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Box 17.10: Maternity protection standards under the International Labour Organization Maternity 
Protection Convention (2000) 
Article 3: Health protection: national laws must protect pregnant or breastfeeding women from 
performing work that harms or creates a serious risk to the health of the mother or child. 
Article 4: Maternity leave: national laws must provide for not less than 14 weeks’ maternity leave; in 
order to protect maternal and child health, 6 weeks of this period must be postnatal leave. Countries 
ratifying the Convention are to specify the minimum period of maternity leave to which women are 
entitled. 
Article 5: Illness or complications: in addition to maternity leave, national laws must also provide for 
leave in the case of documented illness, complications, or risk of complications arising out of 
pregnancy or childbirth. 
Article 6: Benefits: the financial support provided to women under articles 4 and 5 “shall be at a level 
which ensures that the woman can maintain herself and her child in proper conditions of health and 
with a suitable standard of living”. In general, these benefits must not be less than two thirds of the 
woman’s previous earnings. 
Article 8: Employment protection: national laws must ensure that it is unlawful for an employer to 
terminate the employment of a women during pregnancy, or during a period of leave under articles 
4 or 5, or following her return to work, except on grounds that are unrelated to her pregnancy, 
childbirth, or nursing. Following maternity leave, a woman is guaranteed the right to return to her 
previous position or an equivalent position. 
Article 9: Non-discrimination: countries shall adopt measures to ensure that maternity does not 
constitute a source of discrimination in employment. Employers may not require a woman to be 
tested for pregnancy as a condition of employment, except where national laws prohibit pregnant or 
breastfeeding women from performing specified work, or where such work would create a 
significant risk to the health of the mother and child. 
Article 10: Breastfeeding: national laws must specify permitted nursing breaks, which shall be 
counted as working time and remunerated accordingly. 
17.6 Education 
Achieving universal primary and secondary education is a critical step towards improving maternal 
and child health. The education of women not only benefits women themselves, but the survival and 
development of children: child mortality rates are highest in households where the mother’s level of 
education is lowest.91 National laws can mandate primary and, where possible, secondary education 
and should commit governments to spending the resources that are needed to ensure that all 
children can attend school, without discriminatory barriers, and regardless of the economic position 
of their family (Box 17.11). 
National governments may also create economic incentives or impose conditions on the payment of 
grants to city and local governments, and regional authorities, as a strategy for encouraging higher 
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rates of school attendance. In the poorest communities, where children work in order to ensure the 
economic survival of the family, school attendance cannot be separated from family-focused poverty 
reduction efforts, including safety nets and new economic opportunities. Similarly, mandatory 
education for all children will require governments to address human workforce issues, including 
teacher shortages, and to implement plans for building or opening new schools in underserved 
areas. 
Box 17.11: Mandatory childhood education: an example from India 
The Right of Children to Free and Compulsory Education Act92 
3. Right of child to free and compulsory education: (1) Every child of the age six to fourteen years… 
shall have a right to free and compulsory education in a neighbourhood school till the completion of 
his or her elementary education. 
(2) For the purpose of sub-section (1), no child shall be liable to pay any kind of fee or charge or 
expenses which may prevent him or her from pursuing and completing elementary education. 
8. Duties of appropriate Government: The appropriate Government shall – 
(a) provide free and compulsory education to every child … 
(b) ensure availability of a neighbourhood school … 
(c) ensure that the child belonging to the weaker section and the child belonging to disadvantaged 
group are not discriminated against and prevented from pursuing and completing elementary 
education on any grounds; 
… 
(g) ensure good quality elementary education conforming to the standards and norms specified in 
the Schedule. 
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